data_2hlt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hlt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.5 mtp . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.05 151.0 43.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 108.887 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -114.92 140.43 49.0 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -124.93 154.95 40.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.317 1.447 . . . . 0.0 108.938 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.34 138.67 52.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 159.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.79 143.38 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 mm -129.58 138.15 54.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.59 147.85 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -143.29 156.75 44.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.519 1.128 . . . . 0.0 110.027 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.65 -154.23 23.55 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.481 1.515 . . . . 0.0 110.138 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.63 89.37 1.31 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 158.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.62 18.46 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.997 0.919 . . . . 0.0 111.392 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -138.81 153.82 48.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.137 0.975 . . . . 0.0 109.186 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.24 32.17 81.34 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -133.47 -8.0 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 111.695 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.81 24.5 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.67 -44.5 85.77 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.424 1.612 . . . . 0.0 109.882 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -53.89 -49.55 68.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.611 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -61.78 -49.05 77.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.355 0.525 . . . . 0.0 110.681 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -62.89 -41.77 99.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.082 0.401 . . . . 0.0 110.855 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.98 -40.8 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.909 0.777 . . . . 0.0 110.249 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -59.91 -48.4 81.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.224 0.92 . . . . 0.0 109.531 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.9 ptm -70.81 -32.03 68.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.316 0.507 . . . . 0.0 111.67 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -69.48 -28.24 65.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.458 1.026 . . . . 0.0 111.84 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.4 -44.35 52.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.932 0.493 . . . . 0.0 109.833 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.42 -42.15 98.3 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 123.967 0.907 . . . . 0.0 111.291 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -6.54 35.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -113.06 2.27 15.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.871 1.668 . . . . 0.0 111.34 171.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.28 38.45 5.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.537 1.535 . . . . 0.0 112.037 -169.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.75 165.68 14.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.76 156.5 44.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.516 1.127 . . . . 0.0 108.011 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.79 -154.79 26.16 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.223 0.919 . . . . 0.0 112.692 -170.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -145.92 167.53 23.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.102 -0.646 . . . . 0.0 112.625 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.48 145.68 30.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.775 1.23 . . . . 0.0 108.456 167.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.71 160.16 40.75 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 108.045 170.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -125.9 113.54 17.34 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -86.48 153.25 22.0 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.236 1.014 . . . . 0.0 110.193 -157.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -29.47 70.45 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.631 0.372 . . . . 0.0 111.878 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.99 -9.24 43.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.97 -20.2 26.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.505 1.05 . . . . 0.0 113.331 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.3 mtm180 -80.03 154.66 28.02 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.692 1.246 . . . . 0.0 110.045 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.88 150.67 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 161.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -134.07 142.33 47.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -139.61 150.07 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -134.7 128.81 33.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.25 44.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.12 0.873 . . . . 0.0 109.412 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -140.41 136.09 32.73 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 107.881 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.46 43.24 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.962 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.3 138.32 42.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.267 1.978 . . . . 0.0 109.411 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.54 -30.37 67.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 113.018 -168.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -69.75 -46.53 65.65 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.763 -1.211 . . . . 0.0 111.647 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.19 -39.02 89.37 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 tp -61.53 -47.73 84.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.156 0.982 . . . . 0.0 110.167 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -60.14 -44.41 94.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.75 0.42 . . . . 0.0 110.872 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m -62.48 -38.6 90.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.495 0.589 . . . . 0.0 111.179 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -61.28 -44.7 96.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.518 -0.739 . . . . 0.0 110.161 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.4 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.542 1.065 . . . . 0.0 110.15 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -55.5 -39.55 70.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.671 1.123 . . . . 0.0 110.495 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.73 82.73 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.171 0.588 . . . . 0.0 111.471 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.33 -31.41 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.758 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -61.64 -33.36 73.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.054 1.297 . . . . 0.0 111.533 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -71.58 -45.35 62.47 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.704 0.684 . . . . 0.0 109.999 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.39 -156.77 34.0 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -170.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.9 p -62.04 168.83 3.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 122.699 0.4 . . . . 0.0 110.573 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.35 -10.08 1.97 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.53 2.82 . . . . 0.0 114.763 165.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -124.04 -0.77 8.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.263 1.425 . . . . 0.0 111.799 -171.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -77.18 166.22 23.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.082 0.953 . . . . 0.0 112.006 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -142.75 88.38 2.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 159.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.02 142.19 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -123.77 -18.32 6.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.287 1.035 . . . . 0.0 111.091 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -153.3 149.87 28.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.276 1.031 . . . . 0.0 109.241 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.74 144.22 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -139.75 152.22 46.45 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.122 1.369 . . . . 0.0 108.566 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -136.45 145.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.724 1.209 . . . . 0.0 108.169 -176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -132.3 160.35 36.5 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 167.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.43 161.75 37.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.281 0.946 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 m -142.84 124.79 15.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.86 11.77 3.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.76 0.824 . . . . 0.0 112.234 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -138.39 143.69 39.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.992 1.717 . . . . 0.0 106.936 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 mt -84.49 159.17 20.79 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.824 0.45 . . . . 0.0 110.658 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.02 -37.67 38.56 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 156.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 50.14 1.59 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.229 0.918 . . . . 0.0 111.386 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -58.01 144.89 38.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.524 0.729 . . . . 0.0 110.191 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -86.59 -28.2 23.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.246 0.618 . . . . 0.0 112.193 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -151.97 -178.75 6.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.783 1.633 . . . . 0.0 108.808 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -114.28 127.82 56.06 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -132.65 139.87 47.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.563 0.696 . . . . 0.0 112.464 -166.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.1 mt -76.7 131.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 0.0 109.142 -178.087 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.8 mt -136.7 170.52 15.94 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.673 1.589 . . . . 0.0 108.266 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -117.96 138.85 51.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 106.335 166.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.58 155.68 28.3 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.265 1.426 . . . . 0.0 107.304 167.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -124.48 139.66 53.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 162.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 mt -134.36 140.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.87 139.49 51.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.0 144.2 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -138.11 156.16 48.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.809 1.244 . . . . 0.0 110.033 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.43 -154.54 22.51 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.416 1.484 . . . . 0.0 110.44 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -72.55 82.65 1.11 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.8 m -135.07 18.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.274 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -137.01 146.86 45.8 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.949 0.9 . . . . 0.0 108.653 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.6 33.13 83.58 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -134.7 -9.23 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.702 1.201 . . . . 0.0 111.824 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.12 20.58 15.59 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.217 1.389 . . . . 0.0 110.468 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.59 -41.86 98.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.995 1.398 . . . . 0.0 110.43 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -54.48 -49.0 71.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.789 0.722 . . . . 0.0 111.473 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -66.75 -42.04 86.83 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.308 0.504 . . . . 0.0 111.231 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.22 -51.67 67.24 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.082 0.553 . . . . 0.0 110.22 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.68 -41.5 88.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.091 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -58.44 -45.53 88.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.797 0.726 . . . . 0.0 109.902 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.4 mtm -74.01 -33.85 63.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.743 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -66.67 -40.14 88.46 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.867 1.212 . . . . 0.0 110.249 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.17 97.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.172 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.81 -44.49 93.97 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.761 0.824 . . . . 0.0 110.832 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -58.89 -41.22 86.66 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.253 1.021 . . . . 0.0 111.182 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -86.22 0.93 52.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.371 -0.823 . . . . 0.0 113.161 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mptt 49.67 37.15 12.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.572 1.549 . . . . 0.0 111.933 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.87 165.71 22.66 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.837 0.855 . . . . 0.0 109.584 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.85 165.02 14.16 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.522 1.129 . . . . 0.0 108.058 165.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.84 -154.39 24.81 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 118.856 0.753 . . . . 0.0 112.335 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -153.81 167.59 29.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 112.049 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -137.07 145.2 30.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 108.796 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -140.44 164.52 29.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.258 1.023 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.2 109.19 12.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -76.15 152.93 36.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.473 0.709 . . . . 0.0 111.056 -157.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.28 -27.58 69.43 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.884 0.474 . . . . 0.0 111.25 164.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -14.58 19.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.323 1.849 . . . . 0.0 112.853 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -9.01 50.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.125 0.869 . . . . 0.0 113.165 167.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -104.91 156.09 18.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.592 1.157 . . . . 0.0 109.226 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.45 147.27 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 168.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -133.28 135.56 44.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -136.46 146.07 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -172.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 tt -135.87 126.96 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 167.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.04 152.34 49.97 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.644 0.778 . . . . 0.0 109.339 -172.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -141.17 133.93 28.81 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.67 1.188 . . . . 0.0 107.949 -169.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.93 -171.46 40.34 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.547 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.29 156.88 54.49 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.798 2.332 . . . . 0.0 110.666 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -58.54 -44.8 89.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.588 0.755 . . . . 0.0 111.124 -173.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.74 -39.53 89.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.89 0.768 . . . . 0.0 111.928 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.62 -47.51 72.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.7 -38.82 92.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.1 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.5 -51.95 66.53 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.62 0.768 . . . . 0.0 110.184 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 m -62.15 -38.93 90.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.418 0.554 . . . . 0.0 110.893 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.19 -44.06 97.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.109 0.964 . . . . 0.0 110.403 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 t -57.81 -47.98 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.325 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.63 -40.47 75.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.663 1.12 . . . . 0.0 111.18 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.1 82.69 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.141 0.576 . . . . 0.0 110.882 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.5 t -63.28 -28.09 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.035 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -59.32 -37.67 78.36 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.563 1.528 . . . . 0.0 110.921 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.08 -42.77 56.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.222 0.465 . . . . 0.0 110.421 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.64 -174.18 51.04 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.54 160.09 28.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.076 0.55 . . . . 0.0 110.588 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.16 -32.9 51.84 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.124 2.549 . . . . 0.0 113.771 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -88.43 -7.31 56.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.66 1.184 . . . . 0.0 112.763 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -91.91 168.75 11.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.943 1.297 . . . . 0.0 110.725 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -145.24 95.86 2.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 165.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.6 t -63.79 145.19 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.7 p -123.11 -21.85 5.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.311 1.044 . . . . 0.0 111.192 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -154.79 153.12 30.71 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.149 0.98 . . . . 0.0 109.469 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.78 146.0 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.352 1.461 . . . . 0.0 107.402 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.5 m -139.37 151.01 45.99 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.153 1.381 . . . . 0.0 108.369 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.15 145.41 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.403 1.081 . . . . 0.0 108.239 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -136.32 161.03 36.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 106.173 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -149.28 163.18 38.42 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.131 -0.981 . . . . 0.0 111.527 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -149.17 148.23 29.38 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.583 1.953 . . . . 0.0 108.536 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -72.58 -40.54 66.51 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.038 168.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 m -61.63 145.24 52.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.937 0.895 . . . . 0.0 109.13 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.6 157.16 42.67 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.527 1.531 . . . . 0.0 108.645 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.12 -33.39 56.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.695 0.798 . . . . 0.0 110.114 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.45 49.51 14.81 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -169.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -54.72 151.06 8.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.101 0.96 . . . . 0.0 111.789 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -76.51 -19.36 58.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -150.54 178.3 9.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.656 1.582 . . . . 0.0 108.415 -172.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.38 116.42 31.94 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 153.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.7 m -117.18 142.31 47.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 111.996 -167.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.16 135.57 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 162.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 124.926 1.29 . . . . 0.0 108.303 179.543 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.5 mt -137.83 -179.96 6.07 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.004 1.322 . . . . 0.0 109.5 -167.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -130.55 132.14 45.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.648 1.979 . . . . 0.0 107.229 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.67 155.48 28.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -120.42 143.81 48.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 158.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.0 mt -132.72 142.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mm -131.35 136.79 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.1 147.64 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.32 156.93 44.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.56 -153.93 23.89 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.383 1.468 . . . . 0.0 110.374 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -72.38 84.75 1.09 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.02 19.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.101 0.96 . . . . 0.0 110.994 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -138.54 149.18 45.06 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 109.053 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.38 31.27 79.83 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -134.7 -9.85 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.654 1.181 . . . . 0.0 111.731 -173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.78 22.79 17.18 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.932 1.253 . . . . 0.0 110.119 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -64.08 -39.6 94.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.239 1.52 . . . . 0.0 110.243 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -55.51 -46.19 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.904 0.774 . . . . 0.0 111.695 172.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -68.58 -40.39 80.57 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.508 0.594 . . . . 0.0 111.108 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -56.03 -51.65 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.388 0.54 . . . . 0.0 110.151 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.21 -41.35 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 118.954 -0.546 . . . . 0.0 110.211 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.79 -46.13 88.27 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.826 0.739 . . . . 0.0 110.329 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.9 mtm -72.62 -35.97 67.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.347 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -67.0 -39.36 87.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.677 1.126 . . . . 0.0 110.292 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.32 97.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.177 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.31 -45.05 93.17 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.389 0.676 . . . . 0.0 110.685 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -59.48 -33.85 71.84 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.902 0.881 . . . . 0.0 111.311 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -89.7 1.73 55.69 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.675 1.19 . . . . 0.0 112.839 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm 41.33 38.88 0.88 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.115 2.166 . . . . 0.0 112.503 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.06 165.75 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.816 0.846 . . . . 0.0 109.406 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.19 14.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 162.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.49 -163.53 29.27 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.881 0.764 . . . . 0.0 113.332 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -147.01 166.4 26.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 122.214 -0.58 . . . . 0.0 111.623 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.76 144.06 34.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.526 1.13 . . . . 0.0 109.047 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -139.25 161.94 36.2 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.48 1.112 . . . . 0.0 108.653 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -125.54 111.43 15.03 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.28 153.08 23.76 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.799 1.239 . . . . 0.0 110.383 -157.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.77 -29.32 70.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.94 -10.29 52.17 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.47 -22.62 17.08 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.427 1.013 . . . . 0.0 113.292 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -78.28 154.76 30.66 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.67 1.235 . . . . 0.0 110.327 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.61 148.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.07 135.02 43.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.57 143.15 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.72 125.28 22.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.88 43.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.65 0.78 . . . . 0.0 110.121 -171.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -139.09 143.52 38.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.822 1.249 . . . . 0.0 108.138 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.89 -171.8 39.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.321 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 152.61 57.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.687 2.258 . . . . 0.0 110.712 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.94 -34.52 76.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.62 0.768 . . . . 0.0 112.133 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.22 -40.4 77.99 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.025 -1.047 . . . . 0.0 111.476 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.83 85.74 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.95 -42.19 90.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.968 0.507 . . . . 0.0 110.621 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.98 -51.58 69.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.797 0.726 . . . . 0.0 110.789 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 p -66.45 -31.67 72.56 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.871 -0.518 . . . . 0.0 111.316 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.22 -43.35 99.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.72 171.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.54 -49.56 80.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 119.539 1.063 . . . . 0.0 108.744 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.81 -39.25 73.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.395 0.998 . . . . 0.0 111.464 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.13 -44.12 85.13 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 110.61 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.36 -30.87 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.455 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -59.49 -45.84 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.873 1.67 . . . . 0.0 109.988 172.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.3 -38.48 85.05 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.58 0.352 . . . . 0.0 111.27 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 177.06 27.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.113 0.863 . . . . 0.0 112.041 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.48 153.17 90.83 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.278 -0.542 . . . . 0.0 110.589 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.65 -31.48 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.195 2.597 . . . . 0.0 114.16 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -92.13 10.79 27.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.988 1.315 . . . . 0.0 111.991 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -128.58 169.07 14.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.417 1.487 . . . . 0.0 109.882 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -147.02 96.18 2.69 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.66 140.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.8 p -126.93 -14.17 5.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 111.268 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.51 150.63 29.79 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 109.17 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.86 147.7 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.866 1.266 . . . . 0.0 107.846 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -143.6 161.58 38.13 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.521 1.528 . . . . 0.0 108.753 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.6 t -138.39 149.23 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.609 1.164 . . . . 0.0 108.141 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.36 161.78 33.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.548 1.939 . . . . 0.0 106.189 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -140.79 158.09 44.47 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 120.943 -1.098 . . . . 0.0 111.034 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 m -134.92 138.27 43.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 156.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -89.44 24.09 2.36 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.207 -0.933 . . . . 0.0 111.171 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -142.12 179.27 7.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.822 2.449 . . . . 0.0 106.973 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -144.92 156.32 43.92 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.528 1.131 . . . . 0.0 109.405 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.8 -5.13 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -164.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.21 -3.1 0.79 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 120.036 1.289 . . . . 0.0 115.125 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -48.76 113.6 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.761 1.624 . . . . 0.0 112.126 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -150.93 -49.1 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.372 1.069 . . . . 0.0 111.115 173.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -152.92 -179.57 7.78 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 108.976 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -115.65 137.5 52.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -139.74 139.84 36.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.62 137.59 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 163.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 125.048 1.339 . . . . 0.0 108.316 179.799 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt -139.01 166.35 24.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.751 1.621 . . . . 0.0 108.953 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -112.15 138.61 48.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.606 1.563 . . . . 0.0 106.921 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -119.16 154.91 32.56 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.721 1.608 . . . . 0.0 107.051 166.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -127.9 138.73 52.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 165.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.64 143.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mm -131.68 136.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.91 150.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -143.57 158.28 43.78 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.981 1.313 . . . . 0.0 109.65 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.65 -155.54 24.86 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.436 1.493 . . . . 0.0 110.094 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -75.91 87.36 2.87 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 159.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.11 19.81 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.846 0.859 . . . . 0.0 111.282 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.68 151.97 46.34 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.365 1.066 . . . . 0.0 108.146 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.33 32.12 82.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.78 -1.63 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.513 1.525 . . . . 0.0 111.435 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.68 25.58 34.98 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.457 -1.191 . . . . 0.0 110.127 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.9 -47.5 80.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.268 1.534 . . . . 0.0 109.935 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -62.83 -41.12 99.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.038 0.835 . . . . 0.0 110.64 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -61.97 -45.19 94.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.764 0.425 . . . . 0.0 110.705 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -58.72 -51.02 71.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.242 0.617 . . . . 0.0 110.177 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.96 -39.45 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.219 0.463 . . . . 0.0 110.493 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -58.81 -47.13 85.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.931 0.787 . . . . 0.0 110.55 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -77.11 -30.75 55.39 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.903 0.774 . . . . 0.0 111.719 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.05 -31.65 69.37 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.194 0.906 . . . . 0.0 111.027 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.69 71.19 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.282 0.492 . . . . 0.0 109.885 168.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.71 -42.98 99.67 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.53 0.732 . . . . 0.0 111.571 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -12.6 60.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -115.36 8.0 15.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.678 1.191 . . . . 0.0 111.633 171.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 41.91 42.18 2.17 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.463 1.905 . . . . 0.0 112.52 -173.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.61 166.03 7.38 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.212 0.605 . . . . 0.0 109.856 166.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.85 154.41 45.51 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.63 1.172 . . . . 0.0 107.987 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.82 -161.37 28.67 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 119.282 0.946 . . . . 0.0 112.896 -171.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.55 166.81 25.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 168.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.49 146.35 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 109.281 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -147.1 163.91 34.78 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -124.86 153.9 41.88 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -123.9 151.18 43.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.289 -144.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.0 -27.19 68.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 111.117 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.5 -16.85 40.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.601 1.96 . . . . 0.0 113.135 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -28.16 15.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.93 1.729 . . . . 0.0 111.838 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.1 mtt85 -74.05 168.18 20.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.699 0.799 . . . . 0.0 111.517 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.64 150.01 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 158.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.79 140.87 46.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mt -139.04 147.0 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.08 127.0 29.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 168.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.05 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.696 0.68 . . . . 0.0 109.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.73 133.85 31.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.78 -169.35 40.08 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.592 -172.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.25 152.76 61.78 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.316 2.011 . . . . 0.0 110.216 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.21 -42.46 81.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.884 0.874 . . . . 0.0 110.93 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.57 -42.88 99.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.264 0.484 . . . . 0.0 111.574 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.56 82.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.673 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -38.34 82.1 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 110.988 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -64.91 -49.94 68.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.592 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -57.76 -39.14 76.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.209 1.368 . . . . 0.0 111.409 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.03 -46.42 84.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.903 0.881 . . . . 0.0 109.927 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 118.953 0.797 . . . . 0.0 109.822 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.06 -40.67 73.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.607 0.763 . . . . 0.0 110.538 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.56 72.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.898 0.879 . . . . 0.0 111.416 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.21 -26.29 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.187 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -57.12 -34.81 68.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.322 1.419 . . . . 0.0 111.223 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -82.12 -41.51 20.38 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.114 0.416 . . . . 0.0 111.01 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.85 -166.11 54.72 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -164.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.8 p -60.71 167.46 3.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.915 0.486 . . . . 0.0 111.451 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.45 -15.04 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.775 2.983 . . . . 0.0 115.252 168.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -115.44 -7.15 12.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.532 1.133 . . . . 0.0 111.903 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -70.74 163.67 26.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.652 0.739 . . . . 0.0 111.014 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -142.77 88.79 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 161.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.82 142.67 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 p -125.49 -18.13 5.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.403 1.081 . . . . 0.0 111.15 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.56 149.62 28.68 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.312 1.045 . . . . 0.0 109.123 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 tt -152.91 145.31 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.844 1.258 . . . . 0.0 107.936 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -142.06 152.4 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.357 1.463 . . . . 0.0 108.524 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.13 145.47 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.756 1.223 . . . . 0.0 107.895 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.91 161.8 35.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.456 1.902 . . . . 0.0 106.416 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -138.82 163.65 31.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.01 0.924 . . . . 0.0 110.364 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -154.53 147.59 24.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.342 166.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.98 -41.71 58.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 m -60.26 156.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.3 mt -129.29 149.8 50.93 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.812 1.245 . . . . 0.0 109.036 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -75.94 -34.34 59.86 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.5 0.72 . . . . 0.0 109.248 161.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 41.37 5.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.212 0.911 . . . . 0.0 111.292 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -57.77 149.06 23.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.932 0.866 . . . . 0.0 109.828 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -118.73 -6.52 10.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.41 1.084 . . . . 0.0 112.129 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -148.96 176.75 10.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.959 1.704 . . . . 0.0 107.706 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -110.72 135.95 50.53 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -136.75 139.5 41.89 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.645 0.736 . . . . 0.0 112.755 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -74.17 134.64 29.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 161.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.536 0.441 0 C-N-CA 124.343 1.057 . . . . 0.0 108.907 179.479 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.72 176.54 7.17 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.532 1.933 . . . . 0.0 107.7 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -125.31 137.0 54.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -118.87 159.06 24.46 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.031 1.732 . . . . 0.0 108.052 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -129.32 140.55 51.36 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -134.27 139.22 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -173.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.9 mm -127.29 138.83 53.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.47 146.64 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -140.5 156.92 46.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.12 1.368 . . . . 0.0 109.913 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.5 22.68 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.402 1.477 . . . . 0.0 110.193 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -73.33 82.32 1.39 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.67 19.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.763 0.825 . . . . 0.0 111.074 -171.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -137.05 147.13 45.98 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.61 33.14 86.43 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.41 -1.38 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.095 1.358 . . . . 0.0 111.238 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 26.71 34.96 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.16 -46.83 82.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.312 1.556 . . . . 0.0 109.697 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -55.91 -45.1 78.79 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.614 -0.679 . . . . 0.0 111.488 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -65.95 -43.24 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.718 0.407 . . . . 0.0 110.859 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.57 -51.7 68.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.396 0.679 . . . . 0.0 110.174 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.68 -40.83 88.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 118.329 0.513 . . . . 0.0 110.386 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.74 -43.68 85.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.494 0.718 . . . . 0.0 110.898 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.8 mtm -74.27 -37.15 63.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.62 0.646 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.2 -37.36 87.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.613 1.097 . . . . 0.0 110.312 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.36 81.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.974 0.51 . . . . 0.0 110.564 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -58.61 -44.21 89.86 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -56.26 -26.11 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.974 1.71 . . . . 0.0 112.499 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -118.93 12.17 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.405 1.082 . . . . 0.0 112.049 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 43.53 43.06 4.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.087 1.755 . . . . 0.0 112.175 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.11 165.55 9.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.879 0.472 . . . . 0.0 109.819 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.25 158.62 20.27 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 162.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.06 -160.96 27.86 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 118.687 0.676 . . . . 0.0 112.774 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.73 168.0 26.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.242 -0.563 . . . . 0.0 112.387 171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.92 144.85 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.171 1.388 . . . . 0.0 108.63 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -143.4 160.52 40.39 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.02 112.22 16.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.5 mtp85 -85.18 155.72 21.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.818 1.247 . . . . 0.0 110.618 -154.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.89 -27.76 69.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.628 0.371 . . . . 0.0 111.882 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -6.42 38.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.924 0.89 . . . . 0.0 113.184 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.07 -15.95 46.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.485 1.041 . . . . 0.0 113.586 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -88.12 155.8 19.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.18 1.49 . . . . 0.0 109.974 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.02 149.91 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 162.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.17 153.68 51.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.972 0.891 . . . . 0.0 109.8 157.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -142.79 146.13 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -171.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.2 154.63 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.241 0.616 . . . . 0.0 109.907 -169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -138.79 131.96 29.86 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.391 1.476 . . . . 0.0 107.376 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.72 178.79 42.31 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.34 156.18 66.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 110.24 171.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.99 -35.53 77.07 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.335 0.654 . . . . 0.0 111.979 -171.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.96 -36.57 80.32 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.924 -1.11 . . . . 0.0 111.686 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.47 72.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.66 -37.97 88.03 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.851 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.01 -50.08 75.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.76 0.709 . . . . 0.0 110.626 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 m -61.57 -37.86 85.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.515 0.598 . . . . 0.0 111.025 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -63.62 -45.66 89.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.015 0.926 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.09 -48.5 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.174 0.897 . . . . 0.0 109.526 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -56.55 -40.83 75.81 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.588 0.755 . . . . 0.0 110.548 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.26 74.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.534 0.734 . . . . 0.0 111.578 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.78 -26.98 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.201 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -57.72 -33.43 68.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.263 1.392 . . . . 0.0 111.355 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.42 -42.04 26.3 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.329 0.513 . . . . 0.0 110.949 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.33 -166.81 54.52 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -165.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.4 p -60.65 167.41 3.36 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 122.915 0.486 . . . . 0.0 111.326 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.43 -15.18 3.65 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.669 2.913 . . . . 0.0 115.175 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -114.1 -7.98 13.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.56 1.144 . . . . 0.0 111.788 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.2 m -72.03 162.99 28.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.699 0.8 . . . . 0.0 110.994 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -143.31 89.4 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 161.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.8 143.88 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.6 p -124.76 -19.36 5.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.32 1.048 . . . . 0.0 111.207 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -153.77 150.73 28.8 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 109.172 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.7 146.07 15.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.02 1.328 . . . . 0.0 107.703 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 m -140.5 152.82 45.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.154 1.382 . . . . 0.0 108.426 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.8 t -137.76 145.47 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -134.32 159.16 41.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.54 1.936 . . . . 0.0 106.042 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -145.88 167.48 23.14 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.899 0.879 . . . . 0.0 110.102 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -140.09 173.45 11.51 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.133 1.373 . . . . 0.0 109.595 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -122.82 19.39 10.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.643 1.577 . . . . 0.0 109.715 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.0 m -135.87 167.27 21.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.176 1.79 . . . . 0.0 108.178 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -134.56 163.59 29.39 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.3 -25.32 4.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.063 1.745 . . . . 0.0 109.443 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.33 56.38 6.92 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.241 0.924 . . . . 0.0 111.189 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -57.6 150.77 18.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.165 0.482 . . . . 0.0 110.455 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -68.3 -26.97 65.9 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -161.34 -173.74 3.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.835 2.054 . . . . 0.0 107.445 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -99.29 132.82 44.35 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 165.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -136.42 139.91 42.78 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -171.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.63 133.38 31.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 161.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 0.0 109.663 -179.142 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 tp -146.05 162.31 38.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.045 1.338 . . . . 0.0 109.001 -166.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.15 138.01 52.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.423 1.489 . . . . 0.0 107.449 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -119.41 156.97 29.16 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.039 1.735 . . . . 0.0 108.419 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -122.78 139.68 53.73 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.77 144.55 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.85 138.11 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.46 147.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -141.95 157.89 44.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.492 1.117 . . . . 0.0 109.991 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.61 -157.33 23.58 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.932 1.729 . . . . 0.0 109.314 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.8 ttp-105 -72.36 85.19 1.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 159.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.51 19.85 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.667 1.187 . . . . 0.0 110.263 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -137.46 143.26 41.69 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.401 -0.812 . . . . 0.0 109.36 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.09 32.37 76.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.51 -7.32 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.785 1.234 . . . . 0.0 111.089 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.96 30.24 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.33 -43.8 83.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.936 1.368 . . . . 0.0 109.758 -173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -59.74 -41.17 90.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.806 0.73 . . . . 0.0 111.705 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.25 -45.01 77.96 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.646 0.657 . . . . 0.0 110.289 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -62.72 -40.11 96.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.955 0.798 . . . . 0.0 110.909 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.2 -38.98 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.106 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.85 -42.42 99.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.215 1.371 . . . . 0.0 110.505 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.64 -38.19 83.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.251 0.932 . . . . 0.0 110.451 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -66.41 -39.67 89.14 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.48 0.712 . . . . 0.0 109.999 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.69 -38.45 91.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.668 0.787 . . . . 0.0 110.327 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.02 -45.27 86.19 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 110.696 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -60.17 -18.23 46.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.919 1.287 . . . . 0.0 112.005 174.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -111.23 7.0 21.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.828 1.651 . . . . 0.0 112.499 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 38.72 40.07 0.38 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.765 2.426 . . . . 0.0 113.271 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -74.63 169.38 17.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.498 1.119 . . . . 0.0 110.237 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.1 164.76 18.01 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 160.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.68 -150.78 23.05 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.723 0.692 . . . . 0.0 112.004 -175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -155.81 170.96 20.87 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.065 0.946 . . . . 0.0 110.855 167.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.43 139.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.516 1.526 . . . . 0.0 107.79 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.59 157.84 45.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.197 1.399 . . . . 0.0 108.85 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.85 114.42 18.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -90.92 153.98 19.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.989 0.916 . . . . 0.0 110.759 -155.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.24 -27.35 68.6 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.049 0.54 . . . . 0.0 111.997 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -7.5 40.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.044 0.938 . . . . 0.0 112.929 175.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.36 -12.86 47.94 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.69 1.138 . . . . 0.0 113.352 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -90.77 154.81 19.25 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.98 1.39 . . . . 0.0 109.603 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.7 151.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -134.49 144.72 48.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.03 145.63 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -137.03 117.67 13.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.23 151.87 46.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.407 0.683 . . . . 0.0 109.933 -165.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -140.95 137.31 32.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.531 1.132 . . . . 0.0 108.583 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 -174.11 43.33 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.27 154.47 69.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.013 1.809 . . . . 0.0 110.263 169.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.67 -41.38 90.53 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.408 0.683 . . . . 0.0 111.442 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.36 -39.59 94.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.587 0.631 . . . . 0.0 111.729 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -40.0 83.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -67.84 -36.76 80.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.076 0.398 . . . . 0.0 111.39 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -64.66 -49.19 71.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.248 0.931 . . . . 0.0 110.285 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 p -66.13 -29.38 69.67 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.729 -0.607 . . . . 0.0 111.352 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -63.66 -43.84 95.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.364 -0.827 . . . . 0.0 110.853 170.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.23 -44.09 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.827 1.194 . . . . 0.0 109.319 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.37 -36.55 78.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.136 0.88 . . . . 0.0 111.545 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.28 -50.1 55.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.804 0.442 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.61 -43.29 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.817 0.847 . . . . 0.0 109.873 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -18.8 62.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.499 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -78.24 -43.66 27.66 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.384 0.993 . . . . 0.0 110.403 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.35 -179.48 25.0 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.606 1.098 . . . . 0.0 111.636 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.5 p -74.23 166.92 40.53 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 122.13 -0.63 . . . . 0.0 109.677 168.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.44 -21.66 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.83 1.687 . . . . 0.0 112.445 170.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -73.17 -37.82 66.41 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.342 0.657 . . . . 0.0 110.338 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -71.55 167.16 20.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.106 0.962 . . . . 0.0 110.809 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -146.0 77.79 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 161.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.32 140.06 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.8 p -127.61 -16.6 4.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.935 1.294 . . . . 0.0 111.618 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -151.61 151.37 31.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.093 0.957 . . . . 0.0 109.59 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.25 149.54 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.894 1.277 . . . . 0.0 108.074 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.8 m -140.57 153.91 46.3 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.611 1.565 . . . . 0.0 108.191 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -137.57 145.18 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.413 1.085 . . . . 0.0 108.291 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.5 164.26 29.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.146 2.178 . . . . 0.0 106.056 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.33 168.76 18.98 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.835 -1.166 . . . . 0.0 111.657 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -142.35 131.97 23.97 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.53 1.932 . . . . 0.0 105.85 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -83.34 17.76 2.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.543 0.737 . . . . 0.0 111.612 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.4 m -139.77 159.75 41.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.166 2.186 . . . . 0.0 106.604 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.93 160.89 39.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.241 1.016 . . . . 0.0 110.354 -172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -78.69 -34.46 46.15 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.811 0.844 . . . . 0.0 110.296 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.57 51.4 7.28 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -55.02 153.32 6.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.267 1.027 . . . . 0.0 112.647 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -42.54 99.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.903 1.281 . . . . 0.0 112.155 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -153.9 -173.07 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 -164.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -114.49 95.5 5.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -79.99 131.33 35.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.981 0.42 . . . . 0.0 111.176 -170.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.45 115.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 154.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--O 1.238 0.485 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 169.366 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttt . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.4 mt -135.61 175.87 9.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.748 1.619 . . . . 0.0 109.526 -171.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -129.27 149.43 51.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 108.121 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.52 165.58 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.893 -0.504 . . . . 0.0 111.243 157.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -123.0 136.23 54.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 167.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.2 mt -134.07 144.58 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mm -130.33 138.19 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 t -137.16 145.24 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -170.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -141.58 156.94 45.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.55 1.14 . . . . 0.0 109.8 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.04 -154.08 24.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.34 1.448 . . . . 0.0 110.371 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 ttp-105 -75.65 80.31 2.63 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 162.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.16 19.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.964 0.906 . . . . 0.0 111.169 -169.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -137.44 148.55 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.096 0.958 . . . . 0.0 108.885 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.64 84.49 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.5 m -134.05 -8.01 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.978 1.311 . . . . 0.0 111.416 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.86 23.02 21.87 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.954 1.264 . . . . 0.0 110.054 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.41 -42.76 99.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 119.22 1.51 . . . . 0.0 110.336 -172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.22 -47.0 75.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.655 0.661 . . . . 0.0 111.619 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -68.89 -41.68 77.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.402 0.546 . . . . 0.0 111.386 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -56.69 -53.03 62.41 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.981 0.513 . . . . 0.0 109.717 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.9 t -62.4 -39.23 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.391 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -57.35 -44.3 84.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.185 0.902 . . . . 0.0 110.97 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.0 mtm -76.55 -36.04 57.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.536 0.607 . . . . 0.0 111.2 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -70.46 -27.81 64.52 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.146 0.885 . . . . 0.0 111.293 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.53 -46.92 65.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.844 -0.535 . . . . 0.0 109.666 168.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.32 -45.35 93.73 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.741 0.816 . . . . 0.0 111.226 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -30.35 69.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.35 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -114.88 18.01 16.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.678 0.672 . . . . 0.0 111.186 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt 52.13 42.64 30.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.273 1.829 . . . . 0.0 112.061 171.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.15 165.66 6.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.004 0.922 . . . . 0.0 108.955 165.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.79 46.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.17 0.988 . . . . 0.0 108.4 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.93 -153.67 24.4 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 119.3 0.955 . . . . 0.0 113.002 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -143.96 165.52 27.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.072 -0.664 . . . . 0.0 112.649 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.42 145.9 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.183 1.393 . . . . 0.0 107.942 165.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -144.39 159.51 42.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.303 1.041 . . . . 0.0 108.584 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -125.88 128.73 48.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -110.55 154.35 23.84 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.733 0.413 . . . . 0.0 110.885 -150.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.75 -27.2 68.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.108 0.563 . . . . 0.0 112.089 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -7.93 42.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.174 0.99 . . . . 0.0 112.989 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.01 -9.07 50.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.73 1.157 . . . . 0.0 113.437 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -97.18 158.12 15.6 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 119.007 1.403 . . . . 0.0 109.855 -173.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.7 153.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 163.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.72 144.03 47.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -134.31 146.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -131.36 127.87 38.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 161.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.59 154.13 50.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.32 0.964 . . . . 0.0 109.85 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' CD ' ' HD1' ' A' ' 83' ' ' HIS . 99.5 mt-10 -140.64 143.28 35.09 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.215 1.806 . . . . 0.0 107.197 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.35 -175.94 41.06 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.146 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.27 153.79 66.29 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.567 2.178 . . . . 0.0 109.594 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.37 -43.58 88.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.378 0.671 . . . . 0.0 111.447 -171.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.01 -43.42 98.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.801 0.728 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.35 83.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.16 -48.51 81.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.377 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -60.07 -46.95 87.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 110.415 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 m -60.49 -37.96 82.77 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.159 -0.338 . . . . 0.0 110.632 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -67.11 -36.06 81.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.694 -1.146 . . . . 0.0 110.985 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 t -58.13 -51.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 120.437 1.471 . . . . 0.0 108.51 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -56.23 -41.61 75.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.96 0.504 . . . . 0.0 110.556 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.99 82.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.338 0.655 . . . . 0.0 111.335 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.05 -35.75 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.746 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -61.67 -37.01 82.5 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.055 1.298 . . . . 0.0 110.861 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -69.3 -44.76 71.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 117.872 0.305 . . . . 0.0 110.266 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.27 -179.62 24.38 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.52 158.62 14.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.106 0.962 . . . . 0.0 111.352 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.04 -37.53 79.08 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.295 2.664 . . . . 0.0 114.394 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -78.96 -21.98 46.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.856 0.862 . . . . 0.0 112.126 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -79.99 168.41 19.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.368 1.467 . . . . 0.0 111.262 -170.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -148.17 104.61 3.56 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.72 143.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -127.35 -18.08 4.55 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.164 0.985 . . . . 0.0 111.152 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.1 150.49 29.97 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.32 145.67 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.958 1.303 . . . . 0.0 107.793 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -141.59 152.24 43.87 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.186 1.394 . . . . 0.0 108.724 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -141.23 144.03 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.718 1.207 . . . . 0.0 108.336 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -138.96 150.88 46.39 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 164.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.88 160.86 40.04 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.248 0.931 . . . . 0.0 111.768 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.1 m -148.93 148.92 30.38 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.848 1.659 . . . . 0.0 108.891 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -48.1 46.72 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 165.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m -57.24 145.13 32.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.164 1.386 . . . . 0.0 109.804 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 pp -151.1 155.21 38.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.067 1.347 . . . . 0.0 109.173 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.33 -32.82 32.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.097 0.559 . . . . 0.0 110.805 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.87 42.28 3.13 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.223 0.916 . . . . 0.0 110.882 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.436 ' HD1' ' CD ' ' A' ' 47' ' ' GLU . 72.4 m80 -53.74 136.7 39.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.742 0.771 . . . . 0.0 109.451 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.46 -20.67 23.61 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.022 0.529 . . . . 0.0 112.109 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -152.7 178.8 9.23 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.855 1.662 . . . . 0.0 108.337 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -107.9 135.37 49.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -138.21 142.9 39.96 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.9 mt -74.05 138.43 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 165.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 125.105 1.362 . . . . 0.0 108.059 176.664 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.6 tp -140.81 162.82 34.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.203 2.201 . . . . 0.0 106.835 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.4 138.7 51.65 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.664 1.186 . . . . 0.0 108.221 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -116.48 154.7 29.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.569 1.548 . . . . 0.0 108.057 165.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -122.85 139.55 53.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 158.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.96 141.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.51 140.38 49.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -136.52 147.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -141.72 157.84 44.55 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.877 1.271 . . . . 0.0 109.71 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.46 -157.65 23.03 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.89 1.709 . . . . 0.0 109.391 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -75.13 88.6 2.46 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 157.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.08 19.06 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.377 1.071 . . . . 0.0 110.751 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -139.55 152.19 46.69 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.55 42.29 99.71 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -142.35 4.67 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.751 1.62 . . . . 0.0 112.045 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.23 54.62 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.438 -1.201 . . . . 0.0 110.185 -172.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.77 -50.31 65.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.468 1.634 . . . . 0.0 110.608 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -62.63 -38.77 91.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.884 0.765 . . . . 0.0 110.521 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -66.98 -42.14 85.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.98 0.512 . . . . 0.0 111.375 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.9 -48.98 78.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.702 0.683 . . . . 0.0 109.9 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.4 t -61.93 -41.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.291 0.496 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -56.66 -47.97 78.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.92 0.782 . . . . 0.0 110.035 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.05 -37.34 69.7 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.102 -0.374 . . . . 0.0 111.158 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.22 -31.58 70.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.906 0.776 . . . . 0.0 111.222 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.13 74.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.271 0.487 . . . . 0.0 109.848 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -61.18 -47.39 86.36 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.04 0.936 . . . . 0.0 111.127 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -11.24 53.57 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -125.68 18.59 8.01 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.234 1.013 . . . . 0.0 111.071 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 tttp 45.98 36.48 3.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.952 2.101 . . . . 0.0 114.165 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.55 162.98 27.86 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.14 153.44 49.38 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.123 1.369 . . . . 0.0 107.718 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.1 -157.13 27.14 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.961 1.255 . . . . 0.0 113.519 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -144.86 166.48 25.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.609 0.764 . . . . 0.0 112.071 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.31 146.63 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.757 1.223 . . . . 0.0 108.343 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -146.24 153.53 40.71 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.75 0.82 . . . . 0.0 110.439 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -78.47 157.79 28.82 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 163.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -117.67 151.2 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.188 0.995 . . . . 0.0 108.767 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.1 -27.65 68.9 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.266 0.626 . . . . 0.0 111.888 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.57 -3.54 21.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.671 1.188 . . . . 0.0 113.135 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.11 -9.62 63.46 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.674 1.13 . . . . 0.0 112.987 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -79.36 177.09 9.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.941 1.37 . . . . 0.0 110.543 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.28 145.56 25.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -115.5 140.96 48.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mt -131.49 146.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.77 127.43 32.72 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.34 150.24 45.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.676 0.671 . . . . 0.0 109.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.447 ' CD ' ' HD1' ' A' ' 83' ' ' HIS . 92.7 mt-10 -138.86 133.68 32.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.779 1.631 . . . . 0.0 107.115 -174.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.31 -169.02 38.26 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.381 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 150.11 51.51 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.557 2.172 . . . . 0.0 110.453 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.19 -32.67 72.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.707 0.803 . . . . 0.0 112.052 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.24 -40.74 90.43 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.875 -1.141 . . . . 0.0 111.477 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.88 77.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.38 -40.33 96.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.907 0.483 . . . . 0.0 110.982 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -61.95 -49.91 74.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.274 0.629 . . . . 0.0 110.993 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -61.6 -38.84 89.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.776 0.798 . . . . 0.0 110.622 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -64.12 -43.76 94.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.615 1.166 . . . . 0.0 110.549 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.16 -49.2 82.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 119.408 1.004 . . . . 0.0 109.545 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.42 -39.14 69.87 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.814 . . . . 0.0 110.802 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.94 71.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 111.387 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.65 -26.65 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.808 0.843 . . . . 0.0 111.137 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -58.27 -34.59 70.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.147 1.339 . . . . 0.0 111.283 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.52 -41.54 27.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.346 0.521 . . . . 0.0 110.735 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.46 -167.39 54.73 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -165.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -60.04 167.29 2.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.246 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -52.84 -13.1 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.696 2.931 . . . . 0.0 115.391 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.23 -5.12 10.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.685 1.194 . . . . 0.0 111.805 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -70.27 162.93 27.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.834 0.854 . . . . 0.0 111.147 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -141.76 78.01 1.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.4 142.69 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -122.9 -21.79 5.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.324 1.05 . . . . 0.0 111.162 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -154.99 153.3 30.81 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.104 0.962 . . . . 0.0 109.558 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.1 tt -151.14 145.07 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.49 1.516 . . . . 0.0 107.196 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -140.39 153.19 46.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.942 1.297 . . . . 0.0 108.448 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.4 t -137.14 145.27 30.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -134.84 159.15 42.28 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 167.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.02 160.48 42.33 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.741 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.0 m -148.45 142.14 25.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.21 1.404 . . . . 0.0 109.015 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -69.14 -43.12 75.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -59.45 145.86 42.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.55 1.14 . . . . 0.0 109.071 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.04 153.73 38.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.148 1.379 . . . . 0.0 108.399 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.81 -30.44 45.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.525 0.33 . . . . 0.0 110.526 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.74 40.6 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.447 ' HD1' ' CD ' ' A' ' 47' ' ' GLU . 78.8 m80 -60.81 152.42 27.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.753 0.776 . . . . 0.0 109.481 173.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -128.98 -5.65 5.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 112.08 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.76 173.09 12.69 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.743 1.617 . . . . 0.0 107.746 173.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -111.56 142.61 43.63 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -130.31 133.3 46.36 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.236 0.541 . . . . 0.0 112.17 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.56 113.77 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 156.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 157.865 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.5 tp -142.13 156.66 45.37 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.943 1.297 . . . . 0.0 108.171 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -110.37 136.66 49.2 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.566 1.546 . . . . 0.0 107.189 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -111.79 148.18 34.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 161.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -114.36 140.14 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 156.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -132.66 141.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -131.86 137.11 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 147.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -169.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -143.08 156.71 44.87 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.507 1.123 . . . . 0.0 109.94 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.67 -154.85 24.5 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.302 1.429 . . . . 0.0 110.256 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -72.18 83.63 1.02 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 159.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.51 18.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 111.1 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -138.08 148.79 45.37 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.866 0.866 . . . . 0.0 109.444 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.38 78.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.19 -9.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.226 . . . . 0.0 111.719 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.16 22.42 17.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.027 1.298 . . . . 0.0 110.153 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 -40.61 96.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.18 1.49 . . . . 0.0 110.363 -171.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -55.63 -48.2 75.34 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.848 0.749 . . . . 0.0 111.449 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -67.23 -39.56 86.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.205 0.457 . . . . 0.0 111.295 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.03 -51.85 67.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.809 0.443 . . . . 0.0 110.239 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -62.22 -39.18 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.532 0.606 . . . . 0.0 110.512 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -55.96 -49.19 74.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.643 0.777 . . . . 0.0 109.892 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.3 mtp -69.79 -39.23 76.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.984 0.357 . . . . 0.0 111.12 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.72 -32.92 73.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.789 0.722 . . . . 0.0 111.019 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.97 81.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.22 0.463 . . . . 0.0 110.235 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.66 -44.36 94.01 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.278 0.631 . . . . 0.0 110.873 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -4.07 19.75 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.369 -0.832 . . . . 0.0 113.213 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -111.37 2.36 17.55 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.321 1.448 . . . . 0.0 111.286 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 42.82 39.58 1.76 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.782 2.033 . . . . 0.0 111.945 -172.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.78 168.3 13.64 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.556 0.742 . . . . 0.0 109.512 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.96 151.27 49.33 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.15 -159.2 28.01 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.603 1.092 . . . . 0.0 113.756 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -141.73 166.01 25.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.269 0.628 . . . . 0.0 112.271 172.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.72 145.48 31.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 125.019 1.328 . . . . 0.0 108.273 164.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -141.48 161.36 38.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.997 1.319 . . . . 0.0 108.401 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -125.89 116.17 21.11 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -91.01 153.19 20.33 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.025 0.93 . . . . 0.0 110.276 -157.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.75 -29.46 70.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.674 0.39 . . . . 0.0 111.845 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.98 -9.75 48.06 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 -21.19 22.08 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.476 1.036 . . . . 0.0 113.285 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtm180 -81.02 154.33 26.94 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 118.591 1.195 . . . . 0.0 110.178 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.7 t -86.66 148.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 161.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -132.55 142.87 49.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.69 149.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.47 127.0 26.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 167.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.23 147.12 43.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.909 0.777 . . . . 0.0 109.352 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -136.89 129.33 30.03 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -170.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.93 -169.18 41.2 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.82 149.62 60.41 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.259 1.973 . . . . 0.0 110.156 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.43 -32.85 72.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.044 0.938 . . . . 0.0 111.817 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -68.56 -39.76 80.92 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.919 -1.113 . . . . 0.0 111.62 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.5 80.91 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -61.34 -43.04 99.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.83 0.852 . . . . 0.0 111.232 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -61.09 -51.53 68.74 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.004 0.522 . . . . 0.0 110.419 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 m -62.73 -35.29 79.29 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.901 -0.5 . . . . 0.0 110.956 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -65.67 -42.04 91.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.561 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.49 -43.64 87.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.044 1.293 . . . . 0.0 109.925 171.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.68 -37.72 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.418 1.008 . . . . 0.0 111.204 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.09 91.01 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.834 -0.542 . . . . 0.0 111.026 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.22 -48.07 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 118.249 -0.882 . . . . 0.0 109.247 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -68.81 -26.29 65.1 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.936 1.243 . . . . 0.0 112.571 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -60.67 -41.18 94.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.753 1.16 . . . . 0.0 110.014 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.39 170.1 33.53 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.698 1.142 . . . . 0.0 111.185 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 163.41 42.08 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 123.765 0.826 . . . . 0.0 111.188 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.23 -13.65 7.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.244 3.296 . . . . 0.0 115.731 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.15 13.71 11.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.337 1.455 . . . . 0.0 111.132 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -132.73 166.61 21.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.783 1.233 . . . . 0.0 110.141 -161.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -149.87 102.33 3.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.37 144.77 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 166.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 p -124.49 -17.5 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.422 1.089 . . . . 0.0 110.934 172.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -153.77 149.45 27.45 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.391 1.076 . . . . 0.0 109.502 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.9 tt -147.12 146.82 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.995 1.318 . . . . 0.0 107.482 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.2 m -140.7 154.69 46.46 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.484 1.513 . . . . 0.0 108.323 175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.14 150.01 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.307 1.043 . . . . 0.0 109.66 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -136.77 160.44 38.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.264 1.826 . . . . 0.0 106.335 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.37 159.69 41.01 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.689 0.795 . . . . 0.0 110.648 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.9 m -157.98 145.17 18.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.096 1.358 . . . . 0.0 108.965 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -79.03 -32.88 45.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.247 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 m -57.54 147.8 25.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.833 0.853 . . . . 0.0 108.817 166.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.21 154.77 44.41 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.746 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.43 -35.05 61.04 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 163.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.18 36.29 4.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.604 1.097 . . . . 0.0 111.474 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -58.58 149.86 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.246 1.023 . . . . 0.0 110.289 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.32 -6.23 7.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.81 1.244 . . . . 0.0 111.781 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -140.92 169.74 17.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.535 1.934 . . . . 0.0 106.894 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -115.04 135.04 54.65 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 m -139.44 143.44 37.59 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.2 134.16 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 162.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.536 0.426 0 C-N-CA 124.582 1.153 . . . . 0.0 108.874 178.455 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.3 mt -138.81 173.1 11.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.593 1.557 . . . . 0.0 108.904 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -135.37 133.06 38.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -115.59 158.42 22.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.968 1.307 . . . . 0.0 108.091 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -120.87 144.59 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 157.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.9 mt -132.37 144.92 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.4 mm -133.1 136.9 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.32 147.48 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -172.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -141.44 154.72 45.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.153 1.381 . . . . 0.0 109.77 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.27 -154.81 25.96 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.504 1.526 . . . . 0.0 109.84 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 -76.67 79.54 3.32 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 161.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.77 19.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.016 0.926 . . . . 0.0 111.037 -171.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -136.76 146.1 45.37 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.15 32.88 85.41 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.46 -3.22 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.811 1.244 . . . . 0.0 111.722 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.17 21.81 34.34 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.526 -1.152 . . . . 0.0 110.418 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -62.71 -44.41 96.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.11 1.455 . . . . 0.0 110.044 -171.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -55.43 -49.29 72.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.765 0.711 . . . . 0.0 111.856 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -67.57 -40.9 84.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.143 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -56.13 -50.19 71.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.449 0.568 . . . . 0.0 110.053 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.5 t -60.2 -43.24 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 118.372 0.533 . . . . 0.0 110.042 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -59.27 -44.46 92.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.67 0.668 . . . . 0.0 110.389 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.1 mtt -71.82 -36.86 70.35 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.734 -0.604 . . . . 0.0 111.171 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.87 -26.12 64.04 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.555 -0.715 . . . . 0.0 111.631 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.35 -45.23 63.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.547 0.612 . . . . 0.0 109.697 165.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.28 -35.59 80.78 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.109 0.563 . . . . 0.0 112.243 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -16.93 63.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.153 0.888 . . . . 0.0 112.998 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -112.84 5.7 17.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.528 1.531 . . . . 0.0 111.072 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 42.58 41.85 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.2 1.8 . . . . 0.0 111.821 -169.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.3 mt -62.66 161.15 12.75 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.73 154.01 49.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.084 0.953 . . . . 0.0 108.496 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.7 -159.34 28.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -170.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.5 168.09 22.06 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 112.074 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.48 144.8 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.158 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -138.66 156.95 46.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.554 1.141 . . . . 0.0 108.142 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -125.19 107.94 11.26 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtp85 -82.47 154.88 24.89 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.778 1.231 . . . . 0.0 110.648 -154.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.582 0.353 . . . . 0.0 111.81 175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.8 -5.57 35.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.038 0.935 . . . . 0.0 113.154 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.91 -17.6 41.5 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.724 1.154 . . . . 0.0 113.627 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -86.07 152.87 22.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.109 1.455 . . . . 0.0 110.196 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.92 146.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 162.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.49 136.59 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.07 145.42 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.62 128.3 28.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.48 155.12 45.86 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.51 0.724 . . . . 0.0 110.471 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.21 134.09 37.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.07 1.748 . . . . 0.0 107.743 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.86 -173.18 41.45 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.716 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.95 157.1 55.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.751 2.301 . . . . 0.0 110.707 172.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.42 -44.62 89.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.552 0.741 . . . . 0.0 111.347 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.72 -39.56 91.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.795 0.725 . . . . 0.0 111.767 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.75 74.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.37 -36.56 83.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.127 0.421 . . . . 0.0 111.402 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -63.21 -47.73 81.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.08 0.854 . . . . 0.0 109.901 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.8 m -60.14 -35.94 76.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 0.0 111.18 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -64.95 -45.92 83.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.941 0.897 . . . . 0.0 110.072 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.7 t -56.7 -48.58 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.357 0.98 . . . . 0.0 109.361 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -57.18 -40.77 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 110.683 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.85 73.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.681 0.793 . . . . 0.0 111.17 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -61.68 -27.46 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.068 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -57.76 -31.44 66.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.19 1.359 . . . . 0.0 111.603 173.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -83.33 -41.91 17.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.374 0.533 . . . . 0.0 111.254 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.7 -168.91 45.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -165.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.3 p -60.36 165.9 4.72 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 117.381 0.59 . . . . 0.0 110.92 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.47 -20.77 12.49 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.388 2.725 . . . . 0.0 114.756 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -103.78 -13.41 16.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.47 1.108 . . . . 0.0 111.53 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 m -68.71 165.65 19.05 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.025 -1.047 . . . . 0.0 111.166 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -143.47 138.47 29.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 156.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.4 t -110.22 140.73 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.0 p -123.26 -18.55 6.25 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.187 0.995 . . . . 0.0 110.965 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -153.54 149.46 27.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.76 144.11 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 m -142.09 159.5 42.11 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.195 1.398 . . . . 0.0 108.882 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 t -136.61 146.86 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.78 1.232 . . . . 0.0 107.679 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.74 167.6 20.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.681 1.993 . . . . 0.0 106.388 173.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -130.44 164.03 25.65 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.168 -0.957 . . . . 0.0 109.996 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -135.61 150.88 49.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 162.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -115.17 27.76 9.16 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 109.545 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.7 m -136.55 168.8 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.52 2.728 . . . . 0.0 105.425 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.65 129.66 47.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.657 0.783 . . . . 0.0 108.938 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -71.14 -25.4 62.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.063 0.392 . . . . 0.0 110.794 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 29.07 18.41 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.314 0.959 . . . . 0.0 112.903 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -59.42 151.16 24.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.178 1.489 . . . . 0.0 109.59 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -126.92 -6.96 6.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.382 1.073 . . . . 0.0 112.259 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -141.46 -178.12 5.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.985 2.114 . . . . 0.0 106.711 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -117.54 124.57 49.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.5 m -117.76 139.41 51.1 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.367 0.603 . . . . 0.0 111.103 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.6 mt -89.52 137.51 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.5 t . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 125.348 1.459 . . . . 0.0 107.315 -173.752 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.9 mmm . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.92 168.28 14.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 107.259 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -120.19 137.07 54.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.162 1.785 . . . . 0.0 106.496 170.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -119.83 155.62 32.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.393 1.477 . . . . 0.0 107.794 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -125.03 138.83 54.2 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.3 mt -134.23 141.81 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mm -130.56 141.09 47.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.18 147.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -140.95 158.08 44.44 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.866 1.266 . . . . 0.0 109.623 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.96 -157.27 23.31 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.701 1.62 . . . . 0.0 109.595 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -75.12 85.71 2.37 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.77 14.96 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.862 0.865 . . . . 0.0 111.695 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -138.39 149.34 45.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.49 33.45 76.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.06 -3.78 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.307 1.443 . . . . 0.0 111.841 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.52 22.69 33.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.796 1.189 . . . . 0.0 110.41 -175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.36 -46.75 82.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.125 1.462 . . . . 0.0 110.377 -172.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -61.96 -42.35 99.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.236 0.926 . . . . 0.0 110.345 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -64.57 -42.41 95.65 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.948 0.499 . . . . 0.0 110.707 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.5 -50.69 72.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.321 0.648 . . . . 0.0 110.558 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.25 -37.8 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.672 -0.643 . . . . 0.0 110.127 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.739 0.699 . . . . 0.0 109.823 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 ptp -72.14 -33.46 67.77 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.758 0.708 . . . . 0.0 111.42 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -69.48 -33.82 73.44 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.047 0.839 . . . . 0.0 111.209 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.25 79.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.0 0.364 . . . . 0.0 110.344 170.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.08 -45.42 93.6 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.803 0.841 . . . . 0.0 110.99 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -9.61 35.49 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -122.27 10.37 9.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.044 1.338 . . . . 0.0 111.415 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 44.96 41.83 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.068 1.747 . . . . 0.0 112.626 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.9 166.59 7.18 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.11 159.05 26.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 163.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.31 -155.5 25.19 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.695 0.679 . . . . 0.0 112.62 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -147.75 166.81 26.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.4 144.56 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 108.014 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.23 149.28 33.61 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.557 0.743 . . . . 0.0 110.402 174.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.97 122.12 27.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 166.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -76.57 148.1 37.24 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.31 -30.33 71.38 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.563 0.345 . . . . 0.0 111.613 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.36 -5.2 21.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.513 1.125 . . . . 0.0 113.548 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -13.75 52.66 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.323 0.963 . . . . 0.0 113.353 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -72.2 170.69 13.49 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.818 1.309 . . . . 0.0 110.551 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.28 148.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 161.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -131.96 143.66 50.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -141.11 147.06 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.68 128.82 27.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.63 158.53 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.184 0.593 . . . . 0.0 110.053 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -140.11 134.63 31.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.411 1.484 . . . . 0.0 107.37 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.67 -177.62 44.38 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.464 -0.631 . . . . 0.0 111.741 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 157.41 59.28 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.385 2.057 . . . . 0.0 110.287 169.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.0 -45.17 91.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.265 0.626 . . . . 0.0 111.137 -172.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.57 -38.02 85.96 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.622 0.646 . . . . 0.0 111.954 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.19 75.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.41 -35.87 80.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.385 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.72 -49.22 77.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.925 0.784 . . . . 0.0 109.977 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 m -61.5 -38.27 86.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 110.919 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -63.87 -44.32 93.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.114 0.966 . . . . 0.0 110.233 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -58.39 -50.07 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.992 0.815 . . . . 0.0 109.303 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.33 -38.49 68.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.687 0.795 . . . . 0.0 110.984 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -46.63 69.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 110.812 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.73 -28.55 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.762 0.825 . . . . 0.0 111.011 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -58.43 -35.2 71.72 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.107 1.321 . . . . 0.0 111.275 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -79.91 -42.93 23.12 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.245 0.475 . . . . 0.0 110.673 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.43 -165.99 54.1 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 p -59.84 166.8 3.15 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.682 . . . . 0.0 111.443 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.85 -14.17 3.27 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.94 3.093 . . . . 0.0 115.988 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -123.07 3.79 9.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.674 1.124 . . . . 0.0 112.053 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.3 m -66.86 159.25 28.64 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.02 -1.05 . . . . 0.0 110.357 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -140.94 77.35 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -59.72 140.49 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.6 p -122.46 -19.59 6.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.424 1.09 . . . . 0.0 111.177 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -154.57 151.9 29.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.154 0.982 . . . . 0.0 109.506 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.18 145.96 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.316 1.447 . . . . 0.0 107.356 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -140.31 152.36 45.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 108.475 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -139.19 145.52 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.522 1.129 . . . . 0.0 108.139 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -136.15 159.74 40.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.252 1.821 . . . . 0.0 106.118 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -148.81 163.29 37.81 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.318 -0.864 . . . . 0.0 111.398 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.7 m -148.76 144.95 27.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.482 1.913 . . . . 0.0 108.451 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.0 tpt85 -76.17 -30.77 58.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.191 162.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 m -57.51 148.56 23.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.625 1.17 . . . . 0.0 109.711 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.7 mt -131.44 168.18 18.06 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.363 1.465 . . . . 0.0 109.238 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 -29.41 2.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.816 1.646 . . . . 0.0 109.876 169.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.39 57.35 5.13 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -56.87 150.46 16.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.489 0.715 . . . . 0.0 110.726 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -67.86 -31.5 71.36 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -149.79 179.0 8.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.524 1.93 . . . . 0.0 107.346 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -94.7 132.8 39.06 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 154.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -138.59 144.42 39.79 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.7 139.83 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 164.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 126.365 1.866 . . . . 0.0 106.661 -178.669 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.764 0.316 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.7 170.73 14.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.249 1.82 . . . . 0.0 107.668 173.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -110.02 138.37 46.48 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.818 1.647 . . . . 0.0 106.817 164.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -116.17 156.95 25.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.144 1.378 . . . . 0.0 107.565 164.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -127.85 140.29 52.11 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 161.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -133.15 142.22 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.04 140.33 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.71 145.06 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.58 157.26 45.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.888 1.275 . . . . 0.0 109.709 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.57 -158.94 24.73 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.982 1.753 . . . . 0.0 109.597 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -75.26 88.77 2.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 157.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.67 20.59 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.445 1.098 . . . . 0.0 109.943 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -138.61 148.5 44.19 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.835 1.254 . . . . 0.0 107.84 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.95 41.53 97.89 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.91 -10.84 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.853 1.261 . . . . 0.0 111.842 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.0 16.98 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.872 1.225 . . . . 0.0 110.124 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.67 -41.73 98.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.307 1.554 . . . . 0.0 110.266 -171.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.75 -45.96 77.93 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.626 -0.671 . . . . 0.0 111.538 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.72 -39.65 80.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.548 0.613 . . . . 0.0 111.515 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.04 -52.09 66.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.199 0.6 . . . . 0.0 109.958 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.0 -38.11 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.44 -48.21 82.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.164 0.893 . . . . 0.0 110.019 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -75.35 -31.85 60.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.923 0.783 . . . . 0.0 111.684 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -68.79 -34.17 75.1 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.032 0.833 . . . . 0.0 110.805 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.31 83.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.162 0.437 . . . . 0.0 110.187 170.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.82 -45.18 93.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.563 0.745 . . . . 0.0 111.129 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -5.71 28.58 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.27 1.17 15.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.519 1.527 . . . . 0.0 111.565 170.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 39.88 42.75 1.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.345 1.858 . . . . 0.0 112.355 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 165.61 18.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 166.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.85 156.76 43.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.61 -154.42 25.79 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.121 0.873 . . . . 0.0 112.433 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -146.24 166.21 26.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 122.139 -0.624 . . . . 0.0 112.251 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.18 141.07 42.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 124.668 1.187 . . . . 0.0 108.239 166.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -138.1 158.65 43.89 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.789 1.236 . . . . 0.0 108.082 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.76 107.63 10.71 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -81.18 146.26 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.318 1.047 . . . . 0.0 109.642 -155.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.16 -25.08 66.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.809 0.444 . . . . 0.0 111.325 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -60.14 -16.92 36.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.439 1.896 . . . . 0.0 113.234 171.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.11 1.51 35.89 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.223 0.916 . . . . 0.0 113.533 171.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.6 mtt85 -117.28 153.74 32.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.751 1.221 . . . . 0.0 109.271 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.22 149.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 164.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -132.71 140.79 48.26 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 167.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.49 145.33 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -173.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -133.49 129.36 37.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.95 152.67 47.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.683 . . . . 0.0 109.575 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' CD ' ' HD1' ' A' ' 83' ' ' HIS . 99.1 mt-10 -139.48 134.85 32.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.252 1.421 . . . . 0.0 107.269 -176.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.8 -172.13 41.16 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.396 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.42 151.89 54.17 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.711 2.274 . . . . 0.0 110.522 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -60.48 -35.95 77.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.128 0.971 . . . . 0.0 112.227 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.63 -39.54 77.09 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.936 -1.102 . . . . 0.0 111.604 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.39 83.24 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.98 -40.03 95.48 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.106 0.562 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.99 -47.42 84.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.763 0.711 . . . . 0.0 110.857 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -61.77 -38.37 87.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.352 0.596 . . . . 0.0 110.796 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -64.14 -43.35 95.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.458 1.103 . . . . 0.0 110.545 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.08 -50.39 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.293 0.952 . . . . 0.0 109.306 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -55.56 -39.38 70.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.821 0.849 . . . . 0.0 110.838 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.91 74.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.641 0.776 . . . . 0.0 110.967 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.81 -27.25 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.128 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -58.65 -38.62 78.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.256 1.389 . . . . 0.0 110.918 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.51 -43.17 50.4 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.111 0.414 . . . . 0.0 110.351 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.81 -172.99 48.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.76 159.28 10.17 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.511 0.724 . . . . 0.0 110.38 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.19 -26.19 64.87 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.068 1.845 . . . . 0.0 112.629 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -83.28 -15.33 50.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.044 0.938 . . . . 0.0 112.29 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -77.95 161.67 27.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.958 0.903 . . . . 0.0 110.93 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -137.11 82.04 1.91 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.1 t -59.77 140.53 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.3 p -123.91 -19.82 5.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.34 1.056 . . . . 0.0 111.267 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -154.01 152.69 30.82 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.128 0.971 . . . . 0.0 109.53 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.82 145.72 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 107.176 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -139.56 152.55 46.96 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.058 1.343 . . . . 0.0 108.238 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -138.61 145.45 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.319 1.048 . . . . 0.0 108.186 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 m -135.23 160.85 37.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.635 1.974 . . . . 0.0 106.052 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.4 166.51 26.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.252 -0.905 . . . . 0.0 110.825 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.5 m -157.0 147.95 21.78 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.982 1.713 . . . . 0.0 108.666 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -73.82 -41.35 62.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -56.1 137.87 50.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 108.97 170.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.12 156.85 41.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.116 1.367 . . . . 0.0 108.662 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.41 -23.36 21.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.852 0.861 . . . . 0.0 111.445 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 46.5 5.74 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.443 ' HD1' ' CD ' ' A' ' 47' ' ' GLU . 68.8 m80 -52.91 137.74 31.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.762 0.825 . . . . 0.0 109.528 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -12.18 39.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.095 0.558 . . . . 0.0 112.096 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -154.58 169.02 24.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.132 1.773 . . . . 0.0 108.412 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -99.79 137.56 38.08 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -134.59 137.71 43.95 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.555 0.616 . . . . 0.0 112.384 -170.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.03 142.53 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 163.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 127.002 2.121 . . . . 0.0 105.795 176.784 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mmm . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.45 164.84 19.57 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.693 1.997 . . . . 0.0 107.704 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -124.96 137.5 54.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.036 1.735 . . . . 0.0 106.389 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -119.85 154.75 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.549 1.54 . . . . 0.0 107.756 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -122.48 139.86 53.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.4 mt -131.94 142.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.3 mm -128.75 136.92 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.87 146.08 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -170.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -143.2 157.26 44.66 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.866 1.266 . . . . 0.0 109.526 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 -156.78 25.3 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.17 1.367 . . . . 0.0 110.474 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -75.05 78.43 2.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.94 20.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.752 0.821 . . . . 0.0 111.9 -168.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -140.93 151.74 44.46 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.44 0.696 . . . . 0.0 109.889 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.61 33.16 83.64 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.5 -10.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.378 1.471 . . . . 0.0 111.853 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.51 18.8 15.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.811 1.672 . . . . 0.0 110.696 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.89 -37.4 87.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.788 1.294 . . . . 0.0 111.117 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -56.02 -51.32 68.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.878 1.217 . . . . 0.0 110.675 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -68.09 -37.74 81.54 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.261 -0.274 . . . . 0.0 110.694 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.01 -50.8 72.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.187 0.595 . . . . 0.0 110.474 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.92 -40.07 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.674 -0.641 . . . . 0.0 109.772 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.9 -45.63 93.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.094 0.861 . . . . 0.0 110.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.36 -32.35 62.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 0.742 . . . . 0.0 111.525 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -73.36 -22.13 60.36 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.219 0.918 . . . . 0.0 111.807 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.27 -49.04 37.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.506 0.594 . . . . 0.0 109.54 164.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.63 -38.33 84.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.392 0.677 . . . . 0.0 111.771 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -22.12 61.61 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -127.15 25.16 6.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.446 1.021 . . . . 0.0 110.581 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 49.26 38.26 13.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 112.646 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.28 156.75 24.69 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.06 155.11 44.88 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.05 -154.22 25.67 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.958 0.799 . . . . 0.0 112.0 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -150.07 166.07 30.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.029 0.532 . . . . 0.0 112.39 174.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.56 151.55 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.694 1.598 . . . . 0.0 108.929 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -143.75 133.63 23.97 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.4 0.68 . . . . 0.0 110.856 171.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.93 115.9 10.61 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 162.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.97 143.85 26.87 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.98 -28.51 70.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.03 -8.12 34.97 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.51 -15.25 38.62 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.455 1.026 . . . . 0.0 113.502 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -76.7 171.87 13.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.72 1.26 . . . . 0.0 110.332 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.6 t -114.18 145.58 19.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 160.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.86 145.99 50.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.57 146.32 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.01 126.05 22.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.8 43.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -140.41 144.6 36.27 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.811 1.644 . . . . 0.0 108.052 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.49 -177.81 41.77 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.02 150.23 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.478 1.452 . . . . 0.0 109.251 167.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.22 -43.69 83.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.968 0.507 . . . . 0.0 110.914 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.64 -29.18 65.47 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.525 -0.735 . . . . 0.0 112.623 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.8 81.97 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 118.674 0.67 . . . . 0.0 110.073 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.79 -33.12 74.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.088 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -62.18 -51.38 68.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.64 1.109 . . . . 0.0 110.26 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 p -63.39 -32.56 74.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.582 1.083 . . . . 0.0 111.418 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.21 -47.16 85.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.952 -0.547 . . . . 0.0 110.169 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.28 -43.45 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.021 0.828 . . . . 0.0 109.996 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -59.74 -41.14 90.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.067 0.849 . . . . 0.0 110.928 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.06 76.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.926 0.491 . . . . 0.0 110.826 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.8 -49.68 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -27.48 64.54 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.893 0.77 . . . . 0.0 112.148 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -64.32 -40.01 95.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.139 0.881 . . . . 0.0 110.459 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 171.97 31.52 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.566 1.079 . . . . 0.0 110.953 -171.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.7 p -64.0 168.8 5.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.977 0.911 . . . . 0.0 109.934 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.16 -2.82 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.186 1.924 . . . . 0.0 113.196 165.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -107.8 -5.48 17.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.882 1.273 . . . . 0.0 112.176 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -124.47 170.75 10.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.684 1.194 . . . . 0.0 111.623 -172.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -146.68 102.17 3.53 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.83 142.05 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.4 p -123.29 -17.81 6.47 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.135 0.974 . . . . 0.0 110.87 173.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -152.15 148.44 27.63 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.296 1.038 . . . . 0.0 109.205 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.77 146.67 16.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.9 m -138.14 150.99 47.32 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.463 1.505 . . . . 0.0 108.059 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.67 145.08 29.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -136.13 159.13 42.65 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.38 157.79 43.72 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.153 -0.967 . . . . 0.0 111.604 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.3 m -140.1 136.92 34.08 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.001 1.72 . . . . 0.0 108.45 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -35.08 61.24 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 m -59.39 150.85 25.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.135 1.374 . . . . 0.0 109.775 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.5 mt -132.84 165.76 23.85 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.392 1.477 . . . . 0.0 109.399 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.61 -21.71 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.661 1.584 . . . . 0.0 110.652 170.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 43.19 7.04 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.73 0.681 . . . . 0.0 112.249 166.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.86 160.04 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.709 0.755 . . . . 0.0 109.996 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -126.27 -20.5 4.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -139.1 -175.74 4.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.825 1.65 . . . . 0.0 107.624 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -120.78 130.75 54.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.522 0.601 . . . . 0.0 109.781 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.0 m -126.19 159.65 32.39 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.854 0.835 . . . . 0.0 111.721 -167.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -111.81 124.89 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 109.567 -168.277 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.3 tp -142.75 163.72 32.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 127.012 2.125 . . . . 0.0 107.204 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -120.1 137.78 53.94 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 107.737 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -116.64 153.85 31.58 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.654 1.582 . . . . 0.0 108.079 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -120.06 139.0 53.21 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 158.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.9 mt -130.96 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.8 mm -130.01 138.87 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -137.07 147.31 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -139.33 157.74 45.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.496 1.118 . . . . 0.0 109.717 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.87 -156.52 22.55 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.474 1.511 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -73.74 81.25 1.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 160.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.92 15.19 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.032 0.933 . . . . 0.0 111.693 -171.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -138.17 150.3 46.65 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 171.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.42 32.0 71.51 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 m -136.65 1.4 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.717 1.607 . . . . 0.0 111.546 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.0 20.13 50.98 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.856 1.217 . . . . 0.0 110.582 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -62.91 -45.28 93.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.757 1.278 . . . . 0.0 110.766 -169.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -62.1 -44.8 95.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.425 1.012 . . . . 0.0 110.99 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -68.51 -40.28 80.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 110.616 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -56.6 -52.28 65.43 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.25 0.62 . . . . 0.0 110.006 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.71 -39.82 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.168 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -60.69 -43.61 97.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.33 0.968 . . . . 0.0 110.647 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.6 mtm -71.74 -35.53 70.17 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.738 0.699 . . . . 0.0 111.499 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -67.38 -39.91 85.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.561 1.073 . . . . 0.0 110.158 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.3 99.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.121 0.569 . . . . 0.0 110.169 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.26 -47.54 85.58 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.65 0.78 . . . . 0.0 110.623 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -59.9 -36.15 76.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.367 1.067 . . . . 0.0 111.275 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -88.11 5.1 42.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.628 1.171 . . . . 0.0 112.729 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 48.82 31.71 3.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.896 1.678 . . . . 0.0 112.591 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.57 165.95 23.12 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.437 1.095 . . . . 0.0 109.62 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 161.48 30.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.348 1.459 . . . . 0.0 107.625 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.52 -148.85 20.76 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.256 0.934 . . . . 0.0 111.844 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -154.04 168.29 26.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.322 0.649 . . . . 0.0 112.689 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.92 147.72 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.868 1.667 . . . . 0.0 108.739 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -144.79 155.56 43.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.871 0.869 . . . . 0.0 110.384 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -84.0 124.2 30.8 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 164.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.12 147.08 38.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.42 -30.0 71.04 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.551 0.34 . . . . 0.0 111.627 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.94 -5.45 21.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.559 1.144 . . . . 0.0 113.518 174.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.48 49.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.332 0.967 . . . . 0.0 113.288 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -73.37 170.88 14.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 1.258 . . . . 0.0 110.551 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.4 t -105.42 150.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -132.73 140.33 48.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.76 146.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.64 153.44 50.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.674 0.79 . . . . 0.0 109.619 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -140.21 135.83 32.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.927 1.291 . . . . 0.0 108.103 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.43 38.84 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.064 -173.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.19 151.79 61.19 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.265 1.977 . . . . 0.0 110.542 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.15 -40.96 82.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 111.527 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.2 -40.08 95.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.821 0.737 . . . . 0.0 111.75 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.34 -41.14 85.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.04 -39.43 93.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.875 0.47 . . . . 0.0 111.1 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -66.65 -49.11 67.29 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.326 -0.859 . . . . 0.0 110.724 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 p -64.38 -31.94 73.36 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.713 -0.617 . . . . 0.0 111.059 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -63.87 -42.86 97.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.821 171.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.25 -46.64 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 120.254 1.388 . . . . 0.0 109.102 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -59.71 -36.97 77.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.891 0.769 . . . . 0.0 110.989 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.05 -43.48 82.63 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.92 -0.487 . . . . 0.0 111.533 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.97 -43.71 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.4 -0.813 . . . . 0.0 109.988 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -68.83 -20.76 64.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.819 1.19 . . . . 0.0 112.549 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.34 -43.28 73.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 120.112 1.324 . . . . 0.0 110.017 167.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.32 -177.62 39.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.236 0.922 . . . . 0.0 111.093 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.1 p -62.57 168.3 4.45 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.973 0.509 . . . . 0.0 110.834 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.87 -14.36 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.727 2.952 . . . . 0.0 115.261 168.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -116.01 -8.47 11.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.526 1.13 . . . . 0.0 111.902 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 m -72.41 164.47 26.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.878 0.871 . . . . 0.0 111.162 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -144.93 93.68 2.43 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 158.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.02 145.72 12.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -121.97 -22.96 5.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.654 1.182 . . . . 0.0 111.038 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -156.75 154.53 30.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.255 1.022 . . . . 0.0 109.88 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.7 tt -149.3 149.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.295 1.438 . . . . 0.0 107.739 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 m -141.88 152.86 43.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.094 1.357 . . . . 0.0 108.496 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.22 145.21 30.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.672 1.189 . . . . 0.0 107.802 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -135.59 160.38 38.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 166.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.43 161.14 41.03 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.985 -1.072 . . . . 0.0 111.009 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -144.19 140.44 29.33 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.96 1.304 . . . . 0.0 108.648 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.1 -41.82 73.53 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.516 0.726 . . . . 0.0 109.101 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.5 m -64.39 147.19 53.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.128 0.971 . . . . 0.0 109.051 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.5 148.12 29.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.998 1.319 . . . . 0.0 108.985 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -152.21 -10.79 0.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.849 0.86 . . . . 0.0 113.202 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.86 -20.28 17.09 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 121.128 -0.982 . . . . 0.0 113.743 -161.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -55.54 111.84 0.99 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.814 1.246 . . . . 0.0 112.722 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -146.63 -49.22 0.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.426 1.49 . . . . 0.0 109.358 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -153.18 -161.48 1.29 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.877 2.471 . . . . 0.0 106.053 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -118.26 96.97 5.55 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.88 1.218 . . . . 0.0 109.142 166.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.2 m -84.12 139.06 32.7 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.466 0.65 . . . . 0.0 110.955 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.54 137.04 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 155.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 C--O 1.236 0.354 0 C-N-CA 125.456 1.502 . . . . 0.0 107.619 -171.433 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.43 160.05 35.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.998 1.719 . . . . 0.0 108.092 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -119.85 139.15 52.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 164.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -122.31 155.13 36.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.894 1.677 . . . . 0.0 107.511 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -129.55 139.18 51.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 162.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.7 mt -134.99 137.7 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -172.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -127.69 137.98 56.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.57 147.23 27.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -146.73 158.45 43.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.753 1.221 . . . . 0.0 109.493 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.4 18.94 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.385 1.469 . . . . 0.0 109.608 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -72.82 89.81 1.4 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 158.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.54 18.31 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.266 1.026 . . . . 0.0 110.125 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -142.27 154.89 45.11 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.6 1.16 . . . . 0.0 108.161 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.98 93.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.8 -3.33 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.663 1.585 . . . . 0.0 111.301 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.02 26.57 40.5 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -173.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.21 -40.75 91.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.618 1.209 . . . . 0.0 110.331 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.93 -43.84 91.25 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.457 -0.777 . . . . 0.0 110.874 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -69.71 -42.03 74.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.931 0.492 . . . . 0.0 110.987 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -56.21 -48.95 75.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.416 0.553 . . . . 0.0 110.306 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.03 -40.01 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.52 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.06 -46.62 85.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.441 1.018 . . . . 0.0 109.968 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.7 mtt -66.96 -38.59 86.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.493 1.042 . . . . 0.0 111.016 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -70.87 -26.59 63.32 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.494 -0.753 . . . . 0.0 112.157 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.38 -39.03 59.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 110.043 168.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.66 -47.02 79.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.619 1.168 . . . . 0.0 110.482 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HE2' ' NH1' ' A' ' 28' ' ' ARG 0.281 0.0 OUTLIER -70.24 -12.82 61.86 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.749 -177.338 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.478 ' NH1' ' HE2' ' A' ' 27' ' ' LYS . 74.7 mtt85 -101.59 -3.17 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.508 1.523 . . . . 0.0 111.96 173.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 45.4 42.25 7.37 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.529 1.532 . . . . 0.0 112.234 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.38 167.44 10.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.47 156.13 44.61 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 167.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.28 -153.58 25.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 119.398 0.999 . . . . 0.0 112.905 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.01 166.4 24.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.626 0.771 . . . . 0.0 112.779 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.38 144.93 31.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 124.949 1.3 . . . . 0.0 107.544 163.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.37 143.29 32.64 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 0.689 . . . . 0.0 111.088 166.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -74.33 110.92 9.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 162.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -79.24 142.81 35.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.04 -23.95 66.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.769 0.428 . . . . 0.0 112.081 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.96 -20.57 62.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.876 1.27 . . . . 0.0 113.032 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.44 -12.38 36.27 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.646 1.117 . . . . 0.0 112.977 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -82.57 170.84 14.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.052 0.941 . . . . 0.0 110.363 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.07 146.14 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -117.97 145.92 44.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -134.39 146.84 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.82 130.61 34.23 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 167.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.78 157.79 44.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 110.253 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.55 134.41 33.82 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.37 -178.01 43.3 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -172.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.08 152.09 72.88 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.23 1.954 . . . . 0.0 109.941 170.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.49 -40.52 87.26 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.937 0.495 . . . . 0.0 111.415 -171.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -64.41 -38.69 91.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.976 0.807 . . . . 0.0 111.968 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -44.54 86.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.98 -35.28 79.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.202 0.455 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -63.83 -51.14 66.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.104 0.866 . . . . 0.0 110.3 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -66.0 -32.27 73.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.016 0.825 . . . . 0.0 111.062 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.59 -45.55 93.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.061 0.944 . . . . 0.0 109.534 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.75 -47.92 84.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 119.158 0.89 . . . . 0.0 109.595 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -57.31 -39.84 76.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.725 0.693 . . . . 0.0 110.765 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.59 81.09 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.857 0.863 . . . . 0.0 111.211 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.76 -32.38 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.653 0.781 . . . . 0.0 110.866 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -60.76 -31.65 70.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.998 1.272 . . . . 0.0 111.393 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -77.7 -45.0 26.13 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.458 0.572 . . . . 0.0 110.324 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.81 -168.86 46.22 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -54.98 153.65 11.29 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.615 166.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -50.61 -31.44 31.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.458 2.772 . . . . 0.0 115.339 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -84.33 -6.38 59.38 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.354 1.062 . . . . 0.0 112.999 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -70.82 163.84 26.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.614 0.766 . . . . 0.0 110.873 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -146.91 81.77 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.9 140.32 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.8 p -120.67 -23.09 6.11 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.448 1.099 . . . . 0.0 111.065 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -155.07 150.51 27.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.808 1.243 . . . . 0.0 108.481 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.7 tt -151.55 147.39 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -139.98 151.3 45.39 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.131 1.372 . . . . 0.0 108.164 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.36 145.12 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -137.04 158.66 43.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.83 162.09 40.97 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.323 -0.861 . . . . 0.0 110.898 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -146.26 140.86 26.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.615 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.41 -36.88 71.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 164.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 m -59.31 153.55 18.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.235 1.414 . . . . 0.0 110.106 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.86 169.16 15.53 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.024 1.33 . . . . 0.0 109.977 -173.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.85 -31.37 4.23 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.101 2.16 . . . . 0.0 108.76 170.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.32 54.64 7.6 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -55.48 145.99 21.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.768 0.827 . . . . 0.0 110.533 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -68.2 -32.9 73.45 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.347 0.659 . . . . 0.0 111.902 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -152.93 -172.03 4.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.914 1.686 . . . . 0.0 108.051 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -102.5 131.67 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 164.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.8 m -125.15 138.15 54.15 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.956 0.503 . . . . 0.0 111.405 -171.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -75.7 139.12 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 159.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 126.474 1.91 . . . . 0.0 106.402 -177.112 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mmm . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.8 tp -145.17 156.32 43.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 0.0 108.386 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.64 138.31 51.54 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.902 1.281 . . . . 0.0 108.229 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -123.71 156.42 36.0 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.714 1.606 . . . . 0.0 108.766 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -123.41 138.99 54.47 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.94 141.44 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.01 138.57 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.67 144.88 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -170.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -138.93 156.83 46.95 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.961 1.305 . . . . 0.0 109.833 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.0 -158.12 23.73 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.582 1.563 . . . . 0.0 110.027 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -74.66 83.84 2.08 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.4 15.98 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.25 1.02 . . . . 0.0 110.941 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -137.98 154.48 49.35 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.97 30.19 70.24 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.12 -9.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.018 1.327 . . . . 0.0 112.138 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.55 21.42 14.68 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.503 1.525 . . . . 0.0 110.494 -177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.61 -41.02 96.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.256 1.528 . . . . 0.0 110.876 -171.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -61.23 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.405 1.002 . . . . 0.0 110.56 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -64.65 -41.82 95.85 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.239 0.472 . . . . 0.0 110.677 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.13 -49.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.07 0.548 . . . . 0.0 110.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.19 -39.79 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 110.159 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -59.06 -49.7 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.793 0.724 . . . . 0.0 109.911 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.8 ptm -72.49 -33.65 67.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.374 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -68.63 -30.75 69.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.003 0.82 . . . . 0.0 111.673 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.26 64.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.184 0.447 . . . . 0.0 109.96 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.98 -43.64 98.54 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.971 0.908 . . . . 0.0 111.025 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -3.32 23.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -114.84 0.27 13.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.662 1.585 . . . . 0.0 111.465 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 45.25 40.02 4.73 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.357 1.463 . . . . 0.0 111.942 -168.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.13 165.37 13.73 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 155.48 45.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.234 1.013 . . . . 0.0 108.367 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.19 -156.14 26.35 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.797 0.726 . . . . 0.0 112.173 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.9 p-90 -153.36 167.13 30.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.975 -0.721 . . . . 0.0 112.211 176.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.9 142.89 34.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.092 1.357 . . . . 0.0 109.036 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 149.41 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.207 0.603 . . . . 0.0 110.608 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -75.73 134.63 40.45 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.23 143.8 30.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.58 -21.86 66.82 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.366 0.53 . . . . 0.0 111.648 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -28.95 59.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.029 1.732 . . . . 0.0 112.85 170.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.8 -25.02 10.47 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.493 1.044 . . . . 0.0 112.669 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -63.64 168.66 4.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.709 1.255 . . . . 0.0 110.754 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.8 150.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 169.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -139.62 140.08 36.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.98 146.63 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -170.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.01 129.12 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 164.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.24 48.07 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 109.443 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -136.79 138.19 40.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.701 1.6 . . . . 0.0 107.955 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.63 -175.22 44.51 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.279 -0.734 . . . . 0.0 111.885 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.37 137.79 40.82 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.365 2.043 . . . . 0.0 109.534 172.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.13 -34.86 61.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.886 1.674 . . . . 0.0 113.1 -168.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -71.34 -46.24 61.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.091 -1.006 . . . . 0.0 111.953 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.62 83.51 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.05 -49.6 76.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.631 1.172 . . . . 0.0 109.692 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 119.188 -0.435 . . . . 0.0 111.362 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 m -62.37 -37.52 86.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.586 0.63 . . . . 0.0 111.199 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.37 -43.82 98.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.01 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.9 t -61.94 -41.95 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.248 1.386 . . . . 0.0 110.593 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.22 -39.27 72.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.717 1.144 . . . . 0.0 110.561 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.7 77.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.294 0.638 . . . . 0.0 111.287 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.8 t -58.68 -32.84 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.455 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -60.88 -35.39 76.52 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.01 1.277 . . . . 0.0 111.535 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -72.7 -43.33 63.16 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.518 0.599 . . . . 0.0 110.288 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.92 -176.17 43.82 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.15 162.23 14.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.659 0.783 . . . . 0.0 110.669 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.92 -32.13 46.13 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.446 2.764 . . . . 0.0 114.52 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -94.33 -9.19 36.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 112.47 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -78.4 165.31 23.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.997 0.919 . . . . 0.0 110.966 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -144.49 93.18 2.39 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.2 t -61.41 143.38 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 p -124.52 -20.61 5.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.265 1.026 . . . . 0.0 111.101 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -155.85 154.12 30.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 0.0 109.243 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.12 148.07 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.904 1.281 . . . . 0.0 107.586 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.1 m -140.68 154.08 46.23 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.35 1.46 . . . . 0.0 108.663 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.43 145.64 29.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 108.178 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 m -134.42 161.25 35.53 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.12 162.92 34.24 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.154 -0.966 . . . . 0.0 110.942 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.4 m -139.8 126.26 20.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 169.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.42 -29.79 66.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.6 m -66.08 161.04 22.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.959 1.303 . . . . 0.0 109.772 167.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.8 mt -133.1 164.32 27.3 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.54 1.136 . . . . 0.0 109.948 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -119.9 -20.24 7.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.393 1.477 . . . . 0.0 110.666 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.37 48.29 5.7 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.443 0.544 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -59.96 156.47 14.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 117.587 0.694 . . . . 0.0 109.239 167.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.71 -6.27 4.6 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.856 0.863 . . . . 0.0 112.78 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.7 mtm-85 -141.31 169.04 18.35 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.901 1.68 . . . . 0.0 107.031 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -110.39 138.05 47.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -133.99 139.23 45.92 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.66 140.61 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 161.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 126.435 1.894 . . . . 0.0 106.533 -177.923 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.6 mmm . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.4 tp -152.5 158.6 42.8 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.413 1.885 . . . . 0.0 107.225 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -123.67 138.33 54.55 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 107.244 173.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -110.53 151.06 28.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.233 1.413 . . . . 0.0 107.704 163.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -117.97 140.34 49.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 152.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -131.41 143.41 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.4 mm -131.99 136.56 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.19 146.34 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -140.46 155.67 46.61 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.748 1.219 . . . . 0.0 109.796 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.78 -155.16 23.56 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.451 1.5 . . . . 0.0 109.73 -176.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -76.91 79.11 3.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 162.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.46 14.6 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.066 0.946 . . . . 0.0 111.711 -170.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -137.76 150.14 47.01 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.15 30.28 63.22 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.83 -1.27 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.55 1.54 . . . . 0.0 112.021 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.58 20.94 42.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.973 1.273 . . . . 0.0 110.641 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -63.08 -44.58 95.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.109 1.454 . . . . 0.0 110.405 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -61.03 -47.08 88.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.231 0.923 . . . . 0.0 110.452 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -64.69 -42.17 95.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.717 0.407 . . . . 0.0 111.048 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -56.23 -52.38 64.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.954 0.502 . . . . 0.0 110.04 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.45 -39.72 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.546 0.612 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -59.2 -44.77 92.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.019 0.827 . . . . 0.0 110.029 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.8 mtp -73.5 -34.0 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.437 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -66.47 -38.79 88.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.019 1.282 . . . . 0.0 110.048 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.04 99.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.086 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.06 -44.99 94.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.664 0.665 . . . . 0.0 111.143 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.03 -8.65 7.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.137 1.775 . . . . 0.0 112.837 174.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -118.48 -0.21 11.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.358 -1.464 . . . . 0.0 111.934 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 39.07 41.72 0.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.03 1.732 . . . . 0.0 112.35 -165.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.92 165.94 23.98 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.571 0.748 . . . . 0.0 109.302 171.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 152.0 46.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.97 -159.17 28.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.506 1.048 . . . . 0.0 113.688 -169.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -141.48 165.52 27.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.812 0.845 . . . . 0.0 111.973 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.1 p -137.58 146.28 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.018 1.327 . . . . 0.0 108.226 165.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -146.54 152.41 38.91 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.908 0.883 . . . . 0.0 110.036 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -84.59 121.64 27.9 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -75.22 147.03 40.68 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.28 -29.99 71.06 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.658 0.383 . . . . 0.0 111.521 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.58 -5.52 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.58 1.152 . . . . 0.0 113.58 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.94 49.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.478 1.037 . . . . 0.0 113.29 170.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.49 170.55 15.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.64 1.22 . . . . 0.0 110.424 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.13 149.5 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -130.97 142.41 50.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.13 147.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.76 128.31 28.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 167.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.55 148.34 44.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -138.61 129.72 26.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.38 -167.66 39.0 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.357 -0.69 . . . . 0.0 111.837 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.58 155.68 49.8 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.818 2.345 . . . . 0.0 111.103 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.9 -44.31 91.18 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.69 0.796 . . . . 0.0 111.417 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -62.55 -39.35 93.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.098 0.863 . . . . 0.0 111.958 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.34 -44.2 83.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.6 mt -65.6 -37.76 87.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.435 0.294 . . . . 0.0 111.383 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -63.0 -52.76 61.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.756 0.823 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -64.1 -32.44 74.01 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.58 -0.7 . . . . 0.0 111.273 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.83 -50.0 70.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.529 175.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -63.94 -37.87 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.678 1.126 . . . . 0.0 110.04 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -56.39 -41.77 76.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.094 0.861 . . . . 0.0 110.571 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.6 83.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.932 0.493 . . . . 0.0 111.582 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.08 -32.22 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.658 0.783 . . . . 0.0 110.668 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.16 -31.18 68.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.821 1.191 . . . . 0.0 111.493 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -78.28 -41.96 32.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.477 0.58 . . . . 0.0 111.195 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.53 -169.28 47.73 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -166.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.2 p -60.69 165.78 5.28 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 117.111 0.455 . . . . 0.0 110.166 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.02 -5.59 8.01 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.356 2.038 . . . . 0.0 113.703 171.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.21 -9.29 14.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.562 1.145 . . . . 0.0 111.761 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -75.46 167.66 21.47 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.077 0.951 . . . . 0.0 111.089 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -143.73 131.01 20.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 155.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.4 t -100.14 139.72 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.0 p -122.39 -19.23 6.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.051 0.941 . . . . 0.0 111.038 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -154.18 150.74 28.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 tt -152.46 145.77 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 m -142.6 153.45 43.51 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.052 1.341 . . . . 0.0 108.765 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.65 148.75 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.688 1.195 . . . . 0.0 109.399 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -137.06 158.18 45.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.01 152.43 47.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.61 0.764 . . . . 0.0 110.133 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -148.12 146.59 28.85 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.448 1.499 . . . . 0.0 108.391 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -83.6 -32.74 25.58 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.878 -0.514 . . . . 0.0 110.476 167.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -58.15 152.22 17.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 109.311 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.52 154.17 42.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.522 1.129 . . . . 0.0 109.131 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -77.23 -35.3 55.59 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 162.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.0 42.57 3.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.591 1.091 . . . . 0.0 111.375 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -62.21 157.6 19.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.986 0.893 . . . . 0.0 110.777 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -130.27 -1.24 4.53 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.858 1.263 . . . . 0.0 112.205 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -148.2 177.37 9.46 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.791 2.037 . . . . 0.0 107.177 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -121.4 122.37 39.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.0 m -124.48 139.69 53.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.635 0.731 . . . . 0.0 111.918 -163.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.6 mt -80.24 128.65 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 124.721 1.208 . . . . 0.0 108.998 -177.559 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.4 tp -133.98 163.83 28.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 -165.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -125.69 134.26 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.36 1.464 . . . . 0.0 108.44 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -117.31 157.9 25.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 108.572 167.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -126.34 140.19 52.7 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.1 mt -134.08 142.38 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -131.99 137.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.57 148.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -142.47 157.34 44.86 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.123 1.369 . . . . 0.0 109.883 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.15 -154.21 23.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.478 1.513 . . . . 0.0 110.387 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -73.27 79.99 1.32 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 160.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.94 19.27 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.858 0.863 . . . . 0.0 111.023 -171.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -136.64 146.68 46.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.275 1.03 . . . . 0.0 108.228 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.07 33.15 86.34 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.66 0.29 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.172 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.47 24.54 42.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.35 -46.17 87.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.207 1.504 . . . . 0.0 109.936 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -56.45 -46.13 80.47 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.818 0.736 . . . . 0.0 111.521 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.79 -40.94 83.9 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.068 0.395 . . . . 0.0 110.823 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.53 -51.86 67.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.276 0.63 . . . . 0.0 109.875 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.24 -40.42 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.213 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.61 -44.93 93.25 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.854 0.752 . . . . 0.0 110.258 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.5 mtm -71.33 -37.38 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.489 0.586 . . . . 0.0 111.305 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.94 -34.6 76.91 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.131 0.878 . . . . 0.0 110.711 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.42 88.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.901 0.48 . . . . 0.0 110.145 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.11 -49.24 76.67 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.729 0.811 . . . . 0.0 110.622 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -4.97 20.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.57 4.07 15.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.683 1.593 . . . . 0.0 111.807 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 11.4 mmpt? 43.45 38.76 1.91 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.5 1.52 . . . . 0.0 112.078 -172.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.29 165.54 20.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 157.28 43.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.71 1.204 . . . . 0.0 107.851 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.76 -152.13 22.43 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 119.231 0.923 . . . . 0.0 111.598 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -150.66 166.6 29.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.971 -0.723 . . . . 0.0 112.839 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 146.42 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.277 1.431 . . . . 0.0 108.669 171.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -142.96 160.57 40.09 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.014 0.925 . . . . 0.0 109.063 168.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.47 110.89 14.44 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -85.77 155.67 20.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.403 1.081 . . . . 0.0 110.662 -154.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.54 -28.34 69.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.702 0.401 . . . . 0.0 111.804 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.59 -5.34 32.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.017 0.927 . . . . 0.0 113.259 175.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.11 -16.37 46.12 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.629 1.109 . . . . 0.0 113.532 172.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -87.66 152.78 21.89 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.047 1.423 . . . . 0.0 110.002 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.7 147.82 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 162.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -137.7 139.81 40.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -140.45 146.58 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -170.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.37 124.04 25.1 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 166.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.05 150.29 46.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -140.11 138.21 35.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 108.082 -170.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.47 -171.48 39.97 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.72 152.93 64.71 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.291 1.994 . . . . 0.0 110.413 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.05 -40.89 91.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.385 0.674 . . . . 0.0 111.65 -171.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -65.3 -37.86 88.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.74 0.7 . . . . 0.0 111.97 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.29 81.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.26 -37.53 87.81 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.361 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.94 -47.54 82.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.169 0.895 . . . . 0.0 110.581 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.41 -37.52 83.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.105 0.562 . . . . 0.0 110.848 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.12 -45.38 81.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.389 1.076 . . . . 0.0 110.521 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.2 t -56.08 -49.5 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.345 0.975 . . . . 0.0 109.235 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.08 -42.22 69.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 110.863 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.4 74.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.503 0.721 . . . . 0.0 111.442 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.33 -24.6 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -57.54 -33.99 68.69 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.445 1.475 . . . . 0.0 111.042 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -83.2 -42.78 16.87 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.364 0.529 . . . . 0.0 111.053 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.6 -167.06 54.84 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -165.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.0 p -59.94 165.04 5.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.178 0.489 . . . . 0.0 110.319 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.13 -12.68 27.74 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.009 1.806 . . . . 0.0 113.22 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -98.51 -14.77 19.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.143 0.977 . . . . 0.0 111.768 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -71.61 163.46 27.7 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.88 0.872 . . . . 0.0 111.022 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -142.2 94.91 2.72 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.06 145.39 11.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.2 p -126.01 -18.72 4.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.311 1.045 . . . . 0.0 111.063 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -152.62 149.46 28.47 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.364 1.065 . . . . 0.0 109.264 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.6 tt -151.84 145.18 16.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.025 1.33 . . . . 0.0 107.807 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 m -141.71 154.04 45.04 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.286 1.434 . . . . 0.0 108.709 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.2 t -137.72 145.42 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.661 1.184 . . . . 0.0 107.852 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.07 164.27 28.41 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.661 1.985 . . . . 0.0 106.083 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.59 169.61 17.25 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.981 -1.074 . . . . 0.0 111.014 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.5 m -140.39 135.59 32.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -76.67 -28.87 56.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 119.099 -0.476 . . . . 0.0 110.245 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.5 m -73.42 165.54 24.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 161.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.41 162.89 38.67 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 109.88 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.92 -40.33 47.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.54 0.736 . . . . 0.0 109.468 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.06 50.82 3.76 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.14 150.84 10.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.683 0.793 . . . . 0.0 110.498 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -91.21 -31.26 16.23 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.612 0.765 . . . . 0.0 112.81 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -147.03 -179.38 6.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.941 1.696 . . . . 0.0 107.956 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.63 134.9 52.89 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -135.11 139.49 44.72 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 73.9 mt -75.75 133.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 162.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.272 1.429 . . . . 0.0 108.542 179.034 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.861 -0.052 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.7 tp -130.42 163.91 25.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.012 1.325 . . . . 0.0 109.297 -169.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -129.37 142.15 50.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.228 1.011 . . . . 0.0 108.437 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.14 155.89 33.51 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.746 1.618 . . . . 0.0 108.38 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm-85 -120.01 140.06 51.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 158.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.2 mt -130.85 143.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.1 mm -126.72 141.98 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.93 146.17 27.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.1 157.69 45.81 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.553 1.141 . . . . 0.0 109.477 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.45 -158.97 23.95 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.479 1.514 . . . . 0.0 109.643 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -74.0 89.2 1.91 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 159.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.25 15.91 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.484 0.713 . . . . 0.0 111.701 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -138.14 149.0 45.49 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.75 32.4 74.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.42 6.72 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.726 1.61 . . . . 0.0 111.314 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.63 21.2 60.31 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.518 1.056 . . . . 0.0 110.529 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.77 -43.91 91.72 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.392 1.096 . . . . 0.0 110.495 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -65.74 -40.76 92.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.134 0.879 . . . . 0.0 111.15 -177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.02 -41.95 90.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.658 0.663 . . . . 0.0 110.6 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -56.64 -49.8 73.93 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.821 0.737 . . . . 0.0 110.005 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.73 -39.85 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.102 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.5 -41.01 93.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.804 1.184 . . . . 0.0 110.491 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.96 -35.68 72.26 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 111.103 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -72.43 -21.82 61.2 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.171 -0.956 . . . . 0.0 112.038 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.68 -46.41 46.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.94 -37.58 87.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.226 1.01 . . . . 0.0 112.255 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -17.64 42.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -130.29 21.53 5.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.133 0.973 . . . . 0.0 110.747 173.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 28.61 54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.868 2.867 . . . . 0.0 113.763 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.14 165.86 15.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.391 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.3 164.48 23.44 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.635 1.574 . . . . 0.0 108.039 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.42 -150.98 23.3 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.68 0.673 . . . . 0.0 112.783 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -151.32 169.8 21.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.68 1.192 . . . . 0.0 110.295 162.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.1 144.66 34.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.855 1.662 . . . . 0.0 107.726 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.01 146.64 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.384 1.074 . . . . 0.0 109.251 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -83.93 120.9 26.65 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 161.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -73.88 149.37 41.55 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.05 -23.65 67.54 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.6 0.36 . . . . 0.0 111.684 172.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.38 -21.07 61.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.466 1.506 . . . . 0.0 112.97 172.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.49 -16.15 52.67 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.56 1.076 . . . . 0.0 112.395 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -71.93 170.44 13.76 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 110.581 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.98 150.84 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 165.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.25 146.13 49.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.66 146.45 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -143.41 116.36 8.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.23 44.07 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.692 0.678 . . . . 0.0 111.911 -162.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -135.0 132.61 38.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.801 2.041 . . . . 0.0 107.551 -166.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.94 -177.49 41.02 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.59 152.74 74.53 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.233 1.955 . . . . 0.0 110.184 173.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.35 -33.87 73.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.96 -35.19 69.48 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.963 -1.086 . . . . 0.0 111.579 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -40.31 70.79 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.36 0.264 . . . . 0.0 110.604 176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.1 mp -58.79 -40.13 83.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.745 0.818 . . . . 0.0 110.552 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -65.32 -49.27 70.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.468 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 p -62.02 -34.16 75.69 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.559 1.527 . . . . 0.0 111.264 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -63.93 -47.03 82.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.677 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.3 t -57.21 -47.15 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.309 0.958 . . . . 0.0 109.462 173.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.8 -41.54 77.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.404 0.682 . . . . 0.0 110.555 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.89 -42.09 77.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.216 0.606 . . . . 0.0 111.84 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.62 -31.52 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 118.341 -0.837 . . . . 0.0 110.635 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -58.55 -36.2 73.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.991 1.269 . . . . 0.0 111.159 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.32 -43.07 71.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.939 0.336 . . . . 0.0 110.548 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.22 -178.29 30.76 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.848 0.737 . . . . 0.0 111.666 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.4 p -63.53 159.33 52.28 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 0.0 110.622 177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.17 -26.17 25.58 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.519 2.813 . . . . 0.0 115.333 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.28 -7.39 24.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 112.198 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.7 p -74.84 167.68 21.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.575 0.702 . . . . 0.0 110.863 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -139.39 77.86 1.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -59.51 140.07 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.4 p -123.65 -21.29 5.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.415 1.086 . . . . 0.0 111.547 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.23 154.86 31.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.886 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.08 145.88 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.564 1.546 . . . . 0.0 107.53 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -141.15 157.4 45.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.33 1.452 . . . . 0.0 109.123 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.54 145.63 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.803 1.241 . . . . 0.0 108.738 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 m -136.52 166.05 24.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.329 2.251 . . . . 0.0 106.095 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.2 163.56 33.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.633 -1.292 . . . . 0.0 111.287 -174.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.6 m -148.14 146.91 28.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.279 1.832 . . . . 0.0 108.284 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -81.64 -34.13 31.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.055 -0.403 . . . . 0.0 110.693 172.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.4 m -65.61 155.96 34.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.001 0.921 . . . . 0.0 109.679 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 164.52 37.95 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.536 1.535 . . . . 0.0 108.831 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -80.98 -34.65 32.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.877 0.762 . . . . 0.0 110.947 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.82 21.53 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.192 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . 0.251 30.1 p80 47.07 42.54 12.93 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.891 2.077 . . . . 0.0 114.188 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.52 -49.98 35.73 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.24 173.76 12.96 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.337 1.455 . . . . 0.0 109.458 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -122.65 100.11 6.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.584 1.084 . . . . 0.0 109.637 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 136.89 35.32 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.919 0.488 . . . . 0.0 110.766 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.6 mt -84.72 126.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 153.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 100.0 t . . . . . 0 C--O 1.237 0.43 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.033 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpt . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.6 tp -153.37 164.88 37.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.563 1.145 . . . . 0.0 109.409 -172.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -117.87 138.27 52.23 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.661 1.584 . . . . 0.0 107.697 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -114.65 155.54 26.39 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.072 1.349 . . . . 0.0 107.36 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -127.51 140.95 51.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 162.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.05 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.08 137.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -171.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -142.76 156.75 45.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.769 1.228 . . . . 0.0 110.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.67 -155.85 24.44 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.509 1.528 . . . . 0.0 110.082 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -74.35 82.25 1.9 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 159.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.96 21.87 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.884 1.274 . . . . 0.0 110.201 -174.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -137.72 149.79 46.77 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.503 1.121 . . . . 0.0 108.358 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.62 74.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.591 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.78 -10.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.376 1.071 . . . . 0.0 111.949 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 23.34 13.69 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.124 1.345 . . . . 0.0 110.243 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.16 -39.14 93.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.506 1.653 . . . . 0.0 110.48 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -55.51 -47.36 76.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.757 0.708 . . . . 0.0 111.448 171.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -68.01 -39.08 83.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.411 0.551 . . . . 0.0 111.291 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -56.29 -54.16 48.66 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 173.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.38 -39.64 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.388 0.54 . . . . 0.0 110.461 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -56.22 -47.52 78.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 0.0 109.943 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.6 mtm -73.78 -34.96 64.89 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.447 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.37 -43.85 93.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.503 1.047 . . . . 0.0 109.869 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.76 92.15 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.227 0.467 . . . . 0.0 110.727 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.21 -47.7 84.86 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.753 0.821 . . . . 0.0 110.304 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -61.2 -41.97 97.77 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.859 0.863 . . . . 0.0 111.007 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -74.98 -3.71 33.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.811 0.844 . . . . 0.0 112.37 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 49.52 35.17 7.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.098 1.759 . . . . 0.0 112.251 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.37 170.68 16.25 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 110.158 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.29 153.49 46.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.349 1.46 . . . . 0.0 107.583 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.15 -155.85 26.72 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.762 1.164 . . . . 0.0 113.67 -171.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.46 165.99 25.99 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.301 0.64 . . . . 0.0 112.542 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.4 144.65 36.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.819 1.248 . . . . 0.0 107.759 161.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.32 158.65 43.46 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.464 1.106 . . . . 0.0 108.265 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.74 118.51 25.73 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -94.13 153.5 18.07 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.829 0.852 . . . . 0.0 110.421 -155.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.48 -29.09 70.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.606 0.362 . . . . 0.0 111.953 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.87 -9.79 47.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.49 -19.63 26.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.441 1.019 . . . . 0.0 113.321 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -83.75 154.73 23.43 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.674 1.237 . . . . 0.0 109.995 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.95 150.64 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 162.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -132.06 141.43 49.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -135.26 144.1 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -134.25 126.01 28.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.5 149.43 48.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -137.11 130.8 31.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.35 -173.54 43.71 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -170.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.85 149.19 59.56 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.481 2.12 . . . . 0.0 110.031 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.97 -34.16 71.49 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.121 0.969 . . . . 0.0 111.939 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.16 -40.52 82.33 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.035 -1.041 . . . . 0.0 111.673 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -41.28 83.36 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.52 -41.58 96.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.05 -49.79 76.26 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.444 0.565 . . . . 0.0 110.362 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 m -65.22 -29.66 70.48 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.961 -0.462 . . . . 0.0 111.446 -177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -68.58 -45.17 72.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.403 1.081 . . . . 0.0 110.461 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.8 -49.18 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.641 1.11 . . . . 0.0 109.038 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -56.86 -41.69 78.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.763 0.825 . . . . 0.0 110.608 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.36 -48.13 74.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.827 0.451 . . . . 0.0 111.553 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.97 -30.15 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.838 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -59.05 -23.33 61.91 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.127 1.33 . . . . 0.0 112.191 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -68.25 -34.87 77.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.6 0.636 . . . . 0.0 111.582 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.36 171.9 3.41 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.252 0.93 . . . . 0.0 112.082 -164.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 157.59 65.71 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 121.88 -0.776 . . . . 0.0 110.157 171.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.69 -31.69 61.77 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.123 2.549 . . . . 0.0 113.66 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.46 1.92 39.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.52 1.528 . . . . 0.0 112.759 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 m -128.03 167.11 17.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.854 0.862 . . . . 0.0 110.759 -158.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -146.19 92.95 2.25 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.87 142.78 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 161.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.6 p -128.47 -17.03 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.958 1.303 . . . . 0.0 111.226 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -150.39 148.73 29.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 108.918 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.26 143.85 13.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.653 1.181 . . . . 0.0 107.919 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -142.97 154.46 44.06 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.263 1.425 . . . . 0.0 108.656 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.83 145.73 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.517 1.127 . . . . 0.0 108.293 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.33 162.6 32.57 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.892 2.077 . . . . 0.0 106.686 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -134.66 157.87 45.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.596 1.158 . . . . 0.0 109.759 -172.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -160.06 162.99 34.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.12 1.368 . . . . 0.0 109.623 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -120.05 -12.86 9.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.954 0.902 . . . . 0.0 111.561 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.8 m -78.25 68.6 4.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.436 1.095 . . . . 0.0 109.507 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.67 148.27 7.48 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.226 1.011 . . . . 0.0 111.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -71.65 -35.09 70.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.252 1.021 . . . . 0.0 109.335 163.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.76 44.73 3.84 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.356 0.979 . . . . 0.0 111.149 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -60.46 157.29 14.33 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.494 0.718 . . . . 0.0 110.612 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.22 -6.19 5.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.57 1.148 . . . . 0.0 111.901 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.75 171.12 14.54 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.447 1.899 . . . . 0.0 106.833 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -117.19 135.38 53.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -138.91 144.63 39.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.51 141.04 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 126.765 2.026 . . . . 0.0 106.607 -178.001 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.5 mtp . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.05 151.0 43.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 108.887 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -114.92 140.43 49.0 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -124.93 154.95 40.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.317 1.447 . . . . 0.0 108.938 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.34 138.67 52.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 159.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.79 143.38 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 mm -129.58 138.15 54.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.59 147.85 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -143.29 156.75 44.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.519 1.128 . . . . 0.0 110.027 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.65 -154.23 23.55 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.481 1.515 . . . . 0.0 110.138 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.63 89.37 1.31 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 158.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.62 18.46 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.997 0.919 . . . . 0.0 111.392 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -138.81 153.82 48.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.137 0.975 . . . . 0.0 109.186 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.24 32.17 81.34 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -133.47 -8.0 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 111.695 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.81 24.5 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.67 -44.5 85.77 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.424 1.612 . . . . 0.0 109.882 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -53.89 -49.55 68.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.611 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -61.78 -49.05 77.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.355 0.525 . . . . 0.0 110.681 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -62.89 -41.77 99.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.082 0.401 . . . . 0.0 110.855 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.98 -40.8 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.909 0.777 . . . . 0.0 110.249 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -59.91 -48.4 81.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.224 0.92 . . . . 0.0 109.531 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.9 ptm -70.81 -32.03 68.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.316 0.507 . . . . 0.0 111.67 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -69.48 -28.24 65.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.458 1.026 . . . . 0.0 111.84 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.4 -44.35 52.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.932 0.493 . . . . 0.0 109.833 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.42 -42.15 98.3 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 123.967 0.907 . . . . 0.0 111.291 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -6.54 35.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -113.06 2.27 15.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.871 1.668 . . . . 0.0 111.34 171.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.28 38.45 5.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.537 1.535 . . . . 0.0 112.037 -169.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.75 165.68 14.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.76 156.5 44.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.516 1.127 . . . . 0.0 108.011 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.79 -154.79 26.16 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.223 0.919 . . . . 0.0 112.692 -170.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -145.92 167.53 23.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.102 -0.646 . . . . 0.0 112.625 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.48 145.68 30.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.775 1.23 . . . . 0.0 108.456 167.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.71 160.16 40.75 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 108.045 170.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -125.9 113.54 17.34 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -86.48 153.25 22.0 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.236 1.014 . . . . 0.0 110.193 -157.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -29.47 70.45 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.631 0.372 . . . . 0.0 111.878 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.99 -9.24 43.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.97 -20.2 26.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.505 1.05 . . . . 0.0 113.331 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.3 mtm180 -80.03 154.66 28.02 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.692 1.246 . . . . 0.0 110.045 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.88 150.67 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 161.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -134.07 142.33 47.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -139.61 150.07 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -134.7 128.81 33.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.25 44.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.12 0.873 . . . . 0.0 109.412 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -140.41 136.09 32.73 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 107.881 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.46 43.24 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.962 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.3 138.32 42.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.267 1.978 . . . . 0.0 109.411 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.54 -30.37 67.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 113.018 -168.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -69.75 -46.53 65.65 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.763 -1.211 . . . . 0.0 111.647 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.19 -39.02 89.37 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 tp -61.53 -47.73 84.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.156 0.982 . . . . 0.0 110.167 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -60.14 -44.41 94.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.75 0.42 . . . . 0.0 110.872 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m -62.48 -38.6 90.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.495 0.589 . . . . 0.0 111.179 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -61.28 -44.7 96.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.518 -0.739 . . . . 0.0 110.161 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.4 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.542 1.065 . . . . 0.0 110.15 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -55.5 -39.55 70.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.671 1.123 . . . . 0.0 110.495 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.73 82.73 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.171 0.588 . . . . 0.0 111.471 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.33 -31.41 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.758 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -61.64 -33.36 73.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.054 1.297 . . . . 0.0 111.533 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -71.58 -45.35 62.47 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.704 0.684 . . . . 0.0 109.999 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.39 -156.77 34.0 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -170.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.9 p -62.04 168.83 3.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 122.699 0.4 . . . . 0.0 110.573 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.35 -10.08 1.97 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.53 2.82 . . . . 0.0 114.763 165.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -124.04 -0.77 8.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.263 1.425 . . . . 0.0 111.799 -171.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -77.18 166.22 23.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.082 0.953 . . . . 0.0 112.006 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -142.75 88.38 2.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 159.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.02 142.19 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -123.77 -18.32 6.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.287 1.035 . . . . 0.0 111.091 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -153.3 149.87 28.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.276 1.031 . . . . 0.0 109.241 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.74 144.22 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -139.75 152.22 46.45 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.122 1.369 . . . . 0.0 108.566 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -136.45 145.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.724 1.209 . . . . 0.0 108.169 -176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -132.3 160.35 36.5 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 167.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.43 161.75 37.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.281 0.946 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 m -142.84 124.79 15.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.86 11.77 3.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.76 0.824 . . . . 0.0 112.234 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -138.39 143.69 39.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.992 1.717 . . . . 0.0 106.936 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 mt -84.49 159.17 20.79 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.824 0.45 . . . . 0.0 110.658 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.02 -37.67 38.56 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 156.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 50.14 1.59 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.229 0.918 . . . . 0.0 111.386 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -58.01 144.89 38.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.524 0.729 . . . . 0.0 110.191 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -86.59 -28.2 23.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.246 0.618 . . . . 0.0 112.193 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -151.97 -178.75 6.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.783 1.633 . . . . 0.0 108.808 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -114.28 127.82 56.06 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -132.65 139.87 47.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.563 0.696 . . . . 0.0 112.464 -166.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.1 mt -76.7 131.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -135.32 167.24 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 0.0 109.142 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.69 -1.08 2.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.927 0.891 . . . . 0.0 111.979 -171.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.033 1.333 . . . . 0.0 110.268 -179.418 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.8 mt -136.7 170.52 15.94 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.673 1.589 . . . . 0.0 108.266 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -117.96 138.85 51.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 106.335 166.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.58 155.68 28.3 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.265 1.426 . . . . 0.0 107.304 167.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -124.48 139.66 53.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 162.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 mt -134.36 140.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.87 139.49 51.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.0 144.2 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -138.11 156.16 48.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.809 1.244 . . . . 0.0 110.033 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.43 -154.54 22.51 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.416 1.484 . . . . 0.0 110.44 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -72.55 82.65 1.11 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.8 m -135.07 18.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.274 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -137.01 146.86 45.8 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.949 0.9 . . . . 0.0 108.653 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.6 33.13 83.58 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -134.7 -9.23 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.702 1.201 . . . . 0.0 111.824 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.12 20.58 15.59 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.217 1.389 . . . . 0.0 110.468 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.59 -41.86 98.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.995 1.398 . . . . 0.0 110.43 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -54.48 -49.0 71.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.789 0.722 . . . . 0.0 111.473 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -66.75 -42.04 86.83 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.308 0.504 . . . . 0.0 111.231 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.22 -51.67 67.24 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.082 0.553 . . . . 0.0 110.22 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.68 -41.5 88.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.091 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -58.44 -45.53 88.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.797 0.726 . . . . 0.0 109.902 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.4 mtm -74.01 -33.85 63.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.743 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -66.67 -40.14 88.46 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.867 1.212 . . . . 0.0 110.249 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.17 97.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.172 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.81 -44.49 93.97 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.761 0.824 . . . . 0.0 110.832 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -58.89 -41.22 86.66 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.253 1.021 . . . . 0.0 111.182 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -86.22 0.93 52.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.371 -0.823 . . . . 0.0 113.161 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mptt 49.67 37.15 12.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.572 1.549 . . . . 0.0 111.933 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.87 165.71 22.66 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.837 0.855 . . . . 0.0 109.584 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.85 165.02 14.16 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.522 1.129 . . . . 0.0 108.058 165.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.84 -154.39 24.81 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 118.856 0.753 . . . . 0.0 112.335 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -153.81 167.59 29.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 112.049 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -137.07 145.2 30.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 108.796 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -140.44 164.52 29.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.258 1.023 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.2 109.19 12.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -76.15 152.93 36.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.473 0.709 . . . . 0.0 111.056 -157.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.28 -27.58 69.43 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.884 0.474 . . . . 0.0 111.25 164.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -14.58 19.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.323 1.849 . . . . 0.0 112.853 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -9.01 50.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.125 0.869 . . . . 0.0 113.165 167.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -104.91 156.09 18.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.592 1.157 . . . . 0.0 109.226 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.45 147.27 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 168.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -133.28 135.56 44.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -136.46 146.07 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -172.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 tt -135.87 126.96 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 167.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.04 152.34 49.97 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.644 0.778 . . . . 0.0 109.339 -172.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -141.17 133.93 28.81 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.67 1.188 . . . . 0.0 107.949 -169.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.93 -171.46 40.34 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.547 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.29 156.88 54.49 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.798 2.332 . . . . 0.0 110.666 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -58.54 -44.8 89.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.588 0.755 . . . . 0.0 111.124 -173.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.74 -39.53 89.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.89 0.768 . . . . 0.0 111.928 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.62 -47.51 72.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.7 -38.82 92.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.1 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.5 -51.95 66.53 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.62 0.768 . . . . 0.0 110.184 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 m -62.15 -38.93 90.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.418 0.554 . . . . 0.0 110.893 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.19 -44.06 97.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.109 0.964 . . . . 0.0 110.403 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 t -57.81 -47.98 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.325 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.63 -40.47 75.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.663 1.12 . . . . 0.0 111.18 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.1 82.69 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.141 0.576 . . . . 0.0 110.882 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.5 t -63.28 -28.09 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.035 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -59.32 -37.67 78.36 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.563 1.528 . . . . 0.0 110.921 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.08 -42.77 56.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.222 0.465 . . . . 0.0 110.421 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.64 -174.18 51.04 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.54 160.09 28.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.076 0.55 . . . . 0.0 110.588 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.16 -32.9 51.84 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.124 2.549 . . . . 0.0 113.771 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -88.43 -7.31 56.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.66 1.184 . . . . 0.0 112.763 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -91.91 168.75 11.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.943 1.297 . . . . 0.0 110.725 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -145.24 95.86 2.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 165.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.6 t -63.79 145.19 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.7 p -123.11 -21.85 5.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.311 1.044 . . . . 0.0 111.192 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -154.79 153.12 30.71 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.149 0.98 . . . . 0.0 109.469 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.78 146.0 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.352 1.461 . . . . 0.0 107.402 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.5 m -139.37 151.01 45.99 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.153 1.381 . . . . 0.0 108.369 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.15 145.41 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.403 1.081 . . . . 0.0 108.239 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -136.32 161.03 36.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 106.173 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -149.28 163.18 38.42 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.131 -0.981 . . . . 0.0 111.527 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -149.17 148.23 29.38 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.583 1.953 . . . . 0.0 108.536 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -72.58 -40.54 66.51 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.038 168.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 m -61.63 145.24 52.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.937 0.895 . . . . 0.0 109.13 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.6 157.16 42.67 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.527 1.531 . . . . 0.0 108.645 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.12 -33.39 56.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.695 0.798 . . . . 0.0 110.114 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.45 49.51 14.81 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -169.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -54.72 151.06 8.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.101 0.96 . . . . 0.0 111.789 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -76.51 -19.36 58.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -150.54 178.3 9.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.656 1.582 . . . . 0.0 108.415 -172.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.38 116.42 31.94 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 153.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.7 m -117.18 142.31 47.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 111.996 -167.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.16 135.57 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 162.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.26 175.73 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.926 1.29 . . . . 0.0 108.303 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -134.82 2.98 3.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.961 0.904 . . . . 0.0 112.299 -169.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 125.706 1.602 . . . . 0.0 107.501 -176.011 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.5 mt -137.83 -179.96 6.07 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.004 1.322 . . . . 0.0 109.5 -167.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -130.55 132.14 45.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.648 1.979 . . . . 0.0 107.229 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.67 155.48 28.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -120.42 143.81 48.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 158.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.0 mt -132.72 142.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mm -131.35 136.79 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.1 147.64 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.32 156.93 44.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.56 -153.93 23.89 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.383 1.468 . . . . 0.0 110.374 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -72.38 84.75 1.09 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.02 19.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.101 0.96 . . . . 0.0 110.994 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -138.54 149.18 45.06 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 109.053 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.38 31.27 79.83 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -134.7 -9.85 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.654 1.181 . . . . 0.0 111.731 -173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.78 22.79 17.18 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.932 1.253 . . . . 0.0 110.119 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -64.08 -39.6 94.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.239 1.52 . . . . 0.0 110.243 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -55.51 -46.19 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.904 0.774 . . . . 0.0 111.695 172.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -68.58 -40.39 80.57 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.508 0.594 . . . . 0.0 111.108 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -56.03 -51.65 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.388 0.54 . . . . 0.0 110.151 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.21 -41.35 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 118.954 -0.546 . . . . 0.0 110.211 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.79 -46.13 88.27 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.826 0.739 . . . . 0.0 110.329 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.9 mtm -72.62 -35.97 67.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.347 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -67.0 -39.36 87.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.677 1.126 . . . . 0.0 110.292 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.32 97.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.177 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.31 -45.05 93.17 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.389 0.676 . . . . 0.0 110.685 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -59.48 -33.85 71.84 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.902 0.881 . . . . 0.0 111.311 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -89.7 1.73 55.69 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.675 1.19 . . . . 0.0 112.839 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm 41.33 38.88 0.88 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.115 2.166 . . . . 0.0 112.503 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.06 165.75 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.816 0.846 . . . . 0.0 109.406 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.19 14.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 162.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.49 -163.53 29.27 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.881 0.764 . . . . 0.0 113.332 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -147.01 166.4 26.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 122.214 -0.58 . . . . 0.0 111.623 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.76 144.06 34.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.526 1.13 . . . . 0.0 109.047 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -139.25 161.94 36.2 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.48 1.112 . . . . 0.0 108.653 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -125.54 111.43 15.03 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.28 153.08 23.76 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.799 1.239 . . . . 0.0 110.383 -157.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.77 -29.32 70.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.94 -10.29 52.17 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.47 -22.62 17.08 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.427 1.013 . . . . 0.0 113.292 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -78.28 154.76 30.66 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.67 1.235 . . . . 0.0 110.327 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.61 148.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.07 135.02 43.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.57 143.15 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.72 125.28 22.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.88 43.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.65 0.78 . . . . 0.0 110.121 -171.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -139.09 143.52 38.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.822 1.249 . . . . 0.0 108.138 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.89 -171.8 39.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.321 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 152.61 57.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.687 2.258 . . . . 0.0 110.712 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.94 -34.52 76.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.62 0.768 . . . . 0.0 112.133 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.22 -40.4 77.99 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.025 -1.047 . . . . 0.0 111.476 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.83 85.74 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.95 -42.19 90.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.968 0.507 . . . . 0.0 110.621 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.98 -51.58 69.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.797 0.726 . . . . 0.0 110.789 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 p -66.45 -31.67 72.56 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.871 -0.518 . . . . 0.0 111.316 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.22 -43.35 99.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.72 171.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.54 -49.56 80.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 119.539 1.063 . . . . 0.0 108.744 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.81 -39.25 73.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.395 0.998 . . . . 0.0 111.464 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.13 -44.12 85.13 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 110.61 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.36 -30.87 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.455 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -59.49 -45.84 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.873 1.67 . . . . 0.0 109.988 172.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.3 -38.48 85.05 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.58 0.352 . . . . 0.0 111.27 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 177.06 27.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.113 0.863 . . . . 0.0 112.041 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.48 153.17 90.83 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.278 -0.542 . . . . 0.0 110.589 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.65 -31.48 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.195 2.597 . . . . 0.0 114.16 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -92.13 10.79 27.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.988 1.315 . . . . 0.0 111.991 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -128.58 169.07 14.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.417 1.487 . . . . 0.0 109.882 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -147.02 96.18 2.69 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.66 140.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.8 p -126.93 -14.17 5.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 111.268 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.51 150.63 29.79 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 109.17 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.86 147.7 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.866 1.266 . . . . 0.0 107.846 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -143.6 161.58 38.13 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.521 1.528 . . . . 0.0 108.753 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.6 t -138.39 149.23 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.609 1.164 . . . . 0.0 108.141 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.36 161.78 33.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.548 1.939 . . . . 0.0 106.189 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -140.79 158.09 44.47 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 120.943 -1.098 . . . . 0.0 111.034 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 m -134.92 138.27 43.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 156.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -89.44 24.09 2.36 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.207 -0.933 . . . . 0.0 111.171 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -142.12 179.27 7.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.822 2.449 . . . . 0.0 106.973 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -144.92 156.32 43.92 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.528 1.131 . . . . 0.0 109.405 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.8 -5.13 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -164.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.21 -3.1 0.79 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 120.036 1.289 . . . . 0.0 115.125 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -48.76 113.6 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.761 1.624 . . . . 0.0 112.126 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -150.93 -49.1 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.372 1.069 . . . . 0.0 111.115 173.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -152.92 -179.57 7.78 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 108.976 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -115.65 137.5 52.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -139.74 139.84 36.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.62 137.59 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 163.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.21 174.21 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.048 1.339 . . . . 0.0 108.316 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -134.69 5.03 3.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.873 0.869 . . . . 0.0 112.231 -168.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.248 1.004 0 C-N-CA 125.824 1.65 . . . . 0.0 107.387 -177.258 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt -139.01 166.35 24.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.751 1.621 . . . . 0.0 108.953 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -112.15 138.61 48.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.606 1.563 . . . . 0.0 106.921 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -119.16 154.91 32.56 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.721 1.608 . . . . 0.0 107.051 166.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -127.9 138.73 52.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 165.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.64 143.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mm -131.68 136.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.91 150.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -143.57 158.28 43.78 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.981 1.313 . . . . 0.0 109.65 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.65 -155.54 24.86 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.436 1.493 . . . . 0.0 110.094 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -75.91 87.36 2.87 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 159.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.11 19.81 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.846 0.859 . . . . 0.0 111.282 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.68 151.97 46.34 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.365 1.066 . . . . 0.0 108.146 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.33 32.12 82.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.78 -1.63 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.513 1.525 . . . . 0.0 111.435 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.68 25.58 34.98 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.457 -1.191 . . . . 0.0 110.127 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.9 -47.5 80.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.268 1.534 . . . . 0.0 109.935 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -62.83 -41.12 99.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.038 0.835 . . . . 0.0 110.64 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -61.97 -45.19 94.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.764 0.425 . . . . 0.0 110.705 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -58.72 -51.02 71.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.242 0.617 . . . . 0.0 110.177 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.96 -39.45 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.219 0.463 . . . . 0.0 110.493 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -58.81 -47.13 85.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.931 0.787 . . . . 0.0 110.55 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -77.11 -30.75 55.39 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.903 0.774 . . . . 0.0 111.719 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.05 -31.65 69.37 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.194 0.906 . . . . 0.0 111.027 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.69 71.19 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.282 0.492 . . . . 0.0 109.885 168.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.71 -42.98 99.67 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.53 0.732 . . . . 0.0 111.571 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -12.6 60.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -115.36 8.0 15.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.678 1.191 . . . . 0.0 111.633 171.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 41.91 42.18 2.17 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.463 1.905 . . . . 0.0 112.52 -173.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.61 166.03 7.38 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.212 0.605 . . . . 0.0 109.856 166.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.85 154.41 45.51 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.63 1.172 . . . . 0.0 107.987 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.82 -161.37 28.67 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 119.282 0.946 . . . . 0.0 112.896 -171.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.55 166.81 25.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 168.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.49 146.35 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 109.281 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -147.1 163.91 34.78 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -124.86 153.9 41.88 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -123.9 151.18 43.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.289 -144.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.0 -27.19 68.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 111.117 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.5 -16.85 40.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.601 1.96 . . . . 0.0 113.135 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -28.16 15.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.93 1.729 . . . . 0.0 111.838 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.1 mtt85 -74.05 168.18 20.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.699 0.799 . . . . 0.0 111.517 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.64 150.01 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 158.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.79 140.87 46.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mt -139.04 147.0 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.08 127.0 29.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 168.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.05 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.696 0.68 . . . . 0.0 109.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.73 133.85 31.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.78 -169.35 40.08 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.592 -172.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.25 152.76 61.78 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.316 2.011 . . . . 0.0 110.216 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.21 -42.46 81.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.884 0.874 . . . . 0.0 110.93 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.57 -42.88 99.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.264 0.484 . . . . 0.0 111.574 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.56 82.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.673 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -38.34 82.1 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 110.988 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -64.91 -49.94 68.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.592 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -57.76 -39.14 76.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.209 1.368 . . . . 0.0 111.409 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.03 -46.42 84.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.903 0.881 . . . . 0.0 109.927 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 118.953 0.797 . . . . 0.0 109.822 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.06 -40.67 73.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.607 0.763 . . . . 0.0 110.538 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.56 72.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.898 0.879 . . . . 0.0 111.416 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.21 -26.29 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.187 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -57.12 -34.81 68.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.322 1.419 . . . . 0.0 111.223 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -82.12 -41.51 20.38 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.114 0.416 . . . . 0.0 111.01 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.85 -166.11 54.72 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -164.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.8 p -60.71 167.46 3.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.915 0.486 . . . . 0.0 111.451 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.45 -15.04 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.775 2.983 . . . . 0.0 115.252 168.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -115.44 -7.15 12.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.532 1.133 . . . . 0.0 111.903 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -70.74 163.67 26.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.652 0.739 . . . . 0.0 111.014 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -142.77 88.79 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 161.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.82 142.67 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 p -125.49 -18.13 5.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.403 1.081 . . . . 0.0 111.15 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.56 149.62 28.68 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.312 1.045 . . . . 0.0 109.123 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 tt -152.91 145.31 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.844 1.258 . . . . 0.0 107.936 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -142.06 152.4 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.357 1.463 . . . . 0.0 108.524 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.13 145.47 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.756 1.223 . . . . 0.0 107.895 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.91 161.8 35.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.456 1.902 . . . . 0.0 106.416 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -138.82 163.65 31.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.01 0.924 . . . . 0.0 110.364 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -154.53 147.59 24.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.342 166.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.98 -41.71 58.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 m -60.26 156.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.3 mt -129.29 149.8 50.93 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.812 1.245 . . . . 0.0 109.036 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -75.94 -34.34 59.86 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.5 0.72 . . . . 0.0 109.248 161.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 41.37 5.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.212 0.911 . . . . 0.0 111.292 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -57.77 149.06 23.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.932 0.866 . . . . 0.0 109.828 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -118.73 -6.52 10.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.41 1.084 . . . . 0.0 112.129 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -148.96 176.75 10.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.959 1.704 . . . . 0.0 107.706 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -110.72 135.95 50.53 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -136.75 139.5 41.89 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.645 0.736 . . . . 0.0 112.755 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -74.17 134.64 29.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 161.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.91 169.12 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.343 1.057 . . . . 0.0 108.907 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -137.48 22.51 2.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.133 0.973 . . . . 0.0 110.998 -166.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.249 1.031 0 C-N-CA 126.007 1.723 . . . . 0.0 111.359 -178.157 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.72 176.54 7.17 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.532 1.933 . . . . 0.0 107.7 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -125.31 137.0 54.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -118.87 159.06 24.46 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.031 1.732 . . . . 0.0 108.052 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -129.32 140.55 51.36 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -134.27 139.22 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -173.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.9 mm -127.29 138.83 53.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.47 146.64 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -140.5 156.92 46.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.12 1.368 . . . . 0.0 109.913 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.5 22.68 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.402 1.477 . . . . 0.0 110.193 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -73.33 82.32 1.39 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.67 19.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.763 0.825 . . . . 0.0 111.074 -171.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -137.05 147.13 45.98 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.61 33.14 86.43 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.41 -1.38 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.095 1.358 . . . . 0.0 111.238 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 26.71 34.96 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.16 -46.83 82.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.312 1.556 . . . . 0.0 109.697 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -55.91 -45.1 78.79 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.614 -0.679 . . . . 0.0 111.488 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -65.95 -43.24 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.718 0.407 . . . . 0.0 110.859 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.57 -51.7 68.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.396 0.679 . . . . 0.0 110.174 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.68 -40.83 88.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 118.329 0.513 . . . . 0.0 110.386 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.74 -43.68 85.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.494 0.718 . . . . 0.0 110.898 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.8 mtm -74.27 -37.15 63.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.62 0.646 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.2 -37.36 87.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.613 1.097 . . . . 0.0 110.312 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.36 81.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.974 0.51 . . . . 0.0 110.564 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -58.61 -44.21 89.86 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -56.26 -26.11 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.974 1.71 . . . . 0.0 112.499 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -118.93 12.17 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.405 1.082 . . . . 0.0 112.049 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 43.53 43.06 4.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.087 1.755 . . . . 0.0 112.175 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.11 165.55 9.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.879 0.472 . . . . 0.0 109.819 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.25 158.62 20.27 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 162.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.06 -160.96 27.86 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 118.687 0.676 . . . . 0.0 112.774 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.73 168.0 26.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.242 -0.563 . . . . 0.0 112.387 171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.92 144.85 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.171 1.388 . . . . 0.0 108.63 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -143.4 160.52 40.39 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.02 112.22 16.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.5 mtp85 -85.18 155.72 21.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.818 1.247 . . . . 0.0 110.618 -154.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.89 -27.76 69.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.628 0.371 . . . . 0.0 111.882 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -6.42 38.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.924 0.89 . . . . 0.0 113.184 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.07 -15.95 46.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.485 1.041 . . . . 0.0 113.586 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -88.12 155.8 19.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.18 1.49 . . . . 0.0 109.974 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.02 149.91 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 162.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.17 153.68 51.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.972 0.891 . . . . 0.0 109.8 157.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -142.79 146.13 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -171.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.2 154.63 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.241 0.616 . . . . 0.0 109.907 -169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -138.79 131.96 29.86 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.391 1.476 . . . . 0.0 107.376 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.72 178.79 42.31 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.34 156.18 66.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 110.24 171.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.99 -35.53 77.07 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.335 0.654 . . . . 0.0 111.979 -171.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.96 -36.57 80.32 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.924 -1.11 . . . . 0.0 111.686 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.47 72.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.66 -37.97 88.03 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.851 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.01 -50.08 75.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.76 0.709 . . . . 0.0 110.626 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 m -61.57 -37.86 85.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.515 0.598 . . . . 0.0 111.025 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -63.62 -45.66 89.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.015 0.926 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.09 -48.5 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.174 0.897 . . . . 0.0 109.526 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -56.55 -40.83 75.81 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.588 0.755 . . . . 0.0 110.548 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.26 74.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.534 0.734 . . . . 0.0 111.578 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.78 -26.98 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.201 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -57.72 -33.43 68.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.263 1.392 . . . . 0.0 111.355 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.42 -42.04 26.3 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.329 0.513 . . . . 0.0 110.949 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.33 -166.81 54.52 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -165.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.4 p -60.65 167.41 3.36 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 122.915 0.486 . . . . 0.0 111.326 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.43 -15.18 3.65 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.669 2.913 . . . . 0.0 115.175 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -114.1 -7.98 13.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.56 1.144 . . . . 0.0 111.788 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.2 m -72.03 162.99 28.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.699 0.8 . . . . 0.0 110.994 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -143.31 89.4 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 161.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.8 143.88 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.6 p -124.76 -19.36 5.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.32 1.048 . . . . 0.0 111.207 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -153.77 150.73 28.8 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 109.172 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.7 146.07 15.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.02 1.328 . . . . 0.0 107.703 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 m -140.5 152.82 45.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.154 1.382 . . . . 0.0 108.426 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.8 t -137.76 145.47 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -134.32 159.16 41.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.54 1.936 . . . . 0.0 106.042 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -145.88 167.48 23.14 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.899 0.879 . . . . 0.0 110.102 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -140.09 173.45 11.51 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.133 1.373 . . . . 0.0 109.595 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -122.82 19.39 10.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.643 1.577 . . . . 0.0 109.715 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.0 m -135.87 167.27 21.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.176 1.79 . . . . 0.0 108.178 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -134.56 163.59 29.39 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.3 -25.32 4.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.063 1.745 . . . . 0.0 109.443 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.33 56.38 6.92 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.241 0.924 . . . . 0.0 111.189 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -57.6 150.77 18.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.165 0.482 . . . . 0.0 110.455 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -68.3 -26.97 65.9 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -161.34 -173.74 3.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.835 2.054 . . . . 0.0 107.445 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -99.29 132.82 44.35 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 165.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -136.42 139.91 42.78 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -171.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.63 133.38 31.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 161.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.1 m -134.19 166.27 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 0.0 109.663 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -136.27 8.38 3.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.688 1.195 . . . . 0.0 111.105 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.78 1.632 . . . . 0.0 110.636 -178.299 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 tp -146.05 162.31 38.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.045 1.338 . . . . 0.0 109.001 -166.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.15 138.01 52.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.423 1.489 . . . . 0.0 107.449 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -119.41 156.97 29.16 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.039 1.735 . . . . 0.0 108.419 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -122.78 139.68 53.73 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.77 144.55 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.85 138.11 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.46 147.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -141.95 157.89 44.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.492 1.117 . . . . 0.0 109.991 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.61 -157.33 23.58 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.932 1.729 . . . . 0.0 109.314 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.8 ttp-105 -72.36 85.19 1.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 159.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.51 19.85 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.667 1.187 . . . . 0.0 110.263 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -137.46 143.26 41.69 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.401 -0.812 . . . . 0.0 109.36 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.09 32.37 76.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.51 -7.32 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.785 1.234 . . . . 0.0 111.089 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.96 30.24 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.33 -43.8 83.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.936 1.368 . . . . 0.0 109.758 -173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -59.74 -41.17 90.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.806 0.73 . . . . 0.0 111.705 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.25 -45.01 77.96 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.646 0.657 . . . . 0.0 110.289 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -62.72 -40.11 96.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.955 0.798 . . . . 0.0 110.909 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.2 -38.98 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.106 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.85 -42.42 99.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.215 1.371 . . . . 0.0 110.505 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.64 -38.19 83.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.251 0.932 . . . . 0.0 110.451 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -66.41 -39.67 89.14 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.48 0.712 . . . . 0.0 109.999 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.69 -38.45 91.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.668 0.787 . . . . 0.0 110.327 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.02 -45.27 86.19 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 110.696 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -60.17 -18.23 46.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.919 1.287 . . . . 0.0 112.005 174.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -111.23 7.0 21.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.828 1.651 . . . . 0.0 112.499 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 38.72 40.07 0.38 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.765 2.426 . . . . 0.0 113.271 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -74.63 169.38 17.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.498 1.119 . . . . 0.0 110.237 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.1 164.76 18.01 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 160.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.68 -150.78 23.05 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.723 0.692 . . . . 0.0 112.004 -175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -155.81 170.96 20.87 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.065 0.946 . . . . 0.0 110.855 167.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.43 139.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.516 1.526 . . . . 0.0 107.79 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.59 157.84 45.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.197 1.399 . . . . 0.0 108.85 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.85 114.42 18.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -90.92 153.98 19.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.989 0.916 . . . . 0.0 110.759 -155.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.24 -27.35 68.6 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.049 0.54 . . . . 0.0 111.997 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -7.5 40.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.044 0.938 . . . . 0.0 112.929 175.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.36 -12.86 47.94 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.69 1.138 . . . . 0.0 113.352 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -90.77 154.81 19.25 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.98 1.39 . . . . 0.0 109.603 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.7 151.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -134.49 144.72 48.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.03 145.63 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -137.03 117.67 13.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.23 151.87 46.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.407 0.683 . . . . 0.0 109.933 -165.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -140.95 137.31 32.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.531 1.132 . . . . 0.0 108.583 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 -174.11 43.33 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.27 154.47 69.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.013 1.809 . . . . 0.0 110.263 169.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.67 -41.38 90.53 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.408 0.683 . . . . 0.0 111.442 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.36 -39.59 94.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.587 0.631 . . . . 0.0 111.729 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -40.0 83.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -67.84 -36.76 80.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.076 0.398 . . . . 0.0 111.39 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -64.66 -49.19 71.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.248 0.931 . . . . 0.0 110.285 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 p -66.13 -29.38 69.67 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.729 -0.607 . . . . 0.0 111.352 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -63.66 -43.84 95.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.364 -0.827 . . . . 0.0 110.853 170.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.23 -44.09 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.827 1.194 . . . . 0.0 109.319 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.37 -36.55 78.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.136 0.88 . . . . 0.0 111.545 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.28 -50.1 55.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.804 0.442 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.61 -43.29 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.817 0.847 . . . . 0.0 109.873 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -18.8 62.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.499 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -78.24 -43.66 27.66 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.384 0.993 . . . . 0.0 110.403 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.35 -179.48 25.0 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.606 1.098 . . . . 0.0 111.636 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.5 p -74.23 166.92 40.53 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 122.13 -0.63 . . . . 0.0 109.677 168.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.44 -21.66 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.83 1.687 . . . . 0.0 112.445 170.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -73.17 -37.82 66.41 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.342 0.657 . . . . 0.0 110.338 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -71.55 167.16 20.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.106 0.962 . . . . 0.0 110.809 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -146.0 77.79 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 161.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.32 140.06 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.8 p -127.61 -16.6 4.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.935 1.294 . . . . 0.0 111.618 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -151.61 151.37 31.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.093 0.957 . . . . 0.0 109.59 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.25 149.54 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.894 1.277 . . . . 0.0 108.074 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.8 m -140.57 153.91 46.3 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.611 1.565 . . . . 0.0 108.191 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -137.57 145.18 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.413 1.085 . . . . 0.0 108.291 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.5 164.26 29.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.146 2.178 . . . . 0.0 106.056 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.33 168.76 18.98 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.835 -1.166 . . . . 0.0 111.657 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -142.35 131.97 23.97 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.53 1.932 . . . . 0.0 105.85 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -83.34 17.76 2.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.543 0.737 . . . . 0.0 111.612 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.4 m -139.77 159.75 41.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.166 2.186 . . . . 0.0 106.604 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.93 160.89 39.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.241 1.016 . . . . 0.0 110.354 -172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -78.69 -34.46 46.15 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.811 0.844 . . . . 0.0 110.296 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.57 51.4 7.28 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -55.02 153.32 6.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.267 1.027 . . . . 0.0 112.647 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -42.54 99.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.903 1.281 . . . . 0.0 112.155 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -153.9 -173.07 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 -164.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -114.49 95.5 5.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -79.99 131.33 35.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.981 0.42 . . . . 0.0 111.176 -170.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.45 115.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 154.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.95 129.22 37.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -84.46 46.29 1.21 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.49 1.116 . . . . 0.0 110.907 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 C-N-CA 125.974 1.71 . . . . 0.0 110.385 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttt . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.4 mt -135.61 175.87 9.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.748 1.619 . . . . 0.0 109.526 -171.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -129.27 149.43 51.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 108.121 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.52 165.58 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.893 -0.504 . . . . 0.0 111.243 157.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -123.0 136.23 54.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 167.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.2 mt -134.07 144.58 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mm -130.33 138.19 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 t -137.16 145.24 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -170.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -141.58 156.94 45.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.55 1.14 . . . . 0.0 109.8 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.04 -154.08 24.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.34 1.448 . . . . 0.0 110.371 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 ttp-105 -75.65 80.31 2.63 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 162.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.16 19.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.964 0.906 . . . . 0.0 111.169 -169.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -137.44 148.55 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.096 0.958 . . . . 0.0 108.885 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.64 84.49 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.5 m -134.05 -8.01 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.978 1.311 . . . . 0.0 111.416 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.86 23.02 21.87 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.954 1.264 . . . . 0.0 110.054 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.41 -42.76 99.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 119.22 1.51 . . . . 0.0 110.336 -172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.22 -47.0 75.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.655 0.661 . . . . 0.0 111.619 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -68.89 -41.68 77.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.402 0.546 . . . . 0.0 111.386 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -56.69 -53.03 62.41 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.981 0.513 . . . . 0.0 109.717 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.9 t -62.4 -39.23 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.391 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -57.35 -44.3 84.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.185 0.902 . . . . 0.0 110.97 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.0 mtm -76.55 -36.04 57.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.536 0.607 . . . . 0.0 111.2 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -70.46 -27.81 64.52 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.146 0.885 . . . . 0.0 111.293 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.53 -46.92 65.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.844 -0.535 . . . . 0.0 109.666 168.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.32 -45.35 93.73 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.741 0.816 . . . . 0.0 111.226 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -30.35 69.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.35 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -114.88 18.01 16.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.678 0.672 . . . . 0.0 111.186 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt 52.13 42.64 30.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.273 1.829 . . . . 0.0 112.061 171.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.15 165.66 6.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.004 0.922 . . . . 0.0 108.955 165.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.79 46.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.17 0.988 . . . . 0.0 108.4 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.93 -153.67 24.4 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 119.3 0.955 . . . . 0.0 113.002 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -143.96 165.52 27.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.072 -0.664 . . . . 0.0 112.649 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.42 145.9 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.183 1.393 . . . . 0.0 107.942 165.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -144.39 159.51 42.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.303 1.041 . . . . 0.0 108.584 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -125.88 128.73 48.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -110.55 154.35 23.84 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.733 0.413 . . . . 0.0 110.885 -150.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.75 -27.2 68.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.108 0.563 . . . . 0.0 112.089 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -7.93 42.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.174 0.99 . . . . 0.0 112.989 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.01 -9.07 50.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.73 1.157 . . . . 0.0 113.437 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -97.18 158.12 15.6 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 119.007 1.403 . . . . 0.0 109.855 -173.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.7 153.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 163.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.72 144.03 47.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -134.31 146.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -131.36 127.87 38.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 161.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.59 154.13 50.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.32 0.964 . . . . 0.0 109.85 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' CD ' ' HD1' ' A' ' 83' ' ' HIS . 99.5 mt-10 -140.64 143.28 35.09 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.215 1.806 . . . . 0.0 107.197 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.35 -175.94 41.06 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.146 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.27 153.79 66.29 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.567 2.178 . . . . 0.0 109.594 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.37 -43.58 88.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.378 0.671 . . . . 0.0 111.447 -171.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.01 -43.42 98.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.801 0.728 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.35 83.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.16 -48.51 81.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.377 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -60.07 -46.95 87.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 110.415 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 m -60.49 -37.96 82.77 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.159 -0.338 . . . . 0.0 110.632 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -67.11 -36.06 81.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.694 -1.146 . . . . 0.0 110.985 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 t -58.13 -51.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 120.437 1.471 . . . . 0.0 108.51 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -56.23 -41.61 75.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.96 0.504 . . . . 0.0 110.556 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.99 82.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.338 0.655 . . . . 0.0 111.335 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.05 -35.75 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.746 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -61.67 -37.01 82.5 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.055 1.298 . . . . 0.0 110.861 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -69.3 -44.76 71.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 117.872 0.305 . . . . 0.0 110.266 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.27 -179.62 24.38 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.52 158.62 14.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.106 0.962 . . . . 0.0 111.352 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.04 -37.53 79.08 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.295 2.664 . . . . 0.0 114.394 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -78.96 -21.98 46.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.856 0.862 . . . . 0.0 112.126 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -79.99 168.41 19.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.368 1.467 . . . . 0.0 111.262 -170.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -148.17 104.61 3.56 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.72 143.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -127.35 -18.08 4.55 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.164 0.985 . . . . 0.0 111.152 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.1 150.49 29.97 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.32 145.67 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.958 1.303 . . . . 0.0 107.793 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -141.59 152.24 43.87 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.186 1.394 . . . . 0.0 108.724 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -141.23 144.03 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.718 1.207 . . . . 0.0 108.336 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -138.96 150.88 46.39 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 164.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.88 160.86 40.04 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.248 0.931 . . . . 0.0 111.768 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.1 m -148.93 148.92 30.38 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.848 1.659 . . . . 0.0 108.891 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -48.1 46.72 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 165.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m -57.24 145.13 32.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.164 1.386 . . . . 0.0 109.804 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 pp -151.1 155.21 38.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.067 1.347 . . . . 0.0 109.173 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.33 -32.82 32.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.097 0.559 . . . . 0.0 110.805 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.87 42.28 3.13 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.223 0.916 . . . . 0.0 110.882 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.436 ' HD1' ' CD ' ' A' ' 47' ' ' GLU . 72.4 m80 -53.74 136.7 39.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.742 0.771 . . . . 0.0 109.451 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.46 -20.67 23.61 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.022 0.529 . . . . 0.0 112.109 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -152.7 178.8 9.23 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.855 1.662 . . . . 0.0 108.337 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -107.9 135.37 49.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -138.21 142.9 39.96 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.9 mt -74.05 138.43 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 165.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.09 171.33 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.105 1.362 . . . . 0.0 108.059 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -135.27 11.26 3.53 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.622 0.769 . . . . 0.0 112.235 -164.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.148 1.379 . . . . 0.0 107.613 -176.572 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.6 tp -140.81 162.82 34.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.203 2.201 . . . . 0.0 106.835 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.4 138.7 51.65 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.664 1.186 . . . . 0.0 108.221 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -116.48 154.7 29.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.569 1.548 . . . . 0.0 108.057 165.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -122.85 139.55 53.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 158.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.96 141.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.51 140.38 49.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -136.52 147.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -141.72 157.84 44.55 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.877 1.271 . . . . 0.0 109.71 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.46 -157.65 23.03 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.89 1.709 . . . . 0.0 109.391 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -75.13 88.6 2.46 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 157.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.08 19.06 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.377 1.071 . . . . 0.0 110.751 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -139.55 152.19 46.69 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.55 42.29 99.71 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -142.35 4.67 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.751 1.62 . . . . 0.0 112.045 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.23 54.62 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.438 -1.201 . . . . 0.0 110.185 -172.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.77 -50.31 65.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.468 1.634 . . . . 0.0 110.608 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -62.63 -38.77 91.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.884 0.765 . . . . 0.0 110.521 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -66.98 -42.14 85.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.98 0.512 . . . . 0.0 111.375 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.9 -48.98 78.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.702 0.683 . . . . 0.0 109.9 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.4 t -61.93 -41.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.291 0.496 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -56.66 -47.97 78.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.92 0.782 . . . . 0.0 110.035 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.05 -37.34 69.7 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.102 -0.374 . . . . 0.0 111.158 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.22 -31.58 70.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.906 0.776 . . . . 0.0 111.222 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.13 74.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.271 0.487 . . . . 0.0 109.848 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -61.18 -47.39 86.36 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.04 0.936 . . . . 0.0 111.127 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -11.24 53.57 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -125.68 18.59 8.01 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.234 1.013 . . . . 0.0 111.071 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 tttp 45.98 36.48 3.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.952 2.101 . . . . 0.0 114.165 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.55 162.98 27.86 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.14 153.44 49.38 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.123 1.369 . . . . 0.0 107.718 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.1 -157.13 27.14 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.961 1.255 . . . . 0.0 113.519 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -144.86 166.48 25.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.609 0.764 . . . . 0.0 112.071 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.31 146.63 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.757 1.223 . . . . 0.0 108.343 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -146.24 153.53 40.71 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.75 0.82 . . . . 0.0 110.439 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -78.47 157.79 28.82 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 163.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -117.67 151.2 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.188 0.995 . . . . 0.0 108.767 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.1 -27.65 68.9 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.266 0.626 . . . . 0.0 111.888 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.57 -3.54 21.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.671 1.188 . . . . 0.0 113.135 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.11 -9.62 63.46 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.674 1.13 . . . . 0.0 112.987 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -79.36 177.09 9.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.941 1.37 . . . . 0.0 110.543 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.28 145.56 25.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -115.5 140.96 48.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mt -131.49 146.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.77 127.43 32.72 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.34 150.24 45.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.676 0.671 . . . . 0.0 109.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' CD ' ' HD1' ' A' ' 83' ' ' HIS . 92.7 mt-10 -138.86 133.68 32.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.779 1.631 . . . . 0.0 107.115 -174.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.31 -169.02 38.26 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.381 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 150.11 51.51 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.557 2.172 . . . . 0.0 110.453 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.19 -32.67 72.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.707 0.803 . . . . 0.0 112.052 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.24 -40.74 90.43 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.875 -1.141 . . . . 0.0 111.477 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.88 77.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.38 -40.33 96.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.907 0.483 . . . . 0.0 110.982 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -61.95 -49.91 74.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.274 0.629 . . . . 0.0 110.993 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -61.6 -38.84 89.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.776 0.798 . . . . 0.0 110.622 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -64.12 -43.76 94.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.615 1.166 . . . . 0.0 110.549 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.16 -49.2 82.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 119.408 1.004 . . . . 0.0 109.545 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.42 -39.14 69.87 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.814 . . . . 0.0 110.802 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.94 71.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 111.387 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.65 -26.65 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.808 0.843 . . . . 0.0 111.137 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -58.27 -34.59 70.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.147 1.339 . . . . 0.0 111.283 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.52 -41.54 27.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.346 0.521 . . . . 0.0 110.735 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.46 -167.39 54.73 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -165.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -60.04 167.29 2.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.246 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -52.84 -13.1 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.696 2.931 . . . . 0.0 115.391 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.23 -5.12 10.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.685 1.194 . . . . 0.0 111.805 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -70.27 162.93 27.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.834 0.854 . . . . 0.0 111.147 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -141.76 78.01 1.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.4 142.69 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -122.9 -21.79 5.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.324 1.05 . . . . 0.0 111.162 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -154.99 153.3 30.81 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.104 0.962 . . . . 0.0 109.558 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.1 tt -151.14 145.07 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.49 1.516 . . . . 0.0 107.196 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -140.39 153.19 46.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.942 1.297 . . . . 0.0 108.448 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.4 t -137.14 145.27 30.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -134.84 159.15 42.28 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 167.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.02 160.48 42.33 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.741 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.0 m -148.45 142.14 25.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.21 1.404 . . . . 0.0 109.015 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -69.14 -43.12 75.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -59.45 145.86 42.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.55 1.14 . . . . 0.0 109.071 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.04 153.73 38.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.148 1.379 . . . . 0.0 108.399 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.81 -30.44 45.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.525 0.33 . . . . 0.0 110.526 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.74 40.6 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.447 ' HD1' ' CD ' ' A' ' 47' ' ' GLU . 78.8 m80 -60.81 152.42 27.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.753 0.776 . . . . 0.0 109.481 173.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -128.98 -5.65 5.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 112.08 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.76 173.09 12.69 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.743 1.617 . . . . 0.0 107.746 173.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -111.56 142.61 43.63 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -130.31 133.3 46.36 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.236 0.541 . . . . 0.0 112.17 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.56 113.77 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 156.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.92 121.51 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 157.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -75.78 2.97 10.79 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -164.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.121 -1.418 . . . . 0.0 109.67 167.356 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.5 tp -142.13 156.66 45.37 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.943 1.297 . . . . 0.0 108.171 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -110.37 136.66 49.2 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.566 1.546 . . . . 0.0 107.189 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -111.79 148.18 34.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 161.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -114.36 140.14 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 156.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -132.66 141.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -131.86 137.11 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 147.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -169.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -143.08 156.71 44.87 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.507 1.123 . . . . 0.0 109.94 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.67 -154.85 24.5 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.302 1.429 . . . . 0.0 110.256 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -72.18 83.63 1.02 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 159.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.51 18.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 111.1 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -138.08 148.79 45.37 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.866 0.866 . . . . 0.0 109.444 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.38 78.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.19 -9.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.226 . . . . 0.0 111.719 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.16 22.42 17.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.027 1.298 . . . . 0.0 110.153 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 -40.61 96.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.18 1.49 . . . . 0.0 110.363 -171.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -55.63 -48.2 75.34 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.848 0.749 . . . . 0.0 111.449 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -67.23 -39.56 86.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.205 0.457 . . . . 0.0 111.295 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.03 -51.85 67.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.809 0.443 . . . . 0.0 110.239 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -62.22 -39.18 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.532 0.606 . . . . 0.0 110.512 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -55.96 -49.19 74.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.643 0.777 . . . . 0.0 109.892 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.3 mtp -69.79 -39.23 76.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.984 0.357 . . . . 0.0 111.12 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.72 -32.92 73.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.789 0.722 . . . . 0.0 111.019 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.97 81.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.22 0.463 . . . . 0.0 110.235 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.66 -44.36 94.01 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.278 0.631 . . . . 0.0 110.873 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -4.07 19.75 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.369 -0.832 . . . . 0.0 113.213 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -111.37 2.36 17.55 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.321 1.448 . . . . 0.0 111.286 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 42.82 39.58 1.76 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.782 2.033 . . . . 0.0 111.945 -172.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.78 168.3 13.64 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.556 0.742 . . . . 0.0 109.512 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.96 151.27 49.33 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.15 -159.2 28.01 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.603 1.092 . . . . 0.0 113.756 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -141.73 166.01 25.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.269 0.628 . . . . 0.0 112.271 172.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.72 145.48 31.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 125.019 1.328 . . . . 0.0 108.273 164.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -141.48 161.36 38.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.997 1.319 . . . . 0.0 108.401 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -125.89 116.17 21.11 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -91.01 153.19 20.33 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.025 0.93 . . . . 0.0 110.276 -157.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.75 -29.46 70.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.674 0.39 . . . . 0.0 111.845 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.98 -9.75 48.06 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 -21.19 22.08 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.476 1.036 . . . . 0.0 113.285 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtm180 -81.02 154.33 26.94 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 118.591 1.195 . . . . 0.0 110.178 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.7 t -86.66 148.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 161.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -132.55 142.87 49.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.69 149.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.47 127.0 26.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 167.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.23 147.12 43.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.909 0.777 . . . . 0.0 109.352 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -136.89 129.33 30.03 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -170.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.93 -169.18 41.2 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.82 149.62 60.41 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.259 1.973 . . . . 0.0 110.156 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.43 -32.85 72.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.044 0.938 . . . . 0.0 111.817 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -68.56 -39.76 80.92 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.919 -1.113 . . . . 0.0 111.62 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.5 80.91 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -61.34 -43.04 99.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.83 0.852 . . . . 0.0 111.232 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -61.09 -51.53 68.74 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.004 0.522 . . . . 0.0 110.419 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 m -62.73 -35.29 79.29 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.901 -0.5 . . . . 0.0 110.956 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -65.67 -42.04 91.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.561 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.49 -43.64 87.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.044 1.293 . . . . 0.0 109.925 171.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.68 -37.72 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.418 1.008 . . . . 0.0 111.204 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.09 91.01 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.834 -0.542 . . . . 0.0 111.026 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.22 -48.07 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 118.249 -0.882 . . . . 0.0 109.247 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -68.81 -26.29 65.1 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.936 1.243 . . . . 0.0 112.571 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -60.67 -41.18 94.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.753 1.16 . . . . 0.0 110.014 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.39 170.1 33.53 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.698 1.142 . . . . 0.0 111.185 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 163.41 42.08 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 123.765 0.826 . . . . 0.0 111.188 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.23 -13.65 7.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.244 3.296 . . . . 0.0 115.731 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.15 13.71 11.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.337 1.455 . . . . 0.0 111.132 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -132.73 166.61 21.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.783 1.233 . . . . 0.0 110.141 -161.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -149.87 102.33 3.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.37 144.77 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 166.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 p -124.49 -17.5 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.422 1.089 . . . . 0.0 110.934 172.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -153.77 149.45 27.45 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.391 1.076 . . . . 0.0 109.502 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.9 tt -147.12 146.82 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.995 1.318 . . . . 0.0 107.482 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.2 m -140.7 154.69 46.46 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.484 1.513 . . . . 0.0 108.323 175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.14 150.01 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.307 1.043 . . . . 0.0 109.66 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -136.77 160.44 38.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.264 1.826 . . . . 0.0 106.335 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.37 159.69 41.01 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.689 0.795 . . . . 0.0 110.648 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.9 m -157.98 145.17 18.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.096 1.358 . . . . 0.0 108.965 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -79.03 -32.88 45.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.247 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 m -57.54 147.8 25.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.833 0.853 . . . . 0.0 108.817 166.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.21 154.77 44.41 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.746 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.43 -35.05 61.04 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 163.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.18 36.29 4.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.604 1.097 . . . . 0.0 111.474 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -58.58 149.86 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.246 1.023 . . . . 0.0 110.289 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.32 -6.23 7.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.81 1.244 . . . . 0.0 111.781 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -140.92 169.74 17.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.535 1.934 . . . . 0.0 106.894 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -115.04 135.04 54.65 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 m -139.44 143.44 37.59 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.2 134.16 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 162.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.8 m -134.86 167.23 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.582 1.153 . . . . 0.0 108.874 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -135.05 -1.59 2.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.795 0.838 . . . . 0.0 112.074 -171.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.248 1.009 0 C-N-CA 124.995 1.318 . . . . 0.0 110.078 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.3 mt -138.81 173.1 11.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.593 1.557 . . . . 0.0 108.904 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -135.37 133.06 38.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -115.59 158.42 22.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.968 1.307 . . . . 0.0 108.091 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -120.87 144.59 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 157.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.9 mt -132.37 144.92 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.4 mm -133.1 136.9 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.32 147.48 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -172.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -141.44 154.72 45.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.153 1.381 . . . . 0.0 109.77 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.27 -154.81 25.96 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.504 1.526 . . . . 0.0 109.84 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 -76.67 79.54 3.32 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 161.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.77 19.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.016 0.926 . . . . 0.0 111.037 -171.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -136.76 146.1 45.37 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.15 32.88 85.41 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.46 -3.22 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.811 1.244 . . . . 0.0 111.722 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.17 21.81 34.34 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.526 -1.152 . . . . 0.0 110.418 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -62.71 -44.41 96.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.11 1.455 . . . . 0.0 110.044 -171.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -55.43 -49.29 72.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.765 0.711 . . . . 0.0 111.856 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -67.57 -40.9 84.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.143 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -56.13 -50.19 71.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.449 0.568 . . . . 0.0 110.053 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.5 t -60.2 -43.24 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 118.372 0.533 . . . . 0.0 110.042 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -59.27 -44.46 92.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.67 0.668 . . . . 0.0 110.389 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.1 mtt -71.82 -36.86 70.35 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.734 -0.604 . . . . 0.0 111.171 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.87 -26.12 64.04 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.555 -0.715 . . . . 0.0 111.631 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.35 -45.23 63.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.547 0.612 . . . . 0.0 109.697 165.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.28 -35.59 80.78 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.109 0.563 . . . . 0.0 112.243 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -16.93 63.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.153 0.888 . . . . 0.0 112.998 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -112.84 5.7 17.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.528 1.531 . . . . 0.0 111.072 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 42.58 41.85 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.2 1.8 . . . . 0.0 111.821 -169.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.3 mt -62.66 161.15 12.75 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.73 154.01 49.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.084 0.953 . . . . 0.0 108.496 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.7 -159.34 28.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -170.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.5 168.09 22.06 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 112.074 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.48 144.8 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.158 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -138.66 156.95 46.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.554 1.141 . . . . 0.0 108.142 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -125.19 107.94 11.26 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtp85 -82.47 154.88 24.89 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.778 1.231 . . . . 0.0 110.648 -154.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.582 0.353 . . . . 0.0 111.81 175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.8 -5.57 35.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.038 0.935 . . . . 0.0 113.154 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.91 -17.6 41.5 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.724 1.154 . . . . 0.0 113.627 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -86.07 152.87 22.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.109 1.455 . . . . 0.0 110.196 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.92 146.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 162.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.49 136.59 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.07 145.42 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.62 128.3 28.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.48 155.12 45.86 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.51 0.724 . . . . 0.0 110.471 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.21 134.09 37.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.07 1.748 . . . . 0.0 107.743 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.86 -173.18 41.45 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.716 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.95 157.1 55.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.751 2.301 . . . . 0.0 110.707 172.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.42 -44.62 89.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.552 0.741 . . . . 0.0 111.347 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.72 -39.56 91.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.795 0.725 . . . . 0.0 111.767 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.75 74.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.37 -36.56 83.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.127 0.421 . . . . 0.0 111.402 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -63.21 -47.73 81.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.08 0.854 . . . . 0.0 109.901 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.8 m -60.14 -35.94 76.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 0.0 111.18 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -64.95 -45.92 83.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.941 0.897 . . . . 0.0 110.072 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.7 t -56.7 -48.58 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.357 0.98 . . . . 0.0 109.361 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -57.18 -40.77 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 110.683 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.85 73.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.681 0.793 . . . . 0.0 111.17 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -61.68 -27.46 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.068 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -57.76 -31.44 66.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.19 1.359 . . . . 0.0 111.603 173.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -83.33 -41.91 17.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.374 0.533 . . . . 0.0 111.254 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.7 -168.91 45.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -165.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.3 p -60.36 165.9 4.72 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 117.381 0.59 . . . . 0.0 110.92 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.47 -20.77 12.49 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.388 2.725 . . . . 0.0 114.756 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -103.78 -13.41 16.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.47 1.108 . . . . 0.0 111.53 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 m -68.71 165.65 19.05 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.025 -1.047 . . . . 0.0 111.166 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -143.47 138.47 29.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 156.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.4 t -110.22 140.73 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.0 p -123.26 -18.55 6.25 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.187 0.995 . . . . 0.0 110.965 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -153.54 149.46 27.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.76 144.11 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 m -142.09 159.5 42.11 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.195 1.398 . . . . 0.0 108.882 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 t -136.61 146.86 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.78 1.232 . . . . 0.0 107.679 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.74 167.6 20.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.681 1.993 . . . . 0.0 106.388 173.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -130.44 164.03 25.65 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.168 -0.957 . . . . 0.0 109.996 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -135.61 150.88 49.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 162.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -115.17 27.76 9.16 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 109.545 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.7 m -136.55 168.8 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.52 2.728 . . . . 0.0 105.425 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.65 129.66 47.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.657 0.783 . . . . 0.0 108.938 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -71.14 -25.4 62.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.063 0.392 . . . . 0.0 110.794 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 29.07 18.41 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.314 0.959 . . . . 0.0 112.903 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -59.42 151.16 24.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.178 1.489 . . . . 0.0 109.59 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -126.92 -6.96 6.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.382 1.073 . . . . 0.0 112.259 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -141.46 -178.12 5.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.985 2.114 . . . . 0.0 106.711 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -117.54 124.57 49.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.5 m -117.76 139.41 51.1 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.367 0.603 . . . . 0.0 111.103 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.6 mt -89.52 137.51 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.5 t -133.06 142.44 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.348 1.459 . . . . 0.0 107.315 -173.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -151.55 10.11 0.56 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.861 1.265 . . . . 0.0 111.647 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.681 1.592 . . . . 0.0 110.899 -179.437 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.9 mmm . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.92 168.28 14.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 107.259 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -120.19 137.07 54.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.162 1.785 . . . . 0.0 106.496 170.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -119.83 155.62 32.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.393 1.477 . . . . 0.0 107.794 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -125.03 138.83 54.2 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.3 mt -134.23 141.81 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mm -130.56 141.09 47.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.18 147.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -140.95 158.08 44.44 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.866 1.266 . . . . 0.0 109.623 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.96 -157.27 23.31 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.701 1.62 . . . . 0.0 109.595 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -75.12 85.71 2.37 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.77 14.96 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.862 0.865 . . . . 0.0 111.695 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -138.39 149.34 45.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.49 33.45 76.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.06 -3.78 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.307 1.443 . . . . 0.0 111.841 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.52 22.69 33.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.796 1.189 . . . . 0.0 110.41 -175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.36 -46.75 82.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.125 1.462 . . . . 0.0 110.377 -172.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -61.96 -42.35 99.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.236 0.926 . . . . 0.0 110.345 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -64.57 -42.41 95.65 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.948 0.499 . . . . 0.0 110.707 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.5 -50.69 72.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.321 0.648 . . . . 0.0 110.558 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.25 -37.8 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.672 -0.643 . . . . 0.0 110.127 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.739 0.699 . . . . 0.0 109.823 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 ptp -72.14 -33.46 67.77 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.758 0.708 . . . . 0.0 111.42 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -69.48 -33.82 73.44 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.047 0.839 . . . . 0.0 111.209 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.25 79.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.0 0.364 . . . . 0.0 110.344 170.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.08 -45.42 93.6 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.803 0.841 . . . . 0.0 110.99 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -9.61 35.49 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -122.27 10.37 9.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.044 1.338 . . . . 0.0 111.415 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 44.96 41.83 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.068 1.747 . . . . 0.0 112.626 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.9 166.59 7.18 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.11 159.05 26.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 163.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.31 -155.5 25.19 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.695 0.679 . . . . 0.0 112.62 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -147.75 166.81 26.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.4 144.56 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 108.014 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.23 149.28 33.61 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.557 0.743 . . . . 0.0 110.402 174.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.97 122.12 27.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 166.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -76.57 148.1 37.24 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.31 -30.33 71.38 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.563 0.345 . . . . 0.0 111.613 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.36 -5.2 21.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.513 1.125 . . . . 0.0 113.548 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -13.75 52.66 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.323 0.963 . . . . 0.0 113.353 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -72.2 170.69 13.49 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.818 1.309 . . . . 0.0 110.551 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.28 148.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 161.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -131.96 143.66 50.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -141.11 147.06 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.68 128.82 27.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.63 158.53 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.184 0.593 . . . . 0.0 110.053 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -140.11 134.63 31.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.411 1.484 . . . . 0.0 107.37 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.67 -177.62 44.38 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.464 -0.631 . . . . 0.0 111.741 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 157.41 59.28 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.385 2.057 . . . . 0.0 110.287 169.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.0 -45.17 91.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.265 0.626 . . . . 0.0 111.137 -172.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.57 -38.02 85.96 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.622 0.646 . . . . 0.0 111.954 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.19 75.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.41 -35.87 80.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.385 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.72 -49.22 77.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.925 0.784 . . . . 0.0 109.977 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 m -61.5 -38.27 86.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 110.919 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -63.87 -44.32 93.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.114 0.966 . . . . 0.0 110.233 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -58.39 -50.07 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.992 0.815 . . . . 0.0 109.303 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.33 -38.49 68.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.687 0.795 . . . . 0.0 110.984 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -46.63 69.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 110.812 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.73 -28.55 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.762 0.825 . . . . 0.0 111.011 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -58.43 -35.2 71.72 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.107 1.321 . . . . 0.0 111.275 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -79.91 -42.93 23.12 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.245 0.475 . . . . 0.0 110.673 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.43 -165.99 54.1 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 p -59.84 166.8 3.15 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.682 . . . . 0.0 111.443 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.85 -14.17 3.27 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.94 3.093 . . . . 0.0 115.988 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -123.07 3.79 9.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.674 1.124 . . . . 0.0 112.053 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.3 m -66.86 159.25 28.64 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.02 -1.05 . . . . 0.0 110.357 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -140.94 77.35 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -59.72 140.49 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.6 p -122.46 -19.59 6.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.424 1.09 . . . . 0.0 111.177 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -154.57 151.9 29.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.154 0.982 . . . . 0.0 109.506 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.18 145.96 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.316 1.447 . . . . 0.0 107.356 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -140.31 152.36 45.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 108.475 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -139.19 145.52 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.522 1.129 . . . . 0.0 108.139 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -136.15 159.74 40.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.252 1.821 . . . . 0.0 106.118 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -148.81 163.29 37.81 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.318 -0.864 . . . . 0.0 111.398 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.7 m -148.76 144.95 27.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.482 1.913 . . . . 0.0 108.451 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.0 tpt85 -76.17 -30.77 58.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.191 162.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 m -57.51 148.56 23.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.625 1.17 . . . . 0.0 109.711 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.7 mt -131.44 168.18 18.06 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.363 1.465 . . . . 0.0 109.238 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 -29.41 2.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.816 1.646 . . . . 0.0 109.876 169.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.39 57.35 5.13 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -56.87 150.46 16.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.489 0.715 . . . . 0.0 110.726 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -67.86 -31.5 71.36 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -149.79 179.0 8.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.524 1.93 . . . . 0.0 107.346 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -94.7 132.8 39.06 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 154.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -138.59 144.42 39.79 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.7 139.83 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 164.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -133.88 155.03 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.365 1.866 . . . . 0.0 106.661 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -132.92 10.59 4.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.921 0.888 . . . . 0.0 112.117 -163.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.25 1.105 0 C-N-CA 125.401 1.48 . . . . 0.0 107.787 -174.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.764 0.316 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.7 170.73 14.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.249 1.82 . . . . 0.0 107.668 173.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -110.02 138.37 46.48 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.818 1.647 . . . . 0.0 106.817 164.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -116.17 156.95 25.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.144 1.378 . . . . 0.0 107.565 164.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -127.85 140.29 52.11 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 161.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -133.15 142.22 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.04 140.33 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.71 145.06 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.58 157.26 45.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.888 1.275 . . . . 0.0 109.709 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.57 -158.94 24.73 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.982 1.753 . . . . 0.0 109.597 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -75.26 88.77 2.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 157.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.67 20.59 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.445 1.098 . . . . 0.0 109.943 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -138.61 148.5 44.19 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.835 1.254 . . . . 0.0 107.84 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.95 41.53 97.89 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.91 -10.84 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.853 1.261 . . . . 0.0 111.842 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.0 16.98 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.872 1.225 . . . . 0.0 110.124 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.67 -41.73 98.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.307 1.554 . . . . 0.0 110.266 -171.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.75 -45.96 77.93 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.626 -0.671 . . . . 0.0 111.538 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.72 -39.65 80.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.548 0.613 . . . . 0.0 111.515 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.04 -52.09 66.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.199 0.6 . . . . 0.0 109.958 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.0 -38.11 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.44 -48.21 82.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.164 0.893 . . . . 0.0 110.019 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -75.35 -31.85 60.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.923 0.783 . . . . 0.0 111.684 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -68.79 -34.17 75.1 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.032 0.833 . . . . 0.0 110.805 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.31 83.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.162 0.437 . . . . 0.0 110.187 170.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.82 -45.18 93.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.563 0.745 . . . . 0.0 111.129 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -5.71 28.58 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.27 1.17 15.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.519 1.527 . . . . 0.0 111.565 170.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 39.88 42.75 1.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.345 1.858 . . . . 0.0 112.355 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 165.61 18.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 166.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.85 156.76 43.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.61 -154.42 25.79 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.121 0.873 . . . . 0.0 112.433 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -146.24 166.21 26.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 122.139 -0.624 . . . . 0.0 112.251 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.18 141.07 42.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 124.668 1.187 . . . . 0.0 108.239 166.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -138.1 158.65 43.89 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.789 1.236 . . . . 0.0 108.082 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.76 107.63 10.71 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -81.18 146.26 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.318 1.047 . . . . 0.0 109.642 -155.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.16 -25.08 66.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.809 0.444 . . . . 0.0 111.325 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -60.14 -16.92 36.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.439 1.896 . . . . 0.0 113.234 171.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.11 1.51 35.89 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.223 0.916 . . . . 0.0 113.533 171.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.6 mtt85 -117.28 153.74 32.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.751 1.221 . . . . 0.0 109.271 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.22 149.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 164.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -132.71 140.79 48.26 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 167.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.49 145.33 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -173.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -133.49 129.36 37.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.95 152.67 47.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.683 . . . . 0.0 109.575 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' CD ' ' HD1' ' A' ' 83' ' ' HIS . 99.1 mt-10 -139.48 134.85 32.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.252 1.421 . . . . 0.0 107.269 -176.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.8 -172.13 41.16 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.396 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.42 151.89 54.17 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.711 2.274 . . . . 0.0 110.522 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -60.48 -35.95 77.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.128 0.971 . . . . 0.0 112.227 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.63 -39.54 77.09 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.936 -1.102 . . . . 0.0 111.604 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.39 83.24 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.98 -40.03 95.48 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.106 0.562 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.99 -47.42 84.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.763 0.711 . . . . 0.0 110.857 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -61.77 -38.37 87.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.352 0.596 . . . . 0.0 110.796 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -64.14 -43.35 95.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.458 1.103 . . . . 0.0 110.545 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.08 -50.39 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.293 0.952 . . . . 0.0 109.306 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -55.56 -39.38 70.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.821 0.849 . . . . 0.0 110.838 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.91 74.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.641 0.776 . . . . 0.0 110.967 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.81 -27.25 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.128 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -58.65 -38.62 78.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.256 1.389 . . . . 0.0 110.918 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.51 -43.17 50.4 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.111 0.414 . . . . 0.0 110.351 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.81 -172.99 48.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.76 159.28 10.17 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.511 0.724 . . . . 0.0 110.38 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.19 -26.19 64.87 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.068 1.845 . . . . 0.0 112.629 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -83.28 -15.33 50.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.044 0.938 . . . . 0.0 112.29 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -77.95 161.67 27.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.958 0.903 . . . . 0.0 110.93 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -137.11 82.04 1.91 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.1 t -59.77 140.53 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.3 p -123.91 -19.82 5.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.34 1.056 . . . . 0.0 111.267 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -154.01 152.69 30.82 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.128 0.971 . . . . 0.0 109.53 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.82 145.72 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 107.176 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -139.56 152.55 46.96 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.058 1.343 . . . . 0.0 108.238 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -138.61 145.45 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.319 1.048 . . . . 0.0 108.186 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 m -135.23 160.85 37.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.635 1.974 . . . . 0.0 106.052 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.4 166.51 26.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.252 -0.905 . . . . 0.0 110.825 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.5 m -157.0 147.95 21.78 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.982 1.713 . . . . 0.0 108.666 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -73.82 -41.35 62.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -56.1 137.87 50.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 108.97 170.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.12 156.85 41.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.116 1.367 . . . . 0.0 108.662 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.41 -23.36 21.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.852 0.861 . . . . 0.0 111.445 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 46.5 5.74 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.443 ' HD1' ' CD ' ' A' ' 47' ' ' GLU . 68.8 m80 -52.91 137.74 31.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.762 0.825 . . . . 0.0 109.528 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -12.18 39.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.095 0.558 . . . . 0.0 112.096 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -154.58 169.02 24.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.132 1.773 . . . . 0.0 108.412 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -99.79 137.56 38.08 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -134.59 137.71 43.95 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.555 0.616 . . . . 0.0 112.384 -170.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.03 142.53 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 163.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.6 t -132.54 155.63 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.002 2.121 . . . . 0.0 105.795 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -122.22 28.59 7.4 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.751 0.82 . . . . 0.0 111.581 -160.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.251 1.172 0 C-N-CA 126.243 1.817 . . . . 0.0 111.314 176.095 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mmm . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.45 164.84 19.57 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.693 1.997 . . . . 0.0 107.704 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -124.96 137.5 54.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.036 1.735 . . . . 0.0 106.389 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -119.85 154.75 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.549 1.54 . . . . 0.0 107.756 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -122.48 139.86 53.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.4 mt -131.94 142.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.3 mm -128.75 136.92 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.87 146.08 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -170.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -143.2 157.26 44.66 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.866 1.266 . . . . 0.0 109.526 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 -156.78 25.3 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.17 1.367 . . . . 0.0 110.474 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -75.05 78.43 2.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.94 20.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.752 0.821 . . . . 0.0 111.9 -168.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -140.93 151.74 44.46 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.44 0.696 . . . . 0.0 109.889 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.61 33.16 83.64 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.5 -10.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.378 1.471 . . . . 0.0 111.853 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.51 18.8 15.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.811 1.672 . . . . 0.0 110.696 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.89 -37.4 87.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.788 1.294 . . . . 0.0 111.117 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.443 HH21 ' P ' ' A' ' 92' ' ' PO4 . 60.2 mtm180 -56.02 -51.32 68.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.878 1.217 . . . . 0.0 110.675 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -68.09 -37.74 81.54 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.261 -0.274 . . . . 0.0 110.694 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.01 -50.8 72.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.187 0.595 . . . . 0.0 110.474 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.92 -40.07 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.674 -0.641 . . . . 0.0 109.772 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.9 -45.63 93.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.094 0.861 . . . . 0.0 110.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.36 -32.35 62.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 0.742 . . . . 0.0 111.525 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -73.36 -22.13 60.36 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.219 0.918 . . . . 0.0 111.807 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.27 -49.04 37.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.506 0.594 . . . . 0.0 109.54 164.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.63 -38.33 84.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.392 0.677 . . . . 0.0 111.771 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -22.12 61.61 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -127.15 25.16 6.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.446 1.021 . . . . 0.0 110.581 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 49.26 38.26 13.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 112.646 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.28 156.75 24.69 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.06 155.11 44.88 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.05 -154.22 25.67 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.958 0.799 . . . . 0.0 112.0 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -150.07 166.07 30.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.029 0.532 . . . . 0.0 112.39 174.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.56 151.55 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.694 1.598 . . . . 0.0 108.929 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -143.75 133.63 23.97 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.4 0.68 . . . . 0.0 110.856 171.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.93 115.9 10.61 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 162.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.97 143.85 26.87 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.98 -28.51 70.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.03 -8.12 34.97 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.51 -15.25 38.62 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.455 1.026 . . . . 0.0 113.502 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -76.7 171.87 13.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.72 1.26 . . . . 0.0 110.332 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.6 t -114.18 145.58 19.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 160.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.86 145.99 50.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.57 146.32 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.01 126.05 22.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.8 43.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -140.41 144.6 36.27 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.811 1.644 . . . . 0.0 108.052 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.49 -177.81 41.77 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.02 150.23 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.478 1.452 . . . . 0.0 109.251 167.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.22 -43.69 83.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.968 0.507 . . . . 0.0 110.914 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.64 -29.18 65.47 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.525 -0.735 . . . . 0.0 112.623 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.8 81.97 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 118.674 0.67 . . . . 0.0 110.073 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.79 -33.12 74.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.088 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -62.18 -51.38 68.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.64 1.109 . . . . 0.0 110.26 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 p -63.39 -32.56 74.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.582 1.083 . . . . 0.0 111.418 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.21 -47.16 85.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.952 -0.547 . . . . 0.0 110.169 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.28 -43.45 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.021 0.828 . . . . 0.0 109.996 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -59.74 -41.14 90.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.067 0.849 . . . . 0.0 110.928 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.06 76.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.926 0.491 . . . . 0.0 110.826 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.8 -49.68 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -27.48 64.54 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.893 0.77 . . . . 0.0 112.148 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -64.32 -40.01 95.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.139 0.881 . . . . 0.0 110.459 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 171.97 31.52 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.566 1.079 . . . . 0.0 110.953 -171.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.7 p -64.0 168.8 5.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.977 0.911 . . . . 0.0 109.934 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.16 -2.82 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.186 1.924 . . . . 0.0 113.196 165.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -107.8 -5.48 17.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.882 1.273 . . . . 0.0 112.176 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -124.47 170.75 10.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.684 1.194 . . . . 0.0 111.623 -172.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -146.68 102.17 3.53 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.83 142.05 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.4 p -123.29 -17.81 6.47 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.135 0.974 . . . . 0.0 110.87 173.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -152.15 148.44 27.63 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.296 1.038 . . . . 0.0 109.205 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.77 146.67 16.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.9 m -138.14 150.99 47.32 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.463 1.505 . . . . 0.0 108.059 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.67 145.08 29.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -136.13 159.13 42.65 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.38 157.79 43.72 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.153 -0.967 . . . . 0.0 111.604 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.3 m -140.1 136.92 34.08 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.001 1.72 . . . . 0.0 108.45 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -35.08 61.24 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 m -59.39 150.85 25.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.135 1.374 . . . . 0.0 109.775 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.5 mt -132.84 165.76 23.85 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.392 1.477 . . . . 0.0 109.399 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.61 -21.71 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.661 1.584 . . . . 0.0 110.652 170.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 43.19 7.04 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.73 0.681 . . . . 0.0 112.249 166.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.86 160.04 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.709 0.755 . . . . 0.0 109.996 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -126.27 -20.5 4.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -139.1 -175.74 4.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.825 1.65 . . . . 0.0 107.624 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -120.78 130.75 54.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.522 0.601 . . . . 0.0 109.781 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.0 m -126.19 159.65 32.39 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.854 0.835 . . . . 0.0 111.721 -167.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -111.81 124.89 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.17 175.26 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 109.567 -168.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -142.41 19.37 2.05 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.487 1.115 . . . . 0.0 111.389 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.25 1.091 0 C-N-CA 125.747 1.619 . . . . 0.0 111.131 -176.912 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . 0.443 ' P ' HH21 ' A' ' 18' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.3 tp -142.75 163.72 32.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 127.012 2.125 . . . . 0.0 107.204 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -120.1 137.78 53.94 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 107.737 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -116.64 153.85 31.58 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.654 1.582 . . . . 0.0 108.079 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -120.06 139.0 53.21 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 158.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.9 mt -130.96 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.8 mm -130.01 138.87 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -137.07 147.31 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -139.33 157.74 45.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.496 1.118 . . . . 0.0 109.717 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.87 -156.52 22.55 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.474 1.511 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -73.74 81.25 1.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 160.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.92 15.19 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.032 0.933 . . . . 0.0 111.693 -171.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -138.17 150.3 46.65 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 171.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.42 32.0 71.51 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 m -136.65 1.4 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.717 1.607 . . . . 0.0 111.546 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.0 20.13 50.98 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.856 1.217 . . . . 0.0 110.582 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -62.91 -45.28 93.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.757 1.278 . . . . 0.0 110.766 -169.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -62.1 -44.8 95.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.425 1.012 . . . . 0.0 110.99 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -68.51 -40.28 80.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 110.616 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -56.6 -52.28 65.43 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.25 0.62 . . . . 0.0 110.006 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.71 -39.82 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.168 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -60.69 -43.61 97.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.33 0.968 . . . . 0.0 110.647 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.6 mtm -71.74 -35.53 70.17 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.738 0.699 . . . . 0.0 111.499 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -67.38 -39.91 85.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.561 1.073 . . . . 0.0 110.158 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.3 99.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.121 0.569 . . . . 0.0 110.169 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.26 -47.54 85.58 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.65 0.78 . . . . 0.0 110.623 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -59.9 -36.15 76.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.367 1.067 . . . . 0.0 111.275 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -88.11 5.1 42.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.628 1.171 . . . . 0.0 112.729 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 48.82 31.71 3.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.896 1.678 . . . . 0.0 112.591 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.57 165.95 23.12 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.437 1.095 . . . . 0.0 109.62 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 161.48 30.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.348 1.459 . . . . 0.0 107.625 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.52 -148.85 20.76 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.256 0.934 . . . . 0.0 111.844 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -154.04 168.29 26.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.322 0.649 . . . . 0.0 112.689 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.92 147.72 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.868 1.667 . . . . 0.0 108.739 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -144.79 155.56 43.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.871 0.869 . . . . 0.0 110.384 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -84.0 124.2 30.8 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 164.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.12 147.08 38.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.42 -30.0 71.04 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.551 0.34 . . . . 0.0 111.627 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.94 -5.45 21.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.559 1.144 . . . . 0.0 113.518 174.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.48 49.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.332 0.967 . . . . 0.0 113.288 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -73.37 170.88 14.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 1.258 . . . . 0.0 110.551 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.4 t -105.42 150.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -132.73 140.33 48.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.76 146.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.64 153.44 50.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.674 0.79 . . . . 0.0 109.619 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -140.21 135.83 32.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.927 1.291 . . . . 0.0 108.103 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.43 38.84 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.064 -173.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.19 151.79 61.19 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.265 1.977 . . . . 0.0 110.542 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.15 -40.96 82.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 111.527 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.2 -40.08 95.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.821 0.737 . . . . 0.0 111.75 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.34 -41.14 85.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.04 -39.43 93.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.875 0.47 . . . . 0.0 111.1 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -66.65 -49.11 67.29 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.326 -0.859 . . . . 0.0 110.724 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 p -64.38 -31.94 73.36 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.713 -0.617 . . . . 0.0 111.059 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -63.87 -42.86 97.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.821 171.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.25 -46.64 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 120.254 1.388 . . . . 0.0 109.102 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -59.71 -36.97 77.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.891 0.769 . . . . 0.0 110.989 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.05 -43.48 82.63 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.92 -0.487 . . . . 0.0 111.533 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.97 -43.71 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.4 -0.813 . . . . 0.0 109.988 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -68.83 -20.76 64.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.819 1.19 . . . . 0.0 112.549 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.34 -43.28 73.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 120.112 1.324 . . . . 0.0 110.017 167.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.32 -177.62 39.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.236 0.922 . . . . 0.0 111.093 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.1 p -62.57 168.3 4.45 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.973 0.509 . . . . 0.0 110.834 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.87 -14.36 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.727 2.952 . . . . 0.0 115.261 168.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -116.01 -8.47 11.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.526 1.13 . . . . 0.0 111.902 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 m -72.41 164.47 26.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.878 0.871 . . . . 0.0 111.162 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -144.93 93.68 2.43 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 158.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.02 145.72 12.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -121.97 -22.96 5.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.654 1.182 . . . . 0.0 111.038 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -156.75 154.53 30.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.255 1.022 . . . . 0.0 109.88 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.7 tt -149.3 149.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.295 1.438 . . . . 0.0 107.739 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 m -141.88 152.86 43.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.094 1.357 . . . . 0.0 108.496 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.22 145.21 30.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.672 1.189 . . . . 0.0 107.802 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -135.59 160.38 38.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 166.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.43 161.14 41.03 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.985 -1.072 . . . . 0.0 111.009 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -144.19 140.44 29.33 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.96 1.304 . . . . 0.0 108.648 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.1 -41.82 73.53 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.516 0.726 . . . . 0.0 109.101 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.5 m -64.39 147.19 53.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.128 0.971 . . . . 0.0 109.051 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.5 148.12 29.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.998 1.319 . . . . 0.0 108.985 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -152.21 -10.79 0.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.849 0.86 . . . . 0.0 113.202 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.86 -20.28 17.09 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 121.128 -0.982 . . . . 0.0 113.743 -161.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -55.54 111.84 0.99 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.814 1.246 . . . . 0.0 112.722 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -146.63 -49.22 0.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.426 1.49 . . . . 0.0 109.358 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -153.18 -161.48 1.29 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.877 2.471 . . . . 0.0 106.053 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -118.26 96.97 5.55 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.88 1.218 . . . . 0.0 109.142 166.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.2 m -84.12 139.06 32.7 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.466 0.65 . . . . 0.0 110.955 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.54 137.04 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 155.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.64 152.58 37.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 125.456 1.502 . . . . 0.0 107.619 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -130.55 -15.81 3.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.461 1.105 . . . . 0.0 111.817 -171.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.04 1.336 . . . . 0.0 109.995 179.516 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.43 160.05 35.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.998 1.719 . . . . 0.0 108.092 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -119.85 139.15 52.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 164.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -122.31 155.13 36.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.894 1.677 . . . . 0.0 107.511 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -129.55 139.18 51.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 162.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.7 mt -134.99 137.7 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -172.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -127.69 137.98 56.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.57 147.23 27.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -146.73 158.45 43.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.753 1.221 . . . . 0.0 109.493 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.4 18.94 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.385 1.469 . . . . 0.0 109.608 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -72.82 89.81 1.4 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 158.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.54 18.31 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.266 1.026 . . . . 0.0 110.125 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -142.27 154.89 45.11 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.6 1.16 . . . . 0.0 108.161 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.98 93.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.8 -3.33 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.663 1.585 . . . . 0.0 111.301 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.02 26.57 40.5 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -173.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.21 -40.75 91.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.618 1.209 . . . . 0.0 110.331 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.93 -43.84 91.25 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.457 -0.777 . . . . 0.0 110.874 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -69.71 -42.03 74.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.931 0.492 . . . . 0.0 110.987 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -56.21 -48.95 75.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.416 0.553 . . . . 0.0 110.306 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.03 -40.01 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.52 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.06 -46.62 85.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.441 1.018 . . . . 0.0 109.968 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.7 mtt -66.96 -38.59 86.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.493 1.042 . . . . 0.0 111.016 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -70.87 -26.59 63.32 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.494 -0.753 . . . . 0.0 112.157 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.38 -39.03 59.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 110.043 168.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.66 -47.02 79.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.619 1.168 . . . . 0.0 110.482 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HE2' ' NH1' ' A' ' 28' ' ' ARG 0.281 0.0 OUTLIER -70.24 -12.82 61.86 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.749 -177.338 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.478 ' NH1' ' HE2' ' A' ' 27' ' ' LYS . 74.7 mtt85 -101.59 -3.17 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.508 1.523 . . . . 0.0 111.96 173.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 45.4 42.25 7.37 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.529 1.532 . . . . 0.0 112.234 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.38 167.44 10.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.47 156.13 44.61 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 167.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.28 -153.58 25.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 119.398 0.999 . . . . 0.0 112.905 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.01 166.4 24.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.626 0.771 . . . . 0.0 112.779 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.38 144.93 31.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 124.949 1.3 . . . . 0.0 107.544 163.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.37 143.29 32.64 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 0.689 . . . . 0.0 111.088 166.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -74.33 110.92 9.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 162.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -79.24 142.81 35.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.04 -23.95 66.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.769 0.428 . . . . 0.0 112.081 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.96 -20.57 62.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.876 1.27 . . . . 0.0 113.032 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.44 -12.38 36.27 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.646 1.117 . . . . 0.0 112.977 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -82.57 170.84 14.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.052 0.941 . . . . 0.0 110.363 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.07 146.14 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -117.97 145.92 44.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -134.39 146.84 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.82 130.61 34.23 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 167.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.78 157.79 44.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 110.253 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.55 134.41 33.82 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.37 -178.01 43.3 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -172.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.08 152.09 72.88 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.23 1.954 . . . . 0.0 109.941 170.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.49 -40.52 87.26 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.937 0.495 . . . . 0.0 111.415 -171.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -64.41 -38.69 91.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.976 0.807 . . . . 0.0 111.968 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -44.54 86.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.98 -35.28 79.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.202 0.455 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -63.83 -51.14 66.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.104 0.866 . . . . 0.0 110.3 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -66.0 -32.27 73.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.016 0.825 . . . . 0.0 111.062 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.59 -45.55 93.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.061 0.944 . . . . 0.0 109.534 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.75 -47.92 84.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 119.158 0.89 . . . . 0.0 109.595 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -57.31 -39.84 76.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.725 0.693 . . . . 0.0 110.765 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.59 81.09 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.857 0.863 . . . . 0.0 111.211 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.76 -32.38 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.653 0.781 . . . . 0.0 110.866 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -60.76 -31.65 70.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.998 1.272 . . . . 0.0 111.393 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -77.7 -45.0 26.13 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.458 0.572 . . . . 0.0 110.324 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.81 -168.86 46.22 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -54.98 153.65 11.29 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.615 166.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -50.61 -31.44 31.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.458 2.772 . . . . 0.0 115.339 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -84.33 -6.38 59.38 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.354 1.062 . . . . 0.0 112.999 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -70.82 163.84 26.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.614 0.766 . . . . 0.0 110.873 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -146.91 81.77 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.9 140.32 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.8 p -120.67 -23.09 6.11 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.448 1.099 . . . . 0.0 111.065 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -155.07 150.51 27.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.808 1.243 . . . . 0.0 108.481 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.7 tt -151.55 147.39 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -139.98 151.3 45.39 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.131 1.372 . . . . 0.0 108.164 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.36 145.12 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -137.04 158.66 43.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.83 162.09 40.97 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.323 -0.861 . . . . 0.0 110.898 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -146.26 140.86 26.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.615 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.41 -36.88 71.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 164.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 m -59.31 153.55 18.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.235 1.414 . . . . 0.0 110.106 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.86 169.16 15.53 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.024 1.33 . . . . 0.0 109.977 -173.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.85 -31.37 4.23 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.101 2.16 . . . . 0.0 108.76 170.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.32 54.64 7.6 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -55.48 145.99 21.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.768 0.827 . . . . 0.0 110.533 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -68.2 -32.9 73.45 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.347 0.659 . . . . 0.0 111.902 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -152.93 -172.03 4.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.914 1.686 . . . . 0.0 108.051 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -102.5 131.67 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 164.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.8 m -125.15 138.15 54.15 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.956 0.503 . . . . 0.0 111.405 -171.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -75.7 139.12 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 159.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.0 t -133.09 156.8 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.474 1.91 . . . . 0.0 106.402 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -130.02 13.88 5.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.991 0.917 . . . . 0.0 111.887 -162.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.248 1.014 0 C-N-CA 126.279 1.831 . . . . 0.0 107.15 -177.551 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mmm . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.8 tp -145.17 156.32 43.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 0.0 108.386 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.64 138.31 51.54 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.902 1.281 . . . . 0.0 108.229 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -123.71 156.42 36.0 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.714 1.606 . . . . 0.0 108.766 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -123.41 138.99 54.47 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.94 141.44 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.01 138.57 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.67 144.88 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -170.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -138.93 156.83 46.95 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.961 1.305 . . . . 0.0 109.833 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.0 -158.12 23.73 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.582 1.563 . . . . 0.0 110.027 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -74.66 83.84 2.08 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.4 15.98 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.25 1.02 . . . . 0.0 110.941 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -137.98 154.48 49.35 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.97 30.19 70.24 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.12 -9.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.018 1.327 . . . . 0.0 112.138 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.55 21.42 14.68 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.503 1.525 . . . . 0.0 110.494 -177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.61 -41.02 96.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.256 1.528 . . . . 0.0 110.876 -171.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -61.23 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.405 1.002 . . . . 0.0 110.56 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -64.65 -41.82 95.85 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.239 0.472 . . . . 0.0 110.677 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.13 -49.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.07 0.548 . . . . 0.0 110.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.19 -39.79 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 110.159 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -59.06 -49.7 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.793 0.724 . . . . 0.0 109.911 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.8 ptm -72.49 -33.65 67.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.374 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -68.63 -30.75 69.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.003 0.82 . . . . 0.0 111.673 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.26 64.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.184 0.447 . . . . 0.0 109.96 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.98 -43.64 98.54 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.971 0.908 . . . . 0.0 111.025 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -3.32 23.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -114.84 0.27 13.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.662 1.585 . . . . 0.0 111.465 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 45.25 40.02 4.73 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.357 1.463 . . . . 0.0 111.942 -168.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.13 165.37 13.73 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 155.48 45.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.234 1.013 . . . . 0.0 108.367 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.19 -156.14 26.35 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.797 0.726 . . . . 0.0 112.173 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.9 p-90 -153.36 167.13 30.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.975 -0.721 . . . . 0.0 112.211 176.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.9 142.89 34.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.092 1.357 . . . . 0.0 109.036 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 149.41 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.207 0.603 . . . . 0.0 110.608 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -75.73 134.63 40.45 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.23 143.8 30.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.58 -21.86 66.82 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.366 0.53 . . . . 0.0 111.648 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -28.95 59.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.029 1.732 . . . . 0.0 112.85 170.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.8 -25.02 10.47 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.493 1.044 . . . . 0.0 112.669 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -63.64 168.66 4.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.709 1.255 . . . . 0.0 110.754 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.8 150.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 169.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -139.62 140.08 36.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.98 146.63 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -170.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.01 129.12 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 164.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.24 48.07 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 109.443 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -136.79 138.19 40.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.701 1.6 . . . . 0.0 107.955 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.63 -175.22 44.51 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.279 -0.734 . . . . 0.0 111.885 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.37 137.79 40.82 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.365 2.043 . . . . 0.0 109.534 172.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.13 -34.86 61.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.886 1.674 . . . . 0.0 113.1 -168.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -71.34 -46.24 61.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.091 -1.006 . . . . 0.0 111.953 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.62 83.51 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.05 -49.6 76.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.631 1.172 . . . . 0.0 109.692 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 119.188 -0.435 . . . . 0.0 111.362 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 m -62.37 -37.52 86.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.586 0.63 . . . . 0.0 111.199 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.37 -43.82 98.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.01 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.9 t -61.94 -41.95 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.248 1.386 . . . . 0.0 110.593 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.22 -39.27 72.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.717 1.144 . . . . 0.0 110.561 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.7 77.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.294 0.638 . . . . 0.0 111.287 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.8 t -58.68 -32.84 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.455 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -60.88 -35.39 76.52 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.01 1.277 . . . . 0.0 111.535 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -72.7 -43.33 63.16 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.518 0.599 . . . . 0.0 110.288 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.92 -176.17 43.82 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.15 162.23 14.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.659 0.783 . . . . 0.0 110.669 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.92 -32.13 46.13 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.446 2.764 . . . . 0.0 114.52 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -94.33 -9.19 36.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 112.47 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -78.4 165.31 23.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.997 0.919 . . . . 0.0 110.966 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -144.49 93.18 2.39 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.2 t -61.41 143.38 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 p -124.52 -20.61 5.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.265 1.026 . . . . 0.0 111.101 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -155.85 154.12 30.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 0.0 109.243 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.12 148.07 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.904 1.281 . . . . 0.0 107.586 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.1 m -140.68 154.08 46.23 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.35 1.46 . . . . 0.0 108.663 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.43 145.64 29.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 108.178 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 m -134.42 161.25 35.53 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.12 162.92 34.24 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.154 -0.966 . . . . 0.0 110.942 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.4 m -139.8 126.26 20.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 169.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.42 -29.79 66.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.6 m -66.08 161.04 22.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.959 1.303 . . . . 0.0 109.772 167.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.8 mt -133.1 164.32 27.3 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.54 1.136 . . . . 0.0 109.948 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -119.9 -20.24 7.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.393 1.477 . . . . 0.0 110.666 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.37 48.29 5.7 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.443 0.544 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -59.96 156.47 14.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 117.587 0.694 . . . . 0.0 109.239 167.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.71 -6.27 4.6 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.856 0.863 . . . . 0.0 112.78 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.7 mtm-85 -141.31 169.04 18.35 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.901 1.68 . . . . 0.0 107.031 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -110.39 138.05 47.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -133.99 139.23 45.92 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.66 140.61 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 161.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.49 158.6 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.435 1.894 . . . . 0.0 106.533 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -128.89 -6.4 5.03 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.205 1.002 . . . . 0.0 111.814 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.25 1.098 0 C-N-CA 124.919 1.288 . . . . 0.0 109.396 172.934 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.6 mmm . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.4 tp -152.5 158.6 42.8 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.413 1.885 . . . . 0.0 107.225 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -123.67 138.33 54.55 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 107.244 173.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -110.53 151.06 28.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.233 1.413 . . . . 0.0 107.704 163.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -117.97 140.34 49.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 152.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -131.41 143.41 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.4 mm -131.99 136.56 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.19 146.34 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -140.46 155.67 46.61 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.748 1.219 . . . . 0.0 109.796 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.78 -155.16 23.56 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.451 1.5 . . . . 0.0 109.73 -176.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -76.91 79.11 3.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 162.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.46 14.6 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.066 0.946 . . . . 0.0 111.711 -170.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -137.76 150.14 47.01 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.15 30.28 63.22 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.83 -1.27 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.55 1.54 . . . . 0.0 112.021 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.58 20.94 42.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.973 1.273 . . . . 0.0 110.641 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -63.08 -44.58 95.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.109 1.454 . . . . 0.0 110.405 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -61.03 -47.08 88.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.231 0.923 . . . . 0.0 110.452 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -64.69 -42.17 95.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.717 0.407 . . . . 0.0 111.048 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -56.23 -52.38 64.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.954 0.502 . . . . 0.0 110.04 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.45 -39.72 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.546 0.612 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -59.2 -44.77 92.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.019 0.827 . . . . 0.0 110.029 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.8 mtp -73.5 -34.0 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.437 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -66.47 -38.79 88.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.019 1.282 . . . . 0.0 110.048 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.04 99.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.086 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.06 -44.99 94.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.664 0.665 . . . . 0.0 111.143 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.03 -8.65 7.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.137 1.775 . . . . 0.0 112.837 174.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -118.48 -0.21 11.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.358 -1.464 . . . . 0.0 111.934 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 39.07 41.72 0.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.03 1.732 . . . . 0.0 112.35 -165.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.92 165.94 23.98 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.571 0.748 . . . . 0.0 109.302 171.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 152.0 46.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.97 -159.17 28.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.506 1.048 . . . . 0.0 113.688 -169.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -141.48 165.52 27.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.812 0.845 . . . . 0.0 111.973 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.1 p -137.58 146.28 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.018 1.327 . . . . 0.0 108.226 165.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -146.54 152.41 38.91 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.908 0.883 . . . . 0.0 110.036 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -84.59 121.64 27.9 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -75.22 147.03 40.68 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.28 -29.99 71.06 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.658 0.383 . . . . 0.0 111.521 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.58 -5.52 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.58 1.152 . . . . 0.0 113.58 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.94 49.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.478 1.037 . . . . 0.0 113.29 170.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.49 170.55 15.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.64 1.22 . . . . 0.0 110.424 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.13 149.5 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -130.97 142.41 50.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.13 147.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.76 128.31 28.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 167.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.55 148.34 44.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -138.61 129.72 26.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.38 -167.66 39.0 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.357 -0.69 . . . . 0.0 111.837 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.58 155.68 49.8 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.818 2.345 . . . . 0.0 111.103 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.9 -44.31 91.18 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.69 0.796 . . . . 0.0 111.417 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -62.55 -39.35 93.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.098 0.863 . . . . 0.0 111.958 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.34 -44.2 83.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.6 mt -65.6 -37.76 87.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.435 0.294 . . . . 0.0 111.383 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -63.0 -52.76 61.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.756 0.823 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -64.1 -32.44 74.01 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.58 -0.7 . . . . 0.0 111.273 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.83 -50.0 70.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.529 175.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -63.94 -37.87 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.678 1.126 . . . . 0.0 110.04 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -56.39 -41.77 76.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.094 0.861 . . . . 0.0 110.571 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.6 83.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.932 0.493 . . . . 0.0 111.582 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.08 -32.22 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.658 0.783 . . . . 0.0 110.668 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.16 -31.18 68.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.821 1.191 . . . . 0.0 111.493 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -78.28 -41.96 32.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.477 0.58 . . . . 0.0 111.195 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.53 -169.28 47.73 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -166.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.2 p -60.69 165.78 5.28 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 117.111 0.455 . . . . 0.0 110.166 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.02 -5.59 8.01 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.356 2.038 . . . . 0.0 113.703 171.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.21 -9.29 14.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.562 1.145 . . . . 0.0 111.761 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -75.46 167.66 21.47 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.077 0.951 . . . . 0.0 111.089 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -143.73 131.01 20.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 155.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.4 t -100.14 139.72 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.0 p -122.39 -19.23 6.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.051 0.941 . . . . 0.0 111.038 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -154.18 150.74 28.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 tt -152.46 145.77 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 m -142.6 153.45 43.51 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.052 1.341 . . . . 0.0 108.765 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.65 148.75 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.688 1.195 . . . . 0.0 109.399 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -137.06 158.18 45.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.01 152.43 47.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.61 0.764 . . . . 0.0 110.133 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -148.12 146.59 28.85 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.448 1.499 . . . . 0.0 108.391 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -83.6 -32.74 25.58 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.878 -0.514 . . . . 0.0 110.476 167.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -58.15 152.22 17.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 109.311 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.52 154.17 42.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.522 1.129 . . . . 0.0 109.131 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -77.23 -35.3 55.59 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 162.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.0 42.57 3.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.591 1.091 . . . . 0.0 111.375 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -62.21 157.6 19.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.986 0.893 . . . . 0.0 110.777 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -130.27 -1.24 4.53 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.858 1.263 . . . . 0.0 112.205 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -148.2 177.37 9.46 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.791 2.037 . . . . 0.0 107.177 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -121.4 122.37 39.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.0 m -124.48 139.69 53.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.635 0.731 . . . . 0.0 111.918 -163.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.6 mt -80.24 128.65 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.87 177.05 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.721 1.208 . . . . 0.0 108.998 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -133.08 2.33 3.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.541 0.736 . . . . 0.0 112.475 -167.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.248 1.024 0 C-N-CA 126.377 1.871 . . . . 0.0 106.751 -179.077 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.4 tp -133.98 163.83 28.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 -165.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -125.69 134.26 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.36 1.464 . . . . 0.0 108.44 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -117.31 157.9 25.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 108.572 167.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -126.34 140.19 52.7 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.1 mt -134.08 142.38 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -131.99 137.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.57 148.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -142.47 157.34 44.86 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.123 1.369 . . . . 0.0 109.883 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.15 -154.21 23.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.478 1.513 . . . . 0.0 110.387 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -73.27 79.99 1.32 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 160.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.94 19.27 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.858 0.863 . . . . 0.0 111.023 -171.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -136.64 146.68 46.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.275 1.03 . . . . 0.0 108.228 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.07 33.15 86.34 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.66 0.29 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.172 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.47 24.54 42.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.35 -46.17 87.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.207 1.504 . . . . 0.0 109.936 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -56.45 -46.13 80.47 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.818 0.736 . . . . 0.0 111.521 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.79 -40.94 83.9 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.068 0.395 . . . . 0.0 110.823 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.53 -51.86 67.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.276 0.63 . . . . 0.0 109.875 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.24 -40.42 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.213 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.61 -44.93 93.25 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.854 0.752 . . . . 0.0 110.258 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.5 mtm -71.33 -37.38 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.489 0.586 . . . . 0.0 111.305 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.94 -34.6 76.91 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.131 0.878 . . . . 0.0 110.711 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.42 88.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.901 0.48 . . . . 0.0 110.145 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.11 -49.24 76.67 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.729 0.811 . . . . 0.0 110.622 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -4.97 20.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.57 4.07 15.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.683 1.593 . . . . 0.0 111.807 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 11.4 mmpt? 43.45 38.76 1.91 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.5 1.52 . . . . 0.0 112.078 -172.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.29 165.54 20.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 157.28 43.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.71 1.204 . . . . 0.0 107.851 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.76 -152.13 22.43 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 119.231 0.923 . . . . 0.0 111.598 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -150.66 166.6 29.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.971 -0.723 . . . . 0.0 112.839 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 146.42 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.277 1.431 . . . . 0.0 108.669 171.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -142.96 160.57 40.09 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.014 0.925 . . . . 0.0 109.063 168.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.47 110.89 14.44 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -85.77 155.67 20.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.403 1.081 . . . . 0.0 110.662 -154.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.54 -28.34 69.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.702 0.401 . . . . 0.0 111.804 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.59 -5.34 32.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.017 0.927 . . . . 0.0 113.259 175.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.11 -16.37 46.12 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.629 1.109 . . . . 0.0 113.532 172.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -87.66 152.78 21.89 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.047 1.423 . . . . 0.0 110.002 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.7 147.82 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 162.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -137.7 139.81 40.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -140.45 146.58 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -170.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.37 124.04 25.1 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 166.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.05 150.29 46.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -140.11 138.21 35.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 108.082 -170.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.47 -171.48 39.97 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.72 152.93 64.71 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.291 1.994 . . . . 0.0 110.413 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.05 -40.89 91.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.385 0.674 . . . . 0.0 111.65 -171.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -65.3 -37.86 88.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.74 0.7 . . . . 0.0 111.97 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.29 81.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.26 -37.53 87.81 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.361 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.94 -47.54 82.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.169 0.895 . . . . 0.0 110.581 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.41 -37.52 83.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.105 0.562 . . . . 0.0 110.848 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.12 -45.38 81.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.389 1.076 . . . . 0.0 110.521 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.2 t -56.08 -49.5 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.345 0.975 . . . . 0.0 109.235 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.08 -42.22 69.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 110.863 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.4 74.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.503 0.721 . . . . 0.0 111.442 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.33 -24.6 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -57.54 -33.99 68.69 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.445 1.475 . . . . 0.0 111.042 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -83.2 -42.78 16.87 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.364 0.529 . . . . 0.0 111.053 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.6 -167.06 54.84 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -165.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.0 p -59.94 165.04 5.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.178 0.489 . . . . 0.0 110.319 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.13 -12.68 27.74 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.009 1.806 . . . . 0.0 113.22 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -98.51 -14.77 19.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.143 0.977 . . . . 0.0 111.768 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -71.61 163.46 27.7 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.88 0.872 . . . . 0.0 111.022 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -142.2 94.91 2.72 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.06 145.39 11.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.2 p -126.01 -18.72 4.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.311 1.045 . . . . 0.0 111.063 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -152.62 149.46 28.47 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.364 1.065 . . . . 0.0 109.264 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.6 tt -151.84 145.18 16.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.025 1.33 . . . . 0.0 107.807 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 m -141.71 154.04 45.04 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.286 1.434 . . . . 0.0 108.709 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.2 t -137.72 145.42 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.661 1.184 . . . . 0.0 107.852 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.07 164.27 28.41 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.661 1.985 . . . . 0.0 106.083 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.59 169.61 17.25 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.981 -1.074 . . . . 0.0 111.014 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.5 m -140.39 135.59 32.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -76.67 -28.87 56.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 119.099 -0.476 . . . . 0.0 110.245 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.5 m -73.42 165.54 24.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 161.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.41 162.89 38.67 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 109.88 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.92 -40.33 47.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.54 0.736 . . . . 0.0 109.468 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.06 50.82 3.76 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.14 150.84 10.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.683 0.793 . . . . 0.0 110.498 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -91.21 -31.26 16.23 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.612 0.765 . . . . 0.0 112.81 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -147.03 -179.38 6.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.941 1.696 . . . . 0.0 107.956 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.63 134.9 52.89 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -135.11 139.49 44.72 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 73.9 mt -75.75 133.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 162.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.19 172.48 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.272 1.429 . . . . 0.0 108.542 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -137.06 11.41 3.07 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -162.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.201 1.4 . . . . 0.0 107.68 -177.732 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.861 -0.052 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.7 tp -130.42 163.91 25.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.012 1.325 . . . . 0.0 109.297 -169.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -129.37 142.15 50.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.228 1.011 . . . . 0.0 108.437 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.14 155.89 33.51 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.746 1.618 . . . . 0.0 108.38 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm-85 -120.01 140.06 51.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 158.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.2 mt -130.85 143.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.1 mm -126.72 141.98 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.93 146.17 27.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.1 157.69 45.81 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.553 1.141 . . . . 0.0 109.477 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.45 -158.97 23.95 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.479 1.514 . . . . 0.0 109.643 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -74.0 89.2 1.91 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 159.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.25 15.91 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.484 0.713 . . . . 0.0 111.701 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -138.14 149.0 45.49 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.75 32.4 74.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.42 6.72 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.726 1.61 . . . . 0.0 111.314 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.63 21.2 60.31 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.518 1.056 . . . . 0.0 110.529 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.77 -43.91 91.72 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.392 1.096 . . . . 0.0 110.495 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -65.74 -40.76 92.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.134 0.879 . . . . 0.0 111.15 -177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.02 -41.95 90.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.658 0.663 . . . . 0.0 110.6 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -56.64 -49.8 73.93 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.821 0.737 . . . . 0.0 110.005 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.73 -39.85 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.102 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.5 -41.01 93.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.804 1.184 . . . . 0.0 110.491 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.96 -35.68 72.26 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 111.103 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -72.43 -21.82 61.2 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.171 -0.956 . . . . 0.0 112.038 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.68 -46.41 46.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.94 -37.58 87.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.226 1.01 . . . . 0.0 112.255 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -17.64 42.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -130.29 21.53 5.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.133 0.973 . . . . 0.0 110.747 173.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 28.61 54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.868 2.867 . . . . 0.0 113.763 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.14 165.86 15.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.391 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.3 164.48 23.44 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.635 1.574 . . . . 0.0 108.039 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.42 -150.98 23.3 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.68 0.673 . . . . 0.0 112.783 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -151.32 169.8 21.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.68 1.192 . . . . 0.0 110.295 162.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.1 144.66 34.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.855 1.662 . . . . 0.0 107.726 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.01 146.64 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.384 1.074 . . . . 0.0 109.251 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -83.93 120.9 26.65 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 161.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -73.88 149.37 41.55 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.05 -23.65 67.54 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.6 0.36 . . . . 0.0 111.684 172.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.38 -21.07 61.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.466 1.506 . . . . 0.0 112.97 172.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.49 -16.15 52.67 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.56 1.076 . . . . 0.0 112.395 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -71.93 170.44 13.76 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 110.581 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.98 150.84 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 165.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.25 146.13 49.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.66 146.45 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -143.41 116.36 8.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.23 44.07 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.692 0.678 . . . . 0.0 111.911 -162.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -135.0 132.61 38.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.801 2.041 . . . . 0.0 107.551 -166.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.94 -177.49 41.02 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.59 152.74 74.53 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.233 1.955 . . . . 0.0 110.184 173.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.35 -33.87 73.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.96 -35.19 69.48 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.963 -1.086 . . . . 0.0 111.579 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -40.31 70.79 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.36 0.264 . . . . 0.0 110.604 176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.1 mp -58.79 -40.13 83.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.745 0.818 . . . . 0.0 110.552 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -65.32 -49.27 70.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.468 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 p -62.02 -34.16 75.69 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.559 1.527 . . . . 0.0 111.264 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -63.93 -47.03 82.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.677 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.3 t -57.21 -47.15 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.309 0.958 . . . . 0.0 109.462 173.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.8 -41.54 77.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.404 0.682 . . . . 0.0 110.555 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.89 -42.09 77.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.216 0.606 . . . . 0.0 111.84 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.62 -31.52 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 118.341 -0.837 . . . . 0.0 110.635 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -58.55 -36.2 73.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.991 1.269 . . . . 0.0 111.159 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.32 -43.07 71.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.939 0.336 . . . . 0.0 110.548 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.22 -178.29 30.76 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.848 0.737 . . . . 0.0 111.666 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.4 p -63.53 159.33 52.28 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 0.0 110.622 177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.17 -26.17 25.58 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.519 2.813 . . . . 0.0 115.333 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.28 -7.39 24.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 112.198 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.7 p -74.84 167.68 21.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.575 0.702 . . . . 0.0 110.863 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -139.39 77.86 1.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -59.51 140.07 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.4 p -123.65 -21.29 5.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.415 1.086 . . . . 0.0 111.547 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.23 154.86 31.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.886 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.08 145.88 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.564 1.546 . . . . 0.0 107.53 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -141.15 157.4 45.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.33 1.452 . . . . 0.0 109.123 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.54 145.63 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.803 1.241 . . . . 0.0 108.738 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 m -136.52 166.05 24.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.329 2.251 . . . . 0.0 106.095 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.2 163.56 33.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.633 -1.292 . . . . 0.0 111.287 -174.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.6 m -148.14 146.91 28.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.279 1.832 . . . . 0.0 108.284 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -81.64 -34.13 31.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.055 -0.403 . . . . 0.0 110.693 172.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.4 m -65.61 155.96 34.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.001 0.921 . . . . 0.0 109.679 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 164.52 37.95 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.536 1.535 . . . . 0.0 108.831 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -80.98 -34.65 32.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.877 0.762 . . . . 0.0 110.947 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.82 21.53 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.192 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . 0.251 30.1 p80 47.07 42.54 12.93 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.891 2.077 . . . . 0.0 114.188 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.52 -49.98 35.73 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.24 173.76 12.96 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.337 1.455 . . . . 0.0 109.458 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -122.65 100.11 6.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.584 1.084 . . . . 0.0 109.637 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 136.89 35.32 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.919 0.488 . . . . 0.0 110.766 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.6 mt -84.72 126.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 153.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 100.0 t -87.77 117.4 31.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -84.43 52.26 2.31 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.598 1.159 . . . . 0.0 110.683 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.662 -1.161 . . . . 0.0 109.452 165.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpt . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.6 tp -153.37 164.88 37.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.563 1.145 . . . . 0.0 109.409 -172.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -117.87 138.27 52.23 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.661 1.584 . . . . 0.0 107.697 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -114.65 155.54 26.39 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.072 1.349 . . . . 0.0 107.36 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -127.51 140.95 51.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 162.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.05 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.08 137.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -171.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -142.76 156.75 45.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.769 1.228 . . . . 0.0 110.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.67 -155.85 24.44 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.509 1.528 . . . . 0.0 110.082 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -74.35 82.25 1.9 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 159.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.96 21.87 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.884 1.274 . . . . 0.0 110.201 -174.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -137.72 149.79 46.77 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.503 1.121 . . . . 0.0 108.358 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.62 74.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.591 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.78 -10.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.376 1.071 . . . . 0.0 111.949 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 23.34 13.69 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.124 1.345 . . . . 0.0 110.243 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.16 -39.14 93.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.506 1.653 . . . . 0.0 110.48 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -55.51 -47.36 76.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.757 0.708 . . . . 0.0 111.448 171.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -68.01 -39.08 83.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.411 0.551 . . . . 0.0 111.291 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -56.29 -54.16 48.66 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 173.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.38 -39.64 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.388 0.54 . . . . 0.0 110.461 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -56.22 -47.52 78.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 0.0 109.943 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.6 mtm -73.78 -34.96 64.89 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.447 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.37 -43.85 93.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.503 1.047 . . . . 0.0 109.869 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.76 92.15 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.227 0.467 . . . . 0.0 110.727 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.21 -47.7 84.86 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.753 0.821 . . . . 0.0 110.304 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -61.2 -41.97 97.77 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.859 0.863 . . . . 0.0 111.007 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -74.98 -3.71 33.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.811 0.844 . . . . 0.0 112.37 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 49.52 35.17 7.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.098 1.759 . . . . 0.0 112.251 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.37 170.68 16.25 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 110.158 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.29 153.49 46.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.349 1.46 . . . . 0.0 107.583 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.15 -155.85 26.72 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.762 1.164 . . . . 0.0 113.67 -171.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.46 165.99 25.99 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.301 0.64 . . . . 0.0 112.542 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.4 144.65 36.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.819 1.248 . . . . 0.0 107.759 161.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.32 158.65 43.46 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.464 1.106 . . . . 0.0 108.265 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.74 118.51 25.73 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -94.13 153.5 18.07 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.829 0.852 . . . . 0.0 110.421 -155.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.48 -29.09 70.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.606 0.362 . . . . 0.0 111.953 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.87 -9.79 47.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.49 -19.63 26.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.441 1.019 . . . . 0.0 113.321 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -83.75 154.73 23.43 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.674 1.237 . . . . 0.0 109.995 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.95 150.64 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 162.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -132.06 141.43 49.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -135.26 144.1 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -134.25 126.01 28.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.5 149.43 48.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -137.11 130.8 31.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.35 -173.54 43.71 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -170.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.85 149.19 59.56 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.481 2.12 . . . . 0.0 110.031 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.97 -34.16 71.49 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.121 0.969 . . . . 0.0 111.939 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.16 -40.52 82.33 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.035 -1.041 . . . . 0.0 111.673 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -41.28 83.36 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.52 -41.58 96.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.05 -49.79 76.26 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.444 0.565 . . . . 0.0 110.362 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 m -65.22 -29.66 70.48 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.961 -0.462 . . . . 0.0 111.446 -177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -68.58 -45.17 72.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.403 1.081 . . . . 0.0 110.461 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.8 -49.18 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.641 1.11 . . . . 0.0 109.038 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -56.86 -41.69 78.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.763 0.825 . . . . 0.0 110.608 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.36 -48.13 74.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.827 0.451 . . . . 0.0 111.553 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.97 -30.15 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.838 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -59.05 -23.33 61.91 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.127 1.33 . . . . 0.0 112.191 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -68.25 -34.87 77.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.6 0.636 . . . . 0.0 111.582 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.36 171.9 3.41 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.252 0.93 . . . . 0.0 112.082 -164.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 157.59 65.71 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 121.88 -0.776 . . . . 0.0 110.157 171.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.69 -31.69 61.77 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.123 2.549 . . . . 0.0 113.66 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.46 1.92 39.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.52 1.528 . . . . 0.0 112.759 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 m -128.03 167.11 17.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.854 0.862 . . . . 0.0 110.759 -158.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -146.19 92.95 2.25 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.87 142.78 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 161.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.6 p -128.47 -17.03 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.958 1.303 . . . . 0.0 111.226 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -150.39 148.73 29.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 108.918 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.26 143.85 13.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.653 1.181 . . . . 0.0 107.919 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -142.97 154.46 44.06 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.263 1.425 . . . . 0.0 108.656 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.83 145.73 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.517 1.127 . . . . 0.0 108.293 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.33 162.6 32.57 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.892 2.077 . . . . 0.0 106.686 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -134.66 157.87 45.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.596 1.158 . . . . 0.0 109.759 -172.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -160.06 162.99 34.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.12 1.368 . . . . 0.0 109.623 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -120.05 -12.86 9.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.954 0.902 . . . . 0.0 111.561 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.8 m -78.25 68.6 4.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.436 1.095 . . . . 0.0 109.507 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.67 148.27 7.48 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.226 1.011 . . . . 0.0 111.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -71.65 -35.09 70.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.252 1.021 . . . . 0.0 109.335 163.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.76 44.73 3.84 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.356 0.979 . . . . 0.0 111.149 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -60.46 157.29 14.33 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.494 0.718 . . . . 0.0 110.612 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.22 -6.19 5.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.57 1.148 . . . . 0.0 111.901 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.75 171.12 14.54 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.447 1.899 . . . . 0.0 106.833 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -117.19 135.38 53.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -138.91 144.63 39.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.51 141.04 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -134.28 154.56 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.765 2.026 . . . . 0.0 106.607 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -133.55 13.17 4.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.113 0.965 . . . . 0.0 111.883 -164.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.529 1.532 . . . . 0.0 107.921 -174.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.5 mtp . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.05 151.0 43.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 108.887 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -114.92 140.43 49.0 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -124.93 154.95 40.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.317 1.447 . . . . 0.0 108.938 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.34 138.67 52.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 159.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.79 143.38 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 mm -129.58 138.15 54.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.59 147.85 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -143.29 156.75 44.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.519 1.128 . . . . 0.0 110.027 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.65 -154.23 23.55 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.481 1.515 . . . . 0.0 110.138 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.63 89.37 1.31 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 158.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.62 18.46 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.997 0.919 . . . . 0.0 111.392 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -138.81 153.82 48.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.137 0.975 . . . . 0.0 109.186 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.24 32.17 81.34 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -133.47 -8.0 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 111.695 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.81 24.5 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.67 -44.5 85.77 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.424 1.612 . . . . 0.0 109.882 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -53.89 -49.55 68.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.611 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -61.78 -49.05 77.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.355 0.525 . . . . 0.0 110.681 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -62.89 -41.77 99.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.082 0.401 . . . . 0.0 110.855 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.98 -40.8 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.909 0.777 . . . . 0.0 110.249 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -59.91 -48.4 81.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.224 0.92 . . . . 0.0 109.531 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.9 ptm -70.81 -32.03 68.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.316 0.507 . . . . 0.0 111.67 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -69.48 -28.24 65.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.458 1.026 . . . . 0.0 111.84 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.4 -44.35 52.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.932 0.493 . . . . 0.0 109.833 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.42 -42.15 98.3 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 123.967 0.907 . . . . 0.0 111.291 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -6.54 35.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -113.06 2.27 15.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.871 1.668 . . . . 0.0 111.34 171.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.28 38.45 5.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.537 1.535 . . . . 0.0 112.037 -169.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.75 165.68 14.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.76 156.5 44.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.516 1.127 . . . . 0.0 108.011 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.79 -154.79 26.16 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.223 0.919 . . . . 0.0 112.692 -170.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -145.92 167.53 23.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.102 -0.646 . . . . 0.0 112.625 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.48 145.68 30.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.775 1.23 . . . . 0.0 108.456 167.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.71 160.16 40.75 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 108.045 170.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -125.9 113.54 17.34 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -86.48 153.25 22.0 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.236 1.014 . . . . 0.0 110.193 -157.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -29.47 70.45 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.631 0.372 . . . . 0.0 111.878 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.99 -9.24 43.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.97 -20.2 26.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.505 1.05 . . . . 0.0 113.331 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.3 mtm180 -80.03 154.66 28.02 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.692 1.246 . . . . 0.0 110.045 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.88 150.67 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 161.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -134.07 142.33 47.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -139.61 150.07 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -134.7 128.81 33.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.25 44.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.12 0.873 . . . . 0.0 109.412 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -140.41 136.09 32.73 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 107.881 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.46 43.24 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.962 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.3 138.32 42.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.267 1.978 . . . . 0.0 109.411 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.54 -30.37 67.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 113.018 -168.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -69.75 -46.53 65.65 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.763 -1.211 . . . . 0.0 111.647 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.19 -39.02 89.37 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 tp -61.53 -47.73 84.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.156 0.982 . . . . 0.0 110.167 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -60.14 -44.41 94.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.75 0.42 . . . . 0.0 110.872 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m -62.48 -38.6 90.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.495 0.589 . . . . 0.0 111.179 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -61.28 -44.7 96.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.518 -0.739 . . . . 0.0 110.161 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.4 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.542 1.065 . . . . 0.0 110.15 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -55.5 -39.55 70.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.671 1.123 . . . . 0.0 110.495 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.73 82.73 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.171 0.588 . . . . 0.0 111.471 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.33 -31.41 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.758 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -61.64 -33.36 73.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.054 1.297 . . . . 0.0 111.533 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -71.58 -45.35 62.47 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.704 0.684 . . . . 0.0 109.999 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.39 -156.77 34.0 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -170.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.9 p -62.04 168.83 3.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 122.699 0.4 . . . . 0.0 110.573 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.35 -10.08 1.97 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.53 2.82 . . . . 0.0 114.763 165.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -124.04 -0.77 8.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.263 1.425 . . . . 0.0 111.799 -171.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -77.18 166.22 23.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.082 0.953 . . . . 0.0 112.006 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -142.75 88.38 2.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 159.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.02 142.19 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -123.77 -18.32 6.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.287 1.035 . . . . 0.0 111.091 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -153.3 149.87 28.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.276 1.031 . . . . 0.0 109.241 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.74 144.22 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -139.75 152.22 46.45 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.122 1.369 . . . . 0.0 108.566 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -136.45 145.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.724 1.209 . . . . 0.0 108.169 -176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -132.3 160.35 36.5 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 167.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.43 161.75 37.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.281 0.946 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 m -142.84 124.79 15.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.86 11.77 3.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.76 0.824 . . . . 0.0 112.234 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -138.39 143.69 39.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.992 1.717 . . . . 0.0 106.936 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 mt -84.49 159.17 20.79 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.824 0.45 . . . . 0.0 110.658 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.02 -37.67 38.56 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 156.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 50.14 1.59 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.229 0.918 . . . . 0.0 111.386 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -58.01 144.89 38.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.524 0.729 . . . . 0.0 110.191 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -86.59 -28.2 23.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.246 0.618 . . . . 0.0 112.193 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -151.97 -178.75 6.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.783 1.633 . . . . 0.0 108.808 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -114.28 127.82 56.06 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -132.65 139.87 47.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.563 0.696 . . . . 0.0 112.464 -166.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.1 mt -76.7 131.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 0.0 109.142 -178.087 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.8 mt -136.7 170.52 15.94 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.673 1.589 . . . . 0.0 108.266 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -117.96 138.85 51.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 106.335 166.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.58 155.68 28.3 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.265 1.426 . . . . 0.0 107.304 167.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -124.48 139.66 53.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 162.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 mt -134.36 140.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.87 139.49 51.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.0 144.2 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -138.11 156.16 48.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.809 1.244 . . . . 0.0 110.033 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.43 -154.54 22.51 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.416 1.484 . . . . 0.0 110.44 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -72.55 82.65 1.11 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.8 m -135.07 18.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.274 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -137.01 146.86 45.8 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.949 0.9 . . . . 0.0 108.653 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.6 33.13 83.58 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -134.7 -9.23 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.702 1.201 . . . . 0.0 111.824 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.12 20.58 15.59 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.217 1.389 . . . . 0.0 110.468 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.59 -41.86 98.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.995 1.398 . . . . 0.0 110.43 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -54.48 -49.0 71.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.789 0.722 . . . . 0.0 111.473 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -66.75 -42.04 86.83 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.308 0.504 . . . . 0.0 111.231 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.22 -51.67 67.24 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.082 0.553 . . . . 0.0 110.22 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.68 -41.5 88.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.091 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -58.44 -45.53 88.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.797 0.726 . . . . 0.0 109.902 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.4 mtm -74.01 -33.85 63.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.743 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -66.67 -40.14 88.46 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.867 1.212 . . . . 0.0 110.249 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.17 97.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.172 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.81 -44.49 93.97 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.761 0.824 . . . . 0.0 110.832 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -58.89 -41.22 86.66 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.253 1.021 . . . . 0.0 111.182 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -86.22 0.93 52.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.371 -0.823 . . . . 0.0 113.161 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mptt 49.67 37.15 12.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.572 1.549 . . . . 0.0 111.933 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.87 165.71 22.66 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.837 0.855 . . . . 0.0 109.584 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.85 165.02 14.16 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.522 1.129 . . . . 0.0 108.058 165.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.84 -154.39 24.81 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 118.856 0.753 . . . . 0.0 112.335 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -153.81 167.59 29.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 112.049 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -137.07 145.2 30.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 108.796 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -140.44 164.52 29.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.258 1.023 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.2 109.19 12.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -76.15 152.93 36.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.473 0.709 . . . . 0.0 111.056 -157.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.28 -27.58 69.43 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.884 0.474 . . . . 0.0 111.25 164.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -14.58 19.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.323 1.849 . . . . 0.0 112.853 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -9.01 50.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.125 0.869 . . . . 0.0 113.165 167.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -104.91 156.09 18.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.592 1.157 . . . . 0.0 109.226 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.45 147.27 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 168.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -133.28 135.56 44.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -136.46 146.07 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -172.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 tt -135.87 126.96 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 167.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.04 152.34 49.97 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.644 0.778 . . . . 0.0 109.339 -172.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -141.17 133.93 28.81 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.67 1.188 . . . . 0.0 107.949 -169.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.93 -171.46 40.34 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.547 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.29 156.88 54.49 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.798 2.332 . . . . 0.0 110.666 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -58.54 -44.8 89.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.588 0.755 . . . . 0.0 111.124 -173.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.74 -39.53 89.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.89 0.768 . . . . 0.0 111.928 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.62 -47.51 72.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.7 -38.82 92.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.1 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.5 -51.95 66.53 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.62 0.768 . . . . 0.0 110.184 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 m -62.15 -38.93 90.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.418 0.554 . . . . 0.0 110.893 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.19 -44.06 97.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.109 0.964 . . . . 0.0 110.403 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 t -57.81 -47.98 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.325 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.63 -40.47 75.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.663 1.12 . . . . 0.0 111.18 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.1 82.69 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.141 0.576 . . . . 0.0 110.882 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.5 t -63.28 -28.09 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.035 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -59.32 -37.67 78.36 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.563 1.528 . . . . 0.0 110.921 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.08 -42.77 56.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.222 0.465 . . . . 0.0 110.421 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.64 -174.18 51.04 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.54 160.09 28.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.076 0.55 . . . . 0.0 110.588 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.16 -32.9 51.84 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.124 2.549 . . . . 0.0 113.771 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -88.43 -7.31 56.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.66 1.184 . . . . 0.0 112.763 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -91.91 168.75 11.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.943 1.297 . . . . 0.0 110.725 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -145.24 95.86 2.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 165.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.6 t -63.79 145.19 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.7 p -123.11 -21.85 5.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.311 1.044 . . . . 0.0 111.192 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -154.79 153.12 30.71 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.149 0.98 . . . . 0.0 109.469 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.78 146.0 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.352 1.461 . . . . 0.0 107.402 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.5 m -139.37 151.01 45.99 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.153 1.381 . . . . 0.0 108.369 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.15 145.41 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.403 1.081 . . . . 0.0 108.239 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -136.32 161.03 36.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 106.173 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -149.28 163.18 38.42 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.131 -0.981 . . . . 0.0 111.527 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -149.17 148.23 29.38 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.583 1.953 . . . . 0.0 108.536 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -72.58 -40.54 66.51 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.038 168.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 m -61.63 145.24 52.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.937 0.895 . . . . 0.0 109.13 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.6 157.16 42.67 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.527 1.531 . . . . 0.0 108.645 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.12 -33.39 56.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.695 0.798 . . . . 0.0 110.114 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.45 49.51 14.81 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -169.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -54.72 151.06 8.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.101 0.96 . . . . 0.0 111.789 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -76.51 -19.36 58.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -150.54 178.3 9.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.656 1.582 . . . . 0.0 108.415 -172.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.38 116.42 31.94 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 153.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.7 m -117.18 142.31 47.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 111.996 -167.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.16 135.57 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 162.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 124.926 1.29 . . . . 0.0 108.303 179.543 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.5 mt -137.83 -179.96 6.07 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.004 1.322 . . . . 0.0 109.5 -167.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -130.55 132.14 45.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.648 1.979 . . . . 0.0 107.229 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.67 155.48 28.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -120.42 143.81 48.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 158.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.0 mt -132.72 142.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mm -131.35 136.79 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.1 147.64 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.32 156.93 44.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.56 -153.93 23.89 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.383 1.468 . . . . 0.0 110.374 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -72.38 84.75 1.09 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.02 19.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.101 0.96 . . . . 0.0 110.994 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -138.54 149.18 45.06 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 109.053 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.38 31.27 79.83 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -134.7 -9.85 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.654 1.181 . . . . 0.0 111.731 -173.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.78 22.79 17.18 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.932 1.253 . . . . 0.0 110.119 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -64.08 -39.6 94.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.239 1.52 . . . . 0.0 110.243 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -55.51 -46.19 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.904 0.774 . . . . 0.0 111.695 172.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -68.58 -40.39 80.57 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.508 0.594 . . . . 0.0 111.108 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -56.03 -51.65 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.388 0.54 . . . . 0.0 110.151 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.21 -41.35 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 118.954 -0.546 . . . . 0.0 110.211 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.79 -46.13 88.27 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.826 0.739 . . . . 0.0 110.329 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.9 mtm -72.62 -35.97 67.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.347 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -67.0 -39.36 87.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.677 1.126 . . . . 0.0 110.292 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.32 97.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.177 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.31 -45.05 93.17 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.389 0.676 . . . . 0.0 110.685 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -59.48 -33.85 71.84 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.902 0.881 . . . . 0.0 111.311 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -89.7 1.73 55.69 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.675 1.19 . . . . 0.0 112.839 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm 41.33 38.88 0.88 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.115 2.166 . . . . 0.0 112.503 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.06 165.75 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.816 0.846 . . . . 0.0 109.406 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.19 14.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 162.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.49 -163.53 29.27 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.881 0.764 . . . . 0.0 113.332 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -147.01 166.4 26.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 122.214 -0.58 . . . . 0.0 111.623 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.76 144.06 34.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.526 1.13 . . . . 0.0 109.047 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -139.25 161.94 36.2 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.48 1.112 . . . . 0.0 108.653 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -125.54 111.43 15.03 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.28 153.08 23.76 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.799 1.239 . . . . 0.0 110.383 -157.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.77 -29.32 70.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.94 -10.29 52.17 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.47 -22.62 17.08 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.427 1.013 . . . . 0.0 113.292 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -78.28 154.76 30.66 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.67 1.235 . . . . 0.0 110.327 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.61 148.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.07 135.02 43.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.57 143.15 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.72 125.28 22.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.88 43.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.65 0.78 . . . . 0.0 110.121 -171.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -139.09 143.52 38.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.822 1.249 . . . . 0.0 108.138 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.89 -171.8 39.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.321 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 152.61 57.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.687 2.258 . . . . 0.0 110.712 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.94 -34.52 76.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.62 0.768 . . . . 0.0 112.133 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.22 -40.4 77.99 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.025 -1.047 . . . . 0.0 111.476 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.83 85.74 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.95 -42.19 90.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.968 0.507 . . . . 0.0 110.621 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.98 -51.58 69.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.797 0.726 . . . . 0.0 110.789 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 p -66.45 -31.67 72.56 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.871 -0.518 . . . . 0.0 111.316 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.22 -43.35 99.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.72 171.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.54 -49.56 80.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 119.539 1.063 . . . . 0.0 108.744 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.81 -39.25 73.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.395 0.998 . . . . 0.0 111.464 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.13 -44.12 85.13 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 110.61 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.36 -30.87 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.455 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -59.49 -45.84 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.873 1.67 . . . . 0.0 109.988 172.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.3 -38.48 85.05 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.58 0.352 . . . . 0.0 111.27 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 177.06 27.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.113 0.863 . . . . 0.0 112.041 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.48 153.17 90.83 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.278 -0.542 . . . . 0.0 110.589 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.65 -31.48 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.195 2.597 . . . . 0.0 114.16 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -92.13 10.79 27.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.988 1.315 . . . . 0.0 111.991 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -128.58 169.07 14.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.417 1.487 . . . . 0.0 109.882 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -147.02 96.18 2.69 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.66 140.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.8 p -126.93 -14.17 5.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 111.268 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.51 150.63 29.79 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 109.17 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.86 147.7 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.866 1.266 . . . . 0.0 107.846 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -143.6 161.58 38.13 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.521 1.528 . . . . 0.0 108.753 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.6 t -138.39 149.23 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.609 1.164 . . . . 0.0 108.141 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.36 161.78 33.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.548 1.939 . . . . 0.0 106.189 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -140.79 158.09 44.47 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 120.943 -1.098 . . . . 0.0 111.034 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 m -134.92 138.27 43.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 156.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -89.44 24.09 2.36 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.207 -0.933 . . . . 0.0 111.171 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -142.12 179.27 7.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.822 2.449 . . . . 0.0 106.973 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -144.92 156.32 43.92 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.528 1.131 . . . . 0.0 109.405 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.8 -5.13 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -164.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.21 -3.1 0.79 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 120.036 1.289 . . . . 0.0 115.125 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -48.76 113.6 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.761 1.624 . . . . 0.0 112.126 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -150.93 -49.1 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.372 1.069 . . . . 0.0 111.115 173.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -152.92 -179.57 7.78 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 108.976 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -115.65 137.5 52.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -139.74 139.84 36.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.62 137.59 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 163.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 125.048 1.339 . . . . 0.0 108.316 179.799 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt -139.01 166.35 24.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.751 1.621 . . . . 0.0 108.953 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -112.15 138.61 48.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.606 1.563 . . . . 0.0 106.921 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -119.16 154.91 32.56 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.721 1.608 . . . . 0.0 107.051 166.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -127.9 138.73 52.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 165.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.64 143.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mm -131.68 136.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.91 150.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -143.57 158.28 43.78 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.981 1.313 . . . . 0.0 109.65 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.65 -155.54 24.86 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.436 1.493 . . . . 0.0 110.094 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -75.91 87.36 2.87 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 159.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.11 19.81 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.846 0.859 . . . . 0.0 111.282 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.68 151.97 46.34 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.365 1.066 . . . . 0.0 108.146 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.33 32.12 82.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.78 -1.63 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.513 1.525 . . . . 0.0 111.435 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.68 25.58 34.98 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.457 -1.191 . . . . 0.0 110.127 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.9 -47.5 80.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.268 1.534 . . . . 0.0 109.935 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -62.83 -41.12 99.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.038 0.835 . . . . 0.0 110.64 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -61.97 -45.19 94.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.764 0.425 . . . . 0.0 110.705 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -58.72 -51.02 71.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.242 0.617 . . . . 0.0 110.177 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.96 -39.45 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.219 0.463 . . . . 0.0 110.493 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -58.81 -47.13 85.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.931 0.787 . . . . 0.0 110.55 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -77.11 -30.75 55.39 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.903 0.774 . . . . 0.0 111.719 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.05 -31.65 69.37 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.194 0.906 . . . . 0.0 111.027 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.69 71.19 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.282 0.492 . . . . 0.0 109.885 168.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.71 -42.98 99.67 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.53 0.732 . . . . 0.0 111.571 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -12.6 60.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -115.36 8.0 15.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.678 1.191 . . . . 0.0 111.633 171.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 41.91 42.18 2.17 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.463 1.905 . . . . 0.0 112.52 -173.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.61 166.03 7.38 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.212 0.605 . . . . 0.0 109.856 166.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.85 154.41 45.51 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.63 1.172 . . . . 0.0 107.987 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.82 -161.37 28.67 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 119.282 0.946 . . . . 0.0 112.896 -171.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.55 166.81 25.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 168.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.49 146.35 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 109.281 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -147.1 163.91 34.78 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -124.86 153.9 41.88 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -123.9 151.18 43.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.289 -144.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.0 -27.19 68.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 111.117 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.5 -16.85 40.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.601 1.96 . . . . 0.0 113.135 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -28.16 15.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.93 1.729 . . . . 0.0 111.838 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.1 mtt85 -74.05 168.18 20.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.699 0.799 . . . . 0.0 111.517 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.64 150.01 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 158.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.79 140.87 46.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mt -139.04 147.0 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.08 127.0 29.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 168.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.05 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.696 0.68 . . . . 0.0 109.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.73 133.85 31.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.78 -169.35 40.08 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.592 -172.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.25 152.76 61.78 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.316 2.011 . . . . 0.0 110.216 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.21 -42.46 81.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.884 0.874 . . . . 0.0 110.93 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.57 -42.88 99.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.264 0.484 . . . . 0.0 111.574 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.56 82.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.673 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -38.34 82.1 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 110.988 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -64.91 -49.94 68.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.592 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -57.76 -39.14 76.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.209 1.368 . . . . 0.0 111.409 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.03 -46.42 84.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.903 0.881 . . . . 0.0 109.927 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 118.953 0.797 . . . . 0.0 109.822 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.06 -40.67 73.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.607 0.763 . . . . 0.0 110.538 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.56 72.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.898 0.879 . . . . 0.0 111.416 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.21 -26.29 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.187 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -57.12 -34.81 68.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.322 1.419 . . . . 0.0 111.223 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -82.12 -41.51 20.38 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.114 0.416 . . . . 0.0 111.01 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.85 -166.11 54.72 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -164.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.8 p -60.71 167.46 3.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.915 0.486 . . . . 0.0 111.451 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.45 -15.04 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.775 2.983 . . . . 0.0 115.252 168.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -115.44 -7.15 12.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.532 1.133 . . . . 0.0 111.903 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -70.74 163.67 26.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.652 0.739 . . . . 0.0 111.014 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -142.77 88.79 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 161.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.82 142.67 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 p -125.49 -18.13 5.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.403 1.081 . . . . 0.0 111.15 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.56 149.62 28.68 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.312 1.045 . . . . 0.0 109.123 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 tt -152.91 145.31 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.844 1.258 . . . . 0.0 107.936 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -142.06 152.4 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.357 1.463 . . . . 0.0 108.524 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.13 145.47 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.756 1.223 . . . . 0.0 107.895 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.91 161.8 35.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.456 1.902 . . . . 0.0 106.416 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -138.82 163.65 31.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.01 0.924 . . . . 0.0 110.364 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -154.53 147.59 24.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.342 166.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.98 -41.71 58.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 m -60.26 156.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.3 mt -129.29 149.8 50.93 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.812 1.245 . . . . 0.0 109.036 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -75.94 -34.34 59.86 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.5 0.72 . . . . 0.0 109.248 161.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 41.37 5.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.212 0.911 . . . . 0.0 111.292 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -57.77 149.06 23.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.932 0.866 . . . . 0.0 109.828 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -118.73 -6.52 10.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.41 1.084 . . . . 0.0 112.129 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -148.96 176.75 10.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.959 1.704 . . . . 0.0 107.706 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -110.72 135.95 50.53 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -136.75 139.5 41.89 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.645 0.736 . . . . 0.0 112.755 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -74.17 134.64 29.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 161.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.536 0.441 0 C-N-CA 124.343 1.057 . . . . 0.0 108.907 179.479 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.72 176.54 7.17 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.532 1.933 . . . . 0.0 107.7 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -125.31 137.0 54.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -118.87 159.06 24.46 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.031 1.732 . . . . 0.0 108.052 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -129.32 140.55 51.36 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -134.27 139.22 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -173.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.9 mm -127.29 138.83 53.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.47 146.64 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -140.5 156.92 46.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.12 1.368 . . . . 0.0 109.913 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.5 22.68 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.402 1.477 . . . . 0.0 110.193 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -73.33 82.32 1.39 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.67 19.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.763 0.825 . . . . 0.0 111.074 -171.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -137.05 147.13 45.98 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.61 33.14 86.43 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.41 -1.38 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.095 1.358 . . . . 0.0 111.238 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 26.71 34.96 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.16 -46.83 82.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.312 1.556 . . . . 0.0 109.697 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -55.91 -45.1 78.79 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.614 -0.679 . . . . 0.0 111.488 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -65.95 -43.24 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.718 0.407 . . . . 0.0 110.859 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.57 -51.7 68.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.396 0.679 . . . . 0.0 110.174 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.68 -40.83 88.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 118.329 0.513 . . . . 0.0 110.386 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.74 -43.68 85.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.494 0.718 . . . . 0.0 110.898 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.8 mtm -74.27 -37.15 63.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.62 0.646 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.2 -37.36 87.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.613 1.097 . . . . 0.0 110.312 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.36 81.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.974 0.51 . . . . 0.0 110.564 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -58.61 -44.21 89.86 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -56.26 -26.11 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.974 1.71 . . . . 0.0 112.499 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -118.93 12.17 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.405 1.082 . . . . 0.0 112.049 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 43.53 43.06 4.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.087 1.755 . . . . 0.0 112.175 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.11 165.55 9.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.879 0.472 . . . . 0.0 109.819 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.25 158.62 20.27 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 162.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.06 -160.96 27.86 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 118.687 0.676 . . . . 0.0 112.774 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.73 168.0 26.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.242 -0.563 . . . . 0.0 112.387 171.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.92 144.85 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.171 1.388 . . . . 0.0 108.63 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -143.4 160.52 40.39 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.02 112.22 16.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.5 mtp85 -85.18 155.72 21.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.818 1.247 . . . . 0.0 110.618 -154.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.89 -27.76 69.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.628 0.371 . . . . 0.0 111.882 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -6.42 38.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.924 0.89 . . . . 0.0 113.184 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.07 -15.95 46.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.485 1.041 . . . . 0.0 113.586 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -88.12 155.8 19.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.18 1.49 . . . . 0.0 109.974 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.02 149.91 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 162.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.17 153.68 51.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.972 0.891 . . . . 0.0 109.8 157.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -142.79 146.13 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -171.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.2 154.63 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.241 0.616 . . . . 0.0 109.907 -169.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -138.79 131.96 29.86 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.391 1.476 . . . . 0.0 107.376 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.72 178.79 42.31 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.34 156.18 66.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 110.24 171.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.99 -35.53 77.07 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.335 0.654 . . . . 0.0 111.979 -171.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.96 -36.57 80.32 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.924 -1.11 . . . . 0.0 111.686 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.47 72.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.66 -37.97 88.03 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.851 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.01 -50.08 75.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.76 0.709 . . . . 0.0 110.626 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 m -61.57 -37.86 85.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.515 0.598 . . . . 0.0 111.025 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -63.62 -45.66 89.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.015 0.926 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.09 -48.5 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.174 0.897 . . . . 0.0 109.526 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -56.55 -40.83 75.81 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.588 0.755 . . . . 0.0 110.548 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.26 74.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.534 0.734 . . . . 0.0 111.578 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.78 -26.98 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.201 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -57.72 -33.43 68.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.263 1.392 . . . . 0.0 111.355 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.42 -42.04 26.3 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.329 0.513 . . . . 0.0 110.949 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.33 -166.81 54.52 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -165.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.4 p -60.65 167.41 3.36 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 122.915 0.486 . . . . 0.0 111.326 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.43 -15.18 3.65 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.669 2.913 . . . . 0.0 115.175 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -114.1 -7.98 13.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.56 1.144 . . . . 0.0 111.788 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.2 m -72.03 162.99 28.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.699 0.8 . . . . 0.0 110.994 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -143.31 89.4 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 161.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.8 143.88 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.6 p -124.76 -19.36 5.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.32 1.048 . . . . 0.0 111.207 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -153.77 150.73 28.8 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 109.172 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.7 146.07 15.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.02 1.328 . . . . 0.0 107.703 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 m -140.5 152.82 45.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.154 1.382 . . . . 0.0 108.426 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.8 t -137.76 145.47 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -134.32 159.16 41.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.54 1.936 . . . . 0.0 106.042 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -145.88 167.48 23.14 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.899 0.879 . . . . 0.0 110.102 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -140.09 173.45 11.51 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.133 1.373 . . . . 0.0 109.595 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -122.82 19.39 10.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.643 1.577 . . . . 0.0 109.715 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.0 m -135.87 167.27 21.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.176 1.79 . . . . 0.0 108.178 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -134.56 163.59 29.39 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.3 -25.32 4.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.063 1.745 . . . . 0.0 109.443 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.33 56.38 6.92 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.241 0.924 . . . . 0.0 111.189 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -57.6 150.77 18.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.165 0.482 . . . . 0.0 110.455 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -68.3 -26.97 65.9 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -161.34 -173.74 3.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.835 2.054 . . . . 0.0 107.445 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -99.29 132.82 44.35 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 165.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -136.42 139.91 42.78 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -171.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.63 133.38 31.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 161.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 0.0 109.663 -179.142 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 tp -146.05 162.31 38.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.045 1.338 . . . . 0.0 109.001 -166.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.15 138.01 52.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.423 1.489 . . . . 0.0 107.449 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -119.41 156.97 29.16 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.039 1.735 . . . . 0.0 108.419 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -122.78 139.68 53.73 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.77 144.55 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.85 138.11 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.46 147.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -141.95 157.89 44.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.492 1.117 . . . . 0.0 109.991 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.61 -157.33 23.58 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.932 1.729 . . . . 0.0 109.314 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.8 ttp-105 -72.36 85.19 1.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 159.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.51 19.85 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.667 1.187 . . . . 0.0 110.263 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -137.46 143.26 41.69 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.401 -0.812 . . . . 0.0 109.36 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.09 32.37 76.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.51 -7.32 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.785 1.234 . . . . 0.0 111.089 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.96 30.24 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.33 -43.8 83.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.936 1.368 . . . . 0.0 109.758 -173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -59.74 -41.17 90.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.806 0.73 . . . . 0.0 111.705 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.25 -45.01 77.96 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.646 0.657 . . . . 0.0 110.289 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -62.72 -40.11 96.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.955 0.798 . . . . 0.0 110.909 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.2 -38.98 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.106 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.85 -42.42 99.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.215 1.371 . . . . 0.0 110.505 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.64 -38.19 83.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.251 0.932 . . . . 0.0 110.451 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -66.41 -39.67 89.14 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.48 0.712 . . . . 0.0 109.999 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.69 -38.45 91.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.668 0.787 . . . . 0.0 110.327 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.02 -45.27 86.19 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 110.696 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -60.17 -18.23 46.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.919 1.287 . . . . 0.0 112.005 174.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -111.23 7.0 21.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.828 1.651 . . . . 0.0 112.499 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 38.72 40.07 0.38 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.765 2.426 . . . . 0.0 113.271 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -74.63 169.38 17.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.498 1.119 . . . . 0.0 110.237 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.1 164.76 18.01 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 160.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.68 -150.78 23.05 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.723 0.692 . . . . 0.0 112.004 -175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -155.81 170.96 20.87 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.065 0.946 . . . . 0.0 110.855 167.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.43 139.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.516 1.526 . . . . 0.0 107.79 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.59 157.84 45.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.197 1.399 . . . . 0.0 108.85 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.85 114.42 18.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -90.92 153.98 19.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.989 0.916 . . . . 0.0 110.759 -155.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.24 -27.35 68.6 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.049 0.54 . . . . 0.0 111.997 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -7.5 40.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.044 0.938 . . . . 0.0 112.929 175.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.36 -12.86 47.94 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.69 1.138 . . . . 0.0 113.352 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -90.77 154.81 19.25 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.98 1.39 . . . . 0.0 109.603 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.7 151.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -134.49 144.72 48.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.03 145.63 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -137.03 117.67 13.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.23 151.87 46.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.407 0.683 . . . . 0.0 109.933 -165.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -140.95 137.31 32.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.531 1.132 . . . . 0.0 108.583 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 -174.11 43.33 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.27 154.47 69.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.013 1.809 . . . . 0.0 110.263 169.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.67 -41.38 90.53 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.408 0.683 . . . . 0.0 111.442 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.36 -39.59 94.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.587 0.631 . . . . 0.0 111.729 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -40.0 83.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -67.84 -36.76 80.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.076 0.398 . . . . 0.0 111.39 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -64.66 -49.19 71.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.248 0.931 . . . . 0.0 110.285 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 p -66.13 -29.38 69.67 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.729 -0.607 . . . . 0.0 111.352 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -63.66 -43.84 95.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.364 -0.827 . . . . 0.0 110.853 170.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.23 -44.09 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.827 1.194 . . . . 0.0 109.319 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.37 -36.55 78.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.136 0.88 . . . . 0.0 111.545 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.28 -50.1 55.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.804 0.442 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.61 -43.29 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.817 0.847 . . . . 0.0 109.873 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -18.8 62.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.499 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -78.24 -43.66 27.66 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.384 0.993 . . . . 0.0 110.403 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.35 -179.48 25.0 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.606 1.098 . . . . 0.0 111.636 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.5 p -74.23 166.92 40.53 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 122.13 -0.63 . . . . 0.0 109.677 168.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.44 -21.66 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.83 1.687 . . . . 0.0 112.445 170.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -73.17 -37.82 66.41 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.342 0.657 . . . . 0.0 110.338 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -71.55 167.16 20.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.106 0.962 . . . . 0.0 110.809 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -146.0 77.79 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 161.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.32 140.06 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.8 p -127.61 -16.6 4.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.935 1.294 . . . . 0.0 111.618 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -151.61 151.37 31.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.093 0.957 . . . . 0.0 109.59 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.25 149.54 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.894 1.277 . . . . 0.0 108.074 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.8 m -140.57 153.91 46.3 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.611 1.565 . . . . 0.0 108.191 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -137.57 145.18 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.413 1.085 . . . . 0.0 108.291 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.5 164.26 29.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.146 2.178 . . . . 0.0 106.056 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.33 168.76 18.98 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.835 -1.166 . . . . 0.0 111.657 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -142.35 131.97 23.97 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.53 1.932 . . . . 0.0 105.85 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -83.34 17.76 2.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.543 0.737 . . . . 0.0 111.612 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.4 m -139.77 159.75 41.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.166 2.186 . . . . 0.0 106.604 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.93 160.89 39.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.241 1.016 . . . . 0.0 110.354 -172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -78.69 -34.46 46.15 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.811 0.844 . . . . 0.0 110.296 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.57 51.4 7.28 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -55.02 153.32 6.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.267 1.027 . . . . 0.0 112.647 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -42.54 99.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.903 1.281 . . . . 0.0 112.155 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -153.9 -173.07 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 -164.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -114.49 95.5 5.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -79.99 131.33 35.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.981 0.42 . . . . 0.0 111.176 -170.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.45 115.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 154.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--O 1.238 0.485 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 169.366 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttt . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.4 mt -135.61 175.87 9.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.748 1.619 . . . . 0.0 109.526 -171.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -129.27 149.43 51.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 108.121 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -140.52 165.58 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.893 -0.504 . . . . 0.0 111.243 157.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -123.0 136.23 54.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 167.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.2 mt -134.07 144.58 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mm -130.33 138.19 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 t -137.16 145.24 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -170.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -141.58 156.94 45.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.55 1.14 . . . . 0.0 109.8 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.04 -154.08 24.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.34 1.448 . . . . 0.0 110.371 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 ttp-105 -75.65 80.31 2.63 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 162.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.16 19.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.964 0.906 . . . . 0.0 111.169 -169.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -137.44 148.55 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.096 0.958 . . . . 0.0 108.885 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.64 84.49 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.5 m -134.05 -8.01 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.978 1.311 . . . . 0.0 111.416 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.86 23.02 21.87 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.954 1.264 . . . . 0.0 110.054 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.41 -42.76 99.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 119.22 1.51 . . . . 0.0 110.336 -172.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.22 -47.0 75.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.655 0.661 . . . . 0.0 111.619 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -68.89 -41.68 77.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.402 0.546 . . . . 0.0 111.386 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -56.69 -53.03 62.41 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.981 0.513 . . . . 0.0 109.717 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.9 t -62.4 -39.23 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.391 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -57.35 -44.3 84.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.185 0.902 . . . . 0.0 110.97 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.0 mtm -76.55 -36.04 57.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.536 0.607 . . . . 0.0 111.2 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -70.46 -27.81 64.52 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.146 0.885 . . . . 0.0 111.293 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.53 -46.92 65.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.844 -0.535 . . . . 0.0 109.666 168.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.32 -45.35 93.73 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.741 0.816 . . . . 0.0 111.226 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -30.35 69.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.35 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -114.88 18.01 16.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.678 0.672 . . . . 0.0 111.186 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt 52.13 42.64 30.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.273 1.829 . . . . 0.0 112.061 171.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.15 165.66 6.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.004 0.922 . . . . 0.0 108.955 165.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.79 46.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.17 0.988 . . . . 0.0 108.4 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.93 -153.67 24.4 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 119.3 0.955 . . . . 0.0 113.002 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -143.96 165.52 27.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.072 -0.664 . . . . 0.0 112.649 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.42 145.9 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.183 1.393 . . . . 0.0 107.942 165.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -144.39 159.51 42.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.303 1.041 . . . . 0.0 108.584 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -125.88 128.73 48.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -110.55 154.35 23.84 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.733 0.413 . . . . 0.0 110.885 -150.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.75 -27.2 68.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.108 0.563 . . . . 0.0 112.089 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -7.93 42.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.174 0.99 . . . . 0.0 112.989 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.01 -9.07 50.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.73 1.157 . . . . 0.0 113.437 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -97.18 158.12 15.6 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 119.007 1.403 . . . . 0.0 109.855 -173.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.7 153.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 163.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.72 144.03 47.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -134.31 146.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -131.36 127.87 38.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 161.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . . . -136.59 154.13 50.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.32 0.964 . . . . 0.0 109.85 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -140.64 143.28 35.09 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.215 1.806 . . . . 0.0 107.197 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.35 -175.94 41.06 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.146 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.27 153.79 66.29 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.567 2.178 . . . . 0.0 109.594 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.37 -43.58 88.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.378 0.671 . . . . 0.0 111.447 -171.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.01 -43.42 98.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.801 0.728 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.35 83.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.16 -48.51 81.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.377 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -60.07 -46.95 87.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 110.415 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 m -60.49 -37.96 82.77 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.159 -0.338 . . . . 0.0 110.632 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -67.11 -36.06 81.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.694 -1.146 . . . . 0.0 110.985 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 t -58.13 -51.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 120.437 1.471 . . . . 0.0 108.51 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -56.23 -41.61 75.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.96 0.504 . . . . 0.0 110.556 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.99 82.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.338 0.655 . . . . 0.0 111.335 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.05 -35.75 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.746 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -61.67 -37.01 82.5 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.055 1.298 . . . . 0.0 110.861 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -69.3 -44.76 71.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 117.872 0.305 . . . . 0.0 110.266 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.27 -179.62 24.38 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.52 158.62 14.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.106 0.962 . . . . 0.0 111.352 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.04 -37.53 79.08 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.295 2.664 . . . . 0.0 114.394 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -78.96 -21.98 46.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.856 0.862 . . . . 0.0 112.126 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -79.99 168.41 19.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.368 1.467 . . . . 0.0 111.262 -170.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -148.17 104.61 3.56 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.72 143.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -127.35 -18.08 4.55 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.164 0.985 . . . . 0.0 111.152 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.1 150.49 29.97 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.32 145.67 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.958 1.303 . . . . 0.0 107.793 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -141.59 152.24 43.87 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.186 1.394 . . . . 0.0 108.724 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -141.23 144.03 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.718 1.207 . . . . 0.0 108.336 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -138.96 150.88 46.39 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 164.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.88 160.86 40.04 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.248 0.931 . . . . 0.0 111.768 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.1 m -148.93 148.92 30.38 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.848 1.659 . . . . 0.0 108.891 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -48.1 46.72 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 165.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m -57.24 145.13 32.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.164 1.386 . . . . 0.0 109.804 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 pp -151.1 155.21 38.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.067 1.347 . . . . 0.0 109.173 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.33 -32.82 32.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.097 0.559 . . . . 0.0 110.805 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.87 42.28 3.13 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.223 0.916 . . . . 0.0 110.882 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -53.74 136.7 39.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.742 0.771 . . . . 0.0 109.451 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.46 -20.67 23.61 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.022 0.529 . . . . 0.0 112.109 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -152.7 178.8 9.23 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.855 1.662 . . . . 0.0 108.337 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -107.9 135.37 49.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -138.21 142.9 39.96 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.9 mt -74.05 138.43 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 165.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 125.105 1.362 . . . . 0.0 108.059 176.664 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.6 tp -140.81 162.82 34.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.203 2.201 . . . . 0.0 106.835 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.4 138.7 51.65 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.664 1.186 . . . . 0.0 108.221 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -116.48 154.7 29.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.569 1.548 . . . . 0.0 108.057 165.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -122.85 139.55 53.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 158.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.96 141.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.51 140.38 49.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -136.52 147.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -141.72 157.84 44.55 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.877 1.271 . . . . 0.0 109.71 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.46 -157.65 23.03 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.89 1.709 . . . . 0.0 109.391 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -75.13 88.6 2.46 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 157.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.08 19.06 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.377 1.071 . . . . 0.0 110.751 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -139.55 152.19 46.69 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.55 42.29 99.71 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -142.35 4.67 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.751 1.62 . . . . 0.0 112.045 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.23 54.62 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.438 -1.201 . . . . 0.0 110.185 -172.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.77 -50.31 65.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.468 1.634 . . . . 0.0 110.608 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -62.63 -38.77 91.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.884 0.765 . . . . 0.0 110.521 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -66.98 -42.14 85.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.98 0.512 . . . . 0.0 111.375 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.9 -48.98 78.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.702 0.683 . . . . 0.0 109.9 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.4 t -61.93 -41.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.291 0.496 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -56.66 -47.97 78.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.92 0.782 . . . . 0.0 110.035 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.05 -37.34 69.7 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.102 -0.374 . . . . 0.0 111.158 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.22 -31.58 70.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.906 0.776 . . . . 0.0 111.222 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.13 74.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.271 0.487 . . . . 0.0 109.848 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -61.18 -47.39 86.36 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.04 0.936 . . . . 0.0 111.127 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -11.24 53.57 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -125.68 18.59 8.01 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.234 1.013 . . . . 0.0 111.071 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 tttp 45.98 36.48 3.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.952 2.101 . . . . 0.0 114.165 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.55 162.98 27.86 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.14 153.44 49.38 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.123 1.369 . . . . 0.0 107.718 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.1 -157.13 27.14 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.961 1.255 . . . . 0.0 113.519 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -144.86 166.48 25.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.609 0.764 . . . . 0.0 112.071 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.31 146.63 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.757 1.223 . . . . 0.0 108.343 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -146.24 153.53 40.71 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.75 0.82 . . . . 0.0 110.439 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -78.47 157.79 28.82 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 163.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -117.67 151.2 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.188 0.995 . . . . 0.0 108.767 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.1 -27.65 68.9 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.266 0.626 . . . . 0.0 111.888 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.57 -3.54 21.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.671 1.188 . . . . 0.0 113.135 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.11 -9.62 63.46 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.674 1.13 . . . . 0.0 112.987 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -79.36 177.09 9.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.941 1.37 . . . . 0.0 110.543 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.28 145.56 25.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -115.5 140.96 48.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mt -131.49 146.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.77 127.43 32.72 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.34 150.24 45.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.676 0.671 . . . . 0.0 109.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -138.86 133.68 32.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.779 1.631 . . . . 0.0 107.115 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.31 -169.02 38.26 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.381 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 150.11 51.51 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.557 2.172 . . . . 0.0 110.453 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.19 -32.67 72.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.707 0.803 . . . . 0.0 112.052 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.24 -40.74 90.43 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.875 -1.141 . . . . 0.0 111.477 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.88 77.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.38 -40.33 96.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.907 0.483 . . . . 0.0 110.982 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -61.95 -49.91 74.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.274 0.629 . . . . 0.0 110.993 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -61.6 -38.84 89.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.776 0.798 . . . . 0.0 110.622 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -64.12 -43.76 94.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.615 1.166 . . . . 0.0 110.549 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.16 -49.2 82.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 119.408 1.004 . . . . 0.0 109.545 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.42 -39.14 69.87 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.814 . . . . 0.0 110.802 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.94 71.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 111.387 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.65 -26.65 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.808 0.843 . . . . 0.0 111.137 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -58.27 -34.59 70.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.147 1.339 . . . . 0.0 111.283 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.52 -41.54 27.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.346 0.521 . . . . 0.0 110.735 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.46 -167.39 54.73 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -165.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -60.04 167.29 2.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.246 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -52.84 -13.1 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.696 2.931 . . . . 0.0 115.391 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.23 -5.12 10.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.685 1.194 . . . . 0.0 111.805 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -70.27 162.93 27.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.834 0.854 . . . . 0.0 111.147 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -141.76 78.01 1.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.4 142.69 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -122.9 -21.79 5.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.324 1.05 . . . . 0.0 111.162 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -154.99 153.3 30.81 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.104 0.962 . . . . 0.0 109.558 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.1 tt -151.14 145.07 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.49 1.516 . . . . 0.0 107.196 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -140.39 153.19 46.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.942 1.297 . . . . 0.0 108.448 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.4 t -137.14 145.27 30.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -134.84 159.15 42.28 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 167.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.02 160.48 42.33 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.741 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.0 m -148.45 142.14 25.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.21 1.404 . . . . 0.0 109.015 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -69.14 -43.12 75.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -59.45 145.86 42.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.55 1.14 . . . . 0.0 109.071 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.04 153.73 38.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.148 1.379 . . . . 0.0 108.399 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.81 -30.44 45.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.525 0.33 . . . . 0.0 110.526 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.74 40.6 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.81 152.42 27.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.753 0.776 . . . . 0.0 109.481 173.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -128.98 -5.65 5.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 112.08 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.76 173.09 12.69 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.743 1.617 . . . . 0.0 107.746 173.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -111.56 142.61 43.63 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -130.31 133.3 46.36 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.236 0.541 . . . . 0.0 112.17 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.56 113.77 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 156.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 157.865 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.5 tp -142.13 156.66 45.37 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.943 1.297 . . . . 0.0 108.171 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -110.37 136.66 49.2 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.566 1.546 . . . . 0.0 107.189 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -111.79 148.18 34.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 161.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -114.36 140.14 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 156.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -132.66 141.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -131.86 137.11 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 147.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -169.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -143.08 156.71 44.87 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.507 1.123 . . . . 0.0 109.94 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.67 -154.85 24.5 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.302 1.429 . . . . 0.0 110.256 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -72.18 83.63 1.02 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 159.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.51 18.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 111.1 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -138.08 148.79 45.37 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.866 0.866 . . . . 0.0 109.444 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.38 78.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.19 -9.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.226 . . . . 0.0 111.719 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.16 22.42 17.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.027 1.298 . . . . 0.0 110.153 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 -40.61 96.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.18 1.49 . . . . 0.0 110.363 -171.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -55.63 -48.2 75.34 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.848 0.749 . . . . 0.0 111.449 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -67.23 -39.56 86.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.205 0.457 . . . . 0.0 111.295 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.03 -51.85 67.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.809 0.443 . . . . 0.0 110.239 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -62.22 -39.18 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.532 0.606 . . . . 0.0 110.512 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -55.96 -49.19 74.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.643 0.777 . . . . 0.0 109.892 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.3 mtp -69.79 -39.23 76.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.984 0.357 . . . . 0.0 111.12 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.72 -32.92 73.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.789 0.722 . . . . 0.0 111.019 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.97 81.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.22 0.463 . . . . 0.0 110.235 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.66 -44.36 94.01 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.278 0.631 . . . . 0.0 110.873 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -4.07 19.75 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.369 -0.832 . . . . 0.0 113.213 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -111.37 2.36 17.55 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.321 1.448 . . . . 0.0 111.286 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 42.82 39.58 1.76 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.782 2.033 . . . . 0.0 111.945 -172.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.78 168.3 13.64 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.556 0.742 . . . . 0.0 109.512 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.96 151.27 49.33 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.15 -159.2 28.01 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.603 1.092 . . . . 0.0 113.756 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -141.73 166.01 25.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.269 0.628 . . . . 0.0 112.271 172.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.72 145.48 31.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 125.019 1.328 . . . . 0.0 108.273 164.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -141.48 161.36 38.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.997 1.319 . . . . 0.0 108.401 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -125.89 116.17 21.11 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -91.01 153.19 20.33 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.025 0.93 . . . . 0.0 110.276 -157.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.75 -29.46 70.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.674 0.39 . . . . 0.0 111.845 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.98 -9.75 48.06 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 -21.19 22.08 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.476 1.036 . . . . 0.0 113.285 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtm180 -81.02 154.33 26.94 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 118.591 1.195 . . . . 0.0 110.178 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.7 t -86.66 148.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 161.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -132.55 142.87 49.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.69 149.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.47 127.0 26.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 167.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.23 147.12 43.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.909 0.777 . . . . 0.0 109.352 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -136.89 129.33 30.03 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -170.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.93 -169.18 41.2 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.82 149.62 60.41 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.259 1.973 . . . . 0.0 110.156 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.43 -32.85 72.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.044 0.938 . . . . 0.0 111.817 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -68.56 -39.76 80.92 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.919 -1.113 . . . . 0.0 111.62 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.5 80.91 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -61.34 -43.04 99.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.83 0.852 . . . . 0.0 111.232 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -61.09 -51.53 68.74 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.004 0.522 . . . . 0.0 110.419 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 m -62.73 -35.29 79.29 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.901 -0.5 . . . . 0.0 110.956 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -65.67 -42.04 91.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.561 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.49 -43.64 87.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.044 1.293 . . . . 0.0 109.925 171.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.68 -37.72 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.418 1.008 . . . . 0.0 111.204 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.09 91.01 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.834 -0.542 . . . . 0.0 111.026 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.22 -48.07 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 118.249 -0.882 . . . . 0.0 109.247 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -68.81 -26.29 65.1 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.936 1.243 . . . . 0.0 112.571 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -60.67 -41.18 94.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.753 1.16 . . . . 0.0 110.014 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.39 170.1 33.53 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.698 1.142 . . . . 0.0 111.185 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 163.41 42.08 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 123.765 0.826 . . . . 0.0 111.188 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.23 -13.65 7.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.244 3.296 . . . . 0.0 115.731 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.15 13.71 11.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.337 1.455 . . . . 0.0 111.132 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -132.73 166.61 21.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.783 1.233 . . . . 0.0 110.141 -161.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -149.87 102.33 3.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.37 144.77 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 166.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 p -124.49 -17.5 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.422 1.089 . . . . 0.0 110.934 172.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -153.77 149.45 27.45 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.391 1.076 . . . . 0.0 109.502 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.9 tt -147.12 146.82 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.995 1.318 . . . . 0.0 107.482 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.2 m -140.7 154.69 46.46 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.484 1.513 . . . . 0.0 108.323 175.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.14 150.01 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.307 1.043 . . . . 0.0 109.66 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -136.77 160.44 38.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.264 1.826 . . . . 0.0 106.335 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.37 159.69 41.01 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.689 0.795 . . . . 0.0 110.648 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.9 m -157.98 145.17 18.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.096 1.358 . . . . 0.0 108.965 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -79.03 -32.88 45.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.247 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 m -57.54 147.8 25.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.833 0.853 . . . . 0.0 108.817 166.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.21 154.77 44.41 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.746 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.43 -35.05 61.04 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 163.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.18 36.29 4.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.604 1.097 . . . . 0.0 111.474 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -58.58 149.86 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.246 1.023 . . . . 0.0 110.289 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.32 -6.23 7.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.81 1.244 . . . . 0.0 111.781 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -140.92 169.74 17.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.535 1.934 . . . . 0.0 106.894 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -115.04 135.04 54.65 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 m -139.44 143.44 37.59 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.2 134.16 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 162.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.536 0.426 0 C-N-CA 124.582 1.153 . . . . 0.0 108.874 178.455 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.3 mt -138.81 173.1 11.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.593 1.557 . . . . 0.0 108.904 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -135.37 133.06 38.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -115.59 158.42 22.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.968 1.307 . . . . 0.0 108.091 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -120.87 144.59 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 157.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.9 mt -132.37 144.92 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.4 mm -133.1 136.9 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.32 147.48 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -172.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -141.44 154.72 45.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.153 1.381 . . . . 0.0 109.77 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.27 -154.81 25.96 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.504 1.526 . . . . 0.0 109.84 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 -76.67 79.54 3.32 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 161.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.77 19.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.016 0.926 . . . . 0.0 111.037 -171.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -136.76 146.1 45.37 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.15 32.88 85.41 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.46 -3.22 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.811 1.244 . . . . 0.0 111.722 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.17 21.81 34.34 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.526 -1.152 . . . . 0.0 110.418 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -62.71 -44.41 96.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.11 1.455 . . . . 0.0 110.044 -171.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -55.43 -49.29 72.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.765 0.711 . . . . 0.0 111.856 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -67.57 -40.9 84.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.143 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -56.13 -50.19 71.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.449 0.568 . . . . 0.0 110.053 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.5 t -60.2 -43.24 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 118.372 0.533 . . . . 0.0 110.042 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -59.27 -44.46 92.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.67 0.668 . . . . 0.0 110.389 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.1 mtt -71.82 -36.86 70.35 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.734 -0.604 . . . . 0.0 111.171 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.87 -26.12 64.04 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.555 -0.715 . . . . 0.0 111.631 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.35 -45.23 63.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.547 0.612 . . . . 0.0 109.697 165.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.28 -35.59 80.78 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.109 0.563 . . . . 0.0 112.243 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -16.93 63.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.153 0.888 . . . . 0.0 112.998 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -112.84 5.7 17.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.528 1.531 . . . . 0.0 111.072 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 42.58 41.85 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.2 1.8 . . . . 0.0 111.821 -169.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.3 mt -62.66 161.15 12.75 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.73 154.01 49.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.084 0.953 . . . . 0.0 108.496 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.7 -159.34 28.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -170.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.5 168.09 22.06 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 112.074 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.48 144.8 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.158 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -138.66 156.95 46.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.554 1.141 . . . . 0.0 108.142 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -125.19 107.94 11.26 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtp85 -82.47 154.88 24.89 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.778 1.231 . . . . 0.0 110.648 -154.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.582 0.353 . . . . 0.0 111.81 175.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.8 -5.57 35.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.038 0.935 . . . . 0.0 113.154 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.91 -17.6 41.5 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.724 1.154 . . . . 0.0 113.627 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -86.07 152.87 22.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.109 1.455 . . . . 0.0 110.196 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.92 146.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 162.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.49 136.59 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.07 145.42 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.62 128.3 28.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.48 155.12 45.86 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.51 0.724 . . . . 0.0 110.471 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.21 134.09 37.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.07 1.748 . . . . 0.0 107.743 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.86 -173.18 41.45 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.716 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.95 157.1 55.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.751 2.301 . . . . 0.0 110.707 172.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.42 -44.62 89.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.552 0.741 . . . . 0.0 111.347 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.72 -39.56 91.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.795 0.725 . . . . 0.0 111.767 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.75 74.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.37 -36.56 83.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.127 0.421 . . . . 0.0 111.402 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -63.21 -47.73 81.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.08 0.854 . . . . 0.0 109.901 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.8 m -60.14 -35.94 76.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 0.0 111.18 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -64.95 -45.92 83.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.941 0.897 . . . . 0.0 110.072 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.7 t -56.7 -48.58 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.357 0.98 . . . . 0.0 109.361 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -57.18 -40.77 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 110.683 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.85 73.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.681 0.793 . . . . 0.0 111.17 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -61.68 -27.46 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.068 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -57.76 -31.44 66.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.19 1.359 . . . . 0.0 111.603 173.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -83.33 -41.91 17.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.374 0.533 . . . . 0.0 111.254 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.7 -168.91 45.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -165.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.3 p -60.36 165.9 4.72 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 117.381 0.59 . . . . 0.0 110.92 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.47 -20.77 12.49 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.388 2.725 . . . . 0.0 114.756 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -103.78 -13.41 16.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.47 1.108 . . . . 0.0 111.53 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 m -68.71 165.65 19.05 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.025 -1.047 . . . . 0.0 111.166 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -143.47 138.47 29.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 156.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.4 t -110.22 140.73 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.0 p -123.26 -18.55 6.25 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.187 0.995 . . . . 0.0 110.965 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -153.54 149.46 27.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.76 144.11 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 m -142.09 159.5 42.11 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.195 1.398 . . . . 0.0 108.882 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 t -136.61 146.86 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.78 1.232 . . . . 0.0 107.679 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.74 167.6 20.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.681 1.993 . . . . 0.0 106.388 173.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -130.44 164.03 25.65 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.168 -0.957 . . . . 0.0 109.996 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -135.61 150.88 49.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 162.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -115.17 27.76 9.16 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 109.545 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.7 m -136.55 168.8 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.52 2.728 . . . . 0.0 105.425 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.65 129.66 47.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.657 0.783 . . . . 0.0 108.938 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -71.14 -25.4 62.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.063 0.392 . . . . 0.0 110.794 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 29.07 18.41 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.314 0.959 . . . . 0.0 112.903 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -59.42 151.16 24.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.178 1.489 . . . . 0.0 109.59 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -126.92 -6.96 6.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.382 1.073 . . . . 0.0 112.259 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -141.46 -178.12 5.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.985 2.114 . . . . 0.0 106.711 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -117.54 124.57 49.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.5 m -117.76 139.41 51.1 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.367 0.603 . . . . 0.0 111.103 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.6 mt -89.52 137.51 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.5 t . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 125.348 1.459 . . . . 0.0 107.315 -173.752 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.9 mmm . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.92 168.28 14.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 107.259 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -120.19 137.07 54.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.162 1.785 . . . . 0.0 106.496 170.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -119.83 155.62 32.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.393 1.477 . . . . 0.0 107.794 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -125.03 138.83 54.2 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.3 mt -134.23 141.81 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mm -130.56 141.09 47.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.18 147.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -140.95 158.08 44.44 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.866 1.266 . . . . 0.0 109.623 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.96 -157.27 23.31 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.701 1.62 . . . . 0.0 109.595 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -75.12 85.71 2.37 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.77 14.96 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.862 0.865 . . . . 0.0 111.695 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -138.39 149.34 45.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.49 33.45 76.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.06 -3.78 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.307 1.443 . . . . 0.0 111.841 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.52 22.69 33.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.796 1.189 . . . . 0.0 110.41 -175.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.36 -46.75 82.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.125 1.462 . . . . 0.0 110.377 -172.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -61.96 -42.35 99.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.236 0.926 . . . . 0.0 110.345 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -64.57 -42.41 95.65 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.948 0.499 . . . . 0.0 110.707 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.5 -50.69 72.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.321 0.648 . . . . 0.0 110.558 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.25 -37.8 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.672 -0.643 . . . . 0.0 110.127 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.739 0.699 . . . . 0.0 109.823 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 ptp -72.14 -33.46 67.77 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.758 0.708 . . . . 0.0 111.42 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -69.48 -33.82 73.44 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.047 0.839 . . . . 0.0 111.209 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.25 79.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.0 0.364 . . . . 0.0 110.344 170.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.08 -45.42 93.6 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.803 0.841 . . . . 0.0 110.99 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -9.61 35.49 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -122.27 10.37 9.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.044 1.338 . . . . 0.0 111.415 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 44.96 41.83 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.068 1.747 . . . . 0.0 112.626 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.9 166.59 7.18 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.11 159.05 26.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 163.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.31 -155.5 25.19 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.695 0.679 . . . . 0.0 112.62 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -147.75 166.81 26.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.4 144.56 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 108.014 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.23 149.28 33.61 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.557 0.743 . . . . 0.0 110.402 174.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.97 122.12 27.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 166.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -76.57 148.1 37.24 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.31 -30.33 71.38 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.563 0.345 . . . . 0.0 111.613 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.36 -5.2 21.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.513 1.125 . . . . 0.0 113.548 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -13.75 52.66 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.323 0.963 . . . . 0.0 113.353 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -72.2 170.69 13.49 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.818 1.309 . . . . 0.0 110.551 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.28 148.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 161.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -131.96 143.66 50.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -141.11 147.06 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.68 128.82 27.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.63 158.53 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.184 0.593 . . . . 0.0 110.053 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -140.11 134.63 31.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.411 1.484 . . . . 0.0 107.37 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.67 -177.62 44.38 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.464 -0.631 . . . . 0.0 111.741 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 157.41 59.28 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.385 2.057 . . . . 0.0 110.287 169.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.0 -45.17 91.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.265 0.626 . . . . 0.0 111.137 -172.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.57 -38.02 85.96 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.622 0.646 . . . . 0.0 111.954 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.19 75.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.41 -35.87 80.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.385 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.72 -49.22 77.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.925 0.784 . . . . 0.0 109.977 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 m -61.5 -38.27 86.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 110.919 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -63.87 -44.32 93.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.114 0.966 . . . . 0.0 110.233 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -58.39 -50.07 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.992 0.815 . . . . 0.0 109.303 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.33 -38.49 68.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.687 0.795 . . . . 0.0 110.984 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -46.63 69.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 110.812 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.73 -28.55 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.762 0.825 . . . . 0.0 111.011 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -58.43 -35.2 71.72 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.107 1.321 . . . . 0.0 111.275 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -79.91 -42.93 23.12 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.245 0.475 . . . . 0.0 110.673 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.43 -165.99 54.1 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 p -59.84 166.8 3.15 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.682 . . . . 0.0 111.443 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.85 -14.17 3.27 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.94 3.093 . . . . 0.0 115.988 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -123.07 3.79 9.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.674 1.124 . . . . 0.0 112.053 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.3 m -66.86 159.25 28.64 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.02 -1.05 . . . . 0.0 110.357 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -140.94 77.35 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -59.72 140.49 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.6 p -122.46 -19.59 6.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.424 1.09 . . . . 0.0 111.177 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -154.57 151.9 29.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.154 0.982 . . . . 0.0 109.506 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.18 145.96 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.316 1.447 . . . . 0.0 107.356 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -140.31 152.36 45.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 108.475 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -139.19 145.52 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.522 1.129 . . . . 0.0 108.139 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -136.15 159.74 40.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.252 1.821 . . . . 0.0 106.118 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -148.81 163.29 37.81 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.318 -0.864 . . . . 0.0 111.398 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.7 m -148.76 144.95 27.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.482 1.913 . . . . 0.0 108.451 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.0 tpt85 -76.17 -30.77 58.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.191 162.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 m -57.51 148.56 23.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.625 1.17 . . . . 0.0 109.711 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.7 mt -131.44 168.18 18.06 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.363 1.465 . . . . 0.0 109.238 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 -29.41 2.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.816 1.646 . . . . 0.0 109.876 169.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.39 57.35 5.13 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -56.87 150.46 16.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.489 0.715 . . . . 0.0 110.726 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -67.86 -31.5 71.36 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -149.79 179.0 8.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.524 1.93 . . . . 0.0 107.346 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -94.7 132.8 39.06 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 154.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -138.59 144.42 39.79 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.7 139.83 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 164.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 126.365 1.866 . . . . 0.0 106.661 -178.669 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.764 0.316 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.7 170.73 14.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.249 1.82 . . . . 0.0 107.668 173.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -110.02 138.37 46.48 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.818 1.647 . . . . 0.0 106.817 164.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -116.17 156.95 25.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.144 1.378 . . . . 0.0 107.565 164.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -127.85 140.29 52.11 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 161.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -133.15 142.22 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.04 140.33 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.71 145.06 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.58 157.26 45.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.888 1.275 . . . . 0.0 109.709 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.57 -158.94 24.73 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.982 1.753 . . . . 0.0 109.597 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -75.26 88.77 2.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 157.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.67 20.59 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.445 1.098 . . . . 0.0 109.943 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -138.61 148.5 44.19 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.835 1.254 . . . . 0.0 107.84 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.95 41.53 97.89 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.91 -10.84 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.853 1.261 . . . . 0.0 111.842 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.0 16.98 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.872 1.225 . . . . 0.0 110.124 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.67 -41.73 98.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.307 1.554 . . . . 0.0 110.266 -171.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.75 -45.96 77.93 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.626 -0.671 . . . . 0.0 111.538 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.72 -39.65 80.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.548 0.613 . . . . 0.0 111.515 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.04 -52.09 66.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.199 0.6 . . . . 0.0 109.958 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.0 -38.11 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.44 -48.21 82.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.164 0.893 . . . . 0.0 110.019 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -75.35 -31.85 60.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.923 0.783 . . . . 0.0 111.684 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -68.79 -34.17 75.1 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.032 0.833 . . . . 0.0 110.805 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.31 83.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.162 0.437 . . . . 0.0 110.187 170.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.82 -45.18 93.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.563 0.745 . . . . 0.0 111.129 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -5.71 28.58 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.27 1.17 15.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.519 1.527 . . . . 0.0 111.565 170.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 39.88 42.75 1.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.345 1.858 . . . . 0.0 112.355 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 165.61 18.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 166.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.85 156.76 43.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.61 -154.42 25.79 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.121 0.873 . . . . 0.0 112.433 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -146.24 166.21 26.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 122.139 -0.624 . . . . 0.0 112.251 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.18 141.07 42.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 124.668 1.187 . . . . 0.0 108.239 166.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -138.1 158.65 43.89 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.789 1.236 . . . . 0.0 108.082 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.76 107.63 10.71 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -81.18 146.26 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.318 1.047 . . . . 0.0 109.642 -155.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.16 -25.08 66.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.809 0.444 . . . . 0.0 111.325 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -60.14 -16.92 36.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.439 1.896 . . . . 0.0 113.234 171.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.11 1.51 35.89 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.223 0.916 . . . . 0.0 113.533 171.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.6 mtt85 -117.28 153.74 32.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.751 1.221 . . . . 0.0 109.271 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.22 149.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 164.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -132.71 140.79 48.26 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 167.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.49 145.33 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -173.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -133.49 129.36 37.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.95 152.67 47.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.683 . . . . 0.0 109.575 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -139.48 134.85 32.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.252 1.421 . . . . 0.0 107.269 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.8 -172.13 41.16 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.396 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.42 151.89 54.17 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.711 2.274 . . . . 0.0 110.522 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -60.48 -35.95 77.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.128 0.971 . . . . 0.0 112.227 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.63 -39.54 77.09 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.936 -1.102 . . . . 0.0 111.604 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.39 83.24 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.98 -40.03 95.48 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.106 0.562 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.99 -47.42 84.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.763 0.711 . . . . 0.0 110.857 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -61.77 -38.37 87.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.352 0.596 . . . . 0.0 110.796 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -64.14 -43.35 95.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.458 1.103 . . . . 0.0 110.545 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.08 -50.39 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.293 0.952 . . . . 0.0 109.306 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -55.56 -39.38 70.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.821 0.849 . . . . 0.0 110.838 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.91 74.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.641 0.776 . . . . 0.0 110.967 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.81 -27.25 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.128 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -58.65 -38.62 78.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.256 1.389 . . . . 0.0 110.918 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.51 -43.17 50.4 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.111 0.414 . . . . 0.0 110.351 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.81 -172.99 48.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.76 159.28 10.17 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.511 0.724 . . . . 0.0 110.38 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.19 -26.19 64.87 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.068 1.845 . . . . 0.0 112.629 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -83.28 -15.33 50.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.044 0.938 . . . . 0.0 112.29 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -77.95 161.67 27.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.958 0.903 . . . . 0.0 110.93 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -137.11 82.04 1.91 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.1 t -59.77 140.53 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.3 p -123.91 -19.82 5.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.34 1.056 . . . . 0.0 111.267 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -154.01 152.69 30.82 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.128 0.971 . . . . 0.0 109.53 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.82 145.72 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 107.176 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -139.56 152.55 46.96 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.058 1.343 . . . . 0.0 108.238 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -138.61 145.45 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.319 1.048 . . . . 0.0 108.186 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 m -135.23 160.85 37.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.635 1.974 . . . . 0.0 106.052 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.4 166.51 26.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.252 -0.905 . . . . 0.0 110.825 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.5 m -157.0 147.95 21.78 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.982 1.713 . . . . 0.0 108.666 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -73.82 -41.35 62.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -56.1 137.87 50.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 108.97 170.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.12 156.85 41.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.116 1.367 . . . . 0.0 108.662 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.41 -23.36 21.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.852 0.861 . . . . 0.0 111.445 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 46.5 5.74 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -52.91 137.74 31.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.762 0.825 . . . . 0.0 109.528 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -12.18 39.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.095 0.558 . . . . 0.0 112.096 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -154.58 169.02 24.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.132 1.773 . . . . 0.0 108.412 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -99.79 137.56 38.08 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -134.59 137.71 43.95 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.555 0.616 . . . . 0.0 112.384 -170.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.03 142.53 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 163.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 127.002 2.121 . . . . 0.0 105.795 176.784 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mmm . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.45 164.84 19.57 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.693 1.997 . . . . 0.0 107.704 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -124.96 137.5 54.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.036 1.735 . . . . 0.0 106.389 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -119.85 154.75 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.549 1.54 . . . . 0.0 107.756 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -122.48 139.86 53.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.4 mt -131.94 142.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.3 mm -128.75 136.92 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.87 146.08 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -170.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -143.2 157.26 44.66 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.866 1.266 . . . . 0.0 109.526 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 -156.78 25.3 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.17 1.367 . . . . 0.0 110.474 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -75.05 78.43 2.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.94 20.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.752 0.821 . . . . 0.0 111.9 -168.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -140.93 151.74 44.46 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.44 0.696 . . . . 0.0 109.889 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.61 33.16 83.64 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.5 -10.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.378 1.471 . . . . 0.0 111.853 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.51 18.8 15.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.811 1.672 . . . . 0.0 110.696 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.89 -37.4 87.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.788 1.294 . . . . 0.0 111.117 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -56.02 -51.32 68.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.878 1.217 . . . . 0.0 110.675 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -68.09 -37.74 81.54 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.261 -0.274 . . . . 0.0 110.694 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.01 -50.8 72.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.187 0.595 . . . . 0.0 110.474 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.92 -40.07 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.674 -0.641 . . . . 0.0 109.772 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.9 -45.63 93.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.094 0.861 . . . . 0.0 110.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.36 -32.35 62.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 0.742 . . . . 0.0 111.525 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -73.36 -22.13 60.36 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.219 0.918 . . . . 0.0 111.807 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.27 -49.04 37.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.506 0.594 . . . . 0.0 109.54 164.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.63 -38.33 84.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.392 0.677 . . . . 0.0 111.771 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -22.12 61.61 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -127.15 25.16 6.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.446 1.021 . . . . 0.0 110.581 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 49.26 38.26 13.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 112.646 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.28 156.75 24.69 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.06 155.11 44.88 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.05 -154.22 25.67 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.958 0.799 . . . . 0.0 112.0 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -150.07 166.07 30.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.029 0.532 . . . . 0.0 112.39 174.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.56 151.55 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.694 1.598 . . . . 0.0 108.929 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -143.75 133.63 23.97 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.4 0.68 . . . . 0.0 110.856 171.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.93 115.9 10.61 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 162.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.97 143.85 26.87 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.98 -28.51 70.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.03 -8.12 34.97 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.51 -15.25 38.62 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.455 1.026 . . . . 0.0 113.502 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -76.7 171.87 13.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.72 1.26 . . . . 0.0 110.332 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.6 t -114.18 145.58 19.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 160.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.86 145.99 50.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.57 146.32 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.01 126.05 22.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.8 43.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -140.41 144.6 36.27 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.811 1.644 . . . . 0.0 108.052 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.49 -177.81 41.77 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.02 150.23 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.478 1.452 . . . . 0.0 109.251 167.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.22 -43.69 83.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.968 0.507 . . . . 0.0 110.914 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.64 -29.18 65.47 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.525 -0.735 . . . . 0.0 112.623 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.8 81.97 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 118.674 0.67 . . . . 0.0 110.073 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.79 -33.12 74.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.088 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -62.18 -51.38 68.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.64 1.109 . . . . 0.0 110.26 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 p -63.39 -32.56 74.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.582 1.083 . . . . 0.0 111.418 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.21 -47.16 85.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.952 -0.547 . . . . 0.0 110.169 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.28 -43.45 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.021 0.828 . . . . 0.0 109.996 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -59.74 -41.14 90.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.067 0.849 . . . . 0.0 110.928 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.06 76.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.926 0.491 . . . . 0.0 110.826 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.8 -49.68 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -27.48 64.54 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.893 0.77 . . . . 0.0 112.148 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -64.32 -40.01 95.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.139 0.881 . . . . 0.0 110.459 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 171.97 31.52 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.566 1.079 . . . . 0.0 110.953 -171.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.7 p -64.0 168.8 5.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.977 0.911 . . . . 0.0 109.934 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.16 -2.82 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.186 1.924 . . . . 0.0 113.196 165.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -107.8 -5.48 17.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.882 1.273 . . . . 0.0 112.176 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -124.47 170.75 10.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.684 1.194 . . . . 0.0 111.623 -172.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -146.68 102.17 3.53 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.83 142.05 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.4 p -123.29 -17.81 6.47 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.135 0.974 . . . . 0.0 110.87 173.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -152.15 148.44 27.63 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.296 1.038 . . . . 0.0 109.205 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.77 146.67 16.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.9 m -138.14 150.99 47.32 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.463 1.505 . . . . 0.0 108.059 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.67 145.08 29.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -136.13 159.13 42.65 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.38 157.79 43.72 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.153 -0.967 . . . . 0.0 111.604 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.3 m -140.1 136.92 34.08 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.001 1.72 . . . . 0.0 108.45 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -35.08 61.24 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 m -59.39 150.85 25.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.135 1.374 . . . . 0.0 109.775 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.5 mt -132.84 165.76 23.85 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.392 1.477 . . . . 0.0 109.399 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.61 -21.71 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.661 1.584 . . . . 0.0 110.652 170.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 43.19 7.04 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.73 0.681 . . . . 0.0 112.249 166.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.86 160.04 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.709 0.755 . . . . 0.0 109.996 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -126.27 -20.5 4.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -139.1 -175.74 4.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.825 1.65 . . . . 0.0 107.624 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -120.78 130.75 54.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.522 0.601 . . . . 0.0 109.781 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.0 m -126.19 159.65 32.39 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.854 0.835 . . . . 0.0 111.721 -167.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -111.81 124.89 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 109.567 -168.277 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.3 tp -142.75 163.72 32.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 127.012 2.125 . . . . 0.0 107.204 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -120.1 137.78 53.94 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 107.737 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -116.64 153.85 31.58 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.654 1.582 . . . . 0.0 108.079 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -120.06 139.0 53.21 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 158.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.9 mt -130.96 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.8 mm -130.01 138.87 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -137.07 147.31 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -139.33 157.74 45.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.496 1.118 . . . . 0.0 109.717 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.87 -156.52 22.55 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.474 1.511 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -73.74 81.25 1.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 160.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.92 15.19 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.032 0.933 . . . . 0.0 111.693 -171.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -138.17 150.3 46.65 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 171.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.42 32.0 71.51 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 m -136.65 1.4 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.717 1.607 . . . . 0.0 111.546 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.0 20.13 50.98 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.856 1.217 . . . . 0.0 110.582 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -62.91 -45.28 93.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.757 1.278 . . . . 0.0 110.766 -169.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -62.1 -44.8 95.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.425 1.012 . . . . 0.0 110.99 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -68.51 -40.28 80.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 110.616 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -56.6 -52.28 65.43 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.25 0.62 . . . . 0.0 110.006 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.71 -39.82 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.168 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -60.69 -43.61 97.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.33 0.968 . . . . 0.0 110.647 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.6 mtm -71.74 -35.53 70.17 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.738 0.699 . . . . 0.0 111.499 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -67.38 -39.91 85.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.561 1.073 . . . . 0.0 110.158 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.3 99.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.121 0.569 . . . . 0.0 110.169 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.26 -47.54 85.58 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.65 0.78 . . . . 0.0 110.623 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -59.9 -36.15 76.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.367 1.067 . . . . 0.0 111.275 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -88.11 5.1 42.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.628 1.171 . . . . 0.0 112.729 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 48.82 31.71 3.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.896 1.678 . . . . 0.0 112.591 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.57 165.95 23.12 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.437 1.095 . . . . 0.0 109.62 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 161.48 30.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.348 1.459 . . . . 0.0 107.625 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.52 -148.85 20.76 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.256 0.934 . . . . 0.0 111.844 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -154.04 168.29 26.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.322 0.649 . . . . 0.0 112.689 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.92 147.72 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.868 1.667 . . . . 0.0 108.739 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -144.79 155.56 43.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.871 0.869 . . . . 0.0 110.384 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -84.0 124.2 30.8 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 164.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.12 147.08 38.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.42 -30.0 71.04 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.551 0.34 . . . . 0.0 111.627 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.94 -5.45 21.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.559 1.144 . . . . 0.0 113.518 174.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.48 49.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.332 0.967 . . . . 0.0 113.288 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -73.37 170.88 14.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 1.258 . . . . 0.0 110.551 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.4 t -105.42 150.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -132.73 140.33 48.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.76 146.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.64 153.44 50.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.674 0.79 . . . . 0.0 109.619 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -140.21 135.83 32.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.927 1.291 . . . . 0.0 108.103 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.43 38.84 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.064 -173.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.19 151.79 61.19 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.265 1.977 . . . . 0.0 110.542 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.15 -40.96 82.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 111.527 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.2 -40.08 95.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.821 0.737 . . . . 0.0 111.75 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.34 -41.14 85.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.04 -39.43 93.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.875 0.47 . . . . 0.0 111.1 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -66.65 -49.11 67.29 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.326 -0.859 . . . . 0.0 110.724 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 p -64.38 -31.94 73.36 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.713 -0.617 . . . . 0.0 111.059 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -63.87 -42.86 97.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.821 171.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.25 -46.64 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 120.254 1.388 . . . . 0.0 109.102 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -59.71 -36.97 77.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.891 0.769 . . . . 0.0 110.989 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.05 -43.48 82.63 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.92 -0.487 . . . . 0.0 111.533 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.97 -43.71 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.4 -0.813 . . . . 0.0 109.988 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -68.83 -20.76 64.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.819 1.19 . . . . 0.0 112.549 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.34 -43.28 73.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 120.112 1.324 . . . . 0.0 110.017 167.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.32 -177.62 39.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.236 0.922 . . . . 0.0 111.093 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.1 p -62.57 168.3 4.45 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.973 0.509 . . . . 0.0 110.834 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.87 -14.36 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.727 2.952 . . . . 0.0 115.261 168.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -116.01 -8.47 11.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.526 1.13 . . . . 0.0 111.902 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 m -72.41 164.47 26.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.878 0.871 . . . . 0.0 111.162 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -144.93 93.68 2.43 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 158.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.02 145.72 12.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -121.97 -22.96 5.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.654 1.182 . . . . 0.0 111.038 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -156.75 154.53 30.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.255 1.022 . . . . 0.0 109.88 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.7 tt -149.3 149.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.295 1.438 . . . . 0.0 107.739 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 m -141.88 152.86 43.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.094 1.357 . . . . 0.0 108.496 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.22 145.21 30.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.672 1.189 . . . . 0.0 107.802 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -135.59 160.38 38.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 166.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.43 161.14 41.03 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.985 -1.072 . . . . 0.0 111.009 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -144.19 140.44 29.33 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.96 1.304 . . . . 0.0 108.648 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.1 -41.82 73.53 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.516 0.726 . . . . 0.0 109.101 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.5 m -64.39 147.19 53.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.128 0.971 . . . . 0.0 109.051 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.5 148.12 29.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.998 1.319 . . . . 0.0 108.985 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -152.21 -10.79 0.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.849 0.86 . . . . 0.0 113.202 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.86 -20.28 17.09 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 121.128 -0.982 . . . . 0.0 113.743 -161.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -55.54 111.84 0.99 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.814 1.246 . . . . 0.0 112.722 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -146.63 -49.22 0.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.426 1.49 . . . . 0.0 109.358 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -153.18 -161.48 1.29 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.877 2.471 . . . . 0.0 106.053 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -118.26 96.97 5.55 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.88 1.218 . . . . 0.0 109.142 166.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.2 m -84.12 139.06 32.7 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.466 0.65 . . . . 0.0 110.955 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.54 137.04 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 155.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 C--O 1.236 0.354 0 C-N-CA 125.456 1.502 . . . . 0.0 107.619 -171.433 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.43 160.05 35.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.998 1.719 . . . . 0.0 108.092 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -119.85 139.15 52.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 164.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -122.31 155.13 36.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.894 1.677 . . . . 0.0 107.511 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -129.55 139.18 51.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 162.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.7 mt -134.99 137.7 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -172.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -127.69 137.98 56.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.57 147.23 27.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -146.73 158.45 43.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.753 1.221 . . . . 0.0 109.493 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.4 18.94 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.385 1.469 . . . . 0.0 109.608 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -72.82 89.81 1.4 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 158.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.54 18.31 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.266 1.026 . . . . 0.0 110.125 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -142.27 154.89 45.11 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.6 1.16 . . . . 0.0 108.161 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.98 93.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.8 -3.33 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.663 1.585 . . . . 0.0 111.301 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.02 26.57 40.5 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -173.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.21 -40.75 91.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.618 1.209 . . . . 0.0 110.331 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.93 -43.84 91.25 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.457 -0.777 . . . . 0.0 110.874 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -69.71 -42.03 74.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.931 0.492 . . . . 0.0 110.987 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -56.21 -48.95 75.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.416 0.553 . . . . 0.0 110.306 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.03 -40.01 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.52 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.06 -46.62 85.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.441 1.018 . . . . 0.0 109.968 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.7 mtt -66.96 -38.59 86.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.493 1.042 . . . . 0.0 111.016 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -70.87 -26.59 63.32 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.494 -0.753 . . . . 0.0 112.157 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.38 -39.03 59.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 110.043 168.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.66 -47.02 79.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.619 1.168 . . . . 0.0 110.482 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HE2' ' NH1' ' A' ' 28' ' ' ARG 0.281 0.0 OUTLIER -70.24 -12.82 61.86 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.749 -177.338 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.488 ' NH1' ' HE2' ' A' ' 27' ' ' LYS . 74.7 mtt85 -101.59 -3.17 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.508 1.523 . . . . 0.0 111.96 173.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 45.4 42.25 7.37 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.529 1.532 . . . . 0.0 112.234 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.38 167.44 10.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.47 156.13 44.61 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 167.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.28 -153.58 25.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 119.398 0.999 . . . . 0.0 112.905 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.01 166.4 24.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.626 0.771 . . . . 0.0 112.779 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.38 144.93 31.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 124.949 1.3 . . . . 0.0 107.544 163.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.37 143.29 32.64 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 0.689 . . . . 0.0 111.088 166.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -74.33 110.92 9.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 162.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -79.24 142.81 35.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.04 -23.95 66.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.769 0.428 . . . . 0.0 112.081 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.96 -20.57 62.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.876 1.27 . . . . 0.0 113.032 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.44 -12.38 36.27 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.646 1.117 . . . . 0.0 112.977 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -82.57 170.84 14.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.052 0.941 . . . . 0.0 110.363 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.07 146.14 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -117.97 145.92 44.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -134.39 146.84 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.82 130.61 34.23 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 167.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.78 157.79 44.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 110.253 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.55 134.41 33.82 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.37 -178.01 43.3 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -172.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.08 152.09 72.88 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.23 1.954 . . . . 0.0 109.941 170.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.49 -40.52 87.26 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.937 0.495 . . . . 0.0 111.415 -171.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -64.41 -38.69 91.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.976 0.807 . . . . 0.0 111.968 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -44.54 86.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.98 -35.28 79.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.202 0.455 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -63.83 -51.14 66.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.104 0.866 . . . . 0.0 110.3 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -66.0 -32.27 73.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.016 0.825 . . . . 0.0 111.062 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.59 -45.55 93.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.061 0.944 . . . . 0.0 109.534 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.75 -47.92 84.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 119.158 0.89 . . . . 0.0 109.595 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -57.31 -39.84 76.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.725 0.693 . . . . 0.0 110.765 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.59 81.09 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.857 0.863 . . . . 0.0 111.211 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.76 -32.38 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.653 0.781 . . . . 0.0 110.866 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -60.76 -31.65 70.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.998 1.272 . . . . 0.0 111.393 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -77.7 -45.0 26.13 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.458 0.572 . . . . 0.0 110.324 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.81 -168.86 46.22 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -54.98 153.65 11.29 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.615 166.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -50.61 -31.44 31.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.458 2.772 . . . . 0.0 115.339 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -84.33 -6.38 59.38 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.354 1.062 . . . . 0.0 112.999 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -70.82 163.84 26.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.614 0.766 . . . . 0.0 110.873 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -146.91 81.77 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.9 140.32 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.8 p -120.67 -23.09 6.11 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.448 1.099 . . . . 0.0 111.065 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -155.07 150.51 27.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.808 1.243 . . . . 0.0 108.481 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.7 tt -151.55 147.39 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -139.98 151.3 45.39 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.131 1.372 . . . . 0.0 108.164 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.36 145.12 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -137.04 158.66 43.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.83 162.09 40.97 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.323 -0.861 . . . . 0.0 110.898 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -146.26 140.86 26.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.615 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.41 -36.88 71.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 164.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 m -59.31 153.55 18.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.235 1.414 . . . . 0.0 110.106 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.86 169.16 15.53 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.024 1.33 . . . . 0.0 109.977 -173.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.85 -31.37 4.23 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.101 2.16 . . . . 0.0 108.76 170.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.32 54.64 7.6 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -55.48 145.99 21.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.768 0.827 . . . . 0.0 110.533 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -68.2 -32.9 73.45 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.347 0.659 . . . . 0.0 111.902 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -152.93 -172.03 4.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.914 1.686 . . . . 0.0 108.051 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -102.5 131.67 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 164.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.8 m -125.15 138.15 54.15 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.956 0.503 . . . . 0.0 111.405 -171.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -75.7 139.12 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 159.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 126.474 1.91 . . . . 0.0 106.402 -177.112 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mmm . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.8 tp -145.17 156.32 43.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 0.0 108.386 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.64 138.31 51.54 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.902 1.281 . . . . 0.0 108.229 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -123.71 156.42 36.0 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.714 1.606 . . . . 0.0 108.766 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -123.41 138.99 54.47 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.94 141.44 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.01 138.57 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.67 144.88 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -170.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -138.93 156.83 46.95 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.961 1.305 . . . . 0.0 109.833 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.0 -158.12 23.73 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.582 1.563 . . . . 0.0 110.027 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -74.66 83.84 2.08 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.4 15.98 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.25 1.02 . . . . 0.0 110.941 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -137.98 154.48 49.35 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.97 30.19 70.24 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.12 -9.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.018 1.327 . . . . 0.0 112.138 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.55 21.42 14.68 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.503 1.525 . . . . 0.0 110.494 -177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.61 -41.02 96.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.256 1.528 . . . . 0.0 110.876 -171.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -61.23 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.405 1.002 . . . . 0.0 110.56 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -64.65 -41.82 95.85 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.239 0.472 . . . . 0.0 110.677 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.13 -49.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.07 0.548 . . . . 0.0 110.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.19 -39.79 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 110.159 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -59.06 -49.7 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.793 0.724 . . . . 0.0 109.911 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.8 ptm -72.49 -33.65 67.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.374 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -68.63 -30.75 69.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.003 0.82 . . . . 0.0 111.673 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.26 64.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.184 0.447 . . . . 0.0 109.96 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.98 -43.64 98.54 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.971 0.908 . . . . 0.0 111.025 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -3.32 23.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -114.84 0.27 13.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.662 1.585 . . . . 0.0 111.465 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 45.25 40.02 4.73 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.357 1.463 . . . . 0.0 111.942 -168.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.13 165.37 13.73 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 155.48 45.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.234 1.013 . . . . 0.0 108.367 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.19 -156.14 26.35 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.797 0.726 . . . . 0.0 112.173 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.9 p-90 -153.36 167.13 30.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.975 -0.721 . . . . 0.0 112.211 176.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.9 142.89 34.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.092 1.357 . . . . 0.0 109.036 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 149.41 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.207 0.603 . . . . 0.0 110.608 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -75.73 134.63 40.45 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.23 143.8 30.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.58 -21.86 66.82 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.366 0.53 . . . . 0.0 111.648 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -28.95 59.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.029 1.732 . . . . 0.0 112.85 170.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.8 -25.02 10.47 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.493 1.044 . . . . 0.0 112.669 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -63.64 168.66 4.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.709 1.255 . . . . 0.0 110.754 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.8 150.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 169.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -139.62 140.08 36.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.98 146.63 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -170.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.01 129.12 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 164.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.24 48.07 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 109.443 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -136.79 138.19 40.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.701 1.6 . . . . 0.0 107.955 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.63 -175.22 44.51 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.279 -0.734 . . . . 0.0 111.885 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.37 137.79 40.82 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.365 2.043 . . . . 0.0 109.534 172.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.13 -34.86 61.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.886 1.674 . . . . 0.0 113.1 -168.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -71.34 -46.24 61.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.091 -1.006 . . . . 0.0 111.953 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.62 83.51 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.05 -49.6 76.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.631 1.172 . . . . 0.0 109.692 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 119.188 -0.435 . . . . 0.0 111.362 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 m -62.37 -37.52 86.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.586 0.63 . . . . 0.0 111.199 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.37 -43.82 98.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.01 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.9 t -61.94 -41.95 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.248 1.386 . . . . 0.0 110.593 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.22 -39.27 72.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.717 1.144 . . . . 0.0 110.561 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.7 77.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.294 0.638 . . . . 0.0 111.287 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.8 t -58.68 -32.84 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.455 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -60.88 -35.39 76.52 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.01 1.277 . . . . 0.0 111.535 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -72.7 -43.33 63.16 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.518 0.599 . . . . 0.0 110.288 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.92 -176.17 43.82 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.15 162.23 14.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.659 0.783 . . . . 0.0 110.669 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.92 -32.13 46.13 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.446 2.764 . . . . 0.0 114.52 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -94.33 -9.19 36.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 112.47 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -78.4 165.31 23.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.997 0.919 . . . . 0.0 110.966 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -144.49 93.18 2.39 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.2 t -61.41 143.38 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 p -124.52 -20.61 5.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.265 1.026 . . . . 0.0 111.101 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -155.85 154.12 30.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 0.0 109.243 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.12 148.07 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.904 1.281 . . . . 0.0 107.586 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.1 m -140.68 154.08 46.23 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.35 1.46 . . . . 0.0 108.663 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.43 145.64 29.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 108.178 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 m -134.42 161.25 35.53 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.12 162.92 34.24 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.154 -0.966 . . . . 0.0 110.942 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.4 m -139.8 126.26 20.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 169.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.42 -29.79 66.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.6 m -66.08 161.04 22.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.959 1.303 . . . . 0.0 109.772 167.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.8 mt -133.1 164.32 27.3 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.54 1.136 . . . . 0.0 109.948 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -119.9 -20.24 7.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.393 1.477 . . . . 0.0 110.666 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.37 48.29 5.7 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.443 0.544 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -59.96 156.47 14.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 117.587 0.694 . . . . 0.0 109.239 167.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.71 -6.27 4.6 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.856 0.863 . . . . 0.0 112.78 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.7 mtm-85 -141.31 169.04 18.35 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.901 1.68 . . . . 0.0 107.031 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -110.39 138.05 47.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -133.99 139.23 45.92 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.66 140.61 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 161.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 126.435 1.894 . . . . 0.0 106.533 -177.923 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.6 mmm . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.4 tp -152.5 158.6 42.8 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.413 1.885 . . . . 0.0 107.225 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -123.67 138.33 54.55 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 107.244 173.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -110.53 151.06 28.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.233 1.413 . . . . 0.0 107.704 163.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -117.97 140.34 49.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 152.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -131.41 143.41 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.4 mm -131.99 136.56 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.19 146.34 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -140.46 155.67 46.61 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.748 1.219 . . . . 0.0 109.796 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.78 -155.16 23.56 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.451 1.5 . . . . 0.0 109.73 -176.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -76.91 79.11 3.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 162.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.46 14.6 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.066 0.946 . . . . 0.0 111.711 -170.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -137.76 150.14 47.01 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.15 30.28 63.22 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.83 -1.27 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.55 1.54 . . . . 0.0 112.021 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.58 20.94 42.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.973 1.273 . . . . 0.0 110.641 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -63.08 -44.58 95.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.109 1.454 . . . . 0.0 110.405 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -61.03 -47.08 88.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.231 0.923 . . . . 0.0 110.452 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -64.69 -42.17 95.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.717 0.407 . . . . 0.0 111.048 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -56.23 -52.38 64.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.954 0.502 . . . . 0.0 110.04 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.45 -39.72 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.546 0.612 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -59.2 -44.77 92.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.019 0.827 . . . . 0.0 110.029 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.8 mtp -73.5 -34.0 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.437 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -66.47 -38.79 88.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.019 1.282 . . . . 0.0 110.048 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.04 99.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.086 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.06 -44.99 94.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.664 0.665 . . . . 0.0 111.143 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.03 -8.65 7.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.137 1.775 . . . . 0.0 112.837 174.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -118.48 -0.21 11.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.358 -1.464 . . . . 0.0 111.934 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 39.07 41.72 0.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.03 1.732 . . . . 0.0 112.35 -165.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.92 165.94 23.98 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.571 0.748 . . . . 0.0 109.302 171.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 152.0 46.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.97 -159.17 28.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.506 1.048 . . . . 0.0 113.688 -169.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -141.48 165.52 27.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.812 0.845 . . . . 0.0 111.973 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.1 p -137.58 146.28 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.018 1.327 . . . . 0.0 108.226 165.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -146.54 152.41 38.91 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.908 0.883 . . . . 0.0 110.036 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -84.59 121.64 27.9 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -75.22 147.03 40.68 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.28 -29.99 71.06 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.658 0.383 . . . . 0.0 111.521 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.58 -5.52 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.58 1.152 . . . . 0.0 113.58 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.94 49.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.478 1.037 . . . . 0.0 113.29 170.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.49 170.55 15.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.64 1.22 . . . . 0.0 110.424 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.13 149.5 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -130.97 142.41 50.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.13 147.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.76 128.31 28.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 167.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.55 148.34 44.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -138.61 129.72 26.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.38 -167.66 39.0 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.357 -0.69 . . . . 0.0 111.837 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.58 155.68 49.8 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.818 2.345 . . . . 0.0 111.103 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.9 -44.31 91.18 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.69 0.796 . . . . 0.0 111.417 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -62.55 -39.35 93.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.098 0.863 . . . . 0.0 111.958 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.34 -44.2 83.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.6 mt -65.6 -37.76 87.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.435 0.294 . . . . 0.0 111.383 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -63.0 -52.76 61.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.756 0.823 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -64.1 -32.44 74.01 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.58 -0.7 . . . . 0.0 111.273 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.83 -50.0 70.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.529 175.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -63.94 -37.87 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.678 1.126 . . . . 0.0 110.04 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -56.39 -41.77 76.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.094 0.861 . . . . 0.0 110.571 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.6 83.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.932 0.493 . . . . 0.0 111.582 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.08 -32.22 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.658 0.783 . . . . 0.0 110.668 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.16 -31.18 68.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.821 1.191 . . . . 0.0 111.493 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -78.28 -41.96 32.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.477 0.58 . . . . 0.0 111.195 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.53 -169.28 47.73 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -166.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.2 p -60.69 165.78 5.28 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 117.111 0.455 . . . . 0.0 110.166 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.02 -5.59 8.01 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.356 2.038 . . . . 0.0 113.703 171.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.21 -9.29 14.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.562 1.145 . . . . 0.0 111.761 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -75.46 167.66 21.47 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.077 0.951 . . . . 0.0 111.089 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -143.73 131.01 20.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 155.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.4 t -100.14 139.72 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.0 p -122.39 -19.23 6.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.051 0.941 . . . . 0.0 111.038 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -154.18 150.74 28.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 tt -152.46 145.77 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 m -142.6 153.45 43.51 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.052 1.341 . . . . 0.0 108.765 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.65 148.75 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.688 1.195 . . . . 0.0 109.399 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -137.06 158.18 45.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.01 152.43 47.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.61 0.764 . . . . 0.0 110.133 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -148.12 146.59 28.85 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.448 1.499 . . . . 0.0 108.391 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -83.6 -32.74 25.58 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.878 -0.514 . . . . 0.0 110.476 167.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -58.15 152.22 17.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 109.311 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.52 154.17 42.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.522 1.129 . . . . 0.0 109.131 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -77.23 -35.3 55.59 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 162.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.0 42.57 3.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.591 1.091 . . . . 0.0 111.375 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -62.21 157.6 19.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.986 0.893 . . . . 0.0 110.777 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -130.27 -1.24 4.53 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.858 1.263 . . . . 0.0 112.205 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -148.2 177.37 9.46 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.791 2.037 . . . . 0.0 107.177 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -121.4 122.37 39.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.0 m -124.48 139.69 53.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.635 0.731 . . . . 0.0 111.918 -163.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.6 mt -80.24 128.65 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 124.721 1.208 . . . . 0.0 108.998 -177.559 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.4 tp -133.98 163.83 28.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 -165.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -125.69 134.26 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.36 1.464 . . . . 0.0 108.44 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -117.31 157.9 25.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 108.572 167.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -126.34 140.19 52.7 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.1 mt -134.08 142.38 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -131.99 137.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.57 148.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -142.47 157.34 44.86 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.123 1.369 . . . . 0.0 109.883 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.15 -154.21 23.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.478 1.513 . . . . 0.0 110.387 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -73.27 79.99 1.32 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 160.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.94 19.27 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.858 0.863 . . . . 0.0 111.023 -171.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -136.64 146.68 46.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.275 1.03 . . . . 0.0 108.228 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.07 33.15 86.34 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.66 0.29 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.172 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.47 24.54 42.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.35 -46.17 87.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.207 1.504 . . . . 0.0 109.936 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -56.45 -46.13 80.47 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.818 0.736 . . . . 0.0 111.521 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.79 -40.94 83.9 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.068 0.395 . . . . 0.0 110.823 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.53 -51.86 67.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.276 0.63 . . . . 0.0 109.875 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.24 -40.42 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.213 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.61 -44.93 93.25 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.854 0.752 . . . . 0.0 110.258 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.5 mtm -71.33 -37.38 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.489 0.586 . . . . 0.0 111.305 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.94 -34.6 76.91 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.131 0.878 . . . . 0.0 110.711 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.42 88.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.901 0.48 . . . . 0.0 110.145 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.11 -49.24 76.67 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.729 0.811 . . . . 0.0 110.622 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -4.97 20.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.57 4.07 15.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.683 1.593 . . . . 0.0 111.807 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 11.4 mmpt? 43.45 38.76 1.91 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.5 1.52 . . . . 0.0 112.078 -172.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.29 165.54 20.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 157.28 43.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.71 1.204 . . . . 0.0 107.851 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.76 -152.13 22.43 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 119.231 0.923 . . . . 0.0 111.598 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -150.66 166.6 29.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.971 -0.723 . . . . 0.0 112.839 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 146.42 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.277 1.431 . . . . 0.0 108.669 171.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -142.96 160.57 40.09 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.014 0.925 . . . . 0.0 109.063 168.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.47 110.89 14.44 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -85.77 155.67 20.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.403 1.081 . . . . 0.0 110.662 -154.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.54 -28.34 69.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.702 0.401 . . . . 0.0 111.804 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.59 -5.34 32.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.017 0.927 . . . . 0.0 113.259 175.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.11 -16.37 46.12 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.629 1.109 . . . . 0.0 113.532 172.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -87.66 152.78 21.89 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.047 1.423 . . . . 0.0 110.002 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.7 147.82 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 162.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -137.7 139.81 40.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -140.45 146.58 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -170.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.37 124.04 25.1 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 166.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.05 150.29 46.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -140.11 138.21 35.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 108.082 -170.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.47 -171.48 39.97 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.72 152.93 64.71 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.291 1.994 . . . . 0.0 110.413 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.05 -40.89 91.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.385 0.674 . . . . 0.0 111.65 -171.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -65.3 -37.86 88.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.74 0.7 . . . . 0.0 111.97 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.29 81.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.26 -37.53 87.81 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.361 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.94 -47.54 82.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.169 0.895 . . . . 0.0 110.581 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.41 -37.52 83.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.105 0.562 . . . . 0.0 110.848 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.12 -45.38 81.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.389 1.076 . . . . 0.0 110.521 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.2 t -56.08 -49.5 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.345 0.975 . . . . 0.0 109.235 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.08 -42.22 69.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 110.863 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.4 74.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.503 0.721 . . . . 0.0 111.442 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.33 -24.6 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -57.54 -33.99 68.69 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.445 1.475 . . . . 0.0 111.042 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -83.2 -42.78 16.87 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.364 0.529 . . . . 0.0 111.053 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.6 -167.06 54.84 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -165.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.0 p -59.94 165.04 5.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.178 0.489 . . . . 0.0 110.319 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.13 -12.68 27.74 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.009 1.806 . . . . 0.0 113.22 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -98.51 -14.77 19.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.143 0.977 . . . . 0.0 111.768 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -71.61 163.46 27.7 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.88 0.872 . . . . 0.0 111.022 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -142.2 94.91 2.72 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.06 145.39 11.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.2 p -126.01 -18.72 4.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.311 1.045 . . . . 0.0 111.063 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -152.62 149.46 28.47 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.364 1.065 . . . . 0.0 109.264 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.6 tt -151.84 145.18 16.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.025 1.33 . . . . 0.0 107.807 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 m -141.71 154.04 45.04 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.286 1.434 . . . . 0.0 108.709 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.2 t -137.72 145.42 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.661 1.184 . . . . 0.0 107.852 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.07 164.27 28.41 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.661 1.985 . . . . 0.0 106.083 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.59 169.61 17.25 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.981 -1.074 . . . . 0.0 111.014 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.5 m -140.39 135.59 32.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -76.67 -28.87 56.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 119.099 -0.476 . . . . 0.0 110.245 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.5 m -73.42 165.54 24.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 161.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.41 162.89 38.67 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 109.88 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.92 -40.33 47.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.54 0.736 . . . . 0.0 109.468 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.06 50.82 3.76 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.14 150.84 10.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.683 0.793 . . . . 0.0 110.498 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -91.21 -31.26 16.23 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.612 0.765 . . . . 0.0 112.81 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -147.03 -179.38 6.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.941 1.696 . . . . 0.0 107.956 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.63 134.9 52.89 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -135.11 139.49 44.72 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 73.9 mt -75.75 133.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 162.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.272 1.429 . . . . 0.0 108.542 179.034 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.861 -0.052 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.7 tp -130.42 163.91 25.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.012 1.325 . . . . 0.0 109.297 -169.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -129.37 142.15 50.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.228 1.011 . . . . 0.0 108.437 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.14 155.89 33.51 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.746 1.618 . . . . 0.0 108.38 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm-85 -120.01 140.06 51.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 158.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.2 mt -130.85 143.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.1 mm -126.72 141.98 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.93 146.17 27.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.1 157.69 45.81 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.553 1.141 . . . . 0.0 109.477 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.45 -158.97 23.95 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.479 1.514 . . . . 0.0 109.643 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -74.0 89.2 1.91 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 159.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.25 15.91 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.484 0.713 . . . . 0.0 111.701 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -138.14 149.0 45.49 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.75 32.4 74.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.42 6.72 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.726 1.61 . . . . 0.0 111.314 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.63 21.2 60.31 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.518 1.056 . . . . 0.0 110.529 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.77 -43.91 91.72 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.392 1.096 . . . . 0.0 110.495 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -65.74 -40.76 92.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.134 0.879 . . . . 0.0 111.15 -177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.02 -41.95 90.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.658 0.663 . . . . 0.0 110.6 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -56.64 -49.8 73.93 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.821 0.737 . . . . 0.0 110.005 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.73 -39.85 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.102 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.5 -41.01 93.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.804 1.184 . . . . 0.0 110.491 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.96 -35.68 72.26 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 111.103 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -72.43 -21.82 61.2 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.171 -0.956 . . . . 0.0 112.038 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.68 -46.41 46.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.94 -37.58 87.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.226 1.01 . . . . 0.0 112.255 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -17.64 42.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -130.29 21.53 5.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.133 0.973 . . . . 0.0 110.747 173.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 28.61 54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.868 2.867 . . . . 0.0 113.763 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.14 165.86 15.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.391 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.3 164.48 23.44 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.635 1.574 . . . . 0.0 108.039 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.42 -150.98 23.3 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.68 0.673 . . . . 0.0 112.783 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -151.32 169.8 21.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.68 1.192 . . . . 0.0 110.295 162.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.1 144.66 34.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.855 1.662 . . . . 0.0 107.726 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.01 146.64 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.384 1.074 . . . . 0.0 109.251 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -83.93 120.9 26.65 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 161.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -73.88 149.37 41.55 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.05 -23.65 67.54 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.6 0.36 . . . . 0.0 111.684 172.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.38 -21.07 61.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.466 1.506 . . . . 0.0 112.97 172.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.49 -16.15 52.67 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.56 1.076 . . . . 0.0 112.395 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -71.93 170.44 13.76 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 110.581 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.98 150.84 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 165.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.25 146.13 49.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.66 146.45 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -143.41 116.36 8.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.23 44.07 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.692 0.678 . . . . 0.0 111.911 -162.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -135.0 132.61 38.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.801 2.041 . . . . 0.0 107.551 -166.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.94 -177.49 41.02 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.59 152.74 74.53 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.233 1.955 . . . . 0.0 110.184 173.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.35 -33.87 73.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.96 -35.19 69.48 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.963 -1.086 . . . . 0.0 111.579 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -40.31 70.79 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.36 0.264 . . . . 0.0 110.604 176.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.1 mp -58.79 -40.13 83.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.745 0.818 . . . . 0.0 110.552 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -65.32 -49.27 70.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.468 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 p -62.02 -34.16 75.69 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.559 1.527 . . . . 0.0 111.264 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -63.93 -47.03 82.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.677 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.3 t -57.21 -47.15 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.309 0.958 . . . . 0.0 109.462 173.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.8 -41.54 77.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.404 0.682 . . . . 0.0 110.555 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.89 -42.09 77.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.216 0.606 . . . . 0.0 111.84 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.62 -31.52 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 118.341 -0.837 . . . . 0.0 110.635 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -58.55 -36.2 73.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.991 1.269 . . . . 0.0 111.159 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.32 -43.07 71.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.939 0.336 . . . . 0.0 110.548 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.22 -178.29 30.76 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.848 0.737 . . . . 0.0 111.666 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.4 p -63.53 159.33 52.28 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 0.0 110.622 177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.17 -26.17 25.58 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.519 2.813 . . . . 0.0 115.333 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.28 -7.39 24.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 112.198 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.7 p -74.84 167.68 21.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.575 0.702 . . . . 0.0 110.863 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -139.39 77.86 1.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -59.51 140.07 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.4 p -123.65 -21.29 5.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.415 1.086 . . . . 0.0 111.547 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.23 154.86 31.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.886 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.08 145.88 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.564 1.546 . . . . 0.0 107.53 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -141.15 157.4 45.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.33 1.452 . . . . 0.0 109.123 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.54 145.63 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.803 1.241 . . . . 0.0 108.738 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 m -136.52 166.05 24.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.329 2.251 . . . . 0.0 106.095 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.2 163.56 33.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.633 -1.292 . . . . 0.0 111.287 -174.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.6 m -148.14 146.91 28.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.279 1.832 . . . . 0.0 108.284 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -81.64 -34.13 31.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.055 -0.403 . . . . 0.0 110.693 172.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.4 m -65.61 155.96 34.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.001 0.921 . . . . 0.0 109.679 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 164.52 37.95 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.536 1.535 . . . . 0.0 108.831 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -80.98 -34.65 32.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.877 0.762 . . . . 0.0 110.947 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.82 21.53 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.192 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . 0.251 30.1 p80 47.07 42.54 12.93 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.891 2.077 . . . . 0.0 114.188 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.52 -49.98 35.73 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.24 173.76 12.96 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.337 1.455 . . . . 0.0 109.458 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -122.65 100.11 6.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.584 1.084 . . . . 0.0 109.637 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 136.89 35.32 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.919 0.488 . . . . 0.0 110.766 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.6 mt -84.72 126.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 153.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 100.0 t . . . . . 0 C--O 1.237 0.43 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.033 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpt . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.6 tp -153.37 164.88 37.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.563 1.145 . . . . 0.0 109.409 -172.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -117.87 138.27 52.23 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.661 1.584 . . . . 0.0 107.697 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -114.65 155.54 26.39 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.072 1.349 . . . . 0.0 107.36 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -127.51 140.95 51.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 162.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.05 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.08 137.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -171.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -142.76 156.75 45.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.769 1.228 . . . . 0.0 110.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.67 -155.85 24.44 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.509 1.528 . . . . 0.0 110.082 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -74.35 82.25 1.9 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 159.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.96 21.87 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.884 1.274 . . . . 0.0 110.201 -174.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -137.72 149.79 46.77 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.503 1.121 . . . . 0.0 108.358 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.62 74.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.591 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.78 -10.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.376 1.071 . . . . 0.0 111.949 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 23.34 13.69 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.124 1.345 . . . . 0.0 110.243 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.16 -39.14 93.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.506 1.653 . . . . 0.0 110.48 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -55.51 -47.36 76.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.757 0.708 . . . . 0.0 111.448 171.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -68.01 -39.08 83.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.411 0.551 . . . . 0.0 111.291 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -56.29 -54.16 48.66 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 173.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.38 -39.64 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.388 0.54 . . . . 0.0 110.461 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -56.22 -47.52 78.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 0.0 109.943 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.6 mtm -73.78 -34.96 64.89 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.447 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.37 -43.85 93.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.503 1.047 . . . . 0.0 109.869 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.76 92.15 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.227 0.467 . . . . 0.0 110.727 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.21 -47.7 84.86 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.753 0.821 . . . . 0.0 110.304 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -61.2 -41.97 97.77 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.859 0.863 . . . . 0.0 111.007 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -74.98 -3.71 33.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.811 0.844 . . . . 0.0 112.37 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 49.52 35.17 7.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.098 1.759 . . . . 0.0 112.251 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.37 170.68 16.25 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 110.158 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.29 153.49 46.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.349 1.46 . . . . 0.0 107.583 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.15 -155.85 26.72 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.762 1.164 . . . . 0.0 113.67 -171.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.46 165.99 25.99 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.301 0.64 . . . . 0.0 112.542 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.4 144.65 36.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.819 1.248 . . . . 0.0 107.759 161.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.32 158.65 43.46 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.464 1.106 . . . . 0.0 108.265 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.74 118.51 25.73 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -94.13 153.5 18.07 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.829 0.852 . . . . 0.0 110.421 -155.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.48 -29.09 70.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.606 0.362 . . . . 0.0 111.953 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.87 -9.79 47.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.49 -19.63 26.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.441 1.019 . . . . 0.0 113.321 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -83.75 154.73 23.43 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.674 1.237 . . . . 0.0 109.995 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.95 150.64 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 162.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -132.06 141.43 49.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -135.26 144.1 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -134.25 126.01 28.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.5 149.43 48.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -137.11 130.8 31.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.35 -173.54 43.71 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -170.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.85 149.19 59.56 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.481 2.12 . . . . 0.0 110.031 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.97 -34.16 71.49 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.121 0.969 . . . . 0.0 111.939 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.16 -40.52 82.33 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.035 -1.041 . . . . 0.0 111.673 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -41.28 83.36 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.52 -41.58 96.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.05 -49.79 76.26 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.444 0.565 . . . . 0.0 110.362 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 m -65.22 -29.66 70.48 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.961 -0.462 . . . . 0.0 111.446 -177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -68.58 -45.17 72.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.403 1.081 . . . . 0.0 110.461 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.8 -49.18 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.641 1.11 . . . . 0.0 109.038 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -56.86 -41.69 78.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.763 0.825 . . . . 0.0 110.608 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.36 -48.13 74.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.827 0.451 . . . . 0.0 111.553 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.97 -30.15 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.838 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -59.05 -23.33 61.91 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.127 1.33 . . . . 0.0 112.191 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -68.25 -34.87 77.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.6 0.636 . . . . 0.0 111.582 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.36 171.9 3.41 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.252 0.93 . . . . 0.0 112.082 -164.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 157.59 65.71 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 121.88 -0.776 . . . . 0.0 110.157 171.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.69 -31.69 61.77 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.123 2.549 . . . . 0.0 113.66 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.46 1.92 39.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.52 1.528 . . . . 0.0 112.759 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 m -128.03 167.11 17.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.854 0.862 . . . . 0.0 110.759 -158.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -146.19 92.95 2.25 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.87 142.78 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 161.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.6 p -128.47 -17.03 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.958 1.303 . . . . 0.0 111.226 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -150.39 148.73 29.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 108.918 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.26 143.85 13.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.653 1.181 . . . . 0.0 107.919 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -142.97 154.46 44.06 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.263 1.425 . . . . 0.0 108.656 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.83 145.73 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.517 1.127 . . . . 0.0 108.293 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.33 162.6 32.57 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.892 2.077 . . . . 0.0 106.686 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -134.66 157.87 45.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.596 1.158 . . . . 0.0 109.759 -172.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -160.06 162.99 34.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.12 1.368 . . . . 0.0 109.623 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -120.05 -12.86 9.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.954 0.902 . . . . 0.0 111.561 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.8 m -78.25 68.6 4.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.436 1.095 . . . . 0.0 109.507 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.67 148.27 7.48 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.226 1.011 . . . . 0.0 111.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -71.65 -35.09 70.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.252 1.021 . . . . 0.0 109.335 163.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.76 44.73 3.84 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.356 0.979 . . . . 0.0 111.149 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -60.46 157.29 14.33 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.494 0.718 . . . . 0.0 110.612 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.22 -6.19 5.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.57 1.148 . . . . 0.0 111.901 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.75 171.12 14.54 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.447 1.899 . . . . 0.0 106.833 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -117.19 135.38 53.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -138.91 144.63 39.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.51 141.04 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 126.765 2.026 . . . . 0.0 106.607 -178.001 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.5 mtp . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.05 151.0 43.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 108.887 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -114.92 140.43 49.0 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -124.93 154.95 40.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.317 1.447 . . . . 0.0 108.938 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.34 138.67 52.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 159.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.79 143.38 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 mm -129.58 138.15 54.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.59 147.85 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -143.29 156.75 44.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.519 1.128 . . . . 0.0 110.027 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.65 -154.23 23.55 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.481 1.515 . . . . 0.0 110.138 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.63 89.37 1.31 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 158.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.62 18.46 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.997 0.919 . . . . 0.0 111.392 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -138.81 153.82 48.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.137 0.975 . . . . 0.0 109.186 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.24 32.17 81.34 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -133.47 -8.0 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 111.695 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.81 24.5 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.67 -44.5 85.77 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.424 1.612 . . . . 0.0 109.882 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -53.89 -49.55 68.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.611 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -61.78 -49.05 77.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.355 0.525 . . . . 0.0 110.681 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -62.89 -41.77 99.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.082 0.401 . . . . 0.0 110.855 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.98 -40.8 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.909 0.777 . . . . 0.0 110.249 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -59.91 -48.4 81.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.224 0.92 . . . . 0.0 109.531 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.9 ptm -70.81 -32.03 68.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.316 0.507 . . . . 0.0 111.67 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -69.48 -28.24 65.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.458 1.026 . . . . 0.0 111.84 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.4 -44.35 52.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.932 0.493 . . . . 0.0 109.833 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.42 -42.15 98.3 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 123.967 0.907 . . . . 0.0 111.291 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -6.54 35.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -113.06 2.27 15.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.871 1.668 . . . . 0.0 111.34 171.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.28 38.45 5.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.537 1.535 . . . . 0.0 112.037 -169.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.75 165.68 14.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.76 156.5 44.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.516 1.127 . . . . 0.0 108.011 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.79 -154.79 26.16 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.223 0.919 . . . . 0.0 112.692 -170.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -145.92 167.53 23.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.102 -0.646 . . . . 0.0 112.625 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.48 145.68 30.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.775 1.23 . . . . 0.0 108.456 167.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.71 160.16 40.75 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 108.045 170.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -125.9 113.54 17.34 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -86.48 153.25 22.0 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.236 1.014 . . . . 0.0 110.193 -157.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -29.47 70.45 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.631 0.372 . . . . 0.0 111.878 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.99 -9.24 43.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.97 -20.2 26.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.505 1.05 . . . . 0.0 113.331 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.3 mtm180 -80.03 154.66 28.02 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.692 1.246 . . . . 0.0 110.045 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.88 150.67 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 161.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -134.07 142.33 47.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -139.61 150.07 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -134.7 128.81 33.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.25 44.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.12 0.873 . . . . 0.0 109.412 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -140.41 136.09 32.73 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 107.881 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.46 43.24 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.962 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.3 138.32 42.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.267 1.978 . . . . 0.0 109.411 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.54 -30.37 67.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 113.018 -168.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -69.75 -46.53 65.65 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.763 -1.211 . . . . 0.0 111.647 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.19 -39.02 89.37 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 tp -61.53 -47.73 84.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.156 0.982 . . . . 0.0 110.167 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -60.14 -44.41 94.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.75 0.42 . . . . 0.0 110.872 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m -62.48 -38.6 90.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.495 0.589 . . . . 0.0 111.179 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -61.28 -44.7 96.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.518 -0.739 . . . . 0.0 110.161 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.4 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.542 1.065 . . . . 0.0 110.15 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -55.5 -39.55 70.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.671 1.123 . . . . 0.0 110.495 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.73 82.73 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.171 0.588 . . . . 0.0 111.471 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.33 -31.41 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.758 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -61.64 -33.36 73.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.054 1.297 . . . . 0.0 111.533 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -71.58 -45.35 62.47 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.704 0.684 . . . . 0.0 109.999 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.39 -156.77 34.0 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -170.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.9 p -62.04 168.83 3.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 122.699 0.4 . . . . 0.0 110.573 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.35 -10.08 1.97 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.53 2.82 . . . . 0.0 114.763 165.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -124.04 -0.77 8.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.263 1.425 . . . . 0.0 111.799 -171.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -77.18 166.22 23.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.082 0.953 . . . . 0.0 112.006 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -142.75 88.38 2.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 159.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.02 142.19 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -123.77 -18.32 6.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.287 1.035 . . . . 0.0 111.091 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -153.3 149.87 28.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.276 1.031 . . . . 0.0 109.241 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.74 144.22 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -139.75 152.22 46.45 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.122 1.369 . . . . 0.0 108.566 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -136.45 145.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.724 1.209 . . . . 0.0 108.169 -176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -132.3 160.35 36.5 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 167.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.43 161.75 37.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.281 0.946 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 m -142.84 124.79 15.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.86 11.77 3.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.76 0.824 . . . . 0.0 112.234 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -138.39 143.69 39.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.992 1.717 . . . . 0.0 106.936 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 mt -84.49 159.17 20.79 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.824 0.45 . . . . 0.0 110.658 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.02 -37.67 38.56 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 156.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 50.14 1.59 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.229 0.918 . . . . 0.0 111.386 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -58.01 144.89 38.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.524 0.729 . . . . 0.0 110.191 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -86.59 -28.2 23.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.246 0.618 . . . . 0.0 112.193 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -151.97 -178.75 6.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.783 1.633 . . . . 0.0 108.808 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -114.28 127.82 56.06 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -132.65 139.87 47.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.563 0.696 . . . . 0.0 112.464 -166.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.1 mt -76.7 131.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -135.32 167.24 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 0.0 109.142 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.69 -1.08 2.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.927 0.891 . . . . 0.0 111.979 -171.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.033 1.333 . . . . 0.0 110.268 -179.418 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.8 mt -136.7 170.52 15.94 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.673 1.589 . . . . 0.0 108.266 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -117.96 138.85 51.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 106.335 166.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.58 155.68 28.3 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.265 1.426 . . . . 0.0 107.304 167.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -124.48 139.66 53.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 162.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 mt -134.36 140.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.87 139.49 51.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.0 144.2 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -138.11 156.16 48.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.809 1.244 . . . . 0.0 110.033 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.43 -154.54 22.51 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.416 1.484 . . . . 0.0 110.44 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -72.55 82.65 1.11 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.8 m -135.07 18.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.274 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -137.01 146.86 45.8 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.949 0.9 . . . . 0.0 108.653 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.6 33.13 83.58 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -134.7 -9.23 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.702 1.201 . . . . 0.0 111.824 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.12 20.58 15.59 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.217 1.389 . . . . 0.0 110.468 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.59 -41.86 98.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.995 1.398 . . . . 0.0 110.43 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -54.48 -49.0 71.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.789 0.722 . . . . 0.0 111.473 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -66.75 -42.04 86.83 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.308 0.504 . . . . 0.0 111.231 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.22 -51.67 67.24 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.082 0.553 . . . . 0.0 110.22 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.68 -41.5 88.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.091 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -58.44 -45.53 88.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.797 0.726 . . . . 0.0 109.902 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.4 mtm -74.01 -33.85 63.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.743 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -66.67 -40.14 88.46 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.867 1.212 . . . . 0.0 110.249 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.17 97.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.172 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.81 -44.49 93.97 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.761 0.824 . . . . 0.0 110.832 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -58.89 -41.22 86.66 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.253 1.021 . . . . 0.0 111.182 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -86.22 0.93 52.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.371 -0.823 . . . . 0.0 113.161 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mptt 49.67 37.15 12.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.572 1.549 . . . . 0.0 111.933 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.87 165.71 22.66 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.837 0.855 . . . . 0.0 109.584 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.85 165.02 14.16 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.522 1.129 . . . . 0.0 108.058 165.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.84 -154.39 24.81 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 118.856 0.753 . . . . 0.0 112.335 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -153.81 167.59 29.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 112.049 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -137.07 145.2 30.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 108.796 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -140.44 164.52 29.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.258 1.023 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.2 109.19 12.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -76.15 152.93 36.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.473 0.709 . . . . 0.0 111.056 -157.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.28 -27.58 69.43 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.884 0.474 . . . . 0.0 111.25 164.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -14.58 19.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.323 1.849 . . . . 0.0 112.853 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -9.01 50.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.125 0.869 . . . . 0.0 113.165 167.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -104.91 156.09 18.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.592 1.157 . . . . 0.0 109.226 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.45 147.27 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 168.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -133.28 135.56 44.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -136.46 146.07 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -172.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 tt -135.87 126.96 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 167.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.04 152.34 49.97 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.644 0.778 . . . . 0.0 109.339 -172.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -141.17 133.93 28.81 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.67 1.188 . . . . 0.0 107.949 -169.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.93 -171.46 40.34 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.547 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.29 156.88 54.49 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.798 2.332 . . . . 0.0 110.666 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -58.54 -44.8 89.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.588 0.755 . . . . 0.0 111.124 -173.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.74 -39.53 89.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.89 0.768 . . . . 0.0 111.928 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.62 -47.51 72.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.7 -38.82 92.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.1 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.5 -51.95 66.53 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.62 0.768 . . . . 0.0 110.184 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 m -62.15 -38.93 90.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.418 0.554 . . . . 0.0 110.893 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.19 -44.06 97.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.109 0.964 . . . . 0.0 110.403 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 t -57.81 -47.98 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.325 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.63 -40.47 75.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.663 1.12 . . . . 0.0 111.18 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.1 82.69 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.141 0.576 . . . . 0.0 110.882 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.5 t -63.28 -28.09 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.035 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -59.32 -37.67 78.36 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.563 1.528 . . . . 0.0 110.921 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.08 -42.77 56.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.222 0.465 . . . . 0.0 110.421 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.64 -174.18 51.04 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.54 160.09 28.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.076 0.55 . . . . 0.0 110.588 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.16 -32.9 51.84 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.124 2.549 . . . . 0.0 113.771 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -88.43 -7.31 56.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.66 1.184 . . . . 0.0 112.763 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -91.91 168.75 11.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.943 1.297 . . . . 0.0 110.725 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -145.24 95.86 2.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 165.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.6 t -63.79 145.19 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.7 p -123.11 -21.85 5.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.311 1.044 . . . . 0.0 111.192 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -154.79 153.12 30.71 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.149 0.98 . . . . 0.0 109.469 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.78 146.0 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.352 1.461 . . . . 0.0 107.402 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.5 m -139.37 151.01 45.99 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.153 1.381 . . . . 0.0 108.369 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.15 145.41 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.403 1.081 . . . . 0.0 108.239 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -136.32 161.03 36.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 106.173 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -149.28 163.18 38.42 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.131 -0.981 . . . . 0.0 111.527 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -149.17 148.23 29.38 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.583 1.953 . . . . 0.0 108.536 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -72.58 -40.54 66.51 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.038 168.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 m -61.63 145.24 52.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.937 0.895 . . . . 0.0 109.13 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.6 157.16 42.67 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.527 1.531 . . . . 0.0 108.645 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.12 -33.39 56.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.695 0.798 . . . . 0.0 110.114 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.45 49.51 14.81 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -169.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -54.72 151.06 8.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.101 0.96 . . . . 0.0 111.789 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -76.51 -19.36 58.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -150.54 178.3 9.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.656 1.582 . . . . 0.0 108.415 -172.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.38 116.42 31.94 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 153.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.7 m -117.18 142.31 47.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 111.996 -167.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.16 135.57 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 162.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.45 HG22 ' H ' ' A' ' 90' ' ' TYR . 7.2 p -141.26 175.73 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.926 1.29 . . . . 0.0 108.303 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.45 ' H ' HG22 ' A' ' 89' ' ' VAL . 72.1 m-85 -134.82 2.98 3.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.961 0.904 . . . . 0.0 112.299 -169.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 125.706 1.602 . . . . 0.0 107.501 -176.011 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.5 mt -137.83 -179.96 6.07 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.004 1.322 . . . . 0.0 109.5 -167.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -130.55 132.14 45.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.648 1.979 . . . . 0.0 107.229 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.67 155.48 28.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -120.42 143.81 48.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 158.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.0 mt -132.72 142.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mm -131.35 136.79 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.1 147.64 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.32 156.93 44.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.56 -153.93 23.89 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.383 1.468 . . . . 0.0 110.374 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -72.38 84.75 1.09 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.02 19.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.101 0.96 . . . . 0.0 110.994 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -138.54 149.18 45.06 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 109.053 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.38 31.27 79.83 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -134.7 -9.85 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.654 1.181 . . . . 0.0 111.731 -173.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.78 22.79 17.18 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.932 1.253 . . . . 0.0 110.119 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -64.08 -39.6 94.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.239 1.52 . . . . 0.0 110.243 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -55.51 -46.19 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.904 0.774 . . . . 0.0 111.695 172.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -68.58 -40.39 80.57 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.508 0.594 . . . . 0.0 111.108 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -56.03 -51.65 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.388 0.54 . . . . 0.0 110.151 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.21 -41.35 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 118.954 -0.546 . . . . 0.0 110.211 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.79 -46.13 88.27 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.826 0.739 . . . . 0.0 110.329 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.9 mtm -72.62 -35.97 67.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.347 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -67.0 -39.36 87.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.677 1.126 . . . . 0.0 110.292 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.32 97.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.177 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.31 -45.05 93.17 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.389 0.676 . . . . 0.0 110.685 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -59.48 -33.85 71.84 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.902 0.881 . . . . 0.0 111.311 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -89.7 1.73 55.69 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.675 1.19 . . . . 0.0 112.839 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm 41.33 38.88 0.88 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.115 2.166 . . . . 0.0 112.503 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.06 165.75 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.816 0.846 . . . . 0.0 109.406 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.19 14.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 162.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.49 -163.53 29.27 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.881 0.764 . . . . 0.0 113.332 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -147.01 166.4 26.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 122.214 -0.58 . . . . 0.0 111.623 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.76 144.06 34.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.526 1.13 . . . . 0.0 109.047 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -139.25 161.94 36.2 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.48 1.112 . . . . 0.0 108.653 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -125.54 111.43 15.03 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.28 153.08 23.76 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.799 1.239 . . . . 0.0 110.383 -157.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.77 -29.32 70.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.94 -10.29 52.17 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.47 -22.62 17.08 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.427 1.013 . . . . 0.0 113.292 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -78.28 154.76 30.66 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.67 1.235 . . . . 0.0 110.327 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.61 148.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.07 135.02 43.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.57 143.15 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.72 125.28 22.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.88 43.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.65 0.78 . . . . 0.0 110.121 -171.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -139.09 143.52 38.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.822 1.249 . . . . 0.0 108.138 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.89 -171.8 39.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.321 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 152.61 57.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.687 2.258 . . . . 0.0 110.712 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.94 -34.52 76.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.62 0.768 . . . . 0.0 112.133 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.22 -40.4 77.99 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.025 -1.047 . . . . 0.0 111.476 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.83 85.74 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.95 -42.19 90.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.968 0.507 . . . . 0.0 110.621 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.98 -51.58 69.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.797 0.726 . . . . 0.0 110.789 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 p -66.45 -31.67 72.56 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.871 -0.518 . . . . 0.0 111.316 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.22 -43.35 99.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.72 171.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.54 -49.56 80.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 119.539 1.063 . . . . 0.0 108.744 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.81 -39.25 73.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.395 0.998 . . . . 0.0 111.464 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.13 -44.12 85.13 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 110.61 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.36 -30.87 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.455 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -59.49 -45.84 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.873 1.67 . . . . 0.0 109.988 172.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.3 -38.48 85.05 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.58 0.352 . . . . 0.0 111.27 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 177.06 27.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.113 0.863 . . . . 0.0 112.041 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.48 153.17 90.83 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.278 -0.542 . . . . 0.0 110.589 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.65 -31.48 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.195 2.597 . . . . 0.0 114.16 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -92.13 10.79 27.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.988 1.315 . . . . 0.0 111.991 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -128.58 169.07 14.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.417 1.487 . . . . 0.0 109.882 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -147.02 96.18 2.69 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.66 140.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.8 p -126.93 -14.17 5.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 111.268 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.51 150.63 29.79 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 109.17 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.86 147.7 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.866 1.266 . . . . 0.0 107.846 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -143.6 161.58 38.13 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.521 1.528 . . . . 0.0 108.753 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.6 t -138.39 149.23 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.609 1.164 . . . . 0.0 108.141 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.36 161.78 33.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.548 1.939 . . . . 0.0 106.189 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -140.79 158.09 44.47 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 120.943 -1.098 . . . . 0.0 111.034 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 m -134.92 138.27 43.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 156.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -89.44 24.09 2.36 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.207 -0.933 . . . . 0.0 111.171 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -142.12 179.27 7.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.822 2.449 . . . . 0.0 106.973 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -144.92 156.32 43.92 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.528 1.131 . . . . 0.0 109.405 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.8 -5.13 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -164.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.21 -3.1 0.79 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 120.036 1.289 . . . . 0.0 115.125 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -48.76 113.6 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.761 1.624 . . . . 0.0 112.126 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -150.93 -49.1 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.372 1.069 . . . . 0.0 111.115 173.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -152.92 -179.57 7.78 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 108.976 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -115.65 137.5 52.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -139.74 139.84 36.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.62 137.59 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 163.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 90' ' ' TYR . 6.5 p -141.21 174.21 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.048 1.339 . . . . 0.0 108.316 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.429 ' H ' HG22 ' A' ' 89' ' ' VAL . 71.3 m-85 -134.69 5.03 3.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.873 0.869 . . . . 0.0 112.231 -168.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.248 1.004 0 C-N-CA 125.824 1.65 . . . . 0.0 107.387 -177.258 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt -139.01 166.35 24.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.751 1.621 . . . . 0.0 108.953 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -112.15 138.61 48.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.606 1.563 . . . . 0.0 106.921 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -119.16 154.91 32.56 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.721 1.608 . . . . 0.0 107.051 166.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -127.9 138.73 52.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 165.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.64 143.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mm -131.68 136.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.91 150.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -143.57 158.28 43.78 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.981 1.313 . . . . 0.0 109.65 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.65 -155.54 24.86 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.436 1.493 . . . . 0.0 110.094 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -75.91 87.36 2.87 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 159.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.11 19.81 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.846 0.859 . . . . 0.0 111.282 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.68 151.97 46.34 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.365 1.066 . . . . 0.0 108.146 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.33 32.12 82.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.78 -1.63 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.513 1.525 . . . . 0.0 111.435 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.68 25.58 34.98 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.457 -1.191 . . . . 0.0 110.127 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.9 -47.5 80.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.268 1.534 . . . . 0.0 109.935 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -62.83 -41.12 99.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.038 0.835 . . . . 0.0 110.64 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -61.97 -45.19 94.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.764 0.425 . . . . 0.0 110.705 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -58.72 -51.02 71.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.242 0.617 . . . . 0.0 110.177 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.96 -39.45 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.219 0.463 . . . . 0.0 110.493 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -58.81 -47.13 85.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.931 0.787 . . . . 0.0 110.55 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -77.11 -30.75 55.39 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.903 0.774 . . . . 0.0 111.719 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.05 -31.65 69.37 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.194 0.906 . . . . 0.0 111.027 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.69 71.19 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.282 0.492 . . . . 0.0 109.885 168.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.71 -42.98 99.67 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.53 0.732 . . . . 0.0 111.571 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -12.6 60.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -115.36 8.0 15.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.678 1.191 . . . . 0.0 111.633 171.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 41.91 42.18 2.17 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.463 1.905 . . . . 0.0 112.52 -173.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.61 166.03 7.38 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.212 0.605 . . . . 0.0 109.856 166.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.85 154.41 45.51 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.63 1.172 . . . . 0.0 107.987 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.82 -161.37 28.67 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 119.282 0.946 . . . . 0.0 112.896 -171.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.55 166.81 25.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 168.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.49 146.35 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 109.281 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -147.1 163.91 34.78 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -124.86 153.9 41.88 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -123.9 151.18 43.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.289 -144.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.0 -27.19 68.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 111.117 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.5 -16.85 40.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.601 1.96 . . . . 0.0 113.135 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -28.16 15.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.93 1.729 . . . . 0.0 111.838 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.1 mtt85 -74.05 168.18 20.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.699 0.799 . . . . 0.0 111.517 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.64 150.01 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 158.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.79 140.87 46.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mt -139.04 147.0 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.08 127.0 29.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 168.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.05 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.696 0.68 . . . . 0.0 109.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.73 133.85 31.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.78 -169.35 40.08 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.592 -172.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.25 152.76 61.78 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.316 2.011 . . . . 0.0 110.216 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.21 -42.46 81.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.884 0.874 . . . . 0.0 110.93 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.57 -42.88 99.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.264 0.484 . . . . 0.0 111.574 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.56 82.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.673 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -38.34 82.1 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 110.988 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -64.91 -49.94 68.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.592 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -57.76 -39.14 76.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.209 1.368 . . . . 0.0 111.409 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.03 -46.42 84.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.903 0.881 . . . . 0.0 109.927 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 118.953 0.797 . . . . 0.0 109.822 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.06 -40.67 73.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.607 0.763 . . . . 0.0 110.538 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.56 72.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.898 0.879 . . . . 0.0 111.416 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.21 -26.29 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.187 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -57.12 -34.81 68.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.322 1.419 . . . . 0.0 111.223 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -82.12 -41.51 20.38 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.114 0.416 . . . . 0.0 111.01 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.85 -166.11 54.72 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -164.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.8 p -60.71 167.46 3.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.915 0.486 . . . . 0.0 111.451 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.45 -15.04 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.775 2.983 . . . . 0.0 115.252 168.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -115.44 -7.15 12.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.532 1.133 . . . . 0.0 111.903 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -70.74 163.67 26.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.652 0.739 . . . . 0.0 111.014 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -142.77 88.79 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 161.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.82 142.67 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 p -125.49 -18.13 5.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.403 1.081 . . . . 0.0 111.15 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.56 149.62 28.68 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.312 1.045 . . . . 0.0 109.123 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 tt -152.91 145.31 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.844 1.258 . . . . 0.0 107.936 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -142.06 152.4 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.357 1.463 . . . . 0.0 108.524 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.13 145.47 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.756 1.223 . . . . 0.0 107.895 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.91 161.8 35.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.456 1.902 . . . . 0.0 106.416 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -138.82 163.65 31.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.01 0.924 . . . . 0.0 110.364 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -154.53 147.59 24.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.342 166.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.98 -41.71 58.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 m -60.26 156.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.3 mt -129.29 149.8 50.93 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.812 1.245 . . . . 0.0 109.036 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -75.94 -34.34 59.86 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.5 0.72 . . . . 0.0 109.248 161.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 41.37 5.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.212 0.911 . . . . 0.0 111.292 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -57.77 149.06 23.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.932 0.866 . . . . 0.0 109.828 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -118.73 -6.52 10.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.41 1.084 . . . . 0.0 112.129 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -148.96 176.75 10.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.959 1.704 . . . . 0.0 107.706 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -110.72 135.95 50.53 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -136.75 139.5 41.89 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.645 0.736 . . . . 0.0 112.755 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -74.17 134.64 29.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 161.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.91 169.12 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.343 1.057 . . . . 0.0 108.907 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -137.48 22.51 2.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.133 0.973 . . . . 0.0 110.998 -166.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.249 1.031 0 C-N-CA 126.007 1.723 . . . . 0.0 111.359 -178.157 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.72 176.54 7.17 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.532 1.933 . . . . 0.0 107.7 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -125.31 137.0 54.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -118.87 159.06 24.46 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.031 1.732 . . . . 0.0 108.052 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -129.32 140.55 51.36 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -134.27 139.22 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -173.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.9 mm -127.29 138.83 53.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.47 146.64 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -140.5 156.92 46.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.12 1.368 . . . . 0.0 109.913 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.5 22.68 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.402 1.477 . . . . 0.0 110.193 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -73.33 82.32 1.39 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.67 19.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.763 0.825 . . . . 0.0 111.074 -171.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -137.05 147.13 45.98 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.61 33.14 86.43 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.41 -1.38 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.095 1.358 . . . . 0.0 111.238 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 26.71 34.96 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.16 -46.83 82.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.312 1.556 . . . . 0.0 109.697 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -55.91 -45.1 78.79 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.614 -0.679 . . . . 0.0 111.488 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -65.95 -43.24 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.718 0.407 . . . . 0.0 110.859 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.57 -51.7 68.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.396 0.679 . . . . 0.0 110.174 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.68 -40.83 88.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 118.329 0.513 . . . . 0.0 110.386 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.74 -43.68 85.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.494 0.718 . . . . 0.0 110.898 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.8 mtm -74.27 -37.15 63.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.62 0.646 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.2 -37.36 87.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.613 1.097 . . . . 0.0 110.312 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.36 81.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.974 0.51 . . . . 0.0 110.564 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -58.61 -44.21 89.86 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -56.26 -26.11 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.974 1.71 . . . . 0.0 112.499 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -118.93 12.17 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.405 1.082 . . . . 0.0 112.049 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 43.53 43.06 4.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.087 1.755 . . . . 0.0 112.175 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.11 165.55 9.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.879 0.472 . . . . 0.0 109.819 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.25 158.62 20.27 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 162.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.06 -160.96 27.86 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 118.687 0.676 . . . . 0.0 112.774 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.73 168.0 26.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.242 -0.563 . . . . 0.0 112.387 171.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.92 144.85 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.171 1.388 . . . . 0.0 108.63 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -143.4 160.52 40.39 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.02 112.22 16.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.5 mtp85 -85.18 155.72 21.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.818 1.247 . . . . 0.0 110.618 -154.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.89 -27.76 69.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.628 0.371 . . . . 0.0 111.882 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -6.42 38.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.924 0.89 . . . . 0.0 113.184 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.07 -15.95 46.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.485 1.041 . . . . 0.0 113.586 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -88.12 155.8 19.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.18 1.49 . . . . 0.0 109.974 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.02 149.91 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 162.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.17 153.68 51.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.972 0.891 . . . . 0.0 109.8 157.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -142.79 146.13 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -171.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.2 154.63 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.241 0.616 . . . . 0.0 109.907 -169.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -138.79 131.96 29.86 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.391 1.476 . . . . 0.0 107.376 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.72 178.79 42.31 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.34 156.18 66.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 110.24 171.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.99 -35.53 77.07 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.335 0.654 . . . . 0.0 111.979 -171.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.96 -36.57 80.32 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.924 -1.11 . . . . 0.0 111.686 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.47 72.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.66 -37.97 88.03 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.851 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.01 -50.08 75.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.76 0.709 . . . . 0.0 110.626 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 m -61.57 -37.86 85.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.515 0.598 . . . . 0.0 111.025 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -63.62 -45.66 89.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.015 0.926 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.09 -48.5 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.174 0.897 . . . . 0.0 109.526 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -56.55 -40.83 75.81 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.588 0.755 . . . . 0.0 110.548 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.26 74.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.534 0.734 . . . . 0.0 111.578 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.78 -26.98 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.201 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -57.72 -33.43 68.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.263 1.392 . . . . 0.0 111.355 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.42 -42.04 26.3 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.329 0.513 . . . . 0.0 110.949 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.33 -166.81 54.52 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -165.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.4 p -60.65 167.41 3.36 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 122.915 0.486 . . . . 0.0 111.326 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.43 -15.18 3.65 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.669 2.913 . . . . 0.0 115.175 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -114.1 -7.98 13.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.56 1.144 . . . . 0.0 111.788 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.2 m -72.03 162.99 28.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.699 0.8 . . . . 0.0 110.994 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -143.31 89.4 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 161.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.8 143.88 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.6 p -124.76 -19.36 5.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.32 1.048 . . . . 0.0 111.207 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -153.77 150.73 28.8 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 109.172 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.7 146.07 15.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.02 1.328 . . . . 0.0 107.703 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 m -140.5 152.82 45.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.154 1.382 . . . . 0.0 108.426 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.8 t -137.76 145.47 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -134.32 159.16 41.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.54 1.936 . . . . 0.0 106.042 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -145.88 167.48 23.14 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.899 0.879 . . . . 0.0 110.102 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -140.09 173.45 11.51 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.133 1.373 . . . . 0.0 109.595 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -122.82 19.39 10.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.643 1.577 . . . . 0.0 109.715 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.0 m -135.87 167.27 21.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.176 1.79 . . . . 0.0 108.178 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -134.56 163.59 29.39 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.3 -25.32 4.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.063 1.745 . . . . 0.0 109.443 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.33 56.38 6.92 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.241 0.924 . . . . 0.0 111.189 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -57.6 150.77 18.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.165 0.482 . . . . 0.0 110.455 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -68.3 -26.97 65.9 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -161.34 -173.74 3.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.835 2.054 . . . . 0.0 107.445 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -99.29 132.82 44.35 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 165.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -136.42 139.91 42.78 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -171.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.63 133.38 31.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 161.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.1 m -134.19 166.27 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 0.0 109.663 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -136.27 8.38 3.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.688 1.195 . . . . 0.0 111.105 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.78 1.632 . . . . 0.0 110.636 -178.299 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 tp -146.05 162.31 38.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.045 1.338 . . . . 0.0 109.001 -166.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.15 138.01 52.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.423 1.489 . . . . 0.0 107.449 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -119.41 156.97 29.16 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.039 1.735 . . . . 0.0 108.419 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -122.78 139.68 53.73 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.77 144.55 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.85 138.11 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.46 147.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -141.95 157.89 44.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.492 1.117 . . . . 0.0 109.991 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.61 -157.33 23.58 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.932 1.729 . . . . 0.0 109.314 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.8 ttp-105 -72.36 85.19 1.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 159.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.51 19.85 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.667 1.187 . . . . 0.0 110.263 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -137.46 143.26 41.69 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.401 -0.812 . . . . 0.0 109.36 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.09 32.37 76.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.51 -7.32 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.785 1.234 . . . . 0.0 111.089 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.96 30.24 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.33 -43.8 83.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.936 1.368 . . . . 0.0 109.758 -173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -59.74 -41.17 90.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.806 0.73 . . . . 0.0 111.705 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.25 -45.01 77.96 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.646 0.657 . . . . 0.0 110.289 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -62.72 -40.11 96.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.955 0.798 . . . . 0.0 110.909 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.2 -38.98 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.106 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.85 -42.42 99.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.215 1.371 . . . . 0.0 110.505 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.64 -38.19 83.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.251 0.932 . . . . 0.0 110.451 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -66.41 -39.67 89.14 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.48 0.712 . . . . 0.0 109.999 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.69 -38.45 91.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.668 0.787 . . . . 0.0 110.327 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.02 -45.27 86.19 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 110.696 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -60.17 -18.23 46.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.919 1.287 . . . . 0.0 112.005 174.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -111.23 7.0 21.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.828 1.651 . . . . 0.0 112.499 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 38.72 40.07 0.38 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.765 2.426 . . . . 0.0 113.271 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -74.63 169.38 17.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.498 1.119 . . . . 0.0 110.237 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.1 164.76 18.01 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 160.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.68 -150.78 23.05 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.723 0.692 . . . . 0.0 112.004 -175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -155.81 170.96 20.87 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.065 0.946 . . . . 0.0 110.855 167.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.43 139.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.516 1.526 . . . . 0.0 107.79 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.59 157.84 45.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.197 1.399 . . . . 0.0 108.85 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.85 114.42 18.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -90.92 153.98 19.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.989 0.916 . . . . 0.0 110.759 -155.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.24 -27.35 68.6 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.049 0.54 . . . . 0.0 111.997 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -7.5 40.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.044 0.938 . . . . 0.0 112.929 175.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.36 -12.86 47.94 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.69 1.138 . . . . 0.0 113.352 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -90.77 154.81 19.25 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.98 1.39 . . . . 0.0 109.603 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.7 151.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -134.49 144.72 48.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.03 145.63 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -137.03 117.67 13.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.23 151.87 46.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.407 0.683 . . . . 0.0 109.933 -165.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -140.95 137.31 32.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.531 1.132 . . . . 0.0 108.583 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 -174.11 43.33 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.27 154.47 69.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.013 1.809 . . . . 0.0 110.263 169.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.67 -41.38 90.53 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.408 0.683 . . . . 0.0 111.442 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.36 -39.59 94.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.587 0.631 . . . . 0.0 111.729 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -40.0 83.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -67.84 -36.76 80.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.076 0.398 . . . . 0.0 111.39 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -64.66 -49.19 71.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.248 0.931 . . . . 0.0 110.285 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 p -66.13 -29.38 69.67 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.729 -0.607 . . . . 0.0 111.352 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -63.66 -43.84 95.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.364 -0.827 . . . . 0.0 110.853 170.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.23 -44.09 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.827 1.194 . . . . 0.0 109.319 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.37 -36.55 78.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.136 0.88 . . . . 0.0 111.545 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.28 -50.1 55.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.804 0.442 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.61 -43.29 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.817 0.847 . . . . 0.0 109.873 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -18.8 62.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.499 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -78.24 -43.66 27.66 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.384 0.993 . . . . 0.0 110.403 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.35 -179.48 25.0 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.606 1.098 . . . . 0.0 111.636 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.5 p -74.23 166.92 40.53 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 122.13 -0.63 . . . . 0.0 109.677 168.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.44 -21.66 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.83 1.687 . . . . 0.0 112.445 170.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -73.17 -37.82 66.41 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.342 0.657 . . . . 0.0 110.338 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -71.55 167.16 20.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.106 0.962 . . . . 0.0 110.809 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -146.0 77.79 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 161.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.32 140.06 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.8 p -127.61 -16.6 4.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.935 1.294 . . . . 0.0 111.618 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -151.61 151.37 31.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.093 0.957 . . . . 0.0 109.59 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.25 149.54 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.894 1.277 . . . . 0.0 108.074 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.8 m -140.57 153.91 46.3 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.611 1.565 . . . . 0.0 108.191 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -137.57 145.18 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.413 1.085 . . . . 0.0 108.291 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.5 164.26 29.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.146 2.178 . . . . 0.0 106.056 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.33 168.76 18.98 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.835 -1.166 . . . . 0.0 111.657 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -142.35 131.97 23.97 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.53 1.932 . . . . 0.0 105.85 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -83.34 17.76 2.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.543 0.737 . . . . 0.0 111.612 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.4 m -139.77 159.75 41.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.166 2.186 . . . . 0.0 106.604 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.93 160.89 39.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.241 1.016 . . . . 0.0 110.354 -172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -78.69 -34.46 46.15 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.811 0.844 . . . . 0.0 110.296 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.57 51.4 7.28 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -55.02 153.32 6.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.267 1.027 . . . . 0.0 112.647 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -42.54 99.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.903 1.281 . . . . 0.0 112.155 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -153.9 -173.07 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 -164.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -114.49 95.5 5.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -79.99 131.33 35.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.981 0.42 . . . . 0.0 111.176 -170.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.45 115.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 154.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.95 129.22 37.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -84.46 46.29 1.21 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.49 1.116 . . . . 0.0 110.907 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 C-N-CA 125.974 1.71 . . . . 0.0 110.385 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttt . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.4 mt -135.61 175.87 9.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.748 1.619 . . . . 0.0 109.526 -171.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -129.27 149.43 51.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 108.121 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -140.52 165.58 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.893 -0.504 . . . . 0.0 111.243 157.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -123.0 136.23 54.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 167.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.2 mt -134.07 144.58 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mm -130.33 138.19 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 t -137.16 145.24 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -170.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -141.58 156.94 45.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.55 1.14 . . . . 0.0 109.8 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.04 -154.08 24.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.34 1.448 . . . . 0.0 110.371 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 ttp-105 -75.65 80.31 2.63 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 162.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.16 19.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.964 0.906 . . . . 0.0 111.169 -169.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -137.44 148.55 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.096 0.958 . . . . 0.0 108.885 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.64 84.49 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.5 m -134.05 -8.01 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.978 1.311 . . . . 0.0 111.416 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.86 23.02 21.87 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.954 1.264 . . . . 0.0 110.054 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.41 -42.76 99.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 119.22 1.51 . . . . 0.0 110.336 -172.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.22 -47.0 75.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.655 0.661 . . . . 0.0 111.619 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -68.89 -41.68 77.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.402 0.546 . . . . 0.0 111.386 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -56.69 -53.03 62.41 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.981 0.513 . . . . 0.0 109.717 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.9 t -62.4 -39.23 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.391 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -57.35 -44.3 84.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.185 0.902 . . . . 0.0 110.97 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.0 mtm -76.55 -36.04 57.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.536 0.607 . . . . 0.0 111.2 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -70.46 -27.81 64.52 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.146 0.885 . . . . 0.0 111.293 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.53 -46.92 65.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.844 -0.535 . . . . 0.0 109.666 168.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.32 -45.35 93.73 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.741 0.816 . . . . 0.0 111.226 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -30.35 69.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.35 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -114.88 18.01 16.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.678 0.672 . . . . 0.0 111.186 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt 52.13 42.64 30.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.273 1.829 . . . . 0.0 112.061 171.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.15 165.66 6.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.004 0.922 . . . . 0.0 108.955 165.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.79 46.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.17 0.988 . . . . 0.0 108.4 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.93 -153.67 24.4 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 119.3 0.955 . . . . 0.0 113.002 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -143.96 165.52 27.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.072 -0.664 . . . . 0.0 112.649 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.42 145.9 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.183 1.393 . . . . 0.0 107.942 165.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -144.39 159.51 42.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.303 1.041 . . . . 0.0 108.584 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -125.88 128.73 48.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -110.55 154.35 23.84 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.733 0.413 . . . . 0.0 110.885 -150.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.75 -27.2 68.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.108 0.563 . . . . 0.0 112.089 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -7.93 42.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.174 0.99 . . . . 0.0 112.989 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.01 -9.07 50.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.73 1.157 . . . . 0.0 113.437 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -97.18 158.12 15.6 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 119.007 1.403 . . . . 0.0 109.855 -173.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.7 153.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 163.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.72 144.03 47.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -134.31 146.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -131.36 127.87 38.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 161.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . . . -136.59 154.13 50.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.32 0.964 . . . . 0.0 109.85 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -140.64 143.28 35.09 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.215 1.806 . . . . 0.0 107.197 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.35 -175.94 41.06 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.146 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.27 153.79 66.29 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.567 2.178 . . . . 0.0 109.594 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.37 -43.58 88.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.378 0.671 . . . . 0.0 111.447 -171.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.01 -43.42 98.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.801 0.728 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.35 83.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.16 -48.51 81.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.377 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -60.07 -46.95 87.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 110.415 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 m -60.49 -37.96 82.77 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.159 -0.338 . . . . 0.0 110.632 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -67.11 -36.06 81.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.694 -1.146 . . . . 0.0 110.985 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 t -58.13 -51.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 120.437 1.471 . . . . 0.0 108.51 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -56.23 -41.61 75.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.96 0.504 . . . . 0.0 110.556 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.99 82.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.338 0.655 . . . . 0.0 111.335 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.05 -35.75 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.746 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -61.67 -37.01 82.5 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.055 1.298 . . . . 0.0 110.861 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -69.3 -44.76 71.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 117.872 0.305 . . . . 0.0 110.266 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.27 -179.62 24.38 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.52 158.62 14.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.106 0.962 . . . . 0.0 111.352 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.04 -37.53 79.08 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.295 2.664 . . . . 0.0 114.394 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -78.96 -21.98 46.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.856 0.862 . . . . 0.0 112.126 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -79.99 168.41 19.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.368 1.467 . . . . 0.0 111.262 -170.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -148.17 104.61 3.56 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.72 143.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -127.35 -18.08 4.55 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.164 0.985 . . . . 0.0 111.152 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.1 150.49 29.97 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.32 145.67 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.958 1.303 . . . . 0.0 107.793 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -141.59 152.24 43.87 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.186 1.394 . . . . 0.0 108.724 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -141.23 144.03 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.718 1.207 . . . . 0.0 108.336 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -138.96 150.88 46.39 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 164.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.88 160.86 40.04 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.248 0.931 . . . . 0.0 111.768 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.1 m -148.93 148.92 30.38 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.848 1.659 . . . . 0.0 108.891 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -48.1 46.72 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 165.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m -57.24 145.13 32.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.164 1.386 . . . . 0.0 109.804 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 pp -151.1 155.21 38.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.067 1.347 . . . . 0.0 109.173 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.33 -32.82 32.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.097 0.559 . . . . 0.0 110.805 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.87 42.28 3.13 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.223 0.916 . . . . 0.0 110.882 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -53.74 136.7 39.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.742 0.771 . . . . 0.0 109.451 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.46 -20.67 23.61 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.022 0.529 . . . . 0.0 112.109 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -152.7 178.8 9.23 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.855 1.662 . . . . 0.0 108.337 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -107.9 135.37 49.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -138.21 142.9 39.96 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.9 mt -74.05 138.43 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 165.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.09 171.33 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.105 1.362 . . . . 0.0 108.059 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -135.27 11.26 3.53 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.622 0.769 . . . . 0.0 112.235 -164.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.148 1.379 . . . . 0.0 107.613 -176.572 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.6 tp -140.81 162.82 34.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.203 2.201 . . . . 0.0 106.835 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.4 138.7 51.65 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.664 1.186 . . . . 0.0 108.221 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -116.48 154.7 29.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.569 1.548 . . . . 0.0 108.057 165.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -122.85 139.55 53.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 158.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.96 141.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.51 140.38 49.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -136.52 147.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -141.72 157.84 44.55 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.877 1.271 . . . . 0.0 109.71 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.46 -157.65 23.03 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.89 1.709 . . . . 0.0 109.391 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -75.13 88.6 2.46 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 157.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.08 19.06 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.377 1.071 . . . . 0.0 110.751 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -139.55 152.19 46.69 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.55 42.29 99.71 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -142.35 4.67 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.751 1.62 . . . . 0.0 112.045 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.23 54.62 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.438 -1.201 . . . . 0.0 110.185 -172.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.77 -50.31 65.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.468 1.634 . . . . 0.0 110.608 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -62.63 -38.77 91.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.884 0.765 . . . . 0.0 110.521 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -66.98 -42.14 85.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.98 0.512 . . . . 0.0 111.375 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.9 -48.98 78.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.702 0.683 . . . . 0.0 109.9 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.4 t -61.93 -41.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.291 0.496 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -56.66 -47.97 78.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.92 0.782 . . . . 0.0 110.035 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.05 -37.34 69.7 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.102 -0.374 . . . . 0.0 111.158 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.22 -31.58 70.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.906 0.776 . . . . 0.0 111.222 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.13 74.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.271 0.487 . . . . 0.0 109.848 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -61.18 -47.39 86.36 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.04 0.936 . . . . 0.0 111.127 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -11.24 53.57 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -125.68 18.59 8.01 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.234 1.013 . . . . 0.0 111.071 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 tttp 45.98 36.48 3.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.952 2.101 . . . . 0.0 114.165 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.55 162.98 27.86 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.14 153.44 49.38 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.123 1.369 . . . . 0.0 107.718 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.1 -157.13 27.14 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.961 1.255 . . . . 0.0 113.519 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -144.86 166.48 25.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.609 0.764 . . . . 0.0 112.071 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.31 146.63 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.757 1.223 . . . . 0.0 108.343 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -146.24 153.53 40.71 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.75 0.82 . . . . 0.0 110.439 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -78.47 157.79 28.82 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 163.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -117.67 151.2 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.188 0.995 . . . . 0.0 108.767 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.1 -27.65 68.9 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.266 0.626 . . . . 0.0 111.888 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.57 -3.54 21.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.671 1.188 . . . . 0.0 113.135 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.11 -9.62 63.46 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.674 1.13 . . . . 0.0 112.987 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -79.36 177.09 9.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.941 1.37 . . . . 0.0 110.543 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.28 145.56 25.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -115.5 140.96 48.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mt -131.49 146.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.77 127.43 32.72 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.34 150.24 45.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.676 0.671 . . . . 0.0 109.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -138.86 133.68 32.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.779 1.631 . . . . 0.0 107.115 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.31 -169.02 38.26 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.381 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 150.11 51.51 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.557 2.172 . . . . 0.0 110.453 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.19 -32.67 72.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.707 0.803 . . . . 0.0 112.052 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.24 -40.74 90.43 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.875 -1.141 . . . . 0.0 111.477 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.88 77.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.38 -40.33 96.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.907 0.483 . . . . 0.0 110.982 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -61.95 -49.91 74.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.274 0.629 . . . . 0.0 110.993 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -61.6 -38.84 89.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.776 0.798 . . . . 0.0 110.622 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -64.12 -43.76 94.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.615 1.166 . . . . 0.0 110.549 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.16 -49.2 82.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 119.408 1.004 . . . . 0.0 109.545 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.42 -39.14 69.87 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.814 . . . . 0.0 110.802 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.94 71.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 111.387 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.65 -26.65 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.808 0.843 . . . . 0.0 111.137 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -58.27 -34.59 70.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.147 1.339 . . . . 0.0 111.283 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.52 -41.54 27.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.346 0.521 . . . . 0.0 110.735 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.46 -167.39 54.73 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -165.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -60.04 167.29 2.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.246 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -52.84 -13.1 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.696 2.931 . . . . 0.0 115.391 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.23 -5.12 10.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.685 1.194 . . . . 0.0 111.805 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -70.27 162.93 27.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.834 0.854 . . . . 0.0 111.147 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -141.76 78.01 1.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.4 142.69 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -122.9 -21.79 5.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.324 1.05 . . . . 0.0 111.162 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -154.99 153.3 30.81 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.104 0.962 . . . . 0.0 109.558 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.1 tt -151.14 145.07 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.49 1.516 . . . . 0.0 107.196 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -140.39 153.19 46.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.942 1.297 . . . . 0.0 108.448 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.4 t -137.14 145.27 30.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -134.84 159.15 42.28 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 167.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.02 160.48 42.33 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.741 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.0 m -148.45 142.14 25.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.21 1.404 . . . . 0.0 109.015 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -69.14 -43.12 75.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -59.45 145.86 42.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.55 1.14 . . . . 0.0 109.071 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.04 153.73 38.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.148 1.379 . . . . 0.0 108.399 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.81 -30.44 45.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.525 0.33 . . . . 0.0 110.526 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.74 40.6 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.81 152.42 27.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.753 0.776 . . . . 0.0 109.481 173.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -128.98 -5.65 5.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 112.08 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.76 173.09 12.69 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.743 1.617 . . . . 0.0 107.746 173.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -111.56 142.61 43.63 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -130.31 133.3 46.36 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.236 0.541 . . . . 0.0 112.17 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.56 113.77 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 156.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.92 121.51 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 157.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -75.78 2.97 10.79 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -164.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.121 -1.418 . . . . 0.0 109.67 167.356 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.5 tp -142.13 156.66 45.37 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.943 1.297 . . . . 0.0 108.171 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -110.37 136.66 49.2 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.566 1.546 . . . . 0.0 107.189 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -111.79 148.18 34.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 161.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -114.36 140.14 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 156.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -132.66 141.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -131.86 137.11 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 147.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -169.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -143.08 156.71 44.87 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.507 1.123 . . . . 0.0 109.94 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.67 -154.85 24.5 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.302 1.429 . . . . 0.0 110.256 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -72.18 83.63 1.02 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 159.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.51 18.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 111.1 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -138.08 148.79 45.37 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.866 0.866 . . . . 0.0 109.444 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.38 78.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.19 -9.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.226 . . . . 0.0 111.719 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.16 22.42 17.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.027 1.298 . . . . 0.0 110.153 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 -40.61 96.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.18 1.49 . . . . 0.0 110.363 -171.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -55.63 -48.2 75.34 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.848 0.749 . . . . 0.0 111.449 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -67.23 -39.56 86.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.205 0.457 . . . . 0.0 111.295 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.03 -51.85 67.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.809 0.443 . . . . 0.0 110.239 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -62.22 -39.18 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.532 0.606 . . . . 0.0 110.512 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -55.96 -49.19 74.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.643 0.777 . . . . 0.0 109.892 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.3 mtp -69.79 -39.23 76.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.984 0.357 . . . . 0.0 111.12 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.72 -32.92 73.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.789 0.722 . . . . 0.0 111.019 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.97 81.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.22 0.463 . . . . 0.0 110.235 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.66 -44.36 94.01 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.278 0.631 . . . . 0.0 110.873 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -4.07 19.75 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.369 -0.832 . . . . 0.0 113.213 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -111.37 2.36 17.55 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.321 1.448 . . . . 0.0 111.286 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 42.82 39.58 1.76 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.782 2.033 . . . . 0.0 111.945 -172.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.78 168.3 13.64 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.556 0.742 . . . . 0.0 109.512 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.96 151.27 49.33 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.15 -159.2 28.01 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.603 1.092 . . . . 0.0 113.756 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -141.73 166.01 25.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.269 0.628 . . . . 0.0 112.271 172.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.72 145.48 31.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 125.019 1.328 . . . . 0.0 108.273 164.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -141.48 161.36 38.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.997 1.319 . . . . 0.0 108.401 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -125.89 116.17 21.11 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -91.01 153.19 20.33 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.025 0.93 . . . . 0.0 110.276 -157.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.75 -29.46 70.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.674 0.39 . . . . 0.0 111.845 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.98 -9.75 48.06 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 -21.19 22.08 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.476 1.036 . . . . 0.0 113.285 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtm180 -81.02 154.33 26.94 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 118.591 1.195 . . . . 0.0 110.178 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.7 t -86.66 148.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 161.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -132.55 142.87 49.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.69 149.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.47 127.0 26.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 167.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.23 147.12 43.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.909 0.777 . . . . 0.0 109.352 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -136.89 129.33 30.03 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -170.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.93 -169.18 41.2 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.82 149.62 60.41 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.259 1.973 . . . . 0.0 110.156 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.43 -32.85 72.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.044 0.938 . . . . 0.0 111.817 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -68.56 -39.76 80.92 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.919 -1.113 . . . . 0.0 111.62 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.5 80.91 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -61.34 -43.04 99.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.83 0.852 . . . . 0.0 111.232 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -61.09 -51.53 68.74 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.004 0.522 . . . . 0.0 110.419 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 m -62.73 -35.29 79.29 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.901 -0.5 . . . . 0.0 110.956 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -65.67 -42.04 91.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.561 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.49 -43.64 87.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.044 1.293 . . . . 0.0 109.925 171.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.68 -37.72 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.418 1.008 . . . . 0.0 111.204 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.09 91.01 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.834 -0.542 . . . . 0.0 111.026 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.22 -48.07 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 118.249 -0.882 . . . . 0.0 109.247 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -68.81 -26.29 65.1 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.936 1.243 . . . . 0.0 112.571 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -60.67 -41.18 94.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.753 1.16 . . . . 0.0 110.014 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.39 170.1 33.53 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.698 1.142 . . . . 0.0 111.185 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 163.41 42.08 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 123.765 0.826 . . . . 0.0 111.188 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.23 -13.65 7.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.244 3.296 . . . . 0.0 115.731 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.15 13.71 11.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.337 1.455 . . . . 0.0 111.132 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -132.73 166.61 21.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.783 1.233 . . . . 0.0 110.141 -161.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -149.87 102.33 3.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.37 144.77 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 166.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 p -124.49 -17.5 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.422 1.089 . . . . 0.0 110.934 172.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -153.77 149.45 27.45 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.391 1.076 . . . . 0.0 109.502 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.9 tt -147.12 146.82 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.995 1.318 . . . . 0.0 107.482 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.2 m -140.7 154.69 46.46 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.484 1.513 . . . . 0.0 108.323 175.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.14 150.01 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.307 1.043 . . . . 0.0 109.66 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -136.77 160.44 38.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.264 1.826 . . . . 0.0 106.335 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.37 159.69 41.01 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.689 0.795 . . . . 0.0 110.648 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.9 m -157.98 145.17 18.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.096 1.358 . . . . 0.0 108.965 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -79.03 -32.88 45.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.247 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 m -57.54 147.8 25.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.833 0.853 . . . . 0.0 108.817 166.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.21 154.77 44.41 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.746 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.43 -35.05 61.04 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 163.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.18 36.29 4.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.604 1.097 . . . . 0.0 111.474 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -58.58 149.86 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.246 1.023 . . . . 0.0 110.289 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.32 -6.23 7.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.81 1.244 . . . . 0.0 111.781 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -140.92 169.74 17.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.535 1.934 . . . . 0.0 106.894 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -115.04 135.04 54.65 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 m -139.44 143.44 37.59 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.2 134.16 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 162.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.8 m -134.86 167.23 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.582 1.153 . . . . 0.0 108.874 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -135.05 -1.59 2.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.795 0.838 . . . . 0.0 112.074 -171.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.248 1.009 0 C-N-CA 124.995 1.318 . . . . 0.0 110.078 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.3 mt -138.81 173.1 11.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.593 1.557 . . . . 0.0 108.904 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -135.37 133.06 38.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -115.59 158.42 22.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.968 1.307 . . . . 0.0 108.091 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -120.87 144.59 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 157.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.9 mt -132.37 144.92 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.4 mm -133.1 136.9 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.32 147.48 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -172.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -141.44 154.72 45.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.153 1.381 . . . . 0.0 109.77 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.27 -154.81 25.96 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.504 1.526 . . . . 0.0 109.84 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 -76.67 79.54 3.32 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 161.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.77 19.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.016 0.926 . . . . 0.0 111.037 -171.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -136.76 146.1 45.37 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.15 32.88 85.41 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.46 -3.22 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.811 1.244 . . . . 0.0 111.722 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.17 21.81 34.34 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.526 -1.152 . . . . 0.0 110.418 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -62.71 -44.41 96.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.11 1.455 . . . . 0.0 110.044 -171.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -55.43 -49.29 72.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.765 0.711 . . . . 0.0 111.856 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -67.57 -40.9 84.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.143 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -56.13 -50.19 71.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.449 0.568 . . . . 0.0 110.053 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.5 t -60.2 -43.24 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 118.372 0.533 . . . . 0.0 110.042 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -59.27 -44.46 92.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.67 0.668 . . . . 0.0 110.389 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.1 mtt -71.82 -36.86 70.35 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.734 -0.604 . . . . 0.0 111.171 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.87 -26.12 64.04 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.555 -0.715 . . . . 0.0 111.631 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.35 -45.23 63.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.547 0.612 . . . . 0.0 109.697 165.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.28 -35.59 80.78 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.109 0.563 . . . . 0.0 112.243 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -16.93 63.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.153 0.888 . . . . 0.0 112.998 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -112.84 5.7 17.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.528 1.531 . . . . 0.0 111.072 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 42.58 41.85 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.2 1.8 . . . . 0.0 111.821 -169.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.3 mt -62.66 161.15 12.75 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.73 154.01 49.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.084 0.953 . . . . 0.0 108.496 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.7 -159.34 28.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -170.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.5 168.09 22.06 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 112.074 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.48 144.8 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.158 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -138.66 156.95 46.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.554 1.141 . . . . 0.0 108.142 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -125.19 107.94 11.26 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtp85 -82.47 154.88 24.89 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.778 1.231 . . . . 0.0 110.648 -154.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.582 0.353 . . . . 0.0 111.81 175.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.8 -5.57 35.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.038 0.935 . . . . 0.0 113.154 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.91 -17.6 41.5 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.724 1.154 . . . . 0.0 113.627 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -86.07 152.87 22.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.109 1.455 . . . . 0.0 110.196 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.92 146.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 162.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.49 136.59 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.07 145.42 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.62 128.3 28.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.48 155.12 45.86 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.51 0.724 . . . . 0.0 110.471 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.21 134.09 37.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.07 1.748 . . . . 0.0 107.743 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.86 -173.18 41.45 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.716 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.95 157.1 55.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.751 2.301 . . . . 0.0 110.707 172.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.42 -44.62 89.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.552 0.741 . . . . 0.0 111.347 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.72 -39.56 91.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.795 0.725 . . . . 0.0 111.767 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.75 74.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.37 -36.56 83.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.127 0.421 . . . . 0.0 111.402 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -63.21 -47.73 81.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.08 0.854 . . . . 0.0 109.901 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.8 m -60.14 -35.94 76.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 0.0 111.18 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -64.95 -45.92 83.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.941 0.897 . . . . 0.0 110.072 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.7 t -56.7 -48.58 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.357 0.98 . . . . 0.0 109.361 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -57.18 -40.77 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 110.683 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.85 73.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.681 0.793 . . . . 0.0 111.17 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -61.68 -27.46 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.068 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -57.76 -31.44 66.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.19 1.359 . . . . 0.0 111.603 173.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -83.33 -41.91 17.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.374 0.533 . . . . 0.0 111.254 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.7 -168.91 45.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -165.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.3 p -60.36 165.9 4.72 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 117.381 0.59 . . . . 0.0 110.92 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.47 -20.77 12.49 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.388 2.725 . . . . 0.0 114.756 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -103.78 -13.41 16.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.47 1.108 . . . . 0.0 111.53 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 m -68.71 165.65 19.05 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.025 -1.047 . . . . 0.0 111.166 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -143.47 138.47 29.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 156.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.4 t -110.22 140.73 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.0 p -123.26 -18.55 6.25 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.187 0.995 . . . . 0.0 110.965 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -153.54 149.46 27.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.76 144.11 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 m -142.09 159.5 42.11 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.195 1.398 . . . . 0.0 108.882 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 t -136.61 146.86 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.78 1.232 . . . . 0.0 107.679 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.74 167.6 20.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.681 1.993 . . . . 0.0 106.388 173.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -130.44 164.03 25.65 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.168 -0.957 . . . . 0.0 109.996 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -135.61 150.88 49.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 162.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -115.17 27.76 9.16 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 109.545 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.7 m -136.55 168.8 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.52 2.728 . . . . 0.0 105.425 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.65 129.66 47.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.657 0.783 . . . . 0.0 108.938 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -71.14 -25.4 62.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.063 0.392 . . . . 0.0 110.794 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 29.07 18.41 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.314 0.959 . . . . 0.0 112.903 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -59.42 151.16 24.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.178 1.489 . . . . 0.0 109.59 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -126.92 -6.96 6.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.382 1.073 . . . . 0.0 112.259 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -141.46 -178.12 5.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.985 2.114 . . . . 0.0 106.711 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -117.54 124.57 49.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.5 m -117.76 139.41 51.1 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.367 0.603 . . . . 0.0 111.103 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.6 mt -89.52 137.51 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.5 t -133.06 142.44 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.348 1.459 . . . . 0.0 107.315 -173.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -151.55 10.11 0.56 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.861 1.265 . . . . 0.0 111.647 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.681 1.592 . . . . 0.0 110.899 -179.437 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.9 mmm . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.92 168.28 14.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 107.259 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -120.19 137.07 54.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.162 1.785 . . . . 0.0 106.496 170.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -119.83 155.62 32.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.393 1.477 . . . . 0.0 107.794 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -125.03 138.83 54.2 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.3 mt -134.23 141.81 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mm -130.56 141.09 47.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.18 147.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -140.95 158.08 44.44 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.866 1.266 . . . . 0.0 109.623 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.96 -157.27 23.31 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.701 1.62 . . . . 0.0 109.595 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -75.12 85.71 2.37 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.77 14.96 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.862 0.865 . . . . 0.0 111.695 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -138.39 149.34 45.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.49 33.45 76.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.06 -3.78 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.307 1.443 . . . . 0.0 111.841 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.52 22.69 33.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.796 1.189 . . . . 0.0 110.41 -175.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.36 -46.75 82.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.125 1.462 . . . . 0.0 110.377 -172.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -61.96 -42.35 99.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.236 0.926 . . . . 0.0 110.345 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -64.57 -42.41 95.65 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.948 0.499 . . . . 0.0 110.707 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.5 -50.69 72.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.321 0.648 . . . . 0.0 110.558 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.25 -37.8 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.672 -0.643 . . . . 0.0 110.127 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.739 0.699 . . . . 0.0 109.823 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 ptp -72.14 -33.46 67.77 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.758 0.708 . . . . 0.0 111.42 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -69.48 -33.82 73.44 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.047 0.839 . . . . 0.0 111.209 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.25 79.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.0 0.364 . . . . 0.0 110.344 170.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.08 -45.42 93.6 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.803 0.841 . . . . 0.0 110.99 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -9.61 35.49 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -122.27 10.37 9.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.044 1.338 . . . . 0.0 111.415 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 44.96 41.83 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.068 1.747 . . . . 0.0 112.626 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.9 166.59 7.18 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.11 159.05 26.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 163.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.31 -155.5 25.19 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.695 0.679 . . . . 0.0 112.62 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -147.75 166.81 26.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.4 144.56 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 108.014 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.23 149.28 33.61 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.557 0.743 . . . . 0.0 110.402 174.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.97 122.12 27.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 166.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -76.57 148.1 37.24 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.31 -30.33 71.38 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.563 0.345 . . . . 0.0 111.613 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.36 -5.2 21.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.513 1.125 . . . . 0.0 113.548 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -13.75 52.66 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.323 0.963 . . . . 0.0 113.353 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -72.2 170.69 13.49 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.818 1.309 . . . . 0.0 110.551 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.28 148.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 161.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -131.96 143.66 50.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -141.11 147.06 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.68 128.82 27.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.63 158.53 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.184 0.593 . . . . 0.0 110.053 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -140.11 134.63 31.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.411 1.484 . . . . 0.0 107.37 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.67 -177.62 44.38 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.464 -0.631 . . . . 0.0 111.741 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 157.41 59.28 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.385 2.057 . . . . 0.0 110.287 169.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.0 -45.17 91.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.265 0.626 . . . . 0.0 111.137 -172.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.57 -38.02 85.96 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.622 0.646 . . . . 0.0 111.954 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.19 75.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.41 -35.87 80.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.385 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.72 -49.22 77.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.925 0.784 . . . . 0.0 109.977 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 m -61.5 -38.27 86.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 110.919 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -63.87 -44.32 93.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.114 0.966 . . . . 0.0 110.233 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -58.39 -50.07 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.992 0.815 . . . . 0.0 109.303 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.33 -38.49 68.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.687 0.795 . . . . 0.0 110.984 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -46.63 69.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 110.812 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.73 -28.55 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.762 0.825 . . . . 0.0 111.011 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -58.43 -35.2 71.72 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.107 1.321 . . . . 0.0 111.275 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -79.91 -42.93 23.12 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.245 0.475 . . . . 0.0 110.673 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.43 -165.99 54.1 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 p -59.84 166.8 3.15 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.682 . . . . 0.0 111.443 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.85 -14.17 3.27 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.94 3.093 . . . . 0.0 115.988 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -123.07 3.79 9.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.674 1.124 . . . . 0.0 112.053 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.3 m -66.86 159.25 28.64 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.02 -1.05 . . . . 0.0 110.357 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -140.94 77.35 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -59.72 140.49 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.6 p -122.46 -19.59 6.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.424 1.09 . . . . 0.0 111.177 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -154.57 151.9 29.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.154 0.982 . . . . 0.0 109.506 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.18 145.96 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.316 1.447 . . . . 0.0 107.356 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -140.31 152.36 45.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 108.475 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -139.19 145.52 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.522 1.129 . . . . 0.0 108.139 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -136.15 159.74 40.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.252 1.821 . . . . 0.0 106.118 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -148.81 163.29 37.81 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.318 -0.864 . . . . 0.0 111.398 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.7 m -148.76 144.95 27.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.482 1.913 . . . . 0.0 108.451 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.0 tpt85 -76.17 -30.77 58.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.191 162.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 m -57.51 148.56 23.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.625 1.17 . . . . 0.0 109.711 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.7 mt -131.44 168.18 18.06 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.363 1.465 . . . . 0.0 109.238 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 -29.41 2.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.816 1.646 . . . . 0.0 109.876 169.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.39 57.35 5.13 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -56.87 150.46 16.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.489 0.715 . . . . 0.0 110.726 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -67.86 -31.5 71.36 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -149.79 179.0 8.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.524 1.93 . . . . 0.0 107.346 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -94.7 132.8 39.06 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 154.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -138.59 144.42 39.79 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.7 139.83 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 164.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -133.88 155.03 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.365 1.866 . . . . 0.0 106.661 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -132.92 10.59 4.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.921 0.888 . . . . 0.0 112.117 -163.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.25 1.105 0 C-N-CA 125.401 1.48 . . . . 0.0 107.787 -174.939 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.764 0.316 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.7 170.73 14.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.249 1.82 . . . . 0.0 107.668 173.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -110.02 138.37 46.48 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.818 1.647 . . . . 0.0 106.817 164.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -116.17 156.95 25.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.144 1.378 . . . . 0.0 107.565 164.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -127.85 140.29 52.11 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 161.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -133.15 142.22 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.04 140.33 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.71 145.06 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.58 157.26 45.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.888 1.275 . . . . 0.0 109.709 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.57 -158.94 24.73 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.982 1.753 . . . . 0.0 109.597 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -75.26 88.77 2.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 157.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.67 20.59 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.445 1.098 . . . . 0.0 109.943 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -138.61 148.5 44.19 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.835 1.254 . . . . 0.0 107.84 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.95 41.53 97.89 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.91 -10.84 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.853 1.261 . . . . 0.0 111.842 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.0 16.98 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.872 1.225 . . . . 0.0 110.124 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.67 -41.73 98.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.307 1.554 . . . . 0.0 110.266 -171.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.75 -45.96 77.93 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.626 -0.671 . . . . 0.0 111.538 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.72 -39.65 80.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.548 0.613 . . . . 0.0 111.515 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.04 -52.09 66.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.199 0.6 . . . . 0.0 109.958 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.0 -38.11 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.44 -48.21 82.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.164 0.893 . . . . 0.0 110.019 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -75.35 -31.85 60.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.923 0.783 . . . . 0.0 111.684 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -68.79 -34.17 75.1 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.032 0.833 . . . . 0.0 110.805 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.31 83.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.162 0.437 . . . . 0.0 110.187 170.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.82 -45.18 93.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.563 0.745 . . . . 0.0 111.129 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -5.71 28.58 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.27 1.17 15.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.519 1.527 . . . . 0.0 111.565 170.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 39.88 42.75 1.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.345 1.858 . . . . 0.0 112.355 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 165.61 18.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 166.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.85 156.76 43.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.61 -154.42 25.79 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.121 0.873 . . . . 0.0 112.433 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -146.24 166.21 26.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 122.139 -0.624 . . . . 0.0 112.251 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.18 141.07 42.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 124.668 1.187 . . . . 0.0 108.239 166.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -138.1 158.65 43.89 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.789 1.236 . . . . 0.0 108.082 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.76 107.63 10.71 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -81.18 146.26 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.318 1.047 . . . . 0.0 109.642 -155.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.16 -25.08 66.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.809 0.444 . . . . 0.0 111.325 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -60.14 -16.92 36.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.439 1.896 . . . . 0.0 113.234 171.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.11 1.51 35.89 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.223 0.916 . . . . 0.0 113.533 171.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.6 mtt85 -117.28 153.74 32.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.751 1.221 . . . . 0.0 109.271 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.22 149.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 164.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -132.71 140.79 48.26 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 167.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.49 145.33 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -173.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -133.49 129.36 37.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.95 152.67 47.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.683 . . . . 0.0 109.575 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -139.48 134.85 32.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.252 1.421 . . . . 0.0 107.269 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.8 -172.13 41.16 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.396 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.42 151.89 54.17 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.711 2.274 . . . . 0.0 110.522 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -60.48 -35.95 77.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.128 0.971 . . . . 0.0 112.227 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.63 -39.54 77.09 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.936 -1.102 . . . . 0.0 111.604 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.39 83.24 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.98 -40.03 95.48 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.106 0.562 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.99 -47.42 84.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.763 0.711 . . . . 0.0 110.857 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -61.77 -38.37 87.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.352 0.596 . . . . 0.0 110.796 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -64.14 -43.35 95.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.458 1.103 . . . . 0.0 110.545 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.08 -50.39 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.293 0.952 . . . . 0.0 109.306 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -55.56 -39.38 70.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.821 0.849 . . . . 0.0 110.838 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.91 74.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.641 0.776 . . . . 0.0 110.967 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.81 -27.25 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.128 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -58.65 -38.62 78.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.256 1.389 . . . . 0.0 110.918 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.51 -43.17 50.4 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.111 0.414 . . . . 0.0 110.351 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.81 -172.99 48.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.76 159.28 10.17 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.511 0.724 . . . . 0.0 110.38 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.19 -26.19 64.87 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.068 1.845 . . . . 0.0 112.629 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -83.28 -15.33 50.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.044 0.938 . . . . 0.0 112.29 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -77.95 161.67 27.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.958 0.903 . . . . 0.0 110.93 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -137.11 82.04 1.91 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.1 t -59.77 140.53 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.3 p -123.91 -19.82 5.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.34 1.056 . . . . 0.0 111.267 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -154.01 152.69 30.82 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.128 0.971 . . . . 0.0 109.53 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.82 145.72 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 107.176 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -139.56 152.55 46.96 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.058 1.343 . . . . 0.0 108.238 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -138.61 145.45 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.319 1.048 . . . . 0.0 108.186 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 m -135.23 160.85 37.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.635 1.974 . . . . 0.0 106.052 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.4 166.51 26.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.252 -0.905 . . . . 0.0 110.825 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.5 m -157.0 147.95 21.78 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.982 1.713 . . . . 0.0 108.666 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -73.82 -41.35 62.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -56.1 137.87 50.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 108.97 170.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.12 156.85 41.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.116 1.367 . . . . 0.0 108.662 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.41 -23.36 21.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.852 0.861 . . . . 0.0 111.445 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 46.5 5.74 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -52.91 137.74 31.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.762 0.825 . . . . 0.0 109.528 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -12.18 39.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.095 0.558 . . . . 0.0 112.096 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -154.58 169.02 24.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.132 1.773 . . . . 0.0 108.412 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -99.79 137.56 38.08 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -134.59 137.71 43.95 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.555 0.616 . . . . 0.0 112.384 -170.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.03 142.53 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 163.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.6 t -132.54 155.63 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.002 2.121 . . . . 0.0 105.795 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -122.22 28.59 7.4 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.751 0.82 . . . . 0.0 111.581 -160.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.251 1.172 0 C-N-CA 126.243 1.817 . . . . 0.0 111.314 176.095 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mmm . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.45 164.84 19.57 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.693 1.997 . . . . 0.0 107.704 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -124.96 137.5 54.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.036 1.735 . . . . 0.0 106.389 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -119.85 154.75 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.549 1.54 . . . . 0.0 107.756 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -122.48 139.86 53.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.4 mt -131.94 142.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.3 mm -128.75 136.92 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.87 146.08 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -170.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -143.2 157.26 44.66 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.866 1.266 . . . . 0.0 109.526 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 -156.78 25.3 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.17 1.367 . . . . 0.0 110.474 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -75.05 78.43 2.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.94 20.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.752 0.821 . . . . 0.0 111.9 -168.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -140.93 151.74 44.46 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.44 0.696 . . . . 0.0 109.889 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.61 33.16 83.64 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.5 -10.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.378 1.471 . . . . 0.0 111.853 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.51 18.8 15.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.811 1.672 . . . . 0.0 110.696 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.89 -37.4 87.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.788 1.294 . . . . 0.0 111.117 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.406 HH21 ' P ' ' A' ' 92' ' ' PO4 . 60.2 mtm180 -56.02 -51.32 68.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.878 1.217 . . . . 0.0 110.675 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -68.09 -37.74 81.54 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.261 -0.274 . . . . 0.0 110.694 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.01 -50.8 72.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.187 0.595 . . . . 0.0 110.474 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.92 -40.07 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.674 -0.641 . . . . 0.0 109.772 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.9 -45.63 93.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.094 0.861 . . . . 0.0 110.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.36 -32.35 62.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 0.742 . . . . 0.0 111.525 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -73.36 -22.13 60.36 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.219 0.918 . . . . 0.0 111.807 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.27 -49.04 37.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.506 0.594 . . . . 0.0 109.54 164.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.63 -38.33 84.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.392 0.677 . . . . 0.0 111.771 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -22.12 61.61 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -127.15 25.16 6.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.446 1.021 . . . . 0.0 110.581 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 49.26 38.26 13.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 112.646 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.28 156.75 24.69 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.06 155.11 44.88 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.05 -154.22 25.67 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.958 0.799 . . . . 0.0 112.0 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -150.07 166.07 30.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.029 0.532 . . . . 0.0 112.39 174.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.56 151.55 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.694 1.598 . . . . 0.0 108.929 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -143.75 133.63 23.97 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.4 0.68 . . . . 0.0 110.856 171.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.93 115.9 10.61 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 162.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.97 143.85 26.87 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.98 -28.51 70.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.03 -8.12 34.97 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.51 -15.25 38.62 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.455 1.026 . . . . 0.0 113.502 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -76.7 171.87 13.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.72 1.26 . . . . 0.0 110.332 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.6 t -114.18 145.58 19.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 160.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.86 145.99 50.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.57 146.32 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.01 126.05 22.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.8 43.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -140.41 144.6 36.27 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.811 1.644 . . . . 0.0 108.052 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.49 -177.81 41.77 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.02 150.23 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.478 1.452 . . . . 0.0 109.251 167.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.22 -43.69 83.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.968 0.507 . . . . 0.0 110.914 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.64 -29.18 65.47 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.525 -0.735 . . . . 0.0 112.623 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.8 81.97 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 118.674 0.67 . . . . 0.0 110.073 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.79 -33.12 74.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.088 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -62.18 -51.38 68.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.64 1.109 . . . . 0.0 110.26 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 p -63.39 -32.56 74.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.582 1.083 . . . . 0.0 111.418 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.21 -47.16 85.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.952 -0.547 . . . . 0.0 110.169 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.28 -43.45 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.021 0.828 . . . . 0.0 109.996 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -59.74 -41.14 90.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.067 0.849 . . . . 0.0 110.928 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.06 76.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.926 0.491 . . . . 0.0 110.826 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.8 -49.68 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -27.48 64.54 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.893 0.77 . . . . 0.0 112.148 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -64.32 -40.01 95.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.139 0.881 . . . . 0.0 110.459 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 171.97 31.52 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.566 1.079 . . . . 0.0 110.953 -171.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.7 p -64.0 168.8 5.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.977 0.911 . . . . 0.0 109.934 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.16 -2.82 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.186 1.924 . . . . 0.0 113.196 165.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -107.8 -5.48 17.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.882 1.273 . . . . 0.0 112.176 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -124.47 170.75 10.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.684 1.194 . . . . 0.0 111.623 -172.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -146.68 102.17 3.53 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.83 142.05 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.4 p -123.29 -17.81 6.47 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.135 0.974 . . . . 0.0 110.87 173.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -152.15 148.44 27.63 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.296 1.038 . . . . 0.0 109.205 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.77 146.67 16.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.9 m -138.14 150.99 47.32 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.463 1.505 . . . . 0.0 108.059 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.67 145.08 29.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -136.13 159.13 42.65 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.38 157.79 43.72 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.153 -0.967 . . . . 0.0 111.604 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.3 m -140.1 136.92 34.08 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.001 1.72 . . . . 0.0 108.45 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -35.08 61.24 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 m -59.39 150.85 25.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.135 1.374 . . . . 0.0 109.775 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.5 mt -132.84 165.76 23.85 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.392 1.477 . . . . 0.0 109.399 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.61 -21.71 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.661 1.584 . . . . 0.0 110.652 170.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 43.19 7.04 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.73 0.681 . . . . 0.0 112.249 166.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.86 160.04 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.709 0.755 . . . . 0.0 109.996 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -126.27 -20.5 4.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -139.1 -175.74 4.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.825 1.65 . . . . 0.0 107.624 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -120.78 130.75 54.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.522 0.601 . . . . 0.0 109.781 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.0 m -126.19 159.65 32.39 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.854 0.835 . . . . 0.0 111.721 -167.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -111.81 124.89 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.17 175.26 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 109.567 -168.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -142.41 19.37 2.05 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.487 1.115 . . . . 0.0 111.389 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.25 1.091 0 C-N-CA 125.747 1.619 . . . . 0.0 111.131 -176.912 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . 0.406 ' P ' HH21 ' A' ' 18' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.3 tp -142.75 163.72 32.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 127.012 2.125 . . . . 0.0 107.204 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -120.1 137.78 53.94 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 107.737 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -116.64 153.85 31.58 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.654 1.582 . . . . 0.0 108.079 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -120.06 139.0 53.21 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 158.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.9 mt -130.96 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.8 mm -130.01 138.87 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -137.07 147.31 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -139.33 157.74 45.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.496 1.118 . . . . 0.0 109.717 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.87 -156.52 22.55 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.474 1.511 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -73.74 81.25 1.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 160.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.92 15.19 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.032 0.933 . . . . 0.0 111.693 -171.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -138.17 150.3 46.65 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 171.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.42 32.0 71.51 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 m -136.65 1.4 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.717 1.607 . . . . 0.0 111.546 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.0 20.13 50.98 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.856 1.217 . . . . 0.0 110.582 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -62.91 -45.28 93.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.757 1.278 . . . . 0.0 110.766 -169.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -62.1 -44.8 95.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.425 1.012 . . . . 0.0 110.99 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -68.51 -40.28 80.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 110.616 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -56.6 -52.28 65.43 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.25 0.62 . . . . 0.0 110.006 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.71 -39.82 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.168 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -60.69 -43.61 97.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.33 0.968 . . . . 0.0 110.647 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.6 mtm -71.74 -35.53 70.17 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.738 0.699 . . . . 0.0 111.499 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -67.38 -39.91 85.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.561 1.073 . . . . 0.0 110.158 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.3 99.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.121 0.569 . . . . 0.0 110.169 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.26 -47.54 85.58 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.65 0.78 . . . . 0.0 110.623 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -59.9 -36.15 76.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.367 1.067 . . . . 0.0 111.275 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -88.11 5.1 42.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.628 1.171 . . . . 0.0 112.729 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 48.82 31.71 3.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.896 1.678 . . . . 0.0 112.591 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.57 165.95 23.12 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.437 1.095 . . . . 0.0 109.62 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 161.48 30.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.348 1.459 . . . . 0.0 107.625 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.52 -148.85 20.76 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.256 0.934 . . . . 0.0 111.844 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -154.04 168.29 26.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.322 0.649 . . . . 0.0 112.689 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.92 147.72 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.868 1.667 . . . . 0.0 108.739 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -144.79 155.56 43.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.871 0.869 . . . . 0.0 110.384 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -84.0 124.2 30.8 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 164.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.12 147.08 38.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.42 -30.0 71.04 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.551 0.34 . . . . 0.0 111.627 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.94 -5.45 21.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.559 1.144 . . . . 0.0 113.518 174.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.48 49.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.332 0.967 . . . . 0.0 113.288 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -73.37 170.88 14.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 1.258 . . . . 0.0 110.551 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.4 t -105.42 150.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -132.73 140.33 48.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.76 146.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.64 153.44 50.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.674 0.79 . . . . 0.0 109.619 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -140.21 135.83 32.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.927 1.291 . . . . 0.0 108.103 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.43 38.84 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.064 -173.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.19 151.79 61.19 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.265 1.977 . . . . 0.0 110.542 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.15 -40.96 82.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 111.527 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.2 -40.08 95.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.821 0.737 . . . . 0.0 111.75 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.34 -41.14 85.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.04 -39.43 93.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.875 0.47 . . . . 0.0 111.1 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -66.65 -49.11 67.29 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.326 -0.859 . . . . 0.0 110.724 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 p -64.38 -31.94 73.36 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.713 -0.617 . . . . 0.0 111.059 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -63.87 -42.86 97.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.821 171.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.25 -46.64 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 120.254 1.388 . . . . 0.0 109.102 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -59.71 -36.97 77.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.891 0.769 . . . . 0.0 110.989 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.05 -43.48 82.63 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.92 -0.487 . . . . 0.0 111.533 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.97 -43.71 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.4 -0.813 . . . . 0.0 109.988 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -68.83 -20.76 64.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.819 1.19 . . . . 0.0 112.549 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.34 -43.28 73.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 120.112 1.324 . . . . 0.0 110.017 167.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.32 -177.62 39.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.236 0.922 . . . . 0.0 111.093 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.1 p -62.57 168.3 4.45 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.973 0.509 . . . . 0.0 110.834 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.87 -14.36 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.727 2.952 . . . . 0.0 115.261 168.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -116.01 -8.47 11.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.526 1.13 . . . . 0.0 111.902 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 m -72.41 164.47 26.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.878 0.871 . . . . 0.0 111.162 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -144.93 93.68 2.43 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 158.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.02 145.72 12.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -121.97 -22.96 5.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.654 1.182 . . . . 0.0 111.038 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -156.75 154.53 30.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.255 1.022 . . . . 0.0 109.88 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.7 tt -149.3 149.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.295 1.438 . . . . 0.0 107.739 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 m -141.88 152.86 43.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.094 1.357 . . . . 0.0 108.496 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.22 145.21 30.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.672 1.189 . . . . 0.0 107.802 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -135.59 160.38 38.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 166.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.43 161.14 41.03 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.985 -1.072 . . . . 0.0 111.009 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -144.19 140.44 29.33 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.96 1.304 . . . . 0.0 108.648 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.1 -41.82 73.53 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.516 0.726 . . . . 0.0 109.101 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.5 m -64.39 147.19 53.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.128 0.971 . . . . 0.0 109.051 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.5 148.12 29.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.998 1.319 . . . . 0.0 108.985 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -152.21 -10.79 0.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.849 0.86 . . . . 0.0 113.202 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.86 -20.28 17.09 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 121.128 -0.982 . . . . 0.0 113.743 -161.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -55.54 111.84 0.99 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.814 1.246 . . . . 0.0 112.722 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -146.63 -49.22 0.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.426 1.49 . . . . 0.0 109.358 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -153.18 -161.48 1.29 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.877 2.471 . . . . 0.0 106.053 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -118.26 96.97 5.55 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.88 1.218 . . . . 0.0 109.142 166.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.2 m -84.12 139.06 32.7 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.466 0.65 . . . . 0.0 110.955 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.54 137.04 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 155.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.64 152.58 37.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 125.456 1.502 . . . . 0.0 107.619 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -130.55 -15.81 3.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.461 1.105 . . . . 0.0 111.817 -171.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.04 1.336 . . . . 0.0 109.995 179.516 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.43 160.05 35.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.998 1.719 . . . . 0.0 108.092 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -119.85 139.15 52.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 164.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -122.31 155.13 36.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.894 1.677 . . . . 0.0 107.511 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -129.55 139.18 51.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 162.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.7 mt -134.99 137.7 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -172.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -127.69 137.98 56.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.57 147.23 27.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -146.73 158.45 43.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.753 1.221 . . . . 0.0 109.493 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.4 18.94 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.385 1.469 . . . . 0.0 109.608 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -72.82 89.81 1.4 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 158.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.54 18.31 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.266 1.026 . . . . 0.0 110.125 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -142.27 154.89 45.11 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.6 1.16 . . . . 0.0 108.161 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.98 93.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.8 -3.33 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.663 1.585 . . . . 0.0 111.301 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.02 26.57 40.5 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -173.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.21 -40.75 91.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.618 1.209 . . . . 0.0 110.331 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.93 -43.84 91.25 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.457 -0.777 . . . . 0.0 110.874 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -69.71 -42.03 74.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.931 0.492 . . . . 0.0 110.987 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -56.21 -48.95 75.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.416 0.553 . . . . 0.0 110.306 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.03 -40.01 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.52 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.06 -46.62 85.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.441 1.018 . . . . 0.0 109.968 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.7 mtt -66.96 -38.59 86.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.493 1.042 . . . . 0.0 111.016 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -70.87 -26.59 63.32 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.494 -0.753 . . . . 0.0 112.157 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.38 -39.03 59.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 110.043 168.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.66 -47.02 79.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.619 1.168 . . . . 0.0 110.482 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HE2' ' NH1' ' A' ' 28' ' ' ARG 0.281 0.0 OUTLIER -70.24 -12.82 61.86 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.749 -177.338 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.488 ' NH1' ' HE2' ' A' ' 27' ' ' LYS . 74.7 mtt85 -101.59 -3.17 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.508 1.523 . . . . 0.0 111.96 173.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 45.4 42.25 7.37 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.529 1.532 . . . . 0.0 112.234 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.38 167.44 10.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.47 156.13 44.61 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 167.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.28 -153.58 25.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 119.398 0.999 . . . . 0.0 112.905 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.01 166.4 24.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.626 0.771 . . . . 0.0 112.779 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.38 144.93 31.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 124.949 1.3 . . . . 0.0 107.544 163.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.37 143.29 32.64 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 0.689 . . . . 0.0 111.088 166.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -74.33 110.92 9.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 162.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -79.24 142.81 35.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.04 -23.95 66.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.769 0.428 . . . . 0.0 112.081 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.96 -20.57 62.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.876 1.27 . . . . 0.0 113.032 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.44 -12.38 36.27 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.646 1.117 . . . . 0.0 112.977 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -82.57 170.84 14.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.052 0.941 . . . . 0.0 110.363 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.07 146.14 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -117.97 145.92 44.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -134.39 146.84 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.82 130.61 34.23 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 167.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.78 157.79 44.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 110.253 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.55 134.41 33.82 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.37 -178.01 43.3 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -172.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.08 152.09 72.88 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.23 1.954 . . . . 0.0 109.941 170.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.49 -40.52 87.26 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.937 0.495 . . . . 0.0 111.415 -171.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -64.41 -38.69 91.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.976 0.807 . . . . 0.0 111.968 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -44.54 86.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.98 -35.28 79.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.202 0.455 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -63.83 -51.14 66.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.104 0.866 . . . . 0.0 110.3 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -66.0 -32.27 73.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.016 0.825 . . . . 0.0 111.062 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.59 -45.55 93.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.061 0.944 . . . . 0.0 109.534 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.75 -47.92 84.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 119.158 0.89 . . . . 0.0 109.595 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -57.31 -39.84 76.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.725 0.693 . . . . 0.0 110.765 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.59 81.09 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.857 0.863 . . . . 0.0 111.211 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.76 -32.38 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.653 0.781 . . . . 0.0 110.866 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -60.76 -31.65 70.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.998 1.272 . . . . 0.0 111.393 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -77.7 -45.0 26.13 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.458 0.572 . . . . 0.0 110.324 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.81 -168.86 46.22 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -54.98 153.65 11.29 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.615 166.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -50.61 -31.44 31.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.458 2.772 . . . . 0.0 115.339 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -84.33 -6.38 59.38 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.354 1.062 . . . . 0.0 112.999 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -70.82 163.84 26.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.614 0.766 . . . . 0.0 110.873 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -146.91 81.77 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.9 140.32 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.8 p -120.67 -23.09 6.11 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.448 1.099 . . . . 0.0 111.065 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -155.07 150.51 27.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.808 1.243 . . . . 0.0 108.481 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.7 tt -151.55 147.39 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -139.98 151.3 45.39 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.131 1.372 . . . . 0.0 108.164 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.36 145.12 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -137.04 158.66 43.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.83 162.09 40.97 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.323 -0.861 . . . . 0.0 110.898 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -146.26 140.86 26.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.615 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.41 -36.88 71.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 164.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 m -59.31 153.55 18.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.235 1.414 . . . . 0.0 110.106 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.86 169.16 15.53 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.024 1.33 . . . . 0.0 109.977 -173.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.85 -31.37 4.23 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.101 2.16 . . . . 0.0 108.76 170.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.32 54.64 7.6 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -55.48 145.99 21.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.768 0.827 . . . . 0.0 110.533 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -68.2 -32.9 73.45 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.347 0.659 . . . . 0.0 111.902 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -152.93 -172.03 4.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.914 1.686 . . . . 0.0 108.051 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -102.5 131.67 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 164.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.8 m -125.15 138.15 54.15 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.956 0.503 . . . . 0.0 111.405 -171.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -75.7 139.12 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 159.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.0 t -133.09 156.8 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.474 1.91 . . . . 0.0 106.402 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -130.02 13.88 5.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.991 0.917 . . . . 0.0 111.887 -162.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.248 1.014 0 C-N-CA 126.279 1.831 . . . . 0.0 107.15 -177.551 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mmm . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.8 tp -145.17 156.32 43.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 0.0 108.386 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.64 138.31 51.54 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.902 1.281 . . . . 0.0 108.229 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -123.71 156.42 36.0 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.714 1.606 . . . . 0.0 108.766 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -123.41 138.99 54.47 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.94 141.44 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.01 138.57 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.67 144.88 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -170.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -138.93 156.83 46.95 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.961 1.305 . . . . 0.0 109.833 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.0 -158.12 23.73 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.582 1.563 . . . . 0.0 110.027 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -74.66 83.84 2.08 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.4 15.98 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.25 1.02 . . . . 0.0 110.941 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -137.98 154.48 49.35 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.97 30.19 70.24 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.12 -9.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.018 1.327 . . . . 0.0 112.138 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.55 21.42 14.68 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.503 1.525 . . . . 0.0 110.494 -177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.61 -41.02 96.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.256 1.528 . . . . 0.0 110.876 -171.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -61.23 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.405 1.002 . . . . 0.0 110.56 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -64.65 -41.82 95.85 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.239 0.472 . . . . 0.0 110.677 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.13 -49.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.07 0.548 . . . . 0.0 110.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.19 -39.79 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 110.159 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -59.06 -49.7 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.793 0.724 . . . . 0.0 109.911 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.8 ptm -72.49 -33.65 67.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.374 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -68.63 -30.75 69.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.003 0.82 . . . . 0.0 111.673 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.26 64.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.184 0.447 . . . . 0.0 109.96 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.98 -43.64 98.54 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.971 0.908 . . . . 0.0 111.025 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -3.32 23.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -114.84 0.27 13.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.662 1.585 . . . . 0.0 111.465 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 45.25 40.02 4.73 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.357 1.463 . . . . 0.0 111.942 -168.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.13 165.37 13.73 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 155.48 45.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.234 1.013 . . . . 0.0 108.367 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.19 -156.14 26.35 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.797 0.726 . . . . 0.0 112.173 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.9 p-90 -153.36 167.13 30.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.975 -0.721 . . . . 0.0 112.211 176.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.9 142.89 34.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.092 1.357 . . . . 0.0 109.036 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 149.41 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.207 0.603 . . . . 0.0 110.608 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -75.73 134.63 40.45 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.23 143.8 30.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.58 -21.86 66.82 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.366 0.53 . . . . 0.0 111.648 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -28.95 59.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.029 1.732 . . . . 0.0 112.85 170.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.8 -25.02 10.47 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.493 1.044 . . . . 0.0 112.669 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -63.64 168.66 4.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.709 1.255 . . . . 0.0 110.754 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.8 150.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 169.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -139.62 140.08 36.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.98 146.63 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -170.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.01 129.12 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 164.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.24 48.07 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 109.443 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -136.79 138.19 40.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.701 1.6 . . . . 0.0 107.955 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.63 -175.22 44.51 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.279 -0.734 . . . . 0.0 111.885 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.37 137.79 40.82 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.365 2.043 . . . . 0.0 109.534 172.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.13 -34.86 61.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.886 1.674 . . . . 0.0 113.1 -168.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -71.34 -46.24 61.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.091 -1.006 . . . . 0.0 111.953 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.62 83.51 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.05 -49.6 76.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.631 1.172 . . . . 0.0 109.692 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 119.188 -0.435 . . . . 0.0 111.362 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 m -62.37 -37.52 86.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.586 0.63 . . . . 0.0 111.199 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.37 -43.82 98.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.01 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.9 t -61.94 -41.95 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.248 1.386 . . . . 0.0 110.593 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.22 -39.27 72.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.717 1.144 . . . . 0.0 110.561 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.7 77.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.294 0.638 . . . . 0.0 111.287 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.8 t -58.68 -32.84 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.455 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -60.88 -35.39 76.52 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.01 1.277 . . . . 0.0 111.535 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -72.7 -43.33 63.16 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.518 0.599 . . . . 0.0 110.288 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.92 -176.17 43.82 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.15 162.23 14.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.659 0.783 . . . . 0.0 110.669 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.92 -32.13 46.13 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.446 2.764 . . . . 0.0 114.52 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -94.33 -9.19 36.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 112.47 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -78.4 165.31 23.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.997 0.919 . . . . 0.0 110.966 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -144.49 93.18 2.39 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.2 t -61.41 143.38 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 p -124.52 -20.61 5.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.265 1.026 . . . . 0.0 111.101 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -155.85 154.12 30.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 0.0 109.243 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.12 148.07 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.904 1.281 . . . . 0.0 107.586 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.1 m -140.68 154.08 46.23 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.35 1.46 . . . . 0.0 108.663 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.43 145.64 29.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 108.178 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 m -134.42 161.25 35.53 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.12 162.92 34.24 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.154 -0.966 . . . . 0.0 110.942 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.4 m -139.8 126.26 20.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 169.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.42 -29.79 66.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.6 m -66.08 161.04 22.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.959 1.303 . . . . 0.0 109.772 167.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.8 mt -133.1 164.32 27.3 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.54 1.136 . . . . 0.0 109.948 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -119.9 -20.24 7.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.393 1.477 . . . . 0.0 110.666 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.37 48.29 5.7 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.443 0.544 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -59.96 156.47 14.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 117.587 0.694 . . . . 0.0 109.239 167.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.71 -6.27 4.6 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.856 0.863 . . . . 0.0 112.78 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.7 mtm-85 -141.31 169.04 18.35 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.901 1.68 . . . . 0.0 107.031 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -110.39 138.05 47.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -133.99 139.23 45.92 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.66 140.61 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 161.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.49 158.6 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.435 1.894 . . . . 0.0 106.533 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -128.89 -6.4 5.03 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.205 1.002 . . . . 0.0 111.814 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.25 1.098 0 C-N-CA 124.919 1.288 . . . . 0.0 109.396 172.934 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.6 mmm . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.4 tp -152.5 158.6 42.8 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.413 1.885 . . . . 0.0 107.225 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -123.67 138.33 54.55 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 107.244 173.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -110.53 151.06 28.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.233 1.413 . . . . 0.0 107.704 163.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -117.97 140.34 49.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 152.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -131.41 143.41 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.4 mm -131.99 136.56 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.19 146.34 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -140.46 155.67 46.61 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.748 1.219 . . . . 0.0 109.796 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.78 -155.16 23.56 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.451 1.5 . . . . 0.0 109.73 -176.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -76.91 79.11 3.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 162.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.46 14.6 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.066 0.946 . . . . 0.0 111.711 -170.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -137.76 150.14 47.01 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.15 30.28 63.22 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.83 -1.27 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.55 1.54 . . . . 0.0 112.021 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.58 20.94 42.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.973 1.273 . . . . 0.0 110.641 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -63.08 -44.58 95.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.109 1.454 . . . . 0.0 110.405 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -61.03 -47.08 88.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.231 0.923 . . . . 0.0 110.452 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -64.69 -42.17 95.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.717 0.407 . . . . 0.0 111.048 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -56.23 -52.38 64.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.954 0.502 . . . . 0.0 110.04 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.45 -39.72 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.546 0.612 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -59.2 -44.77 92.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.019 0.827 . . . . 0.0 110.029 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.8 mtp -73.5 -34.0 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.437 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -66.47 -38.79 88.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.019 1.282 . . . . 0.0 110.048 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.04 99.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.086 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.06 -44.99 94.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.664 0.665 . . . . 0.0 111.143 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.03 -8.65 7.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.137 1.775 . . . . 0.0 112.837 174.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -118.48 -0.21 11.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.358 -1.464 . . . . 0.0 111.934 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 39.07 41.72 0.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.03 1.732 . . . . 0.0 112.35 -165.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.92 165.94 23.98 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.571 0.748 . . . . 0.0 109.302 171.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 152.0 46.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.97 -159.17 28.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.506 1.048 . . . . 0.0 113.688 -169.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -141.48 165.52 27.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.812 0.845 . . . . 0.0 111.973 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.1 p -137.58 146.28 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.018 1.327 . . . . 0.0 108.226 165.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -146.54 152.41 38.91 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.908 0.883 . . . . 0.0 110.036 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -84.59 121.64 27.9 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -75.22 147.03 40.68 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.28 -29.99 71.06 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.658 0.383 . . . . 0.0 111.521 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.58 -5.52 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.58 1.152 . . . . 0.0 113.58 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.94 49.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.478 1.037 . . . . 0.0 113.29 170.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.49 170.55 15.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.64 1.22 . . . . 0.0 110.424 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.13 149.5 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -130.97 142.41 50.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.13 147.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.76 128.31 28.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 167.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.55 148.34 44.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -138.61 129.72 26.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.38 -167.66 39.0 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.357 -0.69 . . . . 0.0 111.837 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.58 155.68 49.8 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.818 2.345 . . . . 0.0 111.103 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.9 -44.31 91.18 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.69 0.796 . . . . 0.0 111.417 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -62.55 -39.35 93.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.098 0.863 . . . . 0.0 111.958 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.34 -44.2 83.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.6 mt -65.6 -37.76 87.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.435 0.294 . . . . 0.0 111.383 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -63.0 -52.76 61.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.756 0.823 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -64.1 -32.44 74.01 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.58 -0.7 . . . . 0.0 111.273 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.83 -50.0 70.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.529 175.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -63.94 -37.87 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.678 1.126 . . . . 0.0 110.04 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -56.39 -41.77 76.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.094 0.861 . . . . 0.0 110.571 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.6 83.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.932 0.493 . . . . 0.0 111.582 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.08 -32.22 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.658 0.783 . . . . 0.0 110.668 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.16 -31.18 68.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.821 1.191 . . . . 0.0 111.493 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -78.28 -41.96 32.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.477 0.58 . . . . 0.0 111.195 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.53 -169.28 47.73 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -166.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.2 p -60.69 165.78 5.28 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 117.111 0.455 . . . . 0.0 110.166 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.02 -5.59 8.01 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.356 2.038 . . . . 0.0 113.703 171.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.21 -9.29 14.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.562 1.145 . . . . 0.0 111.761 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -75.46 167.66 21.47 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.077 0.951 . . . . 0.0 111.089 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -143.73 131.01 20.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 155.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.4 t -100.14 139.72 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.0 p -122.39 -19.23 6.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.051 0.941 . . . . 0.0 111.038 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -154.18 150.74 28.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 tt -152.46 145.77 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 m -142.6 153.45 43.51 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.052 1.341 . . . . 0.0 108.765 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.65 148.75 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.688 1.195 . . . . 0.0 109.399 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -137.06 158.18 45.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.01 152.43 47.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.61 0.764 . . . . 0.0 110.133 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -148.12 146.59 28.85 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.448 1.499 . . . . 0.0 108.391 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -83.6 -32.74 25.58 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.878 -0.514 . . . . 0.0 110.476 167.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -58.15 152.22 17.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 109.311 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.52 154.17 42.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.522 1.129 . . . . 0.0 109.131 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -77.23 -35.3 55.59 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 162.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.0 42.57 3.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.591 1.091 . . . . 0.0 111.375 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -62.21 157.6 19.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.986 0.893 . . . . 0.0 110.777 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -130.27 -1.24 4.53 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.858 1.263 . . . . 0.0 112.205 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -148.2 177.37 9.46 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.791 2.037 . . . . 0.0 107.177 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -121.4 122.37 39.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.0 m -124.48 139.69 53.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.635 0.731 . . . . 0.0 111.918 -163.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.6 mt -80.24 128.65 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.87 177.05 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.721 1.208 . . . . 0.0 108.998 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -133.08 2.33 3.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.541 0.736 . . . . 0.0 112.475 -167.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.248 1.024 0 C-N-CA 126.377 1.871 . . . . 0.0 106.751 -179.077 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.4 tp -133.98 163.83 28.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 -165.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -125.69 134.26 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.36 1.464 . . . . 0.0 108.44 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -117.31 157.9 25.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 108.572 167.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -126.34 140.19 52.7 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.1 mt -134.08 142.38 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -131.99 137.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.57 148.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -142.47 157.34 44.86 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.123 1.369 . . . . 0.0 109.883 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.15 -154.21 23.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.478 1.513 . . . . 0.0 110.387 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -73.27 79.99 1.32 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 160.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.94 19.27 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.858 0.863 . . . . 0.0 111.023 -171.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -136.64 146.68 46.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.275 1.03 . . . . 0.0 108.228 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.07 33.15 86.34 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.66 0.29 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.172 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.47 24.54 42.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.35 -46.17 87.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.207 1.504 . . . . 0.0 109.936 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -56.45 -46.13 80.47 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.818 0.736 . . . . 0.0 111.521 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.79 -40.94 83.9 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.068 0.395 . . . . 0.0 110.823 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.53 -51.86 67.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.276 0.63 . . . . 0.0 109.875 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.24 -40.42 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.213 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.61 -44.93 93.25 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.854 0.752 . . . . 0.0 110.258 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.5 mtm -71.33 -37.38 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.489 0.586 . . . . 0.0 111.305 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.94 -34.6 76.91 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.131 0.878 . . . . 0.0 110.711 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.42 88.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.901 0.48 . . . . 0.0 110.145 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.11 -49.24 76.67 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.729 0.811 . . . . 0.0 110.622 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -4.97 20.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.57 4.07 15.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.683 1.593 . . . . 0.0 111.807 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 11.4 mmpt? 43.45 38.76 1.91 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.5 1.52 . . . . 0.0 112.078 -172.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.29 165.54 20.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 157.28 43.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.71 1.204 . . . . 0.0 107.851 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.76 -152.13 22.43 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 119.231 0.923 . . . . 0.0 111.598 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -150.66 166.6 29.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.971 -0.723 . . . . 0.0 112.839 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 146.42 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.277 1.431 . . . . 0.0 108.669 171.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -142.96 160.57 40.09 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.014 0.925 . . . . 0.0 109.063 168.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.47 110.89 14.44 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -85.77 155.67 20.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.403 1.081 . . . . 0.0 110.662 -154.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.54 -28.34 69.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.702 0.401 . . . . 0.0 111.804 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.59 -5.34 32.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.017 0.927 . . . . 0.0 113.259 175.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.11 -16.37 46.12 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.629 1.109 . . . . 0.0 113.532 172.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -87.66 152.78 21.89 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.047 1.423 . . . . 0.0 110.002 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.7 147.82 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 162.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -137.7 139.81 40.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -140.45 146.58 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -170.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.37 124.04 25.1 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 166.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.05 150.29 46.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -140.11 138.21 35.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 108.082 -170.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.47 -171.48 39.97 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.72 152.93 64.71 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.291 1.994 . . . . 0.0 110.413 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.05 -40.89 91.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.385 0.674 . . . . 0.0 111.65 -171.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -65.3 -37.86 88.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.74 0.7 . . . . 0.0 111.97 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.29 81.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.26 -37.53 87.81 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.361 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.94 -47.54 82.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.169 0.895 . . . . 0.0 110.581 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.41 -37.52 83.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.105 0.562 . . . . 0.0 110.848 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.12 -45.38 81.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.389 1.076 . . . . 0.0 110.521 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.2 t -56.08 -49.5 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.345 0.975 . . . . 0.0 109.235 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.08 -42.22 69.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 110.863 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.4 74.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.503 0.721 . . . . 0.0 111.442 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.33 -24.6 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -57.54 -33.99 68.69 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.445 1.475 . . . . 0.0 111.042 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -83.2 -42.78 16.87 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.364 0.529 . . . . 0.0 111.053 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.6 -167.06 54.84 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -165.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.0 p -59.94 165.04 5.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.178 0.489 . . . . 0.0 110.319 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.13 -12.68 27.74 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.009 1.806 . . . . 0.0 113.22 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -98.51 -14.77 19.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.143 0.977 . . . . 0.0 111.768 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -71.61 163.46 27.7 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.88 0.872 . . . . 0.0 111.022 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -142.2 94.91 2.72 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.06 145.39 11.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.2 p -126.01 -18.72 4.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.311 1.045 . . . . 0.0 111.063 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -152.62 149.46 28.47 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.364 1.065 . . . . 0.0 109.264 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.6 tt -151.84 145.18 16.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.025 1.33 . . . . 0.0 107.807 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 m -141.71 154.04 45.04 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.286 1.434 . . . . 0.0 108.709 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.2 t -137.72 145.42 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.661 1.184 . . . . 0.0 107.852 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.07 164.27 28.41 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.661 1.985 . . . . 0.0 106.083 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.59 169.61 17.25 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.981 -1.074 . . . . 0.0 111.014 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.5 m -140.39 135.59 32.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -76.67 -28.87 56.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 119.099 -0.476 . . . . 0.0 110.245 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.5 m -73.42 165.54 24.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 161.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.41 162.89 38.67 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 109.88 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.92 -40.33 47.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.54 0.736 . . . . 0.0 109.468 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.06 50.82 3.76 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.14 150.84 10.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.683 0.793 . . . . 0.0 110.498 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -91.21 -31.26 16.23 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.612 0.765 . . . . 0.0 112.81 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -147.03 -179.38 6.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.941 1.696 . . . . 0.0 107.956 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.63 134.9 52.89 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -135.11 139.49 44.72 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 73.9 mt -75.75 133.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 162.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.19 172.48 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.272 1.429 . . . . 0.0 108.542 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -137.06 11.41 3.07 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -162.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.201 1.4 . . . . 0.0 107.68 -177.732 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.861 -0.052 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.7 tp -130.42 163.91 25.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.012 1.325 . . . . 0.0 109.297 -169.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -129.37 142.15 50.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.228 1.011 . . . . 0.0 108.437 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.14 155.89 33.51 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.746 1.618 . . . . 0.0 108.38 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm-85 -120.01 140.06 51.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 158.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.2 mt -130.85 143.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.1 mm -126.72 141.98 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.93 146.17 27.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.1 157.69 45.81 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.553 1.141 . . . . 0.0 109.477 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.45 -158.97 23.95 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.479 1.514 . . . . 0.0 109.643 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -74.0 89.2 1.91 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 159.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.25 15.91 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.484 0.713 . . . . 0.0 111.701 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -138.14 149.0 45.49 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.75 32.4 74.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.42 6.72 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.726 1.61 . . . . 0.0 111.314 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.63 21.2 60.31 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.518 1.056 . . . . 0.0 110.529 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.77 -43.91 91.72 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.392 1.096 . . . . 0.0 110.495 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -65.74 -40.76 92.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.134 0.879 . . . . 0.0 111.15 -177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.02 -41.95 90.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.658 0.663 . . . . 0.0 110.6 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -56.64 -49.8 73.93 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.821 0.737 . . . . 0.0 110.005 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.73 -39.85 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.102 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.5 -41.01 93.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.804 1.184 . . . . 0.0 110.491 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.96 -35.68 72.26 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 111.103 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -72.43 -21.82 61.2 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.171 -0.956 . . . . 0.0 112.038 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.68 -46.41 46.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.94 -37.58 87.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.226 1.01 . . . . 0.0 112.255 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -17.64 42.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -130.29 21.53 5.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.133 0.973 . . . . 0.0 110.747 173.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 28.61 54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.868 2.867 . . . . 0.0 113.763 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.14 165.86 15.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.391 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.3 164.48 23.44 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.635 1.574 . . . . 0.0 108.039 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.42 -150.98 23.3 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.68 0.673 . . . . 0.0 112.783 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -151.32 169.8 21.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.68 1.192 . . . . 0.0 110.295 162.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.1 144.66 34.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.855 1.662 . . . . 0.0 107.726 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.01 146.64 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.384 1.074 . . . . 0.0 109.251 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -83.93 120.9 26.65 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 161.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -73.88 149.37 41.55 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.05 -23.65 67.54 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.6 0.36 . . . . 0.0 111.684 172.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.38 -21.07 61.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.466 1.506 . . . . 0.0 112.97 172.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.49 -16.15 52.67 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.56 1.076 . . . . 0.0 112.395 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -71.93 170.44 13.76 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 110.581 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.98 150.84 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 165.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.25 146.13 49.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.66 146.45 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -143.41 116.36 8.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.23 44.07 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.692 0.678 . . . . 0.0 111.911 -162.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -135.0 132.61 38.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.801 2.041 . . . . 0.0 107.551 -166.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.94 -177.49 41.02 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.59 152.74 74.53 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.233 1.955 . . . . 0.0 110.184 173.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.35 -33.87 73.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.96 -35.19 69.48 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.963 -1.086 . . . . 0.0 111.579 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -40.31 70.79 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.36 0.264 . . . . 0.0 110.604 176.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.1 mp -58.79 -40.13 83.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.745 0.818 . . . . 0.0 110.552 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -65.32 -49.27 70.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.468 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 p -62.02 -34.16 75.69 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.559 1.527 . . . . 0.0 111.264 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -63.93 -47.03 82.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.677 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.3 t -57.21 -47.15 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.309 0.958 . . . . 0.0 109.462 173.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.8 -41.54 77.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.404 0.682 . . . . 0.0 110.555 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.89 -42.09 77.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.216 0.606 . . . . 0.0 111.84 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.62 -31.52 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 118.341 -0.837 . . . . 0.0 110.635 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -58.55 -36.2 73.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.991 1.269 . . . . 0.0 111.159 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.32 -43.07 71.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.939 0.336 . . . . 0.0 110.548 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.22 -178.29 30.76 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.848 0.737 . . . . 0.0 111.666 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.4 p -63.53 159.33 52.28 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 0.0 110.622 177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.17 -26.17 25.58 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.519 2.813 . . . . 0.0 115.333 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.28 -7.39 24.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 112.198 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.7 p -74.84 167.68 21.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.575 0.702 . . . . 0.0 110.863 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -139.39 77.86 1.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -59.51 140.07 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.4 p -123.65 -21.29 5.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.415 1.086 . . . . 0.0 111.547 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.23 154.86 31.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.886 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.08 145.88 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.564 1.546 . . . . 0.0 107.53 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -141.15 157.4 45.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.33 1.452 . . . . 0.0 109.123 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.54 145.63 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.803 1.241 . . . . 0.0 108.738 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 m -136.52 166.05 24.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.329 2.251 . . . . 0.0 106.095 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.2 163.56 33.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.633 -1.292 . . . . 0.0 111.287 -174.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.6 m -148.14 146.91 28.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.279 1.832 . . . . 0.0 108.284 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -81.64 -34.13 31.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.055 -0.403 . . . . 0.0 110.693 172.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.4 m -65.61 155.96 34.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.001 0.921 . . . . 0.0 109.679 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 164.52 37.95 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.536 1.535 . . . . 0.0 108.831 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -80.98 -34.65 32.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.877 0.762 . . . . 0.0 110.947 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.82 21.53 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.192 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . 0.251 30.1 p80 47.07 42.54 12.93 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.891 2.077 . . . . 0.0 114.188 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.52 -49.98 35.73 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.24 173.76 12.96 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.337 1.455 . . . . 0.0 109.458 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -122.65 100.11 6.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.584 1.084 . . . . 0.0 109.637 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 136.89 35.32 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.919 0.488 . . . . 0.0 110.766 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.6 mt -84.72 126.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 153.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 100.0 t -87.77 117.4 31.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -84.43 52.26 2.31 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.598 1.159 . . . . 0.0 110.683 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.662 -1.161 . . . . 0.0 109.452 165.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpt . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.6 tp -153.37 164.88 37.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.563 1.145 . . . . 0.0 109.409 -172.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -117.87 138.27 52.23 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.661 1.584 . . . . 0.0 107.697 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -114.65 155.54 26.39 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.072 1.349 . . . . 0.0 107.36 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -127.51 140.95 51.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 162.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.05 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.08 137.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -171.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -142.76 156.75 45.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.769 1.228 . . . . 0.0 110.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.67 -155.85 24.44 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.509 1.528 . . . . 0.0 110.082 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -74.35 82.25 1.9 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 159.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.96 21.87 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.884 1.274 . . . . 0.0 110.201 -174.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -137.72 149.79 46.77 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.503 1.121 . . . . 0.0 108.358 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.62 74.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.591 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.78 -10.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.376 1.071 . . . . 0.0 111.949 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 23.34 13.69 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.124 1.345 . . . . 0.0 110.243 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.16 -39.14 93.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.506 1.653 . . . . 0.0 110.48 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -55.51 -47.36 76.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.757 0.708 . . . . 0.0 111.448 171.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -68.01 -39.08 83.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.411 0.551 . . . . 0.0 111.291 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -56.29 -54.16 48.66 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 173.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.38 -39.64 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.388 0.54 . . . . 0.0 110.461 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -56.22 -47.52 78.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 0.0 109.943 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.6 mtm -73.78 -34.96 64.89 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.447 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.37 -43.85 93.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.503 1.047 . . . . 0.0 109.869 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.76 92.15 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.227 0.467 . . . . 0.0 110.727 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.21 -47.7 84.86 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.753 0.821 . . . . 0.0 110.304 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -61.2 -41.97 97.77 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.859 0.863 . . . . 0.0 111.007 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -74.98 -3.71 33.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.811 0.844 . . . . 0.0 112.37 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 49.52 35.17 7.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.098 1.759 . . . . 0.0 112.251 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.37 170.68 16.25 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 110.158 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.29 153.49 46.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.349 1.46 . . . . 0.0 107.583 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.15 -155.85 26.72 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.762 1.164 . . . . 0.0 113.67 -171.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.46 165.99 25.99 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.301 0.64 . . . . 0.0 112.542 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.4 144.65 36.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.819 1.248 . . . . 0.0 107.759 161.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.32 158.65 43.46 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.464 1.106 . . . . 0.0 108.265 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.74 118.51 25.73 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -94.13 153.5 18.07 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.829 0.852 . . . . 0.0 110.421 -155.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.48 -29.09 70.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.606 0.362 . . . . 0.0 111.953 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.87 -9.79 47.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.49 -19.63 26.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.441 1.019 . . . . 0.0 113.321 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -83.75 154.73 23.43 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.674 1.237 . . . . 0.0 109.995 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.95 150.64 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 162.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -132.06 141.43 49.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -135.26 144.1 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -134.25 126.01 28.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.5 149.43 48.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -137.11 130.8 31.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.35 -173.54 43.71 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -170.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.85 149.19 59.56 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.481 2.12 . . . . 0.0 110.031 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.97 -34.16 71.49 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.121 0.969 . . . . 0.0 111.939 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.16 -40.52 82.33 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.035 -1.041 . . . . 0.0 111.673 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -41.28 83.36 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.52 -41.58 96.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.05 -49.79 76.26 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.444 0.565 . . . . 0.0 110.362 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 m -65.22 -29.66 70.48 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.961 -0.462 . . . . 0.0 111.446 -177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -68.58 -45.17 72.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.403 1.081 . . . . 0.0 110.461 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.8 -49.18 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.641 1.11 . . . . 0.0 109.038 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -56.86 -41.69 78.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.763 0.825 . . . . 0.0 110.608 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.36 -48.13 74.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.827 0.451 . . . . 0.0 111.553 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.97 -30.15 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.838 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -59.05 -23.33 61.91 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.127 1.33 . . . . 0.0 112.191 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -68.25 -34.87 77.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.6 0.636 . . . . 0.0 111.582 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.36 171.9 3.41 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.252 0.93 . . . . 0.0 112.082 -164.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 157.59 65.71 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 121.88 -0.776 . . . . 0.0 110.157 171.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.69 -31.69 61.77 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.123 2.549 . . . . 0.0 113.66 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.46 1.92 39.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.52 1.528 . . . . 0.0 112.759 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 m -128.03 167.11 17.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.854 0.862 . . . . 0.0 110.759 -158.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -146.19 92.95 2.25 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.87 142.78 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 161.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.6 p -128.47 -17.03 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.958 1.303 . . . . 0.0 111.226 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -150.39 148.73 29.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 108.918 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.26 143.85 13.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.653 1.181 . . . . 0.0 107.919 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -142.97 154.46 44.06 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.263 1.425 . . . . 0.0 108.656 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.83 145.73 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.517 1.127 . . . . 0.0 108.293 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.33 162.6 32.57 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.892 2.077 . . . . 0.0 106.686 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -134.66 157.87 45.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.596 1.158 . . . . 0.0 109.759 -172.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -160.06 162.99 34.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.12 1.368 . . . . 0.0 109.623 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -120.05 -12.86 9.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.954 0.902 . . . . 0.0 111.561 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.8 m -78.25 68.6 4.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.436 1.095 . . . . 0.0 109.507 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.67 148.27 7.48 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.226 1.011 . . . . 0.0 111.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -71.65 -35.09 70.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.252 1.021 . . . . 0.0 109.335 163.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.76 44.73 3.84 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.356 0.979 . . . . 0.0 111.149 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -60.46 157.29 14.33 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.494 0.718 . . . . 0.0 110.612 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.22 -6.19 5.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.57 1.148 . . . . 0.0 111.901 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.75 171.12 14.54 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.447 1.899 . . . . 0.0 106.833 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -117.19 135.38 53.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -138.91 144.63 39.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.51 141.04 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -134.28 154.56 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.765 2.026 . . . . 0.0 106.607 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -133.55 13.17 4.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.113 0.965 . . . . 0.0 111.883 -164.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.529 1.532 . . . . 0.0 107.921 -174.964 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.5 mtp . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.05 151.0 43.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 108.887 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -114.92 140.43 49.0 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -124.93 154.95 40.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.317 1.447 . . . . 0.0 108.938 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.34 138.67 52.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 159.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.79 143.38 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 mm -129.58 138.15 54.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.59 147.85 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -143.29 156.75 44.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.519 1.128 . . . . 0.0 110.027 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.65 -154.23 23.55 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.481 1.515 . . . . 0.0 110.138 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.63 89.37 1.31 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 158.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.62 18.46 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.997 0.919 . . . . 0.0 111.392 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -138.81 153.82 48.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.137 0.975 . . . . 0.0 109.186 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.24 32.17 81.34 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -133.47 -8.0 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 111.695 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.81 24.5 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.67 -44.5 85.77 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.424 1.612 . . . . 0.0 109.882 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -53.89 -49.55 68.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.611 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -61.78 -49.05 77.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.355 0.525 . . . . 0.0 110.681 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -62.89 -41.77 99.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.082 0.401 . . . . 0.0 110.855 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.98 -40.8 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.909 0.777 . . . . 0.0 110.249 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -59.91 -48.4 81.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.224 0.92 . . . . 0.0 109.531 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.9 ptm -70.81 -32.03 68.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.316 0.507 . . . . 0.0 111.67 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -69.48 -28.24 65.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.458 1.026 . . . . 0.0 111.84 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.4 -44.35 52.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.932 0.493 . . . . 0.0 109.833 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.42 -42.15 98.3 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 123.967 0.907 . . . . 0.0 111.291 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -6.54 35.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -113.06 2.27 15.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.871 1.668 . . . . 0.0 111.34 171.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.28 38.45 5.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.537 1.535 . . . . 0.0 112.037 -169.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.75 165.68 14.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.76 156.5 44.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.516 1.127 . . . . 0.0 108.011 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.79 -154.79 26.16 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.223 0.919 . . . . 0.0 112.692 -170.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -145.92 167.53 23.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.102 -0.646 . . . . 0.0 112.625 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.48 145.68 30.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.775 1.23 . . . . 0.0 108.456 167.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.71 160.16 40.75 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 108.045 170.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -125.9 113.54 17.34 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -86.48 153.25 22.0 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.236 1.014 . . . . 0.0 110.193 -157.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -29.47 70.45 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.631 0.372 . . . . 0.0 111.878 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.99 -9.24 43.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.97 -20.2 26.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.505 1.05 . . . . 0.0 113.331 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.3 mtm180 -80.03 154.66 28.02 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.692 1.246 . . . . 0.0 110.045 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.88 150.67 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 161.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -134.07 142.33 47.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -139.61 150.07 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -134.7 128.81 33.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.25 44.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.12 0.873 . . . . 0.0 109.412 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -140.41 136.09 32.73 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 107.881 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.46 43.24 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.962 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.3 138.32 42.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.267 1.978 . . . . 0.0 109.411 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.54 -30.37 67.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 113.018 -168.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -69.75 -46.53 65.65 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.763 -1.211 . . . . 0.0 111.647 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.19 -39.02 89.37 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 tp -61.53 -47.73 84.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.156 0.982 . . . . 0.0 110.167 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -60.14 -44.41 94.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.75 0.42 . . . . 0.0 110.872 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m -62.48 -38.6 90.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.495 0.589 . . . . 0.0 111.179 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -61.28 -44.7 96.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.518 -0.739 . . . . 0.0 110.161 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.4 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.542 1.065 . . . . 0.0 110.15 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -55.5 -39.55 70.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.671 1.123 . . . . 0.0 110.495 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.73 82.73 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.171 0.588 . . . . 0.0 111.471 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.33 -31.41 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.758 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -61.64 -33.36 73.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.054 1.297 . . . . 0.0 111.533 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -71.58 -45.35 62.47 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.704 0.684 . . . . 0.0 109.999 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.39 -156.77 34.0 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -170.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.9 p -62.04 168.83 3.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 122.699 0.4 . . . . 0.0 110.573 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.35 -10.08 1.97 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.53 2.82 . . . . 0.0 114.763 165.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -124.04 -0.77 8.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.263 1.425 . . . . 0.0 111.799 -171.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -77.18 166.22 23.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.082 0.953 . . . . 0.0 112.006 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -142.75 88.38 2.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 159.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.02 142.19 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -123.77 -18.32 6.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.287 1.035 . . . . 0.0 111.091 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -153.3 149.87 28.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.276 1.031 . . . . 0.0 109.241 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.74 144.22 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -139.75 152.22 46.45 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.122 1.369 . . . . 0.0 108.566 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -136.45 145.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.724 1.209 . . . . 0.0 108.169 -176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -132.3 160.35 36.5 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 167.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.43 161.75 37.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.281 0.946 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 m -142.84 124.79 15.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.86 11.77 3.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.76 0.824 . . . . 0.0 112.234 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -138.39 143.69 39.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.992 1.717 . . . . 0.0 106.936 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 mt -84.49 159.17 20.79 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.824 0.45 . . . . 0.0 110.658 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.02 -37.67 38.56 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 156.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 50.14 1.59 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.229 0.918 . . . . 0.0 111.386 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -58.01 144.89 38.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.524 0.729 . . . . 0.0 110.191 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -86.59 -28.2 23.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.246 0.618 . . . . 0.0 112.193 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -151.97 -178.75 6.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.783 1.633 . . . . 0.0 108.808 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -114.28 127.82 56.06 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -132.65 139.87 47.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.563 0.696 . . . . 0.0 112.464 -166.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.1 mt -76.7 131.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 0.0 109.142 -178.087 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.8 mt -136.7 170.52 15.94 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.673 1.589 . . . . 0.0 108.266 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -117.96 138.85 51.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 106.335 166.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.58 155.68 28.3 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.265 1.426 . . . . 0.0 107.304 167.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -124.48 139.66 53.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 162.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 mt -134.36 140.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.87 139.49 51.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.0 144.2 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -138.11 156.16 48.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.809 1.244 . . . . 0.0 110.033 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.43 -154.54 22.51 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.416 1.484 . . . . 0.0 110.44 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -72.55 82.65 1.11 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.8 m -135.07 18.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.274 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -137.01 146.86 45.8 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.949 0.9 . . . . 0.0 108.653 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.6 33.13 83.58 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -134.7 -9.23 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.702 1.201 . . . . 0.0 111.824 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.12 20.58 15.59 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.217 1.389 . . . . 0.0 110.468 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.59 -41.86 98.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.995 1.398 . . . . 0.0 110.43 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -54.48 -49.0 71.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.789 0.722 . . . . 0.0 111.473 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -66.75 -42.04 86.83 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.308 0.504 . . . . 0.0 111.231 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.22 -51.67 67.24 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.082 0.553 . . . . 0.0 110.22 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.68 -41.5 88.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.091 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -58.44 -45.53 88.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.797 0.726 . . . . 0.0 109.902 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.4 mtm -74.01 -33.85 63.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.743 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -66.67 -40.14 88.46 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.867 1.212 . . . . 0.0 110.249 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.17 97.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.172 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.81 -44.49 93.97 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.761 0.824 . . . . 0.0 110.832 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -58.89 -41.22 86.66 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.253 1.021 . . . . 0.0 111.182 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -86.22 0.93 52.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.371 -0.823 . . . . 0.0 113.161 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mptt 49.67 37.15 12.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.572 1.549 . . . . 0.0 111.933 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.87 165.71 22.66 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.837 0.855 . . . . 0.0 109.584 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.85 165.02 14.16 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.522 1.129 . . . . 0.0 108.058 165.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.84 -154.39 24.81 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 118.856 0.753 . . . . 0.0 112.335 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -153.81 167.59 29.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 112.049 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -137.07 145.2 30.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 108.796 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -140.44 164.52 29.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.258 1.023 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.2 109.19 12.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -76.15 152.93 36.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.473 0.709 . . . . 0.0 111.056 -157.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.28 -27.58 69.43 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.884 0.474 . . . . 0.0 111.25 164.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -14.58 19.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.323 1.849 . . . . 0.0 112.853 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -9.01 50.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.125 0.869 . . . . 0.0 113.165 167.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -104.91 156.09 18.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.592 1.157 . . . . 0.0 109.226 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.45 147.27 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 168.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -133.28 135.56 44.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -136.46 146.07 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -172.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 tt -135.87 126.96 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 167.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.04 152.34 49.97 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.644 0.778 . . . . 0.0 109.339 -172.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -141.17 133.93 28.81 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.67 1.188 . . . . 0.0 107.949 -169.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.93 -171.46 40.34 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.547 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.29 156.88 54.49 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.798 2.332 . . . . 0.0 110.666 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -58.54 -44.8 89.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.588 0.755 . . . . 0.0 111.124 -173.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.74 -39.53 89.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.89 0.768 . . . . 0.0 111.928 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.62 -47.51 72.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.7 -38.82 92.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.1 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.5 -51.95 66.53 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.62 0.768 . . . . 0.0 110.184 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 m -62.15 -38.93 90.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.418 0.554 . . . . 0.0 110.893 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.19 -44.06 97.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.109 0.964 . . . . 0.0 110.403 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 t -57.81 -47.98 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.325 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.63 -40.47 75.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.663 1.12 . . . . 0.0 111.18 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.1 82.69 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.141 0.576 . . . . 0.0 110.882 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.5 t -63.28 -28.09 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.035 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -59.32 -37.67 78.36 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.563 1.528 . . . . 0.0 110.921 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.08 -42.77 56.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.222 0.465 . . . . 0.0 110.421 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.64 -174.18 51.04 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.54 160.09 28.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.076 0.55 . . . . 0.0 110.588 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.16 -32.9 51.84 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.124 2.549 . . . . 0.0 113.771 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -88.43 -7.31 56.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.66 1.184 . . . . 0.0 112.763 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -91.91 168.75 11.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.943 1.297 . . . . 0.0 110.725 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -145.24 95.86 2.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 165.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.6 t -63.79 145.19 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.7 p -123.11 -21.85 5.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.311 1.044 . . . . 0.0 111.192 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -154.79 153.12 30.71 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.149 0.98 . . . . 0.0 109.469 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.78 146.0 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.352 1.461 . . . . 0.0 107.402 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.5 m -139.37 151.01 45.99 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.153 1.381 . . . . 0.0 108.369 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.15 145.41 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.403 1.081 . . . . 0.0 108.239 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -136.32 161.03 36.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 106.173 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -149.28 163.18 38.42 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.131 -0.981 . . . . 0.0 111.527 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -149.17 148.23 29.38 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.583 1.953 . . . . 0.0 108.536 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -72.58 -40.54 66.51 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.038 168.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 m -61.63 145.24 52.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.937 0.895 . . . . 0.0 109.13 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.6 157.16 42.67 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.527 1.531 . . . . 0.0 108.645 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.12 -33.39 56.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.695 0.798 . . . . 0.0 110.114 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.45 49.51 14.81 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -169.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -54.72 151.06 8.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.101 0.96 . . . . 0.0 111.789 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -76.51 -19.36 58.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -150.54 178.3 9.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.656 1.582 . . . . 0.0 108.415 -172.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.38 116.42 31.94 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 153.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.7 m -117.18 142.31 47.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 111.996 -167.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.16 135.57 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 162.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 124.926 1.29 . . . . 0.0 108.303 179.543 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.5 mt -137.83 -179.96 6.07 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.004 1.322 . . . . 0.0 109.5 -167.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -130.55 132.14 45.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.648 1.979 . . . . 0.0 107.229 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.67 155.48 28.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -120.42 143.81 48.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 158.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.0 mt -132.72 142.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mm -131.35 136.79 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.1 147.64 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.32 156.93 44.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.56 -153.93 23.89 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.383 1.468 . . . . 0.0 110.374 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -72.38 84.75 1.09 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.02 19.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.101 0.96 . . . . 0.0 110.994 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -138.54 149.18 45.06 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 109.053 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.38 31.27 79.83 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -134.7 -9.85 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.654 1.181 . . . . 0.0 111.731 -173.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.78 22.79 17.18 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.932 1.253 . . . . 0.0 110.119 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -64.08 -39.6 94.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.239 1.52 . . . . 0.0 110.243 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -55.51 -46.19 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.904 0.774 . . . . 0.0 111.695 172.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -68.58 -40.39 80.57 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.508 0.594 . . . . 0.0 111.108 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -56.03 -51.65 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.388 0.54 . . . . 0.0 110.151 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.21 -41.35 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 118.954 -0.546 . . . . 0.0 110.211 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.79 -46.13 88.27 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.826 0.739 . . . . 0.0 110.329 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.9 mtm -72.62 -35.97 67.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.347 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -67.0 -39.36 87.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.677 1.126 . . . . 0.0 110.292 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.32 97.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.177 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.31 -45.05 93.17 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.389 0.676 . . . . 0.0 110.685 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -59.48 -33.85 71.84 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.902 0.881 . . . . 0.0 111.311 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -89.7 1.73 55.69 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.675 1.19 . . . . 0.0 112.839 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm 41.33 38.88 0.88 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.115 2.166 . . . . 0.0 112.503 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.06 165.75 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.816 0.846 . . . . 0.0 109.406 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.19 14.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 162.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.49 -163.53 29.27 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.881 0.764 . . . . 0.0 113.332 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -147.01 166.4 26.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 122.214 -0.58 . . . . 0.0 111.623 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.76 144.06 34.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.526 1.13 . . . . 0.0 109.047 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -139.25 161.94 36.2 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.48 1.112 . . . . 0.0 108.653 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -125.54 111.43 15.03 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.28 153.08 23.76 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.799 1.239 . . . . 0.0 110.383 -157.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.77 -29.32 70.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.94 -10.29 52.17 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.47 -22.62 17.08 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.427 1.013 . . . . 0.0 113.292 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -78.28 154.76 30.66 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.67 1.235 . . . . 0.0 110.327 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.61 148.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.07 135.02 43.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.57 143.15 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.72 125.28 22.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.88 43.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.65 0.78 . . . . 0.0 110.121 -171.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -139.09 143.52 38.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.822 1.249 . . . . 0.0 108.138 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.89 -171.8 39.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.321 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 152.61 57.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.687 2.258 . . . . 0.0 110.712 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.94 -34.52 76.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.62 0.768 . . . . 0.0 112.133 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.22 -40.4 77.99 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.025 -1.047 . . . . 0.0 111.476 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.83 85.74 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.95 -42.19 90.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.968 0.507 . . . . 0.0 110.621 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.98 -51.58 69.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.797 0.726 . . . . 0.0 110.789 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 p -66.45 -31.67 72.56 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.871 -0.518 . . . . 0.0 111.316 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.22 -43.35 99.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.72 171.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.54 -49.56 80.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 119.539 1.063 . . . . 0.0 108.744 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.81 -39.25 73.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.395 0.998 . . . . 0.0 111.464 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.13 -44.12 85.13 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 110.61 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.36 -30.87 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.455 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -59.49 -45.84 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.873 1.67 . . . . 0.0 109.988 172.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.3 -38.48 85.05 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.58 0.352 . . . . 0.0 111.27 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 177.06 27.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.113 0.863 . . . . 0.0 112.041 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.48 153.17 90.83 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.278 -0.542 . . . . 0.0 110.589 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.65 -31.48 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.195 2.597 . . . . 0.0 114.16 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -92.13 10.79 27.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.988 1.315 . . . . 0.0 111.991 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -128.58 169.07 14.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.417 1.487 . . . . 0.0 109.882 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -147.02 96.18 2.69 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.66 140.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.8 p -126.93 -14.17 5.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 111.268 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.51 150.63 29.79 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 109.17 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.86 147.7 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.866 1.266 . . . . 0.0 107.846 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -143.6 161.58 38.13 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.521 1.528 . . . . 0.0 108.753 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.6 t -138.39 149.23 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.609 1.164 . . . . 0.0 108.141 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.36 161.78 33.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.548 1.939 . . . . 0.0 106.189 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -140.79 158.09 44.47 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 120.943 -1.098 . . . . 0.0 111.034 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 m -134.92 138.27 43.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 156.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -89.44 24.09 2.36 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.207 -0.933 . . . . 0.0 111.171 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -142.12 179.27 7.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.822 2.449 . . . . 0.0 106.973 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -144.92 156.32 43.92 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.528 1.131 . . . . 0.0 109.405 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.8 -5.13 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -164.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.21 -3.1 0.79 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 120.036 1.289 . . . . 0.0 115.125 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -48.76 113.6 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.761 1.624 . . . . 0.0 112.126 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -150.93 -49.1 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.372 1.069 . . . . 0.0 111.115 173.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -152.92 -179.57 7.78 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 108.976 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -115.65 137.5 52.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -139.74 139.84 36.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.62 137.59 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 163.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 125.048 1.339 . . . . 0.0 108.316 179.799 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt -139.01 166.35 24.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.751 1.621 . . . . 0.0 108.953 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -112.15 138.61 48.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.606 1.563 . . . . 0.0 106.921 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -119.16 154.91 32.56 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.721 1.608 . . . . 0.0 107.051 166.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -127.9 138.73 52.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 165.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.64 143.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mm -131.68 136.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.91 150.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -143.57 158.28 43.78 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.981 1.313 . . . . 0.0 109.65 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.65 -155.54 24.86 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.436 1.493 . . . . 0.0 110.094 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -75.91 87.36 2.87 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 159.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.11 19.81 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.846 0.859 . . . . 0.0 111.282 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.68 151.97 46.34 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.365 1.066 . . . . 0.0 108.146 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.33 32.12 82.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.78 -1.63 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.513 1.525 . . . . 0.0 111.435 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.68 25.58 34.98 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.457 -1.191 . . . . 0.0 110.127 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.9 -47.5 80.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.268 1.534 . . . . 0.0 109.935 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -62.83 -41.12 99.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.038 0.835 . . . . 0.0 110.64 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -61.97 -45.19 94.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.764 0.425 . . . . 0.0 110.705 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -58.72 -51.02 71.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.242 0.617 . . . . 0.0 110.177 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.96 -39.45 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.219 0.463 . . . . 0.0 110.493 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -58.81 -47.13 85.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.931 0.787 . . . . 0.0 110.55 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -77.11 -30.75 55.39 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.903 0.774 . . . . 0.0 111.719 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.05 -31.65 69.37 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.194 0.906 . . . . 0.0 111.027 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.69 71.19 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.282 0.492 . . . . 0.0 109.885 168.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.71 -42.98 99.67 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.53 0.732 . . . . 0.0 111.571 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -12.6 60.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -115.36 8.0 15.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.678 1.191 . . . . 0.0 111.633 171.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 41.91 42.18 2.17 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.463 1.905 . . . . 0.0 112.52 -173.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.61 166.03 7.38 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.212 0.605 . . . . 0.0 109.856 166.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.85 154.41 45.51 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.63 1.172 . . . . 0.0 107.987 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.82 -161.37 28.67 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 119.282 0.946 . . . . 0.0 112.896 -171.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.55 166.81 25.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 168.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.49 146.35 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 109.281 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -147.1 163.91 34.78 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -124.86 153.9 41.88 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -123.9 151.18 43.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.289 -144.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.0 -27.19 68.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 111.117 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.5 -16.85 40.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.601 1.96 . . . . 0.0 113.135 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -28.16 15.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.93 1.729 . . . . 0.0 111.838 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.1 mtt85 -74.05 168.18 20.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.699 0.799 . . . . 0.0 111.517 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.64 150.01 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 158.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.79 140.87 46.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mt -139.04 147.0 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.08 127.0 29.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 168.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.05 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.696 0.68 . . . . 0.0 109.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.73 133.85 31.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.78 -169.35 40.08 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.592 -172.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.25 152.76 61.78 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.316 2.011 . . . . 0.0 110.216 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.21 -42.46 81.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.884 0.874 . . . . 0.0 110.93 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.57 -42.88 99.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.264 0.484 . . . . 0.0 111.574 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.56 82.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.673 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -38.34 82.1 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 110.988 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -64.91 -49.94 68.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.592 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -57.76 -39.14 76.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.209 1.368 . . . . 0.0 111.409 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.03 -46.42 84.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.903 0.881 . . . . 0.0 109.927 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 118.953 0.797 . . . . 0.0 109.822 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.06 -40.67 73.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.607 0.763 . . . . 0.0 110.538 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.56 72.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.898 0.879 . . . . 0.0 111.416 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.21 -26.29 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.187 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -57.12 -34.81 68.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.322 1.419 . . . . 0.0 111.223 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -82.12 -41.51 20.38 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.114 0.416 . . . . 0.0 111.01 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.85 -166.11 54.72 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -164.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.8 p -60.71 167.46 3.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.915 0.486 . . . . 0.0 111.451 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.45 -15.04 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.775 2.983 . . . . 0.0 115.252 168.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -115.44 -7.15 12.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.532 1.133 . . . . 0.0 111.903 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -70.74 163.67 26.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.652 0.739 . . . . 0.0 111.014 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -142.77 88.79 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 161.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.82 142.67 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 p -125.49 -18.13 5.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.403 1.081 . . . . 0.0 111.15 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.56 149.62 28.68 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.312 1.045 . . . . 0.0 109.123 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 tt -152.91 145.31 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.844 1.258 . . . . 0.0 107.936 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -142.06 152.4 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.357 1.463 . . . . 0.0 108.524 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.13 145.47 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.756 1.223 . . . . 0.0 107.895 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.91 161.8 35.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.456 1.902 . . . . 0.0 106.416 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -138.82 163.65 31.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.01 0.924 . . . . 0.0 110.364 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -154.53 147.59 24.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.342 166.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.98 -41.71 58.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 m -60.26 156.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.3 mt -129.29 149.8 50.93 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.812 1.245 . . . . 0.0 109.036 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -75.94 -34.34 59.86 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.5 0.72 . . . . 0.0 109.248 161.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 41.37 5.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.212 0.911 . . . . 0.0 111.292 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -57.77 149.06 23.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.932 0.866 . . . . 0.0 109.828 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -118.73 -6.52 10.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.41 1.084 . . . . 0.0 112.129 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -148.96 176.75 10.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.959 1.704 . . . . 0.0 107.706 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -110.72 135.95 50.53 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -136.75 139.5 41.89 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.645 0.736 . . . . 0.0 112.755 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -74.17 134.64 29.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 161.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.536 0.441 0 C-N-CA 124.343 1.057 . . . . 0.0 108.907 179.479 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.72 176.54 7.17 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.532 1.933 . . . . 0.0 107.7 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -125.31 137.0 54.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -118.87 159.06 24.46 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.031 1.732 . . . . 0.0 108.052 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -129.32 140.55 51.36 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -134.27 139.22 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -173.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.9 mm -127.29 138.83 53.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.47 146.64 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -140.5 156.92 46.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.12 1.368 . . . . 0.0 109.913 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.5 22.68 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.402 1.477 . . . . 0.0 110.193 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -73.33 82.32 1.39 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.67 19.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.763 0.825 . . . . 0.0 111.074 -171.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -137.05 147.13 45.98 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.61 33.14 86.43 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.41 -1.38 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.095 1.358 . . . . 0.0 111.238 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 26.71 34.96 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.16 -46.83 82.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.312 1.556 . . . . 0.0 109.697 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -55.91 -45.1 78.79 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.614 -0.679 . . . . 0.0 111.488 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -65.95 -43.24 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.718 0.407 . . . . 0.0 110.859 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.57 -51.7 68.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.396 0.679 . . . . 0.0 110.174 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.68 -40.83 88.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 118.329 0.513 . . . . 0.0 110.386 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.74 -43.68 85.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.494 0.718 . . . . 0.0 110.898 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.8 mtm -74.27 -37.15 63.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.62 0.646 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.2 -37.36 87.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.613 1.097 . . . . 0.0 110.312 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.36 81.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.974 0.51 . . . . 0.0 110.564 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -58.61 -44.21 89.86 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -56.26 -26.11 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.974 1.71 . . . . 0.0 112.499 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -118.93 12.17 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.405 1.082 . . . . 0.0 112.049 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 43.53 43.06 4.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.087 1.755 . . . . 0.0 112.175 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.11 165.55 9.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.879 0.472 . . . . 0.0 109.819 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.25 158.62 20.27 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 162.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.06 -160.96 27.86 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 118.687 0.676 . . . . 0.0 112.774 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.73 168.0 26.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.242 -0.563 . . . . 0.0 112.387 171.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.92 144.85 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.171 1.388 . . . . 0.0 108.63 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -143.4 160.52 40.39 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.02 112.22 16.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.5 mtp85 -85.18 155.72 21.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.818 1.247 . . . . 0.0 110.618 -154.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.89 -27.76 69.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.628 0.371 . . . . 0.0 111.882 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -6.42 38.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.924 0.89 . . . . 0.0 113.184 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.07 -15.95 46.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.485 1.041 . . . . 0.0 113.586 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -88.12 155.8 19.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.18 1.49 . . . . 0.0 109.974 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.02 149.91 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 162.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.17 153.68 51.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.972 0.891 . . . . 0.0 109.8 157.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -142.79 146.13 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -171.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.2 154.63 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.241 0.616 . . . . 0.0 109.907 -169.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -138.79 131.96 29.86 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.391 1.476 . . . . 0.0 107.376 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.72 178.79 42.31 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.34 156.18 66.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 110.24 171.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.99 -35.53 77.07 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.335 0.654 . . . . 0.0 111.979 -171.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.96 -36.57 80.32 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.924 -1.11 . . . . 0.0 111.686 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.47 72.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.66 -37.97 88.03 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.851 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.01 -50.08 75.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.76 0.709 . . . . 0.0 110.626 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 m -61.57 -37.86 85.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.515 0.598 . . . . 0.0 111.025 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -63.62 -45.66 89.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.015 0.926 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.09 -48.5 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.174 0.897 . . . . 0.0 109.526 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -56.55 -40.83 75.81 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.588 0.755 . . . . 0.0 110.548 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.26 74.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.534 0.734 . . . . 0.0 111.578 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.78 -26.98 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.201 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -57.72 -33.43 68.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.263 1.392 . . . . 0.0 111.355 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.42 -42.04 26.3 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.329 0.513 . . . . 0.0 110.949 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.33 -166.81 54.52 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -165.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.4 p -60.65 167.41 3.36 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 122.915 0.486 . . . . 0.0 111.326 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.43 -15.18 3.65 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.669 2.913 . . . . 0.0 115.175 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -114.1 -7.98 13.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.56 1.144 . . . . 0.0 111.788 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.2 m -72.03 162.99 28.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.699 0.8 . . . . 0.0 110.994 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -143.31 89.4 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 161.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.8 143.88 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.6 p -124.76 -19.36 5.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.32 1.048 . . . . 0.0 111.207 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -153.77 150.73 28.8 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 109.172 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.7 146.07 15.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.02 1.328 . . . . 0.0 107.703 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 m -140.5 152.82 45.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.154 1.382 . . . . 0.0 108.426 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.8 t -137.76 145.47 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -134.32 159.16 41.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.54 1.936 . . . . 0.0 106.042 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -145.88 167.48 23.14 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.899 0.879 . . . . 0.0 110.102 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -140.09 173.45 11.51 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.133 1.373 . . . . 0.0 109.595 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -122.82 19.39 10.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.643 1.577 . . . . 0.0 109.715 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.0 m -135.87 167.27 21.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.176 1.79 . . . . 0.0 108.178 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -134.56 163.59 29.39 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.3 -25.32 4.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.063 1.745 . . . . 0.0 109.443 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.33 56.38 6.92 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.241 0.924 . . . . 0.0 111.189 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -57.6 150.77 18.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.165 0.482 . . . . 0.0 110.455 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -68.3 -26.97 65.9 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -161.34 -173.74 3.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.835 2.054 . . . . 0.0 107.445 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -99.29 132.82 44.35 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 165.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -136.42 139.91 42.78 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -171.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.63 133.38 31.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 161.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 0.0 109.663 -179.142 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 tp -146.05 162.31 38.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.045 1.338 . . . . 0.0 109.001 -166.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.15 138.01 52.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.423 1.489 . . . . 0.0 107.449 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -119.41 156.97 29.16 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.039 1.735 . . . . 0.0 108.419 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -122.78 139.68 53.73 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.77 144.55 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.85 138.11 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.46 147.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -141.95 157.89 44.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.492 1.117 . . . . 0.0 109.991 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.61 -157.33 23.58 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.932 1.729 . . . . 0.0 109.314 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.8 ttp-105 -72.36 85.19 1.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 159.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.51 19.85 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.667 1.187 . . . . 0.0 110.263 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -137.46 143.26 41.69 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.401 -0.812 . . . . 0.0 109.36 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.09 32.37 76.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.51 -7.32 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.785 1.234 . . . . 0.0 111.089 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.96 30.24 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.33 -43.8 83.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.936 1.368 . . . . 0.0 109.758 -173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -59.74 -41.17 90.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.806 0.73 . . . . 0.0 111.705 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.25 -45.01 77.96 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.646 0.657 . . . . 0.0 110.289 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -62.72 -40.11 96.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.955 0.798 . . . . 0.0 110.909 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.2 -38.98 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.106 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.85 -42.42 99.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.215 1.371 . . . . 0.0 110.505 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.64 -38.19 83.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.251 0.932 . . . . 0.0 110.451 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -66.41 -39.67 89.14 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.48 0.712 . . . . 0.0 109.999 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.69 -38.45 91.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.668 0.787 . . . . 0.0 110.327 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.02 -45.27 86.19 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 110.696 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -60.17 -18.23 46.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.919 1.287 . . . . 0.0 112.005 174.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -111.23 7.0 21.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.828 1.651 . . . . 0.0 112.499 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 38.72 40.07 0.38 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.765 2.426 . . . . 0.0 113.271 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -74.63 169.38 17.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.498 1.119 . . . . 0.0 110.237 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.1 164.76 18.01 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 160.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.68 -150.78 23.05 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.723 0.692 . . . . 0.0 112.004 -175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -155.81 170.96 20.87 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.065 0.946 . . . . 0.0 110.855 167.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.43 139.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.516 1.526 . . . . 0.0 107.79 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.59 157.84 45.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.197 1.399 . . . . 0.0 108.85 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.85 114.42 18.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -90.92 153.98 19.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.989 0.916 . . . . 0.0 110.759 -155.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.24 -27.35 68.6 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.049 0.54 . . . . 0.0 111.997 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -7.5 40.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.044 0.938 . . . . 0.0 112.929 175.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.36 -12.86 47.94 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.69 1.138 . . . . 0.0 113.352 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -90.77 154.81 19.25 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.98 1.39 . . . . 0.0 109.603 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.7 151.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -134.49 144.72 48.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.03 145.63 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -137.03 117.67 13.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.23 151.87 46.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.407 0.683 . . . . 0.0 109.933 -165.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -140.95 137.31 32.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.531 1.132 . . . . 0.0 108.583 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 -174.11 43.33 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.27 154.47 69.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.013 1.809 . . . . 0.0 110.263 169.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.67 -41.38 90.53 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.408 0.683 . . . . 0.0 111.442 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.36 -39.59 94.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.587 0.631 . . . . 0.0 111.729 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -40.0 83.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -67.84 -36.76 80.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.076 0.398 . . . . 0.0 111.39 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -64.66 -49.19 71.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.248 0.931 . . . . 0.0 110.285 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 p -66.13 -29.38 69.67 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.729 -0.607 . . . . 0.0 111.352 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -63.66 -43.84 95.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.364 -0.827 . . . . 0.0 110.853 170.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.23 -44.09 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.827 1.194 . . . . 0.0 109.319 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.37 -36.55 78.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.136 0.88 . . . . 0.0 111.545 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.28 -50.1 55.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.804 0.442 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.61 -43.29 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.817 0.847 . . . . 0.0 109.873 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -18.8 62.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.499 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -78.24 -43.66 27.66 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.384 0.993 . . . . 0.0 110.403 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.35 -179.48 25.0 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.606 1.098 . . . . 0.0 111.636 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.5 p -74.23 166.92 40.53 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 122.13 -0.63 . . . . 0.0 109.677 168.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.44 -21.66 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.83 1.687 . . . . 0.0 112.445 170.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -73.17 -37.82 66.41 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.342 0.657 . . . . 0.0 110.338 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -71.55 167.16 20.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.106 0.962 . . . . 0.0 110.809 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -146.0 77.79 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 161.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.32 140.06 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.8 p -127.61 -16.6 4.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.935 1.294 . . . . 0.0 111.618 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -151.61 151.37 31.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.093 0.957 . . . . 0.0 109.59 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.25 149.54 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.894 1.277 . . . . 0.0 108.074 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.8 m -140.57 153.91 46.3 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.611 1.565 . . . . 0.0 108.191 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -137.57 145.18 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.413 1.085 . . . . 0.0 108.291 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.5 164.26 29.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.146 2.178 . . . . 0.0 106.056 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.33 168.76 18.98 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.835 -1.166 . . . . 0.0 111.657 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -142.35 131.97 23.97 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.53 1.932 . . . . 0.0 105.85 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -83.34 17.76 2.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.543 0.737 . . . . 0.0 111.612 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.4 m -139.77 159.75 41.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.166 2.186 . . . . 0.0 106.604 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.93 160.89 39.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.241 1.016 . . . . 0.0 110.354 -172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -78.69 -34.46 46.15 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.811 0.844 . . . . 0.0 110.296 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.57 51.4 7.28 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -55.02 153.32 6.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.267 1.027 . . . . 0.0 112.647 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -42.54 99.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.903 1.281 . . . . 0.0 112.155 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -153.9 -173.07 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 -164.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -114.49 95.5 5.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -79.99 131.33 35.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.981 0.42 . . . . 0.0 111.176 -170.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.45 115.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 154.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--O 1.238 0.485 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 169.366 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttt . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.4 mt -135.61 175.87 9.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.748 1.619 . . . . 0.0 109.526 -171.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -129.27 149.43 51.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 108.121 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -140.52 165.58 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.893 -0.504 . . . . 0.0 111.243 157.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -123.0 136.23 54.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 167.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.2 mt -134.07 144.58 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mm -130.33 138.19 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 t -137.16 145.24 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -170.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -141.58 156.94 45.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.55 1.14 . . . . 0.0 109.8 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.04 -154.08 24.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.34 1.448 . . . . 0.0 110.371 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 ttp-105 -75.65 80.31 2.63 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 162.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.16 19.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.964 0.906 . . . . 0.0 111.169 -169.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -137.44 148.55 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.096 0.958 . . . . 0.0 108.885 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.64 84.49 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.5 m -134.05 -8.01 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.978 1.311 . . . . 0.0 111.416 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.86 23.02 21.87 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.954 1.264 . . . . 0.0 110.054 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.41 -42.76 99.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 119.22 1.51 . . . . 0.0 110.336 -172.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.22 -47.0 75.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.655 0.661 . . . . 0.0 111.619 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -68.89 -41.68 77.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.402 0.546 . . . . 0.0 111.386 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -56.69 -53.03 62.41 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.981 0.513 . . . . 0.0 109.717 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.9 t -62.4 -39.23 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.391 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -57.35 -44.3 84.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.185 0.902 . . . . 0.0 110.97 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.0 mtm -76.55 -36.04 57.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.536 0.607 . . . . 0.0 111.2 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -70.46 -27.81 64.52 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.146 0.885 . . . . 0.0 111.293 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.53 -46.92 65.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.844 -0.535 . . . . 0.0 109.666 168.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.32 -45.35 93.73 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.741 0.816 . . . . 0.0 111.226 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -30.35 69.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.35 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -114.88 18.01 16.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.678 0.672 . . . . 0.0 111.186 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt 52.13 42.64 30.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.273 1.829 . . . . 0.0 112.061 171.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.15 165.66 6.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.004 0.922 . . . . 0.0 108.955 165.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.79 46.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.17 0.988 . . . . 0.0 108.4 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.93 -153.67 24.4 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 119.3 0.955 . . . . 0.0 113.002 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -143.96 165.52 27.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.072 -0.664 . . . . 0.0 112.649 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.42 145.9 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.183 1.393 . . . . 0.0 107.942 165.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -144.39 159.51 42.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.303 1.041 . . . . 0.0 108.584 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -125.88 128.73 48.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -110.55 154.35 23.84 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.733 0.413 . . . . 0.0 110.885 -150.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.75 -27.2 68.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.108 0.563 . . . . 0.0 112.089 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -7.93 42.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.174 0.99 . . . . 0.0 112.989 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.01 -9.07 50.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.73 1.157 . . . . 0.0 113.437 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -97.18 158.12 15.6 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 119.007 1.403 . . . . 0.0 109.855 -173.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.7 153.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 163.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.72 144.03 47.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -134.31 146.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -131.36 127.87 38.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 161.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . . . -136.59 154.13 50.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.32 0.964 . . . . 0.0 109.85 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -140.64 143.28 35.09 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.215 1.806 . . . . 0.0 107.197 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.35 -175.94 41.06 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.146 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.27 153.79 66.29 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.567 2.178 . . . . 0.0 109.594 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.37 -43.58 88.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.378 0.671 . . . . 0.0 111.447 -171.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.01 -43.42 98.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.801 0.728 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.35 83.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.16 -48.51 81.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.377 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -60.07 -46.95 87.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 110.415 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 m -60.49 -37.96 82.77 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.159 -0.338 . . . . 0.0 110.632 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -67.11 -36.06 81.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.694 -1.146 . . . . 0.0 110.985 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 t -58.13 -51.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 120.437 1.471 . . . . 0.0 108.51 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -56.23 -41.61 75.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.96 0.504 . . . . 0.0 110.556 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.99 82.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.338 0.655 . . . . 0.0 111.335 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.05 -35.75 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.746 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -61.67 -37.01 82.5 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.055 1.298 . . . . 0.0 110.861 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -69.3 -44.76 71.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 117.872 0.305 . . . . 0.0 110.266 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.27 -179.62 24.38 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.52 158.62 14.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.106 0.962 . . . . 0.0 111.352 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.04 -37.53 79.08 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.295 2.664 . . . . 0.0 114.394 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -78.96 -21.98 46.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.856 0.862 . . . . 0.0 112.126 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -79.99 168.41 19.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.368 1.467 . . . . 0.0 111.262 -170.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -148.17 104.61 3.56 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.72 143.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -127.35 -18.08 4.55 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.164 0.985 . . . . 0.0 111.152 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.1 150.49 29.97 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.32 145.67 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.958 1.303 . . . . 0.0 107.793 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -141.59 152.24 43.87 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.186 1.394 . . . . 0.0 108.724 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -141.23 144.03 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.718 1.207 . . . . 0.0 108.336 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -138.96 150.88 46.39 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 164.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.88 160.86 40.04 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.248 0.931 . . . . 0.0 111.768 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.1 m -148.93 148.92 30.38 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.848 1.659 . . . . 0.0 108.891 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -48.1 46.72 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 165.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m -57.24 145.13 32.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.164 1.386 . . . . 0.0 109.804 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 pp -151.1 155.21 38.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.067 1.347 . . . . 0.0 109.173 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.33 -32.82 32.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.097 0.559 . . . . 0.0 110.805 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.87 42.28 3.13 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.223 0.916 . . . . 0.0 110.882 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -53.74 136.7 39.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.742 0.771 . . . . 0.0 109.451 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.46 -20.67 23.61 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.022 0.529 . . . . 0.0 112.109 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -152.7 178.8 9.23 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.855 1.662 . . . . 0.0 108.337 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -107.9 135.37 49.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -138.21 142.9 39.96 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.9 mt -74.05 138.43 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 165.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 125.105 1.362 . . . . 0.0 108.059 176.664 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.6 tp -140.81 162.82 34.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.203 2.201 . . . . 0.0 106.835 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.4 138.7 51.65 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.664 1.186 . . . . 0.0 108.221 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -116.48 154.7 29.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.569 1.548 . . . . 0.0 108.057 165.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -122.85 139.55 53.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 158.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.96 141.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.51 140.38 49.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -136.52 147.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -141.72 157.84 44.55 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.877 1.271 . . . . 0.0 109.71 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.46 -157.65 23.03 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.89 1.709 . . . . 0.0 109.391 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -75.13 88.6 2.46 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 157.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.08 19.06 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.377 1.071 . . . . 0.0 110.751 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -139.55 152.19 46.69 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.55 42.29 99.71 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -142.35 4.67 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.751 1.62 . . . . 0.0 112.045 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.23 54.62 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.438 -1.201 . . . . 0.0 110.185 -172.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.77 -50.31 65.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.468 1.634 . . . . 0.0 110.608 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -62.63 -38.77 91.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.884 0.765 . . . . 0.0 110.521 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -66.98 -42.14 85.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.98 0.512 . . . . 0.0 111.375 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.9 -48.98 78.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.702 0.683 . . . . 0.0 109.9 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.4 t -61.93 -41.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.291 0.496 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -56.66 -47.97 78.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.92 0.782 . . . . 0.0 110.035 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.05 -37.34 69.7 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.102 -0.374 . . . . 0.0 111.158 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.22 -31.58 70.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.906 0.776 . . . . 0.0 111.222 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.13 74.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.271 0.487 . . . . 0.0 109.848 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -61.18 -47.39 86.36 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.04 0.936 . . . . 0.0 111.127 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -11.24 53.57 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -125.68 18.59 8.01 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.234 1.013 . . . . 0.0 111.071 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 tttp 45.98 36.48 3.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.952 2.101 . . . . 0.0 114.165 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.55 162.98 27.86 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.14 153.44 49.38 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.123 1.369 . . . . 0.0 107.718 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.1 -157.13 27.14 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.961 1.255 . . . . 0.0 113.519 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -144.86 166.48 25.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.609 0.764 . . . . 0.0 112.071 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.31 146.63 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.757 1.223 . . . . 0.0 108.343 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -146.24 153.53 40.71 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.75 0.82 . . . . 0.0 110.439 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -78.47 157.79 28.82 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 163.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -117.67 151.2 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.188 0.995 . . . . 0.0 108.767 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.1 -27.65 68.9 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.266 0.626 . . . . 0.0 111.888 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.57 -3.54 21.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.671 1.188 . . . . 0.0 113.135 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.11 -9.62 63.46 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.674 1.13 . . . . 0.0 112.987 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -79.36 177.09 9.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.941 1.37 . . . . 0.0 110.543 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.28 145.56 25.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -115.5 140.96 48.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mt -131.49 146.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.77 127.43 32.72 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.34 150.24 45.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.676 0.671 . . . . 0.0 109.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -138.86 133.68 32.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.779 1.631 . . . . 0.0 107.115 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.31 -169.02 38.26 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.381 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 150.11 51.51 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.557 2.172 . . . . 0.0 110.453 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.19 -32.67 72.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.707 0.803 . . . . 0.0 112.052 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.24 -40.74 90.43 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.875 -1.141 . . . . 0.0 111.477 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.88 77.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.38 -40.33 96.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.907 0.483 . . . . 0.0 110.982 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -61.95 -49.91 74.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.274 0.629 . . . . 0.0 110.993 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -61.6 -38.84 89.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.776 0.798 . . . . 0.0 110.622 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -64.12 -43.76 94.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.615 1.166 . . . . 0.0 110.549 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.16 -49.2 82.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 119.408 1.004 . . . . 0.0 109.545 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.42 -39.14 69.87 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.814 . . . . 0.0 110.802 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.94 71.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 111.387 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.65 -26.65 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.808 0.843 . . . . 0.0 111.137 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -58.27 -34.59 70.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.147 1.339 . . . . 0.0 111.283 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.52 -41.54 27.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.346 0.521 . . . . 0.0 110.735 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.46 -167.39 54.73 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -165.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -60.04 167.29 2.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.246 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -52.84 -13.1 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.696 2.931 . . . . 0.0 115.391 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.23 -5.12 10.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.685 1.194 . . . . 0.0 111.805 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -70.27 162.93 27.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.834 0.854 . . . . 0.0 111.147 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -141.76 78.01 1.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.4 142.69 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -122.9 -21.79 5.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.324 1.05 . . . . 0.0 111.162 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -154.99 153.3 30.81 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.104 0.962 . . . . 0.0 109.558 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.1 tt -151.14 145.07 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.49 1.516 . . . . 0.0 107.196 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -140.39 153.19 46.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.942 1.297 . . . . 0.0 108.448 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.4 t -137.14 145.27 30.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -134.84 159.15 42.28 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 167.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.02 160.48 42.33 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.741 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.0 m -148.45 142.14 25.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.21 1.404 . . . . 0.0 109.015 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -69.14 -43.12 75.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -59.45 145.86 42.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.55 1.14 . . . . 0.0 109.071 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.04 153.73 38.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.148 1.379 . . . . 0.0 108.399 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.81 -30.44 45.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.525 0.33 . . . . 0.0 110.526 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.74 40.6 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.81 152.42 27.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.753 0.776 . . . . 0.0 109.481 173.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -128.98 -5.65 5.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 112.08 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.76 173.09 12.69 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.743 1.617 . . . . 0.0 107.746 173.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -111.56 142.61 43.63 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -130.31 133.3 46.36 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.236 0.541 . . . . 0.0 112.17 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.56 113.77 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 156.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 157.865 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.5 tp -142.13 156.66 45.37 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.943 1.297 . . . . 0.0 108.171 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -110.37 136.66 49.2 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.566 1.546 . . . . 0.0 107.189 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -111.79 148.18 34.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 161.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -114.36 140.14 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 156.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -132.66 141.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -131.86 137.11 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 147.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -169.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -143.08 156.71 44.87 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.507 1.123 . . . . 0.0 109.94 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.67 -154.85 24.5 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.302 1.429 . . . . 0.0 110.256 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -72.18 83.63 1.02 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 159.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.51 18.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 111.1 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -138.08 148.79 45.37 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.866 0.866 . . . . 0.0 109.444 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.38 78.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.19 -9.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.226 . . . . 0.0 111.719 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.16 22.42 17.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.027 1.298 . . . . 0.0 110.153 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 -40.61 96.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.18 1.49 . . . . 0.0 110.363 -171.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -55.63 -48.2 75.34 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.848 0.749 . . . . 0.0 111.449 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -67.23 -39.56 86.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.205 0.457 . . . . 0.0 111.295 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.03 -51.85 67.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.809 0.443 . . . . 0.0 110.239 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -62.22 -39.18 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.532 0.606 . . . . 0.0 110.512 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -55.96 -49.19 74.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.643 0.777 . . . . 0.0 109.892 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.3 mtp -69.79 -39.23 76.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.984 0.357 . . . . 0.0 111.12 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.72 -32.92 73.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.789 0.722 . . . . 0.0 111.019 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.97 81.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.22 0.463 . . . . 0.0 110.235 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.66 -44.36 94.01 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.278 0.631 . . . . 0.0 110.873 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -4.07 19.75 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.369 -0.832 . . . . 0.0 113.213 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -111.37 2.36 17.55 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.321 1.448 . . . . 0.0 111.286 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 42.82 39.58 1.76 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.782 2.033 . . . . 0.0 111.945 -172.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.78 168.3 13.64 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.556 0.742 . . . . 0.0 109.512 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.96 151.27 49.33 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.15 -159.2 28.01 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.603 1.092 . . . . 0.0 113.756 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -141.73 166.01 25.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.269 0.628 . . . . 0.0 112.271 172.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.72 145.48 31.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 125.019 1.328 . . . . 0.0 108.273 164.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -141.48 161.36 38.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.997 1.319 . . . . 0.0 108.401 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -125.89 116.17 21.11 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -91.01 153.19 20.33 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.025 0.93 . . . . 0.0 110.276 -157.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.75 -29.46 70.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.674 0.39 . . . . 0.0 111.845 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.98 -9.75 48.06 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 -21.19 22.08 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.476 1.036 . . . . 0.0 113.285 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtm180 -81.02 154.33 26.94 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 118.591 1.195 . . . . 0.0 110.178 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.7 t -86.66 148.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 161.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -132.55 142.87 49.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.69 149.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.47 127.0 26.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 167.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.23 147.12 43.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.909 0.777 . . . . 0.0 109.352 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -136.89 129.33 30.03 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -170.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.93 -169.18 41.2 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.82 149.62 60.41 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.259 1.973 . . . . 0.0 110.156 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.43 -32.85 72.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.044 0.938 . . . . 0.0 111.817 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -68.56 -39.76 80.92 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.919 -1.113 . . . . 0.0 111.62 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.5 80.91 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -61.34 -43.04 99.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.83 0.852 . . . . 0.0 111.232 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -61.09 -51.53 68.74 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.004 0.522 . . . . 0.0 110.419 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 m -62.73 -35.29 79.29 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.901 -0.5 . . . . 0.0 110.956 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -65.67 -42.04 91.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.561 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.49 -43.64 87.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.044 1.293 . . . . 0.0 109.925 171.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.68 -37.72 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.418 1.008 . . . . 0.0 111.204 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.09 91.01 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.834 -0.542 . . . . 0.0 111.026 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.22 -48.07 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 118.249 -0.882 . . . . 0.0 109.247 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -68.81 -26.29 65.1 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.936 1.243 . . . . 0.0 112.571 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -60.67 -41.18 94.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.753 1.16 . . . . 0.0 110.014 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.39 170.1 33.53 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.698 1.142 . . . . 0.0 111.185 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 163.41 42.08 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 123.765 0.826 . . . . 0.0 111.188 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.23 -13.65 7.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.244 3.296 . . . . 0.0 115.731 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.15 13.71 11.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.337 1.455 . . . . 0.0 111.132 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -132.73 166.61 21.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.783 1.233 . . . . 0.0 110.141 -161.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -149.87 102.33 3.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.37 144.77 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 166.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 p -124.49 -17.5 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.422 1.089 . . . . 0.0 110.934 172.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -153.77 149.45 27.45 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.391 1.076 . . . . 0.0 109.502 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.9 tt -147.12 146.82 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.995 1.318 . . . . 0.0 107.482 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.2 m -140.7 154.69 46.46 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.484 1.513 . . . . 0.0 108.323 175.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.14 150.01 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.307 1.043 . . . . 0.0 109.66 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -136.77 160.44 38.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.264 1.826 . . . . 0.0 106.335 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.37 159.69 41.01 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.689 0.795 . . . . 0.0 110.648 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.9 m -157.98 145.17 18.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.096 1.358 . . . . 0.0 108.965 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -79.03 -32.88 45.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.247 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 m -57.54 147.8 25.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.833 0.853 . . . . 0.0 108.817 166.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.21 154.77 44.41 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.746 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.43 -35.05 61.04 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 163.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.18 36.29 4.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.604 1.097 . . . . 0.0 111.474 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -58.58 149.86 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.246 1.023 . . . . 0.0 110.289 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.32 -6.23 7.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.81 1.244 . . . . 0.0 111.781 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -140.92 169.74 17.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.535 1.934 . . . . 0.0 106.894 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -115.04 135.04 54.65 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 m -139.44 143.44 37.59 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.2 134.16 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 162.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.536 0.426 0 C-N-CA 124.582 1.153 . . . . 0.0 108.874 178.455 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.3 mt -138.81 173.1 11.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.593 1.557 . . . . 0.0 108.904 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -135.37 133.06 38.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -115.59 158.42 22.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.968 1.307 . . . . 0.0 108.091 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -120.87 144.59 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 157.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.9 mt -132.37 144.92 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.4 mm -133.1 136.9 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.32 147.48 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -172.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -141.44 154.72 45.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.153 1.381 . . . . 0.0 109.77 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.27 -154.81 25.96 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.504 1.526 . . . . 0.0 109.84 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 -76.67 79.54 3.32 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 161.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.77 19.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.016 0.926 . . . . 0.0 111.037 -171.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -136.76 146.1 45.37 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.15 32.88 85.41 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.46 -3.22 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.811 1.244 . . . . 0.0 111.722 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.17 21.81 34.34 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.526 -1.152 . . . . 0.0 110.418 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -62.71 -44.41 96.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.11 1.455 . . . . 0.0 110.044 -171.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -55.43 -49.29 72.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.765 0.711 . . . . 0.0 111.856 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -67.57 -40.9 84.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.143 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -56.13 -50.19 71.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.449 0.568 . . . . 0.0 110.053 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.5 t -60.2 -43.24 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 118.372 0.533 . . . . 0.0 110.042 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -59.27 -44.46 92.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.67 0.668 . . . . 0.0 110.389 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.1 mtt -71.82 -36.86 70.35 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.734 -0.604 . . . . 0.0 111.171 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.87 -26.12 64.04 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.555 -0.715 . . . . 0.0 111.631 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.35 -45.23 63.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.547 0.612 . . . . 0.0 109.697 165.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.28 -35.59 80.78 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.109 0.563 . . . . 0.0 112.243 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -16.93 63.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.153 0.888 . . . . 0.0 112.998 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -112.84 5.7 17.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.528 1.531 . . . . 0.0 111.072 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 42.58 41.85 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.2 1.8 . . . . 0.0 111.821 -169.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.3 mt -62.66 161.15 12.75 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.73 154.01 49.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.084 0.953 . . . . 0.0 108.496 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.7 -159.34 28.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -170.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.5 168.09 22.06 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 112.074 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.48 144.8 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.158 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -138.66 156.95 46.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.554 1.141 . . . . 0.0 108.142 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -125.19 107.94 11.26 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtp85 -82.47 154.88 24.89 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.778 1.231 . . . . 0.0 110.648 -154.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.582 0.353 . . . . 0.0 111.81 175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.8 -5.57 35.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.038 0.935 . . . . 0.0 113.154 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.91 -17.6 41.5 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.724 1.154 . . . . 0.0 113.627 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -86.07 152.87 22.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.109 1.455 . . . . 0.0 110.196 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.92 146.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 162.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.49 136.59 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.07 145.42 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.62 128.3 28.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.48 155.12 45.86 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.51 0.724 . . . . 0.0 110.471 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.21 134.09 37.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.07 1.748 . . . . 0.0 107.743 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.86 -173.18 41.45 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.716 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.95 157.1 55.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.751 2.301 . . . . 0.0 110.707 172.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.42 -44.62 89.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.552 0.741 . . . . 0.0 111.347 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.72 -39.56 91.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.795 0.725 . . . . 0.0 111.767 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.75 74.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.37 -36.56 83.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.127 0.421 . . . . 0.0 111.402 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -63.21 -47.73 81.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.08 0.854 . . . . 0.0 109.901 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.8 m -60.14 -35.94 76.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 0.0 111.18 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -64.95 -45.92 83.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.941 0.897 . . . . 0.0 110.072 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.7 t -56.7 -48.58 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.357 0.98 . . . . 0.0 109.361 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -57.18 -40.77 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 110.683 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.85 73.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.681 0.793 . . . . 0.0 111.17 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -61.68 -27.46 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.068 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -57.76 -31.44 66.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.19 1.359 . . . . 0.0 111.603 173.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -83.33 -41.91 17.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.374 0.533 . . . . 0.0 111.254 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.7 -168.91 45.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -165.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.3 p -60.36 165.9 4.72 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 117.381 0.59 . . . . 0.0 110.92 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.47 -20.77 12.49 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.388 2.725 . . . . 0.0 114.756 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -103.78 -13.41 16.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.47 1.108 . . . . 0.0 111.53 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 m -68.71 165.65 19.05 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.025 -1.047 . . . . 0.0 111.166 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -143.47 138.47 29.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 156.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.4 t -110.22 140.73 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.0 p -123.26 -18.55 6.25 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.187 0.995 . . . . 0.0 110.965 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -153.54 149.46 27.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.76 144.11 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 m -142.09 159.5 42.11 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.195 1.398 . . . . 0.0 108.882 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 t -136.61 146.86 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.78 1.232 . . . . 0.0 107.679 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.74 167.6 20.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.681 1.993 . . . . 0.0 106.388 173.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -130.44 164.03 25.65 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.168 -0.957 . . . . 0.0 109.996 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -135.61 150.88 49.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 162.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -115.17 27.76 9.16 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 109.545 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.7 m -136.55 168.8 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.52 2.728 . . . . 0.0 105.425 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.65 129.66 47.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.657 0.783 . . . . 0.0 108.938 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -71.14 -25.4 62.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.063 0.392 . . . . 0.0 110.794 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 29.07 18.41 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.314 0.959 . . . . 0.0 112.903 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -59.42 151.16 24.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.178 1.489 . . . . 0.0 109.59 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -126.92 -6.96 6.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.382 1.073 . . . . 0.0 112.259 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -141.46 -178.12 5.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.985 2.114 . . . . 0.0 106.711 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -117.54 124.57 49.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.5 m -117.76 139.41 51.1 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.367 0.603 . . . . 0.0 111.103 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.6 mt -89.52 137.51 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.5 t . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 125.348 1.459 . . . . 0.0 107.315 -173.752 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.9 mmm . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.92 168.28 14.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 107.259 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -120.19 137.07 54.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.162 1.785 . . . . 0.0 106.496 170.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -119.83 155.62 32.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.393 1.477 . . . . 0.0 107.794 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -125.03 138.83 54.2 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.3 mt -134.23 141.81 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mm -130.56 141.09 47.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.18 147.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -140.95 158.08 44.44 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.866 1.266 . . . . 0.0 109.623 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.96 -157.27 23.31 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.701 1.62 . . . . 0.0 109.595 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -75.12 85.71 2.37 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.77 14.96 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.862 0.865 . . . . 0.0 111.695 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -138.39 149.34 45.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.49 33.45 76.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.06 -3.78 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.307 1.443 . . . . 0.0 111.841 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.52 22.69 33.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.796 1.189 . . . . 0.0 110.41 -175.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.36 -46.75 82.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.125 1.462 . . . . 0.0 110.377 -172.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -61.96 -42.35 99.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.236 0.926 . . . . 0.0 110.345 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -64.57 -42.41 95.65 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.948 0.499 . . . . 0.0 110.707 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.5 -50.69 72.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.321 0.648 . . . . 0.0 110.558 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.25 -37.8 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.672 -0.643 . . . . 0.0 110.127 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.739 0.699 . . . . 0.0 109.823 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 ptp -72.14 -33.46 67.77 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.758 0.708 . . . . 0.0 111.42 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -69.48 -33.82 73.44 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.047 0.839 . . . . 0.0 111.209 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.25 79.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.0 0.364 . . . . 0.0 110.344 170.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.08 -45.42 93.6 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.803 0.841 . . . . 0.0 110.99 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -9.61 35.49 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -122.27 10.37 9.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.044 1.338 . . . . 0.0 111.415 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 44.96 41.83 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.068 1.747 . . . . 0.0 112.626 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.9 166.59 7.18 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.11 159.05 26.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 163.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.31 -155.5 25.19 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.695 0.679 . . . . 0.0 112.62 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -147.75 166.81 26.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.4 144.56 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 108.014 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.23 149.28 33.61 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.557 0.743 . . . . 0.0 110.402 174.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.97 122.12 27.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 166.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -76.57 148.1 37.24 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.31 -30.33 71.38 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.563 0.345 . . . . 0.0 111.613 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.36 -5.2 21.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.513 1.125 . . . . 0.0 113.548 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -13.75 52.66 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.323 0.963 . . . . 0.0 113.353 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -72.2 170.69 13.49 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.818 1.309 . . . . 0.0 110.551 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.28 148.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 161.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -131.96 143.66 50.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -141.11 147.06 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.68 128.82 27.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.63 158.53 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.184 0.593 . . . . 0.0 110.053 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -140.11 134.63 31.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.411 1.484 . . . . 0.0 107.37 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.67 -177.62 44.38 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.464 -0.631 . . . . 0.0 111.741 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 157.41 59.28 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.385 2.057 . . . . 0.0 110.287 169.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.0 -45.17 91.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.265 0.626 . . . . 0.0 111.137 -172.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.57 -38.02 85.96 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.622 0.646 . . . . 0.0 111.954 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.19 75.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.41 -35.87 80.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.385 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.72 -49.22 77.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.925 0.784 . . . . 0.0 109.977 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 m -61.5 -38.27 86.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 110.919 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -63.87 -44.32 93.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.114 0.966 . . . . 0.0 110.233 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -58.39 -50.07 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.992 0.815 . . . . 0.0 109.303 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.33 -38.49 68.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.687 0.795 . . . . 0.0 110.984 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -46.63 69.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 110.812 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.73 -28.55 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.762 0.825 . . . . 0.0 111.011 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -58.43 -35.2 71.72 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.107 1.321 . . . . 0.0 111.275 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -79.91 -42.93 23.12 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.245 0.475 . . . . 0.0 110.673 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.43 -165.99 54.1 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 p -59.84 166.8 3.15 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.682 . . . . 0.0 111.443 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.85 -14.17 3.27 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.94 3.093 . . . . 0.0 115.988 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -123.07 3.79 9.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.674 1.124 . . . . 0.0 112.053 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.3 m -66.86 159.25 28.64 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.02 -1.05 . . . . 0.0 110.357 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -140.94 77.35 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -59.72 140.49 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.6 p -122.46 -19.59 6.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.424 1.09 . . . . 0.0 111.177 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -154.57 151.9 29.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.154 0.982 . . . . 0.0 109.506 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.18 145.96 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.316 1.447 . . . . 0.0 107.356 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -140.31 152.36 45.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 108.475 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -139.19 145.52 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.522 1.129 . . . . 0.0 108.139 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -136.15 159.74 40.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.252 1.821 . . . . 0.0 106.118 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -148.81 163.29 37.81 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.318 -0.864 . . . . 0.0 111.398 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.7 m -148.76 144.95 27.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.482 1.913 . . . . 0.0 108.451 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.0 tpt85 -76.17 -30.77 58.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.191 162.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 m -57.51 148.56 23.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.625 1.17 . . . . 0.0 109.711 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.7 mt -131.44 168.18 18.06 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.363 1.465 . . . . 0.0 109.238 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 -29.41 2.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.816 1.646 . . . . 0.0 109.876 169.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.39 57.35 5.13 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -56.87 150.46 16.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.489 0.715 . . . . 0.0 110.726 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -67.86 -31.5 71.36 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -149.79 179.0 8.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.524 1.93 . . . . 0.0 107.346 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -94.7 132.8 39.06 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 154.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -138.59 144.42 39.79 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.7 139.83 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 164.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 126.365 1.866 . . . . 0.0 106.661 -178.669 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.764 0.316 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.7 170.73 14.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.249 1.82 . . . . 0.0 107.668 173.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -110.02 138.37 46.48 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.818 1.647 . . . . 0.0 106.817 164.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -116.17 156.95 25.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.144 1.378 . . . . 0.0 107.565 164.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -127.85 140.29 52.11 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 161.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -133.15 142.22 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.04 140.33 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.71 145.06 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.58 157.26 45.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.888 1.275 . . . . 0.0 109.709 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.57 -158.94 24.73 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.982 1.753 . . . . 0.0 109.597 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -75.26 88.77 2.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 157.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.67 20.59 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.445 1.098 . . . . 0.0 109.943 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -138.61 148.5 44.19 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.835 1.254 . . . . 0.0 107.84 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.95 41.53 97.89 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.91 -10.84 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.853 1.261 . . . . 0.0 111.842 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.0 16.98 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.872 1.225 . . . . 0.0 110.124 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.67 -41.73 98.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.307 1.554 . . . . 0.0 110.266 -171.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.75 -45.96 77.93 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.626 -0.671 . . . . 0.0 111.538 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.72 -39.65 80.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.548 0.613 . . . . 0.0 111.515 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.04 -52.09 66.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.199 0.6 . . . . 0.0 109.958 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.0 -38.11 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.44 -48.21 82.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.164 0.893 . . . . 0.0 110.019 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -75.35 -31.85 60.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.923 0.783 . . . . 0.0 111.684 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -68.79 -34.17 75.1 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.032 0.833 . . . . 0.0 110.805 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.31 83.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.162 0.437 . . . . 0.0 110.187 170.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.82 -45.18 93.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.563 0.745 . . . . 0.0 111.129 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -5.71 28.58 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.27 1.17 15.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.519 1.527 . . . . 0.0 111.565 170.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 39.88 42.75 1.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.345 1.858 . . . . 0.0 112.355 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 165.61 18.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 166.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.85 156.76 43.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.61 -154.42 25.79 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.121 0.873 . . . . 0.0 112.433 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -146.24 166.21 26.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 122.139 -0.624 . . . . 0.0 112.251 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.18 141.07 42.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 124.668 1.187 . . . . 0.0 108.239 166.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -138.1 158.65 43.89 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.789 1.236 . . . . 0.0 108.082 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.76 107.63 10.71 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -81.18 146.26 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.318 1.047 . . . . 0.0 109.642 -155.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.16 -25.08 66.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.809 0.444 . . . . 0.0 111.325 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -60.14 -16.92 36.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.439 1.896 . . . . 0.0 113.234 171.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.11 1.51 35.89 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.223 0.916 . . . . 0.0 113.533 171.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.6 mtt85 -117.28 153.74 32.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.751 1.221 . . . . 0.0 109.271 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.22 149.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 164.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -132.71 140.79 48.26 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 167.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.49 145.33 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -173.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -133.49 129.36 37.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.95 152.67 47.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.683 . . . . 0.0 109.575 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -139.48 134.85 32.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.252 1.421 . . . . 0.0 107.269 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.8 -172.13 41.16 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.396 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.42 151.89 54.17 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.711 2.274 . . . . 0.0 110.522 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -60.48 -35.95 77.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.128 0.971 . . . . 0.0 112.227 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.63 -39.54 77.09 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.936 -1.102 . . . . 0.0 111.604 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.39 83.24 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.98 -40.03 95.48 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.106 0.562 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.99 -47.42 84.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.763 0.711 . . . . 0.0 110.857 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -61.77 -38.37 87.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.352 0.596 . . . . 0.0 110.796 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -64.14 -43.35 95.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.458 1.103 . . . . 0.0 110.545 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.08 -50.39 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.293 0.952 . . . . 0.0 109.306 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -55.56 -39.38 70.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.821 0.849 . . . . 0.0 110.838 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.91 74.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.641 0.776 . . . . 0.0 110.967 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.81 -27.25 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.128 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -58.65 -38.62 78.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.256 1.389 . . . . 0.0 110.918 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.51 -43.17 50.4 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.111 0.414 . . . . 0.0 110.351 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.81 -172.99 48.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.76 159.28 10.17 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.511 0.724 . . . . 0.0 110.38 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.19 -26.19 64.87 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.068 1.845 . . . . 0.0 112.629 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -83.28 -15.33 50.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.044 0.938 . . . . 0.0 112.29 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -77.95 161.67 27.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.958 0.903 . . . . 0.0 110.93 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -137.11 82.04 1.91 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.1 t -59.77 140.53 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.3 p -123.91 -19.82 5.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.34 1.056 . . . . 0.0 111.267 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -154.01 152.69 30.82 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.128 0.971 . . . . 0.0 109.53 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.82 145.72 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 107.176 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -139.56 152.55 46.96 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.058 1.343 . . . . 0.0 108.238 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -138.61 145.45 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.319 1.048 . . . . 0.0 108.186 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 m -135.23 160.85 37.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.635 1.974 . . . . 0.0 106.052 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.4 166.51 26.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.252 -0.905 . . . . 0.0 110.825 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.5 m -157.0 147.95 21.78 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.982 1.713 . . . . 0.0 108.666 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -73.82 -41.35 62.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -56.1 137.87 50.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 108.97 170.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.12 156.85 41.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.116 1.367 . . . . 0.0 108.662 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.41 -23.36 21.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.852 0.861 . . . . 0.0 111.445 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 46.5 5.74 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -52.91 137.74 31.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.762 0.825 . . . . 0.0 109.528 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -12.18 39.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.095 0.558 . . . . 0.0 112.096 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -154.58 169.02 24.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.132 1.773 . . . . 0.0 108.412 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -99.79 137.56 38.08 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -134.59 137.71 43.95 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.555 0.616 . . . . 0.0 112.384 -170.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.03 142.53 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 163.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 127.002 2.121 . . . . 0.0 105.795 176.784 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mmm . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.45 164.84 19.57 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.693 1.997 . . . . 0.0 107.704 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -124.96 137.5 54.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.036 1.735 . . . . 0.0 106.389 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -119.85 154.75 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.549 1.54 . . . . 0.0 107.756 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -122.48 139.86 53.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.4 mt -131.94 142.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.3 mm -128.75 136.92 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.87 146.08 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -170.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -143.2 157.26 44.66 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.866 1.266 . . . . 0.0 109.526 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 -156.78 25.3 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.17 1.367 . . . . 0.0 110.474 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -75.05 78.43 2.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.94 20.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.752 0.821 . . . . 0.0 111.9 -168.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -140.93 151.74 44.46 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.44 0.696 . . . . 0.0 109.889 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.61 33.16 83.64 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.5 -10.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.378 1.471 . . . . 0.0 111.853 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.51 18.8 15.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.811 1.672 . . . . 0.0 110.696 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.89 -37.4 87.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.788 1.294 . . . . 0.0 111.117 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -56.02 -51.32 68.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.878 1.217 . . . . 0.0 110.675 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -68.09 -37.74 81.54 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.261 -0.274 . . . . 0.0 110.694 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.01 -50.8 72.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.187 0.595 . . . . 0.0 110.474 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.92 -40.07 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.674 -0.641 . . . . 0.0 109.772 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.9 -45.63 93.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.094 0.861 . . . . 0.0 110.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.36 -32.35 62.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 0.742 . . . . 0.0 111.525 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -73.36 -22.13 60.36 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.219 0.918 . . . . 0.0 111.807 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.27 -49.04 37.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.506 0.594 . . . . 0.0 109.54 164.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.63 -38.33 84.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.392 0.677 . . . . 0.0 111.771 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -22.12 61.61 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -127.15 25.16 6.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.446 1.021 . . . . 0.0 110.581 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 49.26 38.26 13.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 112.646 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.28 156.75 24.69 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.06 155.11 44.88 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.05 -154.22 25.67 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.958 0.799 . . . . 0.0 112.0 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -150.07 166.07 30.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.029 0.532 . . . . 0.0 112.39 174.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.56 151.55 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.694 1.598 . . . . 0.0 108.929 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -143.75 133.63 23.97 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.4 0.68 . . . . 0.0 110.856 171.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.93 115.9 10.61 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 162.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.97 143.85 26.87 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.98 -28.51 70.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.03 -8.12 34.97 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.51 -15.25 38.62 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.455 1.026 . . . . 0.0 113.502 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -76.7 171.87 13.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.72 1.26 . . . . 0.0 110.332 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.6 t -114.18 145.58 19.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 160.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.86 145.99 50.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.57 146.32 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.01 126.05 22.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.8 43.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -140.41 144.6 36.27 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.811 1.644 . . . . 0.0 108.052 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.49 -177.81 41.77 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.02 150.23 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.478 1.452 . . . . 0.0 109.251 167.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.22 -43.69 83.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.968 0.507 . . . . 0.0 110.914 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.64 -29.18 65.47 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.525 -0.735 . . . . 0.0 112.623 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.8 81.97 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 118.674 0.67 . . . . 0.0 110.073 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.79 -33.12 74.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.088 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -62.18 -51.38 68.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.64 1.109 . . . . 0.0 110.26 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 p -63.39 -32.56 74.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.582 1.083 . . . . 0.0 111.418 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.21 -47.16 85.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.952 -0.547 . . . . 0.0 110.169 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.28 -43.45 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.021 0.828 . . . . 0.0 109.996 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -59.74 -41.14 90.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.067 0.849 . . . . 0.0 110.928 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.06 76.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.926 0.491 . . . . 0.0 110.826 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.8 -49.68 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -27.48 64.54 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.893 0.77 . . . . 0.0 112.148 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -64.32 -40.01 95.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.139 0.881 . . . . 0.0 110.459 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 171.97 31.52 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.566 1.079 . . . . 0.0 110.953 -171.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.7 p -64.0 168.8 5.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.977 0.911 . . . . 0.0 109.934 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.16 -2.82 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.186 1.924 . . . . 0.0 113.196 165.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -107.8 -5.48 17.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.882 1.273 . . . . 0.0 112.176 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -124.47 170.75 10.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.684 1.194 . . . . 0.0 111.623 -172.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -146.68 102.17 3.53 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.83 142.05 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.4 p -123.29 -17.81 6.47 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.135 0.974 . . . . 0.0 110.87 173.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -152.15 148.44 27.63 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.296 1.038 . . . . 0.0 109.205 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.77 146.67 16.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.9 m -138.14 150.99 47.32 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.463 1.505 . . . . 0.0 108.059 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.67 145.08 29.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -136.13 159.13 42.65 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.38 157.79 43.72 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.153 -0.967 . . . . 0.0 111.604 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.3 m -140.1 136.92 34.08 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.001 1.72 . . . . 0.0 108.45 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -35.08 61.24 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 m -59.39 150.85 25.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.135 1.374 . . . . 0.0 109.775 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.5 mt -132.84 165.76 23.85 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.392 1.477 . . . . 0.0 109.399 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.61 -21.71 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.661 1.584 . . . . 0.0 110.652 170.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 43.19 7.04 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.73 0.681 . . . . 0.0 112.249 166.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.86 160.04 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.709 0.755 . . . . 0.0 109.996 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -126.27 -20.5 4.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -139.1 -175.74 4.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.825 1.65 . . . . 0.0 107.624 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -120.78 130.75 54.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.522 0.601 . . . . 0.0 109.781 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.0 m -126.19 159.65 32.39 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.854 0.835 . . . . 0.0 111.721 -167.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -111.81 124.89 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 109.567 -168.277 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.3 tp -142.75 163.72 32.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 127.012 2.125 . . . . 0.0 107.204 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -120.1 137.78 53.94 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 107.737 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -116.64 153.85 31.58 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.654 1.582 . . . . 0.0 108.079 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -120.06 139.0 53.21 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 158.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.9 mt -130.96 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.8 mm -130.01 138.87 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -137.07 147.31 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -139.33 157.74 45.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.496 1.118 . . . . 0.0 109.717 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.87 -156.52 22.55 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.474 1.511 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -73.74 81.25 1.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 160.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.92 15.19 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.032 0.933 . . . . 0.0 111.693 -171.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -138.17 150.3 46.65 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 171.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.42 32.0 71.51 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 m -136.65 1.4 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.717 1.607 . . . . 0.0 111.546 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.0 20.13 50.98 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.856 1.217 . . . . 0.0 110.582 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -62.91 -45.28 93.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.757 1.278 . . . . 0.0 110.766 -169.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -62.1 -44.8 95.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.425 1.012 . . . . 0.0 110.99 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -68.51 -40.28 80.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 110.616 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -56.6 -52.28 65.43 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.25 0.62 . . . . 0.0 110.006 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.71 -39.82 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.168 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -60.69 -43.61 97.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.33 0.968 . . . . 0.0 110.647 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.6 mtm -71.74 -35.53 70.17 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.738 0.699 . . . . 0.0 111.499 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -67.38 -39.91 85.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.561 1.073 . . . . 0.0 110.158 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.3 99.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.121 0.569 . . . . 0.0 110.169 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.26 -47.54 85.58 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.65 0.78 . . . . 0.0 110.623 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -59.9 -36.15 76.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.367 1.067 . . . . 0.0 111.275 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -88.11 5.1 42.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.628 1.171 . . . . 0.0 112.729 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 48.82 31.71 3.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.896 1.678 . . . . 0.0 112.591 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.57 165.95 23.12 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.437 1.095 . . . . 0.0 109.62 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 161.48 30.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.348 1.459 . . . . 0.0 107.625 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.52 -148.85 20.76 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.256 0.934 . . . . 0.0 111.844 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -154.04 168.29 26.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.322 0.649 . . . . 0.0 112.689 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.92 147.72 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.868 1.667 . . . . 0.0 108.739 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -144.79 155.56 43.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.871 0.869 . . . . 0.0 110.384 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -84.0 124.2 30.8 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 164.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.12 147.08 38.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.42 -30.0 71.04 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.551 0.34 . . . . 0.0 111.627 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.94 -5.45 21.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.559 1.144 . . . . 0.0 113.518 174.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.48 49.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.332 0.967 . . . . 0.0 113.288 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -73.37 170.88 14.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 1.258 . . . . 0.0 110.551 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.4 t -105.42 150.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -132.73 140.33 48.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.76 146.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.64 153.44 50.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.674 0.79 . . . . 0.0 109.619 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -140.21 135.83 32.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.927 1.291 . . . . 0.0 108.103 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.43 38.84 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.064 -173.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.19 151.79 61.19 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.265 1.977 . . . . 0.0 110.542 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.15 -40.96 82.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 111.527 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.2 -40.08 95.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.821 0.737 . . . . 0.0 111.75 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.34 -41.14 85.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.04 -39.43 93.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.875 0.47 . . . . 0.0 111.1 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -66.65 -49.11 67.29 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.326 -0.859 . . . . 0.0 110.724 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 p -64.38 -31.94 73.36 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.713 -0.617 . . . . 0.0 111.059 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -63.87 -42.86 97.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.821 171.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.25 -46.64 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 120.254 1.388 . . . . 0.0 109.102 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -59.71 -36.97 77.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.891 0.769 . . . . 0.0 110.989 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.05 -43.48 82.63 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.92 -0.487 . . . . 0.0 111.533 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.97 -43.71 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.4 -0.813 . . . . 0.0 109.988 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -68.83 -20.76 64.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.819 1.19 . . . . 0.0 112.549 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.34 -43.28 73.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 120.112 1.324 . . . . 0.0 110.017 167.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.32 -177.62 39.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.236 0.922 . . . . 0.0 111.093 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.1 p -62.57 168.3 4.45 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.973 0.509 . . . . 0.0 110.834 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.87 -14.36 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.727 2.952 . . . . 0.0 115.261 168.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -116.01 -8.47 11.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.526 1.13 . . . . 0.0 111.902 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 m -72.41 164.47 26.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.878 0.871 . . . . 0.0 111.162 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -144.93 93.68 2.43 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 158.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.02 145.72 12.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -121.97 -22.96 5.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.654 1.182 . . . . 0.0 111.038 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -156.75 154.53 30.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.255 1.022 . . . . 0.0 109.88 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.7 tt -149.3 149.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.295 1.438 . . . . 0.0 107.739 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 m -141.88 152.86 43.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.094 1.357 . . . . 0.0 108.496 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.22 145.21 30.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.672 1.189 . . . . 0.0 107.802 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -135.59 160.38 38.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 166.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.43 161.14 41.03 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.985 -1.072 . . . . 0.0 111.009 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -144.19 140.44 29.33 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.96 1.304 . . . . 0.0 108.648 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.1 -41.82 73.53 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.516 0.726 . . . . 0.0 109.101 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.5 m -64.39 147.19 53.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.128 0.971 . . . . 0.0 109.051 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.5 148.12 29.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.998 1.319 . . . . 0.0 108.985 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -152.21 -10.79 0.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.849 0.86 . . . . 0.0 113.202 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.86 -20.28 17.09 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 121.128 -0.982 . . . . 0.0 113.743 -161.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -55.54 111.84 0.99 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.814 1.246 . . . . 0.0 112.722 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -146.63 -49.22 0.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.426 1.49 . . . . 0.0 109.358 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -153.18 -161.48 1.29 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.877 2.471 . . . . 0.0 106.053 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -118.26 96.97 5.55 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.88 1.218 . . . . 0.0 109.142 166.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.2 m -84.12 139.06 32.7 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.466 0.65 . . . . 0.0 110.955 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.54 137.04 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 155.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 C--O 1.236 0.354 0 C-N-CA 125.456 1.502 . . . . 0.0 107.619 -171.433 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.43 160.05 35.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.998 1.719 . . . . 0.0 108.092 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -119.85 139.15 52.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 164.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -122.31 155.13 36.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.894 1.677 . . . . 0.0 107.511 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -129.55 139.18 51.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 162.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.7 mt -134.99 137.7 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -172.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -127.69 137.98 56.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.57 147.23 27.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -146.73 158.45 43.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.753 1.221 . . . . 0.0 109.493 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.4 18.94 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.385 1.469 . . . . 0.0 109.608 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -72.82 89.81 1.4 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 158.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.54 18.31 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.266 1.026 . . . . 0.0 110.125 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -142.27 154.89 45.11 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.6 1.16 . . . . 0.0 108.161 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.98 93.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.8 -3.33 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.663 1.585 . . . . 0.0 111.301 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.02 26.57 40.5 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -173.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.21 -40.75 91.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.618 1.209 . . . . 0.0 110.331 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.93 -43.84 91.25 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.457 -0.777 . . . . 0.0 110.874 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -69.71 -42.03 74.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.931 0.492 . . . . 0.0 110.987 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -56.21 -48.95 75.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.416 0.553 . . . . 0.0 110.306 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.03 -40.01 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.52 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.06 -46.62 85.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.441 1.018 . . . . 0.0 109.968 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.7 mtt -66.96 -38.59 86.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.493 1.042 . . . . 0.0 111.016 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -70.87 -26.59 63.32 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.494 -0.753 . . . . 0.0 112.157 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.38 -39.03 59.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 110.043 168.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.66 -47.02 79.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.619 1.168 . . . . 0.0 110.482 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HE2' ' NH1' ' A' ' 28' ' ' ARG 0.281 0.0 OUTLIER -70.24 -12.82 61.86 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.749 -177.338 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.488 ' NH1' ' HE2' ' A' ' 27' ' ' LYS . 74.7 mtt85 -101.59 -3.17 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.508 1.523 . . . . 0.0 111.96 173.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 45.4 42.25 7.37 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.529 1.532 . . . . 0.0 112.234 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.38 167.44 10.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.47 156.13 44.61 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 167.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.28 -153.58 25.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 119.398 0.999 . . . . 0.0 112.905 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.01 166.4 24.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.626 0.771 . . . . 0.0 112.779 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.38 144.93 31.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 124.949 1.3 . . . . 0.0 107.544 163.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.37 143.29 32.64 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 0.689 . . . . 0.0 111.088 166.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -74.33 110.92 9.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 162.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -79.24 142.81 35.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.04 -23.95 66.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.769 0.428 . . . . 0.0 112.081 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.96 -20.57 62.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.876 1.27 . . . . 0.0 113.032 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.44 -12.38 36.27 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.646 1.117 . . . . 0.0 112.977 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -82.57 170.84 14.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.052 0.941 . . . . 0.0 110.363 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.07 146.14 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -117.97 145.92 44.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -134.39 146.84 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.82 130.61 34.23 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 167.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.78 157.79 44.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 110.253 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.55 134.41 33.82 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.37 -178.01 43.3 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -172.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.08 152.09 72.88 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.23 1.954 . . . . 0.0 109.941 170.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.49 -40.52 87.26 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.937 0.495 . . . . 0.0 111.415 -171.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -64.41 -38.69 91.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.976 0.807 . . . . 0.0 111.968 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -44.54 86.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.98 -35.28 79.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.202 0.455 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -63.83 -51.14 66.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.104 0.866 . . . . 0.0 110.3 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -66.0 -32.27 73.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.016 0.825 . . . . 0.0 111.062 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.59 -45.55 93.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.061 0.944 . . . . 0.0 109.534 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.75 -47.92 84.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 119.158 0.89 . . . . 0.0 109.595 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -57.31 -39.84 76.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.725 0.693 . . . . 0.0 110.765 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.59 81.09 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.857 0.863 . . . . 0.0 111.211 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.76 -32.38 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.653 0.781 . . . . 0.0 110.866 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -60.76 -31.65 70.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.998 1.272 . . . . 0.0 111.393 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -77.7 -45.0 26.13 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.458 0.572 . . . . 0.0 110.324 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.81 -168.86 46.22 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -54.98 153.65 11.29 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.615 166.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -50.61 -31.44 31.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.458 2.772 . . . . 0.0 115.339 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -84.33 -6.38 59.38 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.354 1.062 . . . . 0.0 112.999 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -70.82 163.84 26.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.614 0.766 . . . . 0.0 110.873 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -146.91 81.77 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.9 140.32 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.8 p -120.67 -23.09 6.11 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.448 1.099 . . . . 0.0 111.065 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -155.07 150.51 27.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.808 1.243 . . . . 0.0 108.481 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.7 tt -151.55 147.39 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -139.98 151.3 45.39 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.131 1.372 . . . . 0.0 108.164 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.36 145.12 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -137.04 158.66 43.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.83 162.09 40.97 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.323 -0.861 . . . . 0.0 110.898 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -146.26 140.86 26.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.615 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.41 -36.88 71.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 164.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 m -59.31 153.55 18.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.235 1.414 . . . . 0.0 110.106 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.86 169.16 15.53 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.024 1.33 . . . . 0.0 109.977 -173.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.85 -31.37 4.23 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.101 2.16 . . . . 0.0 108.76 170.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.32 54.64 7.6 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -55.48 145.99 21.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.768 0.827 . . . . 0.0 110.533 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -68.2 -32.9 73.45 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.347 0.659 . . . . 0.0 111.902 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -152.93 -172.03 4.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.914 1.686 . . . . 0.0 108.051 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -102.5 131.67 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 164.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.8 m -125.15 138.15 54.15 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.956 0.503 . . . . 0.0 111.405 -171.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -75.7 139.12 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 159.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 126.474 1.91 . . . . 0.0 106.402 -177.112 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mmm . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.8 tp -145.17 156.32 43.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 0.0 108.386 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.64 138.31 51.54 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.902 1.281 . . . . 0.0 108.229 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -123.71 156.42 36.0 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.714 1.606 . . . . 0.0 108.766 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -123.41 138.99 54.47 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.94 141.44 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.01 138.57 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.67 144.88 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -170.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -138.93 156.83 46.95 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.961 1.305 . . . . 0.0 109.833 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.0 -158.12 23.73 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.582 1.563 . . . . 0.0 110.027 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -74.66 83.84 2.08 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.4 15.98 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.25 1.02 . . . . 0.0 110.941 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -137.98 154.48 49.35 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.97 30.19 70.24 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.12 -9.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.018 1.327 . . . . 0.0 112.138 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.55 21.42 14.68 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.503 1.525 . . . . 0.0 110.494 -177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.61 -41.02 96.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.256 1.528 . . . . 0.0 110.876 -171.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -61.23 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.405 1.002 . . . . 0.0 110.56 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -64.65 -41.82 95.85 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.239 0.472 . . . . 0.0 110.677 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.13 -49.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.07 0.548 . . . . 0.0 110.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.19 -39.79 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 110.159 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -59.06 -49.7 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.793 0.724 . . . . 0.0 109.911 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.8 ptm -72.49 -33.65 67.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.374 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -68.63 -30.75 69.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.003 0.82 . . . . 0.0 111.673 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.26 64.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.184 0.447 . . . . 0.0 109.96 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.98 -43.64 98.54 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.971 0.908 . . . . 0.0 111.025 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -3.32 23.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -114.84 0.27 13.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.662 1.585 . . . . 0.0 111.465 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 45.25 40.02 4.73 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.357 1.463 . . . . 0.0 111.942 -168.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.13 165.37 13.73 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 155.48 45.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.234 1.013 . . . . 0.0 108.367 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.19 -156.14 26.35 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.797 0.726 . . . . 0.0 112.173 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.9 p-90 -153.36 167.13 30.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.975 -0.721 . . . . 0.0 112.211 176.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.9 142.89 34.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.092 1.357 . . . . 0.0 109.036 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 149.41 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.207 0.603 . . . . 0.0 110.608 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -75.73 134.63 40.45 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.23 143.8 30.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.58 -21.86 66.82 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.366 0.53 . . . . 0.0 111.648 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -28.95 59.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.029 1.732 . . . . 0.0 112.85 170.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.8 -25.02 10.47 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.493 1.044 . . . . 0.0 112.669 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -63.64 168.66 4.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.709 1.255 . . . . 0.0 110.754 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.8 150.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 169.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -139.62 140.08 36.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.98 146.63 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -170.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.01 129.12 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 164.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.24 48.07 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 109.443 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -136.79 138.19 40.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.701 1.6 . . . . 0.0 107.955 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.63 -175.22 44.51 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.279 -0.734 . . . . 0.0 111.885 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.37 137.79 40.82 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.365 2.043 . . . . 0.0 109.534 172.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.13 -34.86 61.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.886 1.674 . . . . 0.0 113.1 -168.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -71.34 -46.24 61.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.091 -1.006 . . . . 0.0 111.953 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.62 83.51 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.05 -49.6 76.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.631 1.172 . . . . 0.0 109.692 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 119.188 -0.435 . . . . 0.0 111.362 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 m -62.37 -37.52 86.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.586 0.63 . . . . 0.0 111.199 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.37 -43.82 98.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.01 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.9 t -61.94 -41.95 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.248 1.386 . . . . 0.0 110.593 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.22 -39.27 72.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.717 1.144 . . . . 0.0 110.561 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.7 77.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.294 0.638 . . . . 0.0 111.287 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.8 t -58.68 -32.84 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.455 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -60.88 -35.39 76.52 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.01 1.277 . . . . 0.0 111.535 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -72.7 -43.33 63.16 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.518 0.599 . . . . 0.0 110.288 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.92 -176.17 43.82 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.15 162.23 14.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.659 0.783 . . . . 0.0 110.669 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.92 -32.13 46.13 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.446 2.764 . . . . 0.0 114.52 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -94.33 -9.19 36.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 112.47 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -78.4 165.31 23.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.997 0.919 . . . . 0.0 110.966 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -144.49 93.18 2.39 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.2 t -61.41 143.38 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 p -124.52 -20.61 5.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.265 1.026 . . . . 0.0 111.101 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -155.85 154.12 30.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 0.0 109.243 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.12 148.07 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.904 1.281 . . . . 0.0 107.586 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.1 m -140.68 154.08 46.23 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.35 1.46 . . . . 0.0 108.663 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.43 145.64 29.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 108.178 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 m -134.42 161.25 35.53 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.12 162.92 34.24 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.154 -0.966 . . . . 0.0 110.942 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.4 m -139.8 126.26 20.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 169.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.42 -29.79 66.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.6 m -66.08 161.04 22.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.959 1.303 . . . . 0.0 109.772 167.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.8 mt -133.1 164.32 27.3 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.54 1.136 . . . . 0.0 109.948 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -119.9 -20.24 7.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.393 1.477 . . . . 0.0 110.666 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.37 48.29 5.7 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.443 0.544 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -59.96 156.47 14.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 117.587 0.694 . . . . 0.0 109.239 167.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.71 -6.27 4.6 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.856 0.863 . . . . 0.0 112.78 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.7 mtm-85 -141.31 169.04 18.35 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.901 1.68 . . . . 0.0 107.031 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -110.39 138.05 47.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -133.99 139.23 45.92 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.66 140.61 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 161.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 126.435 1.894 . . . . 0.0 106.533 -177.923 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.6 mmm . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.4 tp -152.5 158.6 42.8 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.413 1.885 . . . . 0.0 107.225 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -123.67 138.33 54.55 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 107.244 173.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -110.53 151.06 28.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.233 1.413 . . . . 0.0 107.704 163.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -117.97 140.34 49.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 152.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -131.41 143.41 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.4 mm -131.99 136.56 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.19 146.34 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -140.46 155.67 46.61 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.748 1.219 . . . . 0.0 109.796 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.78 -155.16 23.56 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.451 1.5 . . . . 0.0 109.73 -176.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -76.91 79.11 3.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 162.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.46 14.6 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.066 0.946 . . . . 0.0 111.711 -170.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -137.76 150.14 47.01 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.15 30.28 63.22 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.83 -1.27 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.55 1.54 . . . . 0.0 112.021 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.58 20.94 42.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.973 1.273 . . . . 0.0 110.641 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -63.08 -44.58 95.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.109 1.454 . . . . 0.0 110.405 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -61.03 -47.08 88.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.231 0.923 . . . . 0.0 110.452 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -64.69 -42.17 95.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.717 0.407 . . . . 0.0 111.048 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -56.23 -52.38 64.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.954 0.502 . . . . 0.0 110.04 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.45 -39.72 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.546 0.612 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -59.2 -44.77 92.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.019 0.827 . . . . 0.0 110.029 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.8 mtp -73.5 -34.0 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.437 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -66.47 -38.79 88.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.019 1.282 . . . . 0.0 110.048 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.04 99.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.086 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.06 -44.99 94.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.664 0.665 . . . . 0.0 111.143 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.03 -8.65 7.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.137 1.775 . . . . 0.0 112.837 174.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -118.48 -0.21 11.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.358 -1.464 . . . . 0.0 111.934 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 39.07 41.72 0.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.03 1.732 . . . . 0.0 112.35 -165.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.92 165.94 23.98 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.571 0.748 . . . . 0.0 109.302 171.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 152.0 46.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.97 -159.17 28.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.506 1.048 . . . . 0.0 113.688 -169.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -141.48 165.52 27.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.812 0.845 . . . . 0.0 111.973 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.1 p -137.58 146.28 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.018 1.327 . . . . 0.0 108.226 165.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -146.54 152.41 38.91 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.908 0.883 . . . . 0.0 110.036 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -84.59 121.64 27.9 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -75.22 147.03 40.68 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.28 -29.99 71.06 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.658 0.383 . . . . 0.0 111.521 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.58 -5.52 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.58 1.152 . . . . 0.0 113.58 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.94 49.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.478 1.037 . . . . 0.0 113.29 170.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.49 170.55 15.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.64 1.22 . . . . 0.0 110.424 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.13 149.5 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -130.97 142.41 50.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.13 147.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.76 128.31 28.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 167.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.55 148.34 44.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -138.61 129.72 26.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.38 -167.66 39.0 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.357 -0.69 . . . . 0.0 111.837 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.58 155.68 49.8 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.818 2.345 . . . . 0.0 111.103 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.9 -44.31 91.18 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.69 0.796 . . . . 0.0 111.417 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -62.55 -39.35 93.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.098 0.863 . . . . 0.0 111.958 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.34 -44.2 83.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.6 mt -65.6 -37.76 87.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.435 0.294 . . . . 0.0 111.383 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -63.0 -52.76 61.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.756 0.823 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -64.1 -32.44 74.01 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.58 -0.7 . . . . 0.0 111.273 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.83 -50.0 70.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.529 175.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -63.94 -37.87 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.678 1.126 . . . . 0.0 110.04 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -56.39 -41.77 76.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.094 0.861 . . . . 0.0 110.571 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.6 83.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.932 0.493 . . . . 0.0 111.582 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.08 -32.22 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.658 0.783 . . . . 0.0 110.668 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.16 -31.18 68.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.821 1.191 . . . . 0.0 111.493 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -78.28 -41.96 32.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.477 0.58 . . . . 0.0 111.195 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.53 -169.28 47.73 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -166.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.2 p -60.69 165.78 5.28 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 117.111 0.455 . . . . 0.0 110.166 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.02 -5.59 8.01 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.356 2.038 . . . . 0.0 113.703 171.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.21 -9.29 14.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.562 1.145 . . . . 0.0 111.761 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -75.46 167.66 21.47 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.077 0.951 . . . . 0.0 111.089 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -143.73 131.01 20.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 155.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.4 t -100.14 139.72 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.0 p -122.39 -19.23 6.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.051 0.941 . . . . 0.0 111.038 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -154.18 150.74 28.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 tt -152.46 145.77 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 m -142.6 153.45 43.51 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.052 1.341 . . . . 0.0 108.765 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.65 148.75 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.688 1.195 . . . . 0.0 109.399 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -137.06 158.18 45.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.01 152.43 47.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.61 0.764 . . . . 0.0 110.133 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -148.12 146.59 28.85 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.448 1.499 . . . . 0.0 108.391 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -83.6 -32.74 25.58 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.878 -0.514 . . . . 0.0 110.476 167.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -58.15 152.22 17.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 109.311 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.52 154.17 42.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.522 1.129 . . . . 0.0 109.131 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -77.23 -35.3 55.59 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 162.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.0 42.57 3.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.591 1.091 . . . . 0.0 111.375 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -62.21 157.6 19.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.986 0.893 . . . . 0.0 110.777 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -130.27 -1.24 4.53 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.858 1.263 . . . . 0.0 112.205 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -148.2 177.37 9.46 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.791 2.037 . . . . 0.0 107.177 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -121.4 122.37 39.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.0 m -124.48 139.69 53.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.635 0.731 . . . . 0.0 111.918 -163.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.6 mt -80.24 128.65 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 124.721 1.208 . . . . 0.0 108.998 -177.559 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.4 tp -133.98 163.83 28.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 -165.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -125.69 134.26 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.36 1.464 . . . . 0.0 108.44 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -117.31 157.9 25.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 108.572 167.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -126.34 140.19 52.7 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.1 mt -134.08 142.38 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -131.99 137.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.57 148.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -142.47 157.34 44.86 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.123 1.369 . . . . 0.0 109.883 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.15 -154.21 23.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.478 1.513 . . . . 0.0 110.387 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -73.27 79.99 1.32 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 160.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.94 19.27 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.858 0.863 . . . . 0.0 111.023 -171.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -136.64 146.68 46.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.275 1.03 . . . . 0.0 108.228 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.07 33.15 86.34 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.66 0.29 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.172 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.47 24.54 42.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.35 -46.17 87.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.207 1.504 . . . . 0.0 109.936 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -56.45 -46.13 80.47 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.818 0.736 . . . . 0.0 111.521 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.79 -40.94 83.9 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.068 0.395 . . . . 0.0 110.823 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.53 -51.86 67.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.276 0.63 . . . . 0.0 109.875 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.24 -40.42 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.213 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.61 -44.93 93.25 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.854 0.752 . . . . 0.0 110.258 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.5 mtm -71.33 -37.38 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.489 0.586 . . . . 0.0 111.305 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.94 -34.6 76.91 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.131 0.878 . . . . 0.0 110.711 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.42 88.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.901 0.48 . . . . 0.0 110.145 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.11 -49.24 76.67 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.729 0.811 . . . . 0.0 110.622 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -4.97 20.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.57 4.07 15.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.683 1.593 . . . . 0.0 111.807 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 11.4 mmpt? 43.45 38.76 1.91 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.5 1.52 . . . . 0.0 112.078 -172.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.29 165.54 20.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 157.28 43.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.71 1.204 . . . . 0.0 107.851 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.76 -152.13 22.43 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 119.231 0.923 . . . . 0.0 111.598 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -150.66 166.6 29.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.971 -0.723 . . . . 0.0 112.839 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 146.42 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.277 1.431 . . . . 0.0 108.669 171.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -142.96 160.57 40.09 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.014 0.925 . . . . 0.0 109.063 168.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.47 110.89 14.44 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -85.77 155.67 20.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.403 1.081 . . . . 0.0 110.662 -154.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.54 -28.34 69.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.702 0.401 . . . . 0.0 111.804 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.59 -5.34 32.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.017 0.927 . . . . 0.0 113.259 175.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.11 -16.37 46.12 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.629 1.109 . . . . 0.0 113.532 172.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -87.66 152.78 21.89 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.047 1.423 . . . . 0.0 110.002 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.7 147.82 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 162.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -137.7 139.81 40.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -140.45 146.58 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -170.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.37 124.04 25.1 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 166.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.05 150.29 46.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -140.11 138.21 35.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 108.082 -170.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.47 -171.48 39.97 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.72 152.93 64.71 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.291 1.994 . . . . 0.0 110.413 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.05 -40.89 91.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.385 0.674 . . . . 0.0 111.65 -171.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -65.3 -37.86 88.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.74 0.7 . . . . 0.0 111.97 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.29 81.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.26 -37.53 87.81 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.361 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.94 -47.54 82.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.169 0.895 . . . . 0.0 110.581 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.41 -37.52 83.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.105 0.562 . . . . 0.0 110.848 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.12 -45.38 81.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.389 1.076 . . . . 0.0 110.521 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.2 t -56.08 -49.5 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.345 0.975 . . . . 0.0 109.235 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.08 -42.22 69.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 110.863 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.4 74.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.503 0.721 . . . . 0.0 111.442 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.33 -24.6 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -57.54 -33.99 68.69 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.445 1.475 . . . . 0.0 111.042 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -83.2 -42.78 16.87 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.364 0.529 . . . . 0.0 111.053 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.6 -167.06 54.84 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -165.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.0 p -59.94 165.04 5.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.178 0.489 . . . . 0.0 110.319 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.13 -12.68 27.74 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.009 1.806 . . . . 0.0 113.22 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -98.51 -14.77 19.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.143 0.977 . . . . 0.0 111.768 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -71.61 163.46 27.7 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.88 0.872 . . . . 0.0 111.022 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -142.2 94.91 2.72 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.06 145.39 11.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.2 p -126.01 -18.72 4.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.311 1.045 . . . . 0.0 111.063 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -152.62 149.46 28.47 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.364 1.065 . . . . 0.0 109.264 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.6 tt -151.84 145.18 16.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.025 1.33 . . . . 0.0 107.807 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 m -141.71 154.04 45.04 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.286 1.434 . . . . 0.0 108.709 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.2 t -137.72 145.42 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.661 1.184 . . . . 0.0 107.852 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.07 164.27 28.41 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.661 1.985 . . . . 0.0 106.083 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.59 169.61 17.25 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.981 -1.074 . . . . 0.0 111.014 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.5 m -140.39 135.59 32.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -76.67 -28.87 56.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 119.099 -0.476 . . . . 0.0 110.245 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.5 m -73.42 165.54 24.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 161.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.41 162.89 38.67 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 109.88 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.92 -40.33 47.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.54 0.736 . . . . 0.0 109.468 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.06 50.82 3.76 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.14 150.84 10.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.683 0.793 . . . . 0.0 110.498 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -91.21 -31.26 16.23 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.612 0.765 . . . . 0.0 112.81 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -147.03 -179.38 6.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.941 1.696 . . . . 0.0 107.956 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.63 134.9 52.89 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -135.11 139.49 44.72 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 73.9 mt -75.75 133.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 162.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.272 1.429 . . . . 0.0 108.542 179.034 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.861 -0.052 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.7 tp -130.42 163.91 25.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.012 1.325 . . . . 0.0 109.297 -169.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -129.37 142.15 50.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.228 1.011 . . . . 0.0 108.437 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.14 155.89 33.51 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.746 1.618 . . . . 0.0 108.38 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm-85 -120.01 140.06 51.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 158.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.2 mt -130.85 143.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.1 mm -126.72 141.98 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.93 146.17 27.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.1 157.69 45.81 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.553 1.141 . . . . 0.0 109.477 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.45 -158.97 23.95 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.479 1.514 . . . . 0.0 109.643 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -74.0 89.2 1.91 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 159.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.25 15.91 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.484 0.713 . . . . 0.0 111.701 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -138.14 149.0 45.49 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.75 32.4 74.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.42 6.72 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.726 1.61 . . . . 0.0 111.314 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.63 21.2 60.31 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.518 1.056 . . . . 0.0 110.529 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.77 -43.91 91.72 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.392 1.096 . . . . 0.0 110.495 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -65.74 -40.76 92.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.134 0.879 . . . . 0.0 111.15 -177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.02 -41.95 90.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.658 0.663 . . . . 0.0 110.6 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -56.64 -49.8 73.93 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.821 0.737 . . . . 0.0 110.005 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.73 -39.85 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.102 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.5 -41.01 93.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.804 1.184 . . . . 0.0 110.491 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.96 -35.68 72.26 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 111.103 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -72.43 -21.82 61.2 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.171 -0.956 . . . . 0.0 112.038 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.68 -46.41 46.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.94 -37.58 87.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.226 1.01 . . . . 0.0 112.255 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -17.64 42.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -130.29 21.53 5.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.133 0.973 . . . . 0.0 110.747 173.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 28.61 54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.868 2.867 . . . . 0.0 113.763 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.14 165.86 15.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.391 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.3 164.48 23.44 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.635 1.574 . . . . 0.0 108.039 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.42 -150.98 23.3 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.68 0.673 . . . . 0.0 112.783 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -151.32 169.8 21.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.68 1.192 . . . . 0.0 110.295 162.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.1 144.66 34.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.855 1.662 . . . . 0.0 107.726 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.01 146.64 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.384 1.074 . . . . 0.0 109.251 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -83.93 120.9 26.65 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 161.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -73.88 149.37 41.55 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.05 -23.65 67.54 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.6 0.36 . . . . 0.0 111.684 172.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.38 -21.07 61.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.466 1.506 . . . . 0.0 112.97 172.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.49 -16.15 52.67 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.56 1.076 . . . . 0.0 112.395 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -71.93 170.44 13.76 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 110.581 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.98 150.84 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 165.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.25 146.13 49.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.66 146.45 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -143.41 116.36 8.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.23 44.07 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.692 0.678 . . . . 0.0 111.911 -162.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -135.0 132.61 38.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.801 2.041 . . . . 0.0 107.551 -166.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.94 -177.49 41.02 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.59 152.74 74.53 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.233 1.955 . . . . 0.0 110.184 173.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.35 -33.87 73.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.96 -35.19 69.48 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.963 -1.086 . . . . 0.0 111.579 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -40.31 70.79 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.36 0.264 . . . . 0.0 110.604 176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.1 mp -58.79 -40.13 83.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.745 0.818 . . . . 0.0 110.552 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -65.32 -49.27 70.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.468 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 p -62.02 -34.16 75.69 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.559 1.527 . . . . 0.0 111.264 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -63.93 -47.03 82.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.677 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.3 t -57.21 -47.15 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.309 0.958 . . . . 0.0 109.462 173.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.8 -41.54 77.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.404 0.682 . . . . 0.0 110.555 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.89 -42.09 77.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.216 0.606 . . . . 0.0 111.84 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.62 -31.52 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 118.341 -0.837 . . . . 0.0 110.635 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -58.55 -36.2 73.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.991 1.269 . . . . 0.0 111.159 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.32 -43.07 71.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.939 0.336 . . . . 0.0 110.548 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.22 -178.29 30.76 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.848 0.737 . . . . 0.0 111.666 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.4 p -63.53 159.33 52.28 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 0.0 110.622 177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.17 -26.17 25.58 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.519 2.813 . . . . 0.0 115.333 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.28 -7.39 24.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 112.198 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.7 p -74.84 167.68 21.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.575 0.702 . . . . 0.0 110.863 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -139.39 77.86 1.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -59.51 140.07 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.4 p -123.65 -21.29 5.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.415 1.086 . . . . 0.0 111.547 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.23 154.86 31.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.886 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.08 145.88 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.564 1.546 . . . . 0.0 107.53 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -141.15 157.4 45.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.33 1.452 . . . . 0.0 109.123 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.54 145.63 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.803 1.241 . . . . 0.0 108.738 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 m -136.52 166.05 24.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.329 2.251 . . . . 0.0 106.095 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.2 163.56 33.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.633 -1.292 . . . . 0.0 111.287 -174.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.6 m -148.14 146.91 28.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.279 1.832 . . . . 0.0 108.284 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -81.64 -34.13 31.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.055 -0.403 . . . . 0.0 110.693 172.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.4 m -65.61 155.96 34.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.001 0.921 . . . . 0.0 109.679 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 164.52 37.95 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.536 1.535 . . . . 0.0 108.831 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -80.98 -34.65 32.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.877 0.762 . . . . 0.0 110.947 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.82 21.53 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.192 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . 0.251 30.1 p80 47.07 42.54 12.93 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.891 2.077 . . . . 0.0 114.188 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.52 -49.98 35.73 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.24 173.76 12.96 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.337 1.455 . . . . 0.0 109.458 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -122.65 100.11 6.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.584 1.084 . . . . 0.0 109.637 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 136.89 35.32 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.919 0.488 . . . . 0.0 110.766 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.6 mt -84.72 126.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 153.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 100.0 t . . . . . 0 C--O 1.237 0.43 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.033 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpt . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.6 tp -153.37 164.88 37.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.563 1.145 . . . . 0.0 109.409 -172.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -117.87 138.27 52.23 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.661 1.584 . . . . 0.0 107.697 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -114.65 155.54 26.39 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.072 1.349 . . . . 0.0 107.36 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -127.51 140.95 51.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 162.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.05 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.08 137.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -171.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -142.76 156.75 45.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.769 1.228 . . . . 0.0 110.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.67 -155.85 24.44 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.509 1.528 . . . . 0.0 110.082 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -74.35 82.25 1.9 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 159.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.96 21.87 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.884 1.274 . . . . 0.0 110.201 -174.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -137.72 149.79 46.77 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.503 1.121 . . . . 0.0 108.358 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.62 74.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.591 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.78 -10.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.376 1.071 . . . . 0.0 111.949 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 23.34 13.69 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.124 1.345 . . . . 0.0 110.243 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.16 -39.14 93.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.506 1.653 . . . . 0.0 110.48 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -55.51 -47.36 76.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.757 0.708 . . . . 0.0 111.448 171.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -68.01 -39.08 83.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.411 0.551 . . . . 0.0 111.291 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -56.29 -54.16 48.66 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 173.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.38 -39.64 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.388 0.54 . . . . 0.0 110.461 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -56.22 -47.52 78.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 0.0 109.943 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.6 mtm -73.78 -34.96 64.89 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.447 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.37 -43.85 93.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.503 1.047 . . . . 0.0 109.869 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.76 92.15 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.227 0.467 . . . . 0.0 110.727 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.21 -47.7 84.86 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.753 0.821 . . . . 0.0 110.304 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -61.2 -41.97 97.77 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.859 0.863 . . . . 0.0 111.007 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -74.98 -3.71 33.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.811 0.844 . . . . 0.0 112.37 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 49.52 35.17 7.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.098 1.759 . . . . 0.0 112.251 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.37 170.68 16.25 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 110.158 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.29 153.49 46.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.349 1.46 . . . . 0.0 107.583 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.15 -155.85 26.72 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.762 1.164 . . . . 0.0 113.67 -171.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.46 165.99 25.99 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.301 0.64 . . . . 0.0 112.542 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.4 144.65 36.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.819 1.248 . . . . 0.0 107.759 161.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.32 158.65 43.46 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.464 1.106 . . . . 0.0 108.265 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.74 118.51 25.73 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -94.13 153.5 18.07 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.829 0.852 . . . . 0.0 110.421 -155.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.48 -29.09 70.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.606 0.362 . . . . 0.0 111.953 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.87 -9.79 47.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.49 -19.63 26.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.441 1.019 . . . . 0.0 113.321 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -83.75 154.73 23.43 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.674 1.237 . . . . 0.0 109.995 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.95 150.64 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 162.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -132.06 141.43 49.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -135.26 144.1 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -134.25 126.01 28.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.5 149.43 48.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -137.11 130.8 31.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.35 -173.54 43.71 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -170.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.85 149.19 59.56 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.481 2.12 . . . . 0.0 110.031 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.97 -34.16 71.49 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.121 0.969 . . . . 0.0 111.939 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.16 -40.52 82.33 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.035 -1.041 . . . . 0.0 111.673 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -41.28 83.36 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.52 -41.58 96.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.05 -49.79 76.26 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.444 0.565 . . . . 0.0 110.362 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 m -65.22 -29.66 70.48 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.961 -0.462 . . . . 0.0 111.446 -177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -68.58 -45.17 72.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.403 1.081 . . . . 0.0 110.461 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.8 -49.18 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.641 1.11 . . . . 0.0 109.038 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -56.86 -41.69 78.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.763 0.825 . . . . 0.0 110.608 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.36 -48.13 74.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.827 0.451 . . . . 0.0 111.553 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.97 -30.15 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.838 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -59.05 -23.33 61.91 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.127 1.33 . . . . 0.0 112.191 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -68.25 -34.87 77.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.6 0.636 . . . . 0.0 111.582 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.36 171.9 3.41 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.252 0.93 . . . . 0.0 112.082 -164.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 157.59 65.71 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 121.88 -0.776 . . . . 0.0 110.157 171.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.69 -31.69 61.77 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.123 2.549 . . . . 0.0 113.66 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.46 1.92 39.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.52 1.528 . . . . 0.0 112.759 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 m -128.03 167.11 17.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.854 0.862 . . . . 0.0 110.759 -158.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -146.19 92.95 2.25 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.87 142.78 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 161.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.6 p -128.47 -17.03 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.958 1.303 . . . . 0.0 111.226 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -150.39 148.73 29.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 108.918 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.26 143.85 13.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.653 1.181 . . . . 0.0 107.919 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -142.97 154.46 44.06 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.263 1.425 . . . . 0.0 108.656 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.83 145.73 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.517 1.127 . . . . 0.0 108.293 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.33 162.6 32.57 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.892 2.077 . . . . 0.0 106.686 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -134.66 157.87 45.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.596 1.158 . . . . 0.0 109.759 -172.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -160.06 162.99 34.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.12 1.368 . . . . 0.0 109.623 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -120.05 -12.86 9.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.954 0.902 . . . . 0.0 111.561 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.8 m -78.25 68.6 4.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.436 1.095 . . . . 0.0 109.507 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.67 148.27 7.48 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.226 1.011 . . . . 0.0 111.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -71.65 -35.09 70.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.252 1.021 . . . . 0.0 109.335 163.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.76 44.73 3.84 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.356 0.979 . . . . 0.0 111.149 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -60.46 157.29 14.33 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.494 0.718 . . . . 0.0 110.612 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.22 -6.19 5.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.57 1.148 . . . . 0.0 111.901 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.75 171.12 14.54 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.447 1.899 . . . . 0.0 106.833 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -117.19 135.38 53.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -138.91 144.63 39.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.51 141.04 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 126.765 2.026 . . . . 0.0 106.607 -178.001 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.5 mtp . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.05 151.0 43.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 108.887 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -114.92 140.43 49.0 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -124.93 154.95 40.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.317 1.447 . . . . 0.0 108.938 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.34 138.67 52.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 159.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.79 143.38 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 mm -129.58 138.15 54.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.59 147.85 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -143.29 156.75 44.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.519 1.128 . . . . 0.0 110.027 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.65 -154.23 23.55 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.481 1.515 . . . . 0.0 110.138 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.63 89.37 1.31 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 158.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.62 18.46 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.997 0.919 . . . . 0.0 111.392 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -138.81 153.82 48.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.137 0.975 . . . . 0.0 109.186 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.24 32.17 81.34 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -133.47 -8.0 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 111.695 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.81 24.5 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.67 -44.5 85.77 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.424 1.612 . . . . 0.0 109.882 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -53.89 -49.55 68.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.611 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -61.78 -49.05 77.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.355 0.525 . . . . 0.0 110.681 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -62.89 -41.77 99.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.082 0.401 . . . . 0.0 110.855 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.98 -40.8 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.909 0.777 . . . . 0.0 110.249 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -59.91 -48.4 81.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.224 0.92 . . . . 0.0 109.531 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.9 ptm -70.81 -32.03 68.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.316 0.507 . . . . 0.0 111.67 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -69.48 -28.24 65.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.458 1.026 . . . . 0.0 111.84 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.4 -44.35 52.38 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.932 0.493 . . . . 0.0 109.833 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.42 -42.15 98.3 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 123.967 0.907 . . . . 0.0 111.291 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -6.54 35.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -113.06 2.27 15.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.871 1.668 . . . . 0.0 111.34 171.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.28 38.45 5.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.537 1.535 . . . . 0.0 112.037 -169.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.75 165.68 14.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.76 156.5 44.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.516 1.127 . . . . 0.0 108.011 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.79 -154.79 26.16 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.223 0.919 . . . . 0.0 112.692 -170.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -145.92 167.53 23.06 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.102 -0.646 . . . . 0.0 112.625 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.48 145.68 30.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.775 1.23 . . . . 0.0 108.456 167.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.71 160.16 40.75 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 108.045 170.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -125.9 113.54 17.34 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -86.48 153.25 22.0 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.236 1.014 . . . . 0.0 110.193 -157.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -29.47 70.45 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.631 0.372 . . . . 0.0 111.878 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.99 -9.24 43.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.97 -20.2 26.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.505 1.05 . . . . 0.0 113.331 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.3 mtm180 -80.03 154.66 28.02 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.692 1.246 . . . . 0.0 110.045 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.88 150.67 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 161.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -134.07 142.33 47.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -139.61 150.07 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -134.7 128.81 33.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.25 44.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.12 0.873 . . . . 0.0 109.412 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -140.41 136.09 32.73 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 107.881 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.61 -171.46 43.24 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.962 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.3 138.32 42.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.267 1.978 . . . . 0.0 109.411 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.54 -30.37 67.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.838 1.255 . . . . 0.0 113.018 -168.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -69.75 -46.53 65.65 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.763 -1.211 . . . . 0.0 111.647 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.19 -39.02 89.37 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 tp -61.53 -47.73 84.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.156 0.982 . . . . 0.0 110.167 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -60.14 -44.41 94.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.75 0.42 . . . . 0.0 110.872 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m -62.48 -38.6 90.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.495 0.589 . . . . 0.0 111.179 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -61.28 -44.7 96.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.518 -0.739 . . . . 0.0 110.161 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.4 -43.81 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.542 1.065 . . . . 0.0 110.15 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -55.5 -39.55 70.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.671 1.123 . . . . 0.0 110.495 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.73 82.73 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.171 0.588 . . . . 0.0 111.471 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.33 -31.41 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.758 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -61.64 -33.36 73.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.054 1.297 . . . . 0.0 111.533 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -71.58 -45.35 62.47 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.704 0.684 . . . . 0.0 109.999 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.39 -156.77 34.0 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -170.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.9 p -62.04 168.83 3.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 122.699 0.4 . . . . 0.0 110.573 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.35 -10.08 1.97 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.53 2.82 . . . . 0.0 114.763 165.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -124.04 -0.77 8.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.263 1.425 . . . . 0.0 111.799 -171.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -77.18 166.22 23.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.082 0.953 . . . . 0.0 112.006 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -142.75 88.38 2.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 159.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.02 142.19 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -123.77 -18.32 6.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.287 1.035 . . . . 0.0 111.091 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -153.3 149.87 28.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.276 1.031 . . . . 0.0 109.241 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.74 144.22 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -139.75 152.22 46.45 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.122 1.369 . . . . 0.0 108.566 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -136.45 145.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.724 1.209 . . . . 0.0 108.169 -176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -132.3 160.35 36.5 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 167.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.43 161.75 37.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.281 0.946 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 m -142.84 124.79 15.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.86 11.77 3.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.76 0.824 . . . . 0.0 112.234 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -138.39 143.69 39.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.992 1.717 . . . . 0.0 106.936 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 mt -84.49 159.17 20.79 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.824 0.45 . . . . 0.0 110.658 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.02 -37.67 38.56 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 156.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 50.14 1.59 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.229 0.918 . . . . 0.0 111.386 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -58.01 144.89 38.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.524 0.729 . . . . 0.0 110.191 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -86.59 -28.2 23.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.246 0.618 . . . . 0.0 112.193 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -151.97 -178.75 6.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.783 1.633 . . . . 0.0 108.808 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -114.28 127.82 56.06 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -132.65 139.87 47.92 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.563 0.696 . . . . 0.0 112.464 -166.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.1 mt -76.7 131.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -135.32 167.24 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 0.0 109.142 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.69 -1.08 2.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.927 0.891 . . . . 0.0 111.979 -171.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.033 1.333 . . . . 0.0 110.268 -179.418 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.8 mt -136.7 170.52 15.94 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.673 1.589 . . . . 0.0 108.266 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -117.96 138.85 51.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 106.335 166.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.58 155.68 28.3 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.265 1.426 . . . . 0.0 107.304 167.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -124.48 139.66 53.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 162.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 mt -134.36 140.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.87 139.49 51.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.0 144.2 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -138.11 156.16 48.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.809 1.244 . . . . 0.0 110.033 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.43 -154.54 22.51 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.416 1.484 . . . . 0.0 110.44 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -72.55 82.65 1.11 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.8 m -135.07 18.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.274 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -137.01 146.86 45.8 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.949 0.9 . . . . 0.0 108.653 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.6 33.13 83.58 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -134.7 -9.23 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.702 1.201 . . . . 0.0 111.824 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.12 20.58 15.59 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.217 1.389 . . . . 0.0 110.468 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.59 -41.86 98.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.995 1.398 . . . . 0.0 110.43 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -54.48 -49.0 71.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.789 0.722 . . . . 0.0 111.473 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -66.75 -42.04 86.83 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.308 0.504 . . . . 0.0 111.231 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.22 -51.67 67.24 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.082 0.553 . . . . 0.0 110.22 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.68 -41.5 88.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.091 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -58.44 -45.53 88.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.797 0.726 . . . . 0.0 109.902 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.4 mtm -74.01 -33.85 63.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.743 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -66.67 -40.14 88.46 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.867 1.212 . . . . 0.0 110.249 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.17 97.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.172 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.81 -44.49 93.97 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.761 0.824 . . . . 0.0 110.832 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -58.89 -41.22 86.66 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.253 1.021 . . . . 0.0 111.182 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -86.22 0.93 52.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.371 -0.823 . . . . 0.0 113.161 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mptt 49.67 37.15 12.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.572 1.549 . . . . 0.0 111.933 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.87 165.71 22.66 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.837 0.855 . . . . 0.0 109.584 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.85 165.02 14.16 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.522 1.129 . . . . 0.0 108.058 165.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.84 -154.39 24.81 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 118.856 0.753 . . . . 0.0 112.335 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -153.81 167.59 29.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 112.049 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -137.07 145.2 30.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 108.796 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -140.44 164.52 29.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.258 1.023 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.2 109.19 12.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -76.15 152.93 36.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.473 0.709 . . . . 0.0 111.056 -157.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.28 -27.58 69.43 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.884 0.474 . . . . 0.0 111.25 164.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -14.58 19.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.323 1.849 . . . . 0.0 112.853 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -9.01 50.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.125 0.869 . . . . 0.0 113.165 167.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -104.91 156.09 18.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.592 1.157 . . . . 0.0 109.226 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.45 147.27 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 168.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -133.28 135.56 44.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -136.46 146.07 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -172.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 tt -135.87 126.96 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 167.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.04 152.34 49.97 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.644 0.778 . . . . 0.0 109.339 -172.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -141.17 133.93 28.81 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.67 1.188 . . . . 0.0 107.949 -169.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.93 -171.46 40.34 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.547 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.29 156.88 54.49 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.798 2.332 . . . . 0.0 110.666 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -58.54 -44.8 89.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.588 0.755 . . . . 0.0 111.124 -173.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.74 -39.53 89.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.89 0.768 . . . . 0.0 111.928 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.62 -47.51 72.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.7 -38.82 92.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.1 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.5 -51.95 66.53 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.62 0.768 . . . . 0.0 110.184 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 m -62.15 -38.93 90.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.418 0.554 . . . . 0.0 110.893 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.19 -44.06 97.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.109 0.964 . . . . 0.0 110.403 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 t -57.81 -47.98 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.325 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.63 -40.47 75.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.663 1.12 . . . . 0.0 111.18 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.1 82.69 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.141 0.576 . . . . 0.0 110.882 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.5 t -63.28 -28.09 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.035 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -59.32 -37.67 78.36 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.563 1.528 . . . . 0.0 110.921 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.08 -42.77 56.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.222 0.465 . . . . 0.0 110.421 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.64 -174.18 51.04 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.54 160.09 28.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.076 0.55 . . . . 0.0 110.588 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.16 -32.9 51.84 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.124 2.549 . . . . 0.0 113.771 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -88.43 -7.31 56.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.66 1.184 . . . . 0.0 112.763 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -91.91 168.75 11.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.943 1.297 . . . . 0.0 110.725 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -145.24 95.86 2.74 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 165.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.6 t -63.79 145.19 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.7 p -123.11 -21.85 5.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.311 1.044 . . . . 0.0 111.192 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -154.79 153.12 30.71 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.149 0.98 . . . . 0.0 109.469 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.78 146.0 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.352 1.461 . . . . 0.0 107.402 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.5 m -139.37 151.01 45.99 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.153 1.381 . . . . 0.0 108.369 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.15 145.41 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.403 1.081 . . . . 0.0 108.239 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -136.32 161.03 36.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 106.173 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -149.28 163.18 38.42 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.131 -0.981 . . . . 0.0 111.527 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -149.17 148.23 29.38 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.583 1.953 . . . . 0.0 108.536 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -72.58 -40.54 66.51 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.038 168.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 m -61.63 145.24 52.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.937 0.895 . . . . 0.0 109.13 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.6 157.16 42.67 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.527 1.531 . . . . 0.0 108.645 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.12 -33.39 56.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.695 0.798 . . . . 0.0 110.114 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.45 49.51 14.81 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -169.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -54.72 151.06 8.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.101 0.96 . . . . 0.0 111.789 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -76.51 -19.36 58.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -150.54 178.3 9.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.656 1.582 . . . . 0.0 108.415 -172.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.38 116.42 31.94 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 153.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.7 m -117.18 142.31 47.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 111.996 -167.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.16 135.57 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 162.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.45 HG22 ' H ' ' A' ' 90' ' ' TYR . 7.2 p -141.26 175.73 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.926 1.29 . . . . 0.0 108.303 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.45 ' H ' HG22 ' A' ' 89' ' ' VAL . 72.1 m-85 -134.82 2.98 3.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.961 0.904 . . . . 0.0 112.299 -169.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 125.706 1.602 . . . . 0.0 107.501 -176.011 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.5 mt -137.83 -179.96 6.07 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.004 1.322 . . . . 0.0 109.5 -167.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -130.55 132.14 45.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.648 1.979 . . . . 0.0 107.229 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -116.67 155.48 28.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -120.42 143.81 48.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 158.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.0 mt -132.72 142.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mm -131.35 136.79 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.1 147.64 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.32 156.93 44.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.482 1.113 . . . . 0.0 109.976 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.56 -153.93 23.89 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.383 1.468 . . . . 0.0 110.374 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -72.38 84.75 1.09 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 158.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.02 19.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.101 0.96 . . . . 0.0 110.994 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -138.54 149.18 45.06 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 109.053 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.38 31.27 79.83 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -134.7 -9.85 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.654 1.181 . . . . 0.0 111.731 -173.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.78 22.79 17.18 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.932 1.253 . . . . 0.0 110.119 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -64.08 -39.6 94.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.239 1.52 . . . . 0.0 110.243 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -55.51 -46.19 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.904 0.774 . . . . 0.0 111.695 172.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -68.58 -40.39 80.57 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.508 0.594 . . . . 0.0 111.108 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -56.03 -51.65 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.388 0.54 . . . . 0.0 110.151 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.21 -41.35 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 118.954 -0.546 . . . . 0.0 110.211 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.79 -46.13 88.27 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.826 0.739 . . . . 0.0 110.329 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.9 mtm -72.62 -35.97 67.96 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.347 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -67.0 -39.36 87.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.677 1.126 . . . . 0.0 110.292 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.32 97.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.177 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.31 -45.05 93.17 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.389 0.676 . . . . 0.0 110.685 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -59.48 -33.85 71.84 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.902 0.881 . . . . 0.0 111.311 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -89.7 1.73 55.69 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.675 1.19 . . . . 0.0 112.839 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm 41.33 38.88 0.88 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.115 2.166 . . . . 0.0 112.503 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.06 165.75 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.816 0.846 . . . . 0.0 109.406 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.19 14.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 162.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.49 -163.53 29.27 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.881 0.764 . . . . 0.0 113.332 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -147.01 166.4 26.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 122.214 -0.58 . . . . 0.0 111.623 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.76 144.06 34.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.526 1.13 . . . . 0.0 109.047 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -139.25 161.94 36.2 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.48 1.112 . . . . 0.0 108.653 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -125.54 111.43 15.03 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.28 153.08 23.76 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.799 1.239 . . . . 0.0 110.383 -157.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.77 -29.32 70.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.94 -10.29 52.17 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.47 -22.62 17.08 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.427 1.013 . . . . 0.0 113.292 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -78.28 154.76 30.66 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.67 1.235 . . . . 0.0 110.327 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.61 148.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.07 135.02 43.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.57 143.15 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.72 125.28 22.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.88 43.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.65 0.78 . . . . 0.0 110.121 -171.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -139.09 143.52 38.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.822 1.249 . . . . 0.0 108.138 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.89 -171.8 39.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.321 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 152.61 57.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.687 2.258 . . . . 0.0 110.712 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.94 -34.52 76.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.62 0.768 . . . . 0.0 112.133 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.22 -40.4 77.99 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.025 -1.047 . . . . 0.0 111.476 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.83 85.74 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.95 -42.19 90.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.968 0.507 . . . . 0.0 110.621 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.98 -51.58 69.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.797 0.726 . . . . 0.0 110.789 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 p -66.45 -31.67 72.56 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.871 -0.518 . . . . 0.0 111.316 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.22 -43.35 99.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.72 171.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.54 -49.56 80.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 119.539 1.063 . . . . 0.0 108.744 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.81 -39.25 73.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.395 0.998 . . . . 0.0 111.464 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.13 -44.12 85.13 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 110.61 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.36 -30.87 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.455 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -59.49 -45.84 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.873 1.67 . . . . 0.0 109.988 172.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.3 -38.48 85.05 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.58 0.352 . . . . 0.0 111.27 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 177.06 27.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.113 0.863 . . . . 0.0 112.041 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.48 153.17 90.83 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.278 -0.542 . . . . 0.0 110.589 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.65 -31.48 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.195 2.597 . . . . 0.0 114.16 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -92.13 10.79 27.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.988 1.315 . . . . 0.0 111.991 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -128.58 169.07 14.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.417 1.487 . . . . 0.0 109.882 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -147.02 96.18 2.69 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.66 140.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.8 p -126.93 -14.17 5.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 111.268 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.51 150.63 29.79 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 109.17 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.86 147.7 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.866 1.266 . . . . 0.0 107.846 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -143.6 161.58 38.13 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.521 1.528 . . . . 0.0 108.753 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.6 t -138.39 149.23 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.609 1.164 . . . . 0.0 108.141 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.36 161.78 33.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.548 1.939 . . . . 0.0 106.189 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -140.79 158.09 44.47 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 120.943 -1.098 . . . . 0.0 111.034 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 m -134.92 138.27 43.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 156.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -89.44 24.09 2.36 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.207 -0.933 . . . . 0.0 111.171 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -142.12 179.27 7.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.822 2.449 . . . . 0.0 106.973 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -144.92 156.32 43.92 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.528 1.131 . . . . 0.0 109.405 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.8 -5.13 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -164.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.21 -3.1 0.79 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 120.036 1.289 . . . . 0.0 115.125 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -48.76 113.6 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.761 1.624 . . . . 0.0 112.126 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -150.93 -49.1 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.372 1.069 . . . . 0.0 111.115 173.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -152.92 -179.57 7.78 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 108.976 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -115.65 137.5 52.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -139.74 139.84 36.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.62 137.59 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 163.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 90' ' ' TYR . 6.5 p -141.21 174.21 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.048 1.339 . . . . 0.0 108.316 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.429 ' H ' HG22 ' A' ' 89' ' ' VAL . 71.3 m-85 -134.69 5.03 3.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.873 0.869 . . . . 0.0 112.231 -168.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.248 1.004 0 C-N-CA 125.824 1.65 . . . . 0.0 107.387 -177.258 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt -139.01 166.35 24.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.751 1.621 . . . . 0.0 108.953 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -112.15 138.61 48.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.606 1.563 . . . . 0.0 106.921 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -119.16 154.91 32.56 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.721 1.608 . . . . 0.0 107.051 166.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -127.9 138.73 52.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 165.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.64 143.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mm -131.68 136.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.91 150.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -143.57 158.28 43.78 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.981 1.313 . . . . 0.0 109.65 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.65 -155.54 24.86 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.436 1.493 . . . . 0.0 110.094 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.0 ttp-105 -75.91 87.36 2.87 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 159.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.11 19.81 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.846 0.859 . . . . 0.0 111.282 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.68 151.97 46.34 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.365 1.066 . . . . 0.0 108.146 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.33 32.12 82.63 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.78 -1.63 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.513 1.525 . . . . 0.0 111.435 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.68 25.58 34.98 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.457 -1.191 . . . . 0.0 110.127 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.9 -47.5 80.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.268 1.534 . . . . 0.0 109.935 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -62.83 -41.12 99.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.038 0.835 . . . . 0.0 110.64 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -61.97 -45.19 94.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.764 0.425 . . . . 0.0 110.705 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -58.72 -51.02 71.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.242 0.617 . . . . 0.0 110.177 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.96 -39.45 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.219 0.463 . . . . 0.0 110.493 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -58.81 -47.13 85.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.931 0.787 . . . . 0.0 110.55 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -77.11 -30.75 55.39 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.903 0.774 . . . . 0.0 111.719 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.05 -31.65 69.37 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.194 0.906 . . . . 0.0 111.027 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.69 71.19 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.282 0.492 . . . . 0.0 109.885 168.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.71 -42.98 99.67 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.53 0.732 . . . . 0.0 111.571 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -12.6 60.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -115.36 8.0 15.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.678 1.191 . . . . 0.0 111.633 171.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 41.91 42.18 2.17 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.463 1.905 . . . . 0.0 112.52 -173.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.61 166.03 7.38 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.212 0.605 . . . . 0.0 109.856 166.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.85 154.41 45.51 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.63 1.172 . . . . 0.0 107.987 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.82 -161.37 28.67 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 119.282 0.946 . . . . 0.0 112.896 -171.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.55 166.81 25.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 168.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.49 146.35 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 109.281 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -147.1 163.91 34.78 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -124.86 153.9 41.88 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -123.9 151.18 43.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.289 -144.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.0 -27.19 68.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 111.117 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.5 -16.85 40.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.601 1.96 . . . . 0.0 113.135 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -28.16 15.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.93 1.729 . . . . 0.0 111.838 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.1 mtt85 -74.05 168.18 20.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.699 0.799 . . . . 0.0 111.517 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.64 150.01 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 158.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.79 140.87 46.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mt -139.04 147.0 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.08 127.0 29.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 168.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.05 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.696 0.68 . . . . 0.0 109.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.73 133.85 31.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.78 -169.35 40.08 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.592 -172.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.25 152.76 61.78 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.316 2.011 . . . . 0.0 110.216 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.21 -42.46 81.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.884 0.874 . . . . 0.0 110.93 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.57 -42.88 99.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.264 0.484 . . . . 0.0 111.574 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.56 82.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.673 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -38.34 82.1 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 110.988 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -64.91 -49.94 68.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.592 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -57.76 -39.14 76.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.209 1.368 . . . . 0.0 111.409 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.03 -46.42 84.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.903 0.881 . . . . 0.0 109.927 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 118.953 0.797 . . . . 0.0 109.822 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.06 -40.67 73.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.607 0.763 . . . . 0.0 110.538 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.56 72.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.898 0.879 . . . . 0.0 111.416 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.21 -26.29 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.187 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -57.12 -34.81 68.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.322 1.419 . . . . 0.0 111.223 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -82.12 -41.51 20.38 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.114 0.416 . . . . 0.0 111.01 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.85 -166.11 54.72 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -164.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.8 p -60.71 167.46 3.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.915 0.486 . . . . 0.0 111.451 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.45 -15.04 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.775 2.983 . . . . 0.0 115.252 168.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -115.44 -7.15 12.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.532 1.133 . . . . 0.0 111.903 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -70.74 163.67 26.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.652 0.739 . . . . 0.0 111.014 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -142.77 88.79 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 161.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.82 142.67 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 p -125.49 -18.13 5.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.403 1.081 . . . . 0.0 111.15 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.56 149.62 28.68 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.312 1.045 . . . . 0.0 109.123 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 tt -152.91 145.31 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.844 1.258 . . . . 0.0 107.936 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -142.06 152.4 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.357 1.463 . . . . 0.0 108.524 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.13 145.47 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.756 1.223 . . . . 0.0 107.895 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.91 161.8 35.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.456 1.902 . . . . 0.0 106.416 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -138.82 163.65 31.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.01 0.924 . . . . 0.0 110.364 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.0 m -154.53 147.59 24.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.342 166.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.98 -41.71 58.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 m -60.26 156.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.3 mt -129.29 149.8 50.93 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.812 1.245 . . . . 0.0 109.036 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -75.94 -34.34 59.86 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.5 0.72 . . . . 0.0 109.248 161.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 41.37 5.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.212 0.911 . . . . 0.0 111.292 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -57.77 149.06 23.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.932 0.866 . . . . 0.0 109.828 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -118.73 -6.52 10.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.41 1.084 . . . . 0.0 112.129 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -148.96 176.75 10.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.959 1.704 . . . . 0.0 107.706 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -110.72 135.95 50.53 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -136.75 139.5 41.89 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.645 0.736 . . . . 0.0 112.755 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -74.17 134.64 29.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 161.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.91 169.12 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.343 1.057 . . . . 0.0 108.907 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -137.48 22.51 2.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.133 0.973 . . . . 0.0 110.998 -166.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.249 1.031 0 C-N-CA 126.007 1.723 . . . . 0.0 111.359 -178.157 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.72 176.54 7.17 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.532 1.933 . . . . 0.0 107.7 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -125.31 137.0 54.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -118.87 159.06 24.46 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.031 1.732 . . . . 0.0 108.052 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -129.32 140.55 51.36 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -134.27 139.22 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -173.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.9 mm -127.29 138.83 53.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.47 146.64 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -140.5 156.92 46.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.12 1.368 . . . . 0.0 109.913 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.5 22.68 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.402 1.477 . . . . 0.0 110.193 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -73.33 82.32 1.39 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.67 19.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.763 0.825 . . . . 0.0 111.074 -171.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -137.05 147.13 45.98 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.61 33.14 86.43 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.41 -1.38 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.095 1.358 . . . . 0.0 111.238 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 26.71 34.96 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.16 -46.83 82.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.312 1.556 . . . . 0.0 109.697 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -55.91 -45.1 78.79 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.614 -0.679 . . . . 0.0 111.488 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -65.95 -43.24 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.718 0.407 . . . . 0.0 110.859 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.57 -51.7 68.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.396 0.679 . . . . 0.0 110.174 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.68 -40.83 88.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 118.329 0.513 . . . . 0.0 110.386 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.74 -43.68 85.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.494 0.718 . . . . 0.0 110.898 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.8 mtm -74.27 -37.15 63.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.62 0.646 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.2 -37.36 87.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.613 1.097 . . . . 0.0 110.312 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.36 81.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.974 0.51 . . . . 0.0 110.564 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -58.61 -44.21 89.86 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -56.26 -26.11 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.974 1.71 . . . . 0.0 112.499 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -118.93 12.17 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.405 1.082 . . . . 0.0 112.049 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 43.53 43.06 4.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.087 1.755 . . . . 0.0 112.175 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.11 165.55 9.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.879 0.472 . . . . 0.0 109.819 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.25 158.62 20.27 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 162.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.06 -160.96 27.86 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 118.687 0.676 . . . . 0.0 112.774 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.73 168.0 26.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.242 -0.563 . . . . 0.0 112.387 171.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.92 144.85 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.171 1.388 . . . . 0.0 108.63 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -143.4 160.52 40.39 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -125.02 112.22 16.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.5 mtp85 -85.18 155.72 21.31 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.818 1.247 . . . . 0.0 110.618 -154.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.89 -27.76 69.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.628 0.371 . . . . 0.0 111.882 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -6.42 38.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.924 0.89 . . . . 0.0 113.184 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.07 -15.95 46.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.485 1.041 . . . . 0.0 113.586 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -88.12 155.8 19.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.18 1.49 . . . . 0.0 109.974 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.02 149.91 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 162.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.17 153.68 51.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.972 0.891 . . . . 0.0 109.8 157.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -142.79 146.13 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -171.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.2 154.63 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.241 0.616 . . . . 0.0 109.907 -169.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -138.79 131.96 29.86 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.391 1.476 . . . . 0.0 107.376 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.72 178.79 42.31 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.34 156.18 66.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 110.24 171.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.99 -35.53 77.07 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.335 0.654 . . . . 0.0 111.979 -171.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.96 -36.57 80.32 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.924 -1.11 . . . . 0.0 111.686 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.47 72.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.66 -37.97 88.03 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.851 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.01 -50.08 75.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.76 0.709 . . . . 0.0 110.626 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 m -61.57 -37.86 85.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.515 0.598 . . . . 0.0 111.025 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -63.62 -45.66 89.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.015 0.926 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.09 -48.5 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.174 0.897 . . . . 0.0 109.526 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -56.55 -40.83 75.81 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.588 0.755 . . . . 0.0 110.548 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.26 74.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.534 0.734 . . . . 0.0 111.578 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.78 -26.98 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.201 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -57.72 -33.43 68.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.263 1.392 . . . . 0.0 111.355 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -79.42 -42.04 26.3 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.329 0.513 . . . . 0.0 110.949 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.33 -166.81 54.52 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -165.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.4 p -60.65 167.41 3.36 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 122.915 0.486 . . . . 0.0 111.326 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.43 -15.18 3.65 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.669 2.913 . . . . 0.0 115.175 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -114.1 -7.98 13.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.56 1.144 . . . . 0.0 111.788 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.2 m -72.03 162.99 28.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.699 0.8 . . . . 0.0 110.994 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -143.31 89.4 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 161.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.8 143.88 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.6 p -124.76 -19.36 5.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.32 1.048 . . . . 0.0 111.207 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -153.77 150.73 28.8 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 109.172 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.7 146.07 15.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.02 1.328 . . . . 0.0 107.703 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 m -140.5 152.82 45.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.154 1.382 . . . . 0.0 108.426 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.8 t -137.76 145.47 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -134.32 159.16 41.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.54 1.936 . . . . 0.0 106.042 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -145.88 167.48 23.14 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.899 0.879 . . . . 0.0 110.102 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -140.09 173.45 11.51 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.133 1.373 . . . . 0.0 109.595 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -122.82 19.39 10.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.643 1.577 . . . . 0.0 109.715 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.0 m -135.87 167.27 21.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.176 1.79 . . . . 0.0 108.178 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -134.56 163.59 29.39 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.3 -25.32 4.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.063 1.745 . . . . 0.0 109.443 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.33 56.38 6.92 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.241 0.924 . . . . 0.0 111.189 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -57.6 150.77 18.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.165 0.482 . . . . 0.0 110.455 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -68.3 -26.97 65.9 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -161.34 -173.74 3.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.835 2.054 . . . . 0.0 107.445 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -99.29 132.82 44.35 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 165.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -136.42 139.91 42.78 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -171.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.63 133.38 31.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 161.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.1 m -134.19 166.27 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 0.0 109.663 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -136.27 8.38 3.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.688 1.195 . . . . 0.0 111.105 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.78 1.632 . . . . 0.0 110.636 -178.299 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 tp -146.05 162.31 38.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.045 1.338 . . . . 0.0 109.001 -166.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.15 138.01 52.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.423 1.489 . . . . 0.0 107.449 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -119.41 156.97 29.16 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.039 1.735 . . . . 0.0 108.419 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -122.78 139.68 53.73 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.77 144.55 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.85 138.11 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.46 147.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -141.95 157.89 44.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.492 1.117 . . . . 0.0 109.991 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.61 -157.33 23.58 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.932 1.729 . . . . 0.0 109.314 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.8 ttp-105 -72.36 85.19 1.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 159.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.51 19.85 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.667 1.187 . . . . 0.0 110.263 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -137.46 143.26 41.69 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.401 -0.812 . . . . 0.0 109.36 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.09 32.37 76.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.51 -7.32 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.785 1.234 . . . . 0.0 111.089 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.96 30.24 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.33 -43.8 83.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.936 1.368 . . . . 0.0 109.758 -173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -59.74 -41.17 90.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.806 0.73 . . . . 0.0 111.705 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.25 -45.01 77.96 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.646 0.657 . . . . 0.0 110.289 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -62.72 -40.11 96.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.955 0.798 . . . . 0.0 110.909 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.2 -38.98 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.106 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.85 -42.42 99.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.215 1.371 . . . . 0.0 110.505 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.64 -38.19 83.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.251 0.932 . . . . 0.0 110.451 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -66.41 -39.67 89.14 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.48 0.712 . . . . 0.0 109.999 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.69 -38.45 91.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.668 0.787 . . . . 0.0 110.327 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.02 -45.27 86.19 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 110.696 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -60.17 -18.23 46.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.919 1.287 . . . . 0.0 112.005 174.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -111.23 7.0 21.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.828 1.651 . . . . 0.0 112.499 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 38.72 40.07 0.38 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.765 2.426 . . . . 0.0 113.271 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -74.63 169.38 17.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.498 1.119 . . . . 0.0 110.237 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.1 164.76 18.01 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 160.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.68 -150.78 23.05 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.723 0.692 . . . . 0.0 112.004 -175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -155.81 170.96 20.87 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.065 0.946 . . . . 0.0 110.855 167.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.43 139.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.516 1.526 . . . . 0.0 107.79 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.59 157.84 45.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.197 1.399 . . . . 0.0 108.85 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.85 114.42 18.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -90.92 153.98 19.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.989 0.916 . . . . 0.0 110.759 -155.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.24 -27.35 68.6 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.049 0.54 . . . . 0.0 111.997 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -7.5 40.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.044 0.938 . . . . 0.0 112.929 175.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.36 -12.86 47.94 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.69 1.138 . . . . 0.0 113.352 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -90.77 154.81 19.25 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.98 1.39 . . . . 0.0 109.603 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.7 151.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -134.49 144.72 48.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.03 145.63 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -137.03 117.67 13.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.23 151.87 46.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.407 0.683 . . . . 0.0 109.933 -165.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -140.95 137.31 32.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.531 1.132 . . . . 0.0 108.583 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 -174.11 43.33 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.27 154.47 69.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.013 1.809 . . . . 0.0 110.263 169.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.67 -41.38 90.53 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.408 0.683 . . . . 0.0 111.442 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.36 -39.59 94.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.587 0.631 . . . . 0.0 111.729 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.92 -40.0 83.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -67.84 -36.76 80.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.076 0.398 . . . . 0.0 111.39 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -64.66 -49.19 71.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.248 0.931 . . . . 0.0 110.285 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 p -66.13 -29.38 69.67 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.729 -0.607 . . . . 0.0 111.352 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -63.66 -43.84 95.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.364 -0.827 . . . . 0.0 110.853 170.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.23 -44.09 87.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.827 1.194 . . . . 0.0 109.319 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.37 -36.55 78.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.136 0.88 . . . . 0.0 111.545 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.28 -50.1 55.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.804 0.442 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.61 -43.29 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.817 0.847 . . . . 0.0 109.873 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -18.8 62.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.499 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -78.24 -43.66 27.66 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.384 0.993 . . . . 0.0 110.403 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.35 -179.48 25.0 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.606 1.098 . . . . 0.0 111.636 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.5 p -74.23 166.92 40.53 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 122.13 -0.63 . . . . 0.0 109.677 168.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.44 -21.66 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.83 1.687 . . . . 0.0 112.445 170.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -73.17 -37.82 66.41 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.342 0.657 . . . . 0.0 110.338 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -71.55 167.16 20.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.106 0.962 . . . . 0.0 110.809 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -146.0 77.79 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 161.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.32 140.06 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.8 p -127.61 -16.6 4.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.935 1.294 . . . . 0.0 111.618 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -151.61 151.37 31.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.093 0.957 . . . . 0.0 109.59 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.25 149.54 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.894 1.277 . . . . 0.0 108.074 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.8 m -140.57 153.91 46.3 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.611 1.565 . . . . 0.0 108.191 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -137.57 145.18 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.413 1.085 . . . . 0.0 108.291 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.1 m -137.5 164.26 29.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.146 2.178 . . . . 0.0 106.056 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.33 168.76 18.98 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.835 -1.166 . . . . 0.0 111.657 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -142.35 131.97 23.97 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.53 1.932 . . . . 0.0 105.85 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -83.34 17.76 2.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.543 0.737 . . . . 0.0 111.612 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.4 m -139.77 159.75 41.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.166 2.186 . . . . 0.0 106.604 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.93 160.89 39.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.241 1.016 . . . . 0.0 110.354 -172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -78.69 -34.46 46.15 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.811 0.844 . . . . 0.0 110.296 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.57 51.4 7.28 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -55.02 153.32 6.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.267 1.027 . . . . 0.0 112.647 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -42.54 99.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.903 1.281 . . . . 0.0 112.155 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -153.9 -173.07 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 -164.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -114.49 95.5 5.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -79.99 131.33 35.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.981 0.42 . . . . 0.0 111.176 -170.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.45 115.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 154.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.95 129.22 37.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -84.46 46.29 1.21 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.49 1.116 . . . . 0.0 110.907 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 C-N-CA 125.974 1.71 . . . . 0.0 110.385 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttt . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.4 mt -135.61 175.87 9.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.748 1.619 . . . . 0.0 109.526 -171.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -129.27 149.43 51.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 108.121 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -140.52 165.58 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.893 -0.504 . . . . 0.0 111.243 157.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -123.0 136.23 54.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 167.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.2 mt -134.07 144.58 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mm -130.33 138.19 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 t -137.16 145.24 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -170.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -141.58 156.94 45.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.55 1.14 . . . . 0.0 109.8 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.04 -154.08 24.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.34 1.448 . . . . 0.0 110.371 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 ttp-105 -75.65 80.31 2.63 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 162.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.16 19.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.964 0.906 . . . . 0.0 111.169 -169.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -137.44 148.55 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.096 0.958 . . . . 0.0 108.885 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.64 84.49 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.5 m -134.05 -8.01 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.978 1.311 . . . . 0.0 111.416 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.86 23.02 21.87 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.954 1.264 . . . . 0.0 110.054 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.41 -42.76 99.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 119.22 1.51 . . . . 0.0 110.336 -172.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.22 -47.0 75.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.655 0.661 . . . . 0.0 111.619 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -68.89 -41.68 77.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.402 0.546 . . . . 0.0 111.386 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -56.69 -53.03 62.41 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.981 0.513 . . . . 0.0 109.717 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.9 t -62.4 -39.23 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.391 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -57.35 -44.3 84.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.185 0.902 . . . . 0.0 110.97 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.0 mtm -76.55 -36.04 57.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.536 0.607 . . . . 0.0 111.2 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -70.46 -27.81 64.52 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.146 0.885 . . . . 0.0 111.293 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.53 -46.92 65.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.844 -0.535 . . . . 0.0 109.666 168.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.32 -45.35 93.73 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.741 0.816 . . . . 0.0 111.226 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -30.35 69.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.35 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -114.88 18.01 16.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.678 0.672 . . . . 0.0 111.186 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt 52.13 42.64 30.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.273 1.829 . . . . 0.0 112.061 171.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.15 165.66 6.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.004 0.922 . . . . 0.0 108.955 165.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.79 46.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.17 0.988 . . . . 0.0 108.4 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.93 -153.67 24.4 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 119.3 0.955 . . . . 0.0 113.002 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -143.96 165.52 27.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.072 -0.664 . . . . 0.0 112.649 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.42 145.9 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.183 1.393 . . . . 0.0 107.942 165.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -144.39 159.51 42.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.303 1.041 . . . . 0.0 108.584 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -125.88 128.73 48.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -110.55 154.35 23.84 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.733 0.413 . . . . 0.0 110.885 -150.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.75 -27.2 68.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.108 0.563 . . . . 0.0 112.089 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -7.93 42.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.174 0.99 . . . . 0.0 112.989 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.01 -9.07 50.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.73 1.157 . . . . 0.0 113.437 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -97.18 158.12 15.6 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 119.007 1.403 . . . . 0.0 109.855 -173.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.7 153.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 163.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.72 144.03 47.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -134.31 146.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -131.36 127.87 38.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 161.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . . . -136.59 154.13 50.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.32 0.964 . . . . 0.0 109.85 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -140.64 143.28 35.09 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.215 1.806 . . . . 0.0 107.197 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.35 -175.94 41.06 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.146 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.27 153.79 66.29 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.567 2.178 . . . . 0.0 109.594 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.37 -43.58 88.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.378 0.671 . . . . 0.0 111.447 -171.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.01 -43.42 98.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.801 0.728 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.35 83.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.16 -48.51 81.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.377 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -60.07 -46.95 87.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 110.415 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 m -60.49 -37.96 82.77 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.159 -0.338 . . . . 0.0 110.632 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -67.11 -36.06 81.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.694 -1.146 . . . . 0.0 110.985 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 t -58.13 -51.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 120.437 1.471 . . . . 0.0 108.51 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -56.23 -41.61 75.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.96 0.504 . . . . 0.0 110.556 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -46.99 82.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.338 0.655 . . . . 0.0 111.335 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.05 -35.75 67.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.746 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -61.67 -37.01 82.5 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.055 1.298 . . . . 0.0 110.861 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -69.3 -44.76 71.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 117.872 0.305 . . . . 0.0 110.266 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.27 -179.62 24.38 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.52 158.62 14.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.106 0.962 . . . . 0.0 111.352 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.04 -37.53 79.08 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.295 2.664 . . . . 0.0 114.394 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -78.96 -21.98 46.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.856 0.862 . . . . 0.0 112.126 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -79.99 168.41 19.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.368 1.467 . . . . 0.0 111.262 -170.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -148.17 104.61 3.56 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 166.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.72 143.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -127.35 -18.08 4.55 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.164 0.985 . . . . 0.0 111.152 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.1 150.49 29.97 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.32 145.67 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.958 1.303 . . . . 0.0 107.793 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -141.59 152.24 43.87 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.186 1.394 . . . . 0.0 108.724 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -141.23 144.03 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.718 1.207 . . . . 0.0 108.336 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -138.96 150.88 46.39 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 164.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.88 160.86 40.04 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.248 0.931 . . . . 0.0 111.768 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.1 m -148.93 148.92 30.38 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.848 1.659 . . . . 0.0 108.891 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -48.1 46.72 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 165.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m -57.24 145.13 32.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.164 1.386 . . . . 0.0 109.804 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 pp -151.1 155.21 38.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.067 1.347 . . . . 0.0 109.173 -173.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.33 -32.82 32.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.097 0.559 . . . . 0.0 110.805 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.87 42.28 3.13 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.223 0.916 . . . . 0.0 110.882 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -53.74 136.7 39.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.742 0.771 . . . . 0.0 109.451 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.46 -20.67 23.61 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.022 0.529 . . . . 0.0 112.109 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -152.7 178.8 9.23 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.855 1.662 . . . . 0.0 108.337 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -107.9 135.37 49.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -138.21 142.9 39.96 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.9 mt -74.05 138.43 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 165.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.09 171.33 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.105 1.362 . . . . 0.0 108.059 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -135.27 11.26 3.53 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.622 0.769 . . . . 0.0 112.235 -164.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.148 1.379 . . . . 0.0 107.613 -176.572 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.6 tp -140.81 162.82 34.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.203 2.201 . . . . 0.0 106.835 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.4 138.7 51.65 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.664 1.186 . . . . 0.0 108.221 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -116.48 154.7 29.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.569 1.548 . . . . 0.0 108.057 165.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -122.85 139.55 53.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 158.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.96 141.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.51 140.38 49.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -136.52 147.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -141.72 157.84 44.55 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.877 1.271 . . . . 0.0 109.71 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.46 -157.65 23.03 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.89 1.709 . . . . 0.0 109.391 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -75.13 88.6 2.46 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 157.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.08 19.06 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.377 1.071 . . . . 0.0 110.751 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -139.55 152.19 46.69 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.55 42.29 99.71 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -142.35 4.67 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.751 1.62 . . . . 0.0 112.045 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.23 54.62 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.438 -1.201 . . . . 0.0 110.185 -172.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.77 -50.31 65.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.468 1.634 . . . . 0.0 110.608 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -62.63 -38.77 91.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.884 0.765 . . . . 0.0 110.521 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -66.98 -42.14 85.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.98 0.512 . . . . 0.0 111.375 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.9 -48.98 78.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.702 0.683 . . . . 0.0 109.9 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.4 t -61.93 -41.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.291 0.496 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -56.66 -47.97 78.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.92 0.782 . . . . 0.0 110.035 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.05 -37.34 69.7 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.102 -0.374 . . . . 0.0 111.158 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.22 -31.58 70.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.906 0.776 . . . . 0.0 111.222 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.13 74.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.271 0.487 . . . . 0.0 109.848 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -61.18 -47.39 86.36 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.04 0.936 . . . . 0.0 111.127 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -11.24 53.57 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -125.68 18.59 8.01 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.234 1.013 . . . . 0.0 111.071 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.6 tttp 45.98 36.48 3.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.952 2.101 . . . . 0.0 114.165 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.55 162.98 27.86 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 167.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.14 153.44 49.38 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.123 1.369 . . . . 0.0 107.718 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.1 -157.13 27.14 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.961 1.255 . . . . 0.0 113.519 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -144.86 166.48 25.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.609 0.764 . . . . 0.0 112.071 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.31 146.63 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.757 1.223 . . . . 0.0 108.343 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -146.24 153.53 40.71 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.75 0.82 . . . . 0.0 110.439 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -78.47 157.79 28.82 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 163.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -117.67 151.2 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.188 0.995 . . . . 0.0 108.767 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.1 -27.65 68.9 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.266 0.626 . . . . 0.0 111.888 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.57 -3.54 21.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.671 1.188 . . . . 0.0 113.135 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.11 -9.62 63.46 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.674 1.13 . . . . 0.0 112.987 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -79.36 177.09 9.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.941 1.37 . . . . 0.0 110.543 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.28 145.56 25.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -115.5 140.96 48.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mt -131.49 146.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.77 127.43 32.72 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.34 150.24 45.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.676 0.671 . . . . 0.0 109.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -138.86 133.68 32.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.779 1.631 . . . . 0.0 107.115 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.31 -169.02 38.26 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.381 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 150.11 51.51 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.557 2.172 . . . . 0.0 110.453 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.19 -32.67 72.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.707 0.803 . . . . 0.0 112.052 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.24 -40.74 90.43 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.875 -1.141 . . . . 0.0 111.477 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.88 77.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.38 -40.33 96.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.907 0.483 . . . . 0.0 110.982 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -61.95 -49.91 74.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.274 0.629 . . . . 0.0 110.993 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -61.6 -38.84 89.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.776 0.798 . . . . 0.0 110.622 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -64.12 -43.76 94.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.615 1.166 . . . . 0.0 110.549 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.16 -49.2 82.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 119.408 1.004 . . . . 0.0 109.545 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.42 -39.14 69.87 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.814 . . . . 0.0 110.802 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.94 71.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 111.387 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.65 -26.65 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.808 0.843 . . . . 0.0 111.137 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -58.27 -34.59 70.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.147 1.339 . . . . 0.0 111.283 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.52 -41.54 27.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.346 0.521 . . . . 0.0 110.735 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.46 -167.39 54.73 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -165.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -60.04 167.29 2.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.246 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -52.84 -13.1 2.33 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.696 2.931 . . . . 0.0 115.391 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.23 -5.12 10.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.685 1.194 . . . . 0.0 111.805 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -70.27 162.93 27.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.834 0.854 . . . . 0.0 111.147 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -141.76 78.01 1.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.4 142.69 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -122.9 -21.79 5.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.324 1.05 . . . . 0.0 111.162 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -154.99 153.3 30.81 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.104 0.962 . . . . 0.0 109.558 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.1 tt -151.14 145.07 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.49 1.516 . . . . 0.0 107.196 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -140.39 153.19 46.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.942 1.297 . . . . 0.0 108.448 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.4 t -137.14 145.27 30.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -134.84 159.15 42.28 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 167.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.02 160.48 42.33 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.741 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.0 m -148.45 142.14 25.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.21 1.404 . . . . 0.0 109.015 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -69.14 -43.12 75.0 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -59.45 145.86 42.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.55 1.14 . . . . 0.0 109.071 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.04 153.73 38.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.148 1.379 . . . . 0.0 108.399 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.81 -30.44 45.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.525 0.33 . . . . 0.0 110.526 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.74 40.6 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.81 152.42 27.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.753 0.776 . . . . 0.0 109.481 173.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -128.98 -5.65 5.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 112.08 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.76 173.09 12.69 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.743 1.617 . . . . 0.0 107.746 173.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -111.56 142.61 43.63 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -130.31 133.3 46.36 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.236 0.541 . . . . 0.0 112.17 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.3 mt -74.56 113.77 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 156.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.92 121.51 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 157.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -75.78 2.97 10.79 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -164.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.121 -1.418 . . . . 0.0 109.67 167.356 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.5 tp -142.13 156.66 45.37 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.943 1.297 . . . . 0.0 108.171 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -110.37 136.66 49.2 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.566 1.546 . . . . 0.0 107.189 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -111.79 148.18 34.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 161.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -114.36 140.14 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 156.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -132.66 141.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -131.86 137.11 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 147.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -169.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -143.08 156.71 44.87 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.507 1.123 . . . . 0.0 109.94 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.67 -154.85 24.5 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.302 1.429 . . . . 0.0 110.256 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -72.18 83.63 1.02 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 159.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.51 18.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 111.1 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -138.08 148.79 45.37 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.866 0.866 . . . . 0.0 109.444 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.38 78.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.19 -9.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.226 . . . . 0.0 111.719 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.16 22.42 17.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.027 1.298 . . . . 0.0 110.153 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.94 -40.61 96.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.18 1.49 . . . . 0.0 110.363 -171.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -55.63 -48.2 75.34 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.848 0.749 . . . . 0.0 111.449 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -67.23 -39.56 86.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.205 0.457 . . . . 0.0 111.295 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.03 -51.85 67.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.809 0.443 . . . . 0.0 110.239 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -62.22 -39.18 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.532 0.606 . . . . 0.0 110.512 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -55.96 -49.19 74.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.643 0.777 . . . . 0.0 109.892 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.3 mtp -69.79 -39.23 76.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.984 0.357 . . . . 0.0 111.12 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.72 -32.92 73.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.789 0.722 . . . . 0.0 111.019 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.97 81.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.22 0.463 . . . . 0.0 110.235 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.66 -44.36 94.01 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.278 0.631 . . . . 0.0 110.873 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -4.07 19.75 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.369 -0.832 . . . . 0.0 113.213 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -111.37 2.36 17.55 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.321 1.448 . . . . 0.0 111.286 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 42.82 39.58 1.76 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.782 2.033 . . . . 0.0 111.945 -172.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.78 168.3 13.64 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.556 0.742 . . . . 0.0 109.512 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.96 151.27 49.33 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.15 -159.2 28.01 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.603 1.092 . . . . 0.0 113.756 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -141.73 166.01 25.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.269 0.628 . . . . 0.0 112.271 172.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.72 145.48 31.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 125.019 1.328 . . . . 0.0 108.273 164.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -141.48 161.36 38.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.997 1.319 . . . . 0.0 108.401 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -125.89 116.17 21.11 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -91.01 153.19 20.33 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.025 0.93 . . . . 0.0 110.276 -157.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.75 -29.46 70.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.674 0.39 . . . . 0.0 111.845 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.98 -9.75 48.06 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 -21.19 22.08 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.476 1.036 . . . . 0.0 113.285 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtm180 -81.02 154.33 26.94 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 118.591 1.195 . . . . 0.0 110.178 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.7 t -86.66 148.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 161.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -132.55 142.87 49.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.69 149.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.47 127.0 26.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 167.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.23 147.12 43.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.909 0.777 . . . . 0.0 109.352 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -136.89 129.33 30.03 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -170.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.93 -169.18 41.2 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.82 149.62 60.41 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.259 1.973 . . . . 0.0 110.156 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.43 -32.85 72.84 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.044 0.938 . . . . 0.0 111.817 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -68.56 -39.76 80.92 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.919 -1.113 . . . . 0.0 111.62 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.5 80.91 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mp -61.34 -43.04 99.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.83 0.852 . . . . 0.0 111.232 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -61.09 -51.53 68.74 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.004 0.522 . . . . 0.0 110.419 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 m -62.73 -35.29 79.29 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.901 -0.5 . . . . 0.0 110.956 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -65.67 -42.04 91.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.561 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.49 -43.64 87.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.044 1.293 . . . . 0.0 109.925 171.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.68 -37.72 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.418 1.008 . . . . 0.0 111.204 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.09 91.01 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.834 -0.542 . . . . 0.0 111.026 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.22 -48.07 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 118.249 -0.882 . . . . 0.0 109.247 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -68.81 -26.29 65.1 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.936 1.243 . . . . 0.0 112.571 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -60.67 -41.18 94.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.753 1.16 . . . . 0.0 110.014 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.39 170.1 33.53 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.698 1.142 . . . . 0.0 111.185 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 163.41 42.08 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 123.765 0.826 . . . . 0.0 111.188 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.23 -13.65 7.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.244 3.296 . . . . 0.0 115.731 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.15 13.71 11.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.337 1.455 . . . . 0.0 111.132 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -132.73 166.61 21.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.783 1.233 . . . . 0.0 110.141 -161.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -149.87 102.33 3.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.37 144.77 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 166.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 p -124.49 -17.5 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.422 1.089 . . . . 0.0 110.934 172.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -153.77 149.45 27.45 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.391 1.076 . . . . 0.0 109.502 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.9 tt -147.12 146.82 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.995 1.318 . . . . 0.0 107.482 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.2 m -140.7 154.69 46.46 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.484 1.513 . . . . 0.0 108.323 175.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.14 150.01 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.307 1.043 . . . . 0.0 109.66 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -136.77 160.44 38.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.264 1.826 . . . . 0.0 106.335 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.37 159.69 41.01 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.689 0.795 . . . . 0.0 110.648 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.9 m -157.98 145.17 18.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.096 1.358 . . . . 0.0 108.965 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -79.03 -32.88 45.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.247 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 m -57.54 147.8 25.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.833 0.853 . . . . 0.0 108.817 166.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.21 154.77 44.41 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.746 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.43 -35.05 61.04 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 163.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.18 36.29 4.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.604 1.097 . . . . 0.0 111.474 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -58.58 149.86 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.246 1.023 . . . . 0.0 110.289 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.32 -6.23 7.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.81 1.244 . . . . 0.0 111.781 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -140.92 169.74 17.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.535 1.934 . . . . 0.0 106.894 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -115.04 135.04 54.65 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 m -139.44 143.44 37.59 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.2 134.16 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 162.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.8 m -134.86 167.23 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.582 1.153 . . . . 0.0 108.874 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -135.05 -1.59 2.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.795 0.838 . . . . 0.0 112.074 -171.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.248 1.009 0 C-N-CA 124.995 1.318 . . . . 0.0 110.078 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.3 mt -138.81 173.1 11.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.593 1.557 . . . . 0.0 108.904 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -135.37 133.06 38.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -115.59 158.42 22.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.968 1.307 . . . . 0.0 108.091 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -120.87 144.59 48.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 157.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.9 mt -132.37 144.92 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.4 mm -133.1 136.9 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.32 147.48 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -172.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -141.44 154.72 45.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.153 1.381 . . . . 0.0 109.77 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.27 -154.81 25.96 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.504 1.526 . . . . 0.0 109.84 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 -76.67 79.54 3.32 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 161.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.77 19.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.016 0.926 . . . . 0.0 111.037 -171.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -136.76 146.1 45.37 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.15 32.88 85.41 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.46 -3.22 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.811 1.244 . . . . 0.0 111.722 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.17 21.81 34.34 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.526 -1.152 . . . . 0.0 110.418 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -62.71 -44.41 96.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.11 1.455 . . . . 0.0 110.044 -171.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -55.43 -49.29 72.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.765 0.711 . . . . 0.0 111.856 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -67.57 -40.9 84.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.143 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -56.13 -50.19 71.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.449 0.568 . . . . 0.0 110.053 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.5 t -60.2 -43.24 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 118.372 0.533 . . . . 0.0 110.042 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -59.27 -44.46 92.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.67 0.668 . . . . 0.0 110.389 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.1 mtt -71.82 -36.86 70.35 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.734 -0.604 . . . . 0.0 111.171 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.87 -26.12 64.04 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.555 -0.715 . . . . 0.0 111.631 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.35 -45.23 63.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.547 0.612 . . . . 0.0 109.697 165.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.28 -35.59 80.78 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.109 0.563 . . . . 0.0 112.243 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -16.93 63.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.153 0.888 . . . . 0.0 112.998 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -112.84 5.7 17.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.528 1.531 . . . . 0.0 111.072 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 42.58 41.85 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.2 1.8 . . . . 0.0 111.821 -169.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.3 mt -62.66 161.15 12.75 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.73 154.01 49.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.084 0.953 . . . . 0.0 108.496 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.7 -159.34 28.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -170.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.5 168.09 22.06 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 112.074 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.48 144.8 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.158 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -138.66 156.95 46.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.554 1.141 . . . . 0.0 108.142 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -125.19 107.94 11.26 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtp85 -82.47 154.88 24.89 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.778 1.231 . . . . 0.0 110.648 -154.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.51 -28.39 69.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.582 0.353 . . . . 0.0 111.81 175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.8 -5.57 35.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.038 0.935 . . . . 0.0 113.154 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.91 -17.6 41.5 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.724 1.154 . . . . 0.0 113.627 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -86.07 152.87 22.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.109 1.455 . . . . 0.0 110.196 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.92 146.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 162.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.49 136.59 43.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.07 145.42 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -136.62 128.3 28.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.48 155.12 45.86 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.51 0.724 . . . . 0.0 110.471 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.21 134.09 37.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.07 1.748 . . . . 0.0 107.743 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.86 -173.18 41.45 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.716 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.95 157.1 55.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.751 2.301 . . . . 0.0 110.707 172.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.42 -44.62 89.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.552 0.741 . . . . 0.0 111.347 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.72 -39.56 91.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.795 0.725 . . . . 0.0 111.767 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.75 74.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.2 mt -66.37 -36.56 83.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.127 0.421 . . . . 0.0 111.402 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -63.21 -47.73 81.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.08 0.854 . . . . 0.0 109.901 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.8 m -60.14 -35.94 76.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.423 0.556 . . . . 0.0 111.18 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -64.95 -45.92 83.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.941 0.897 . . . . 0.0 110.072 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.7 t -56.7 -48.58 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 119.357 0.98 . . . . 0.0 109.361 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -57.18 -40.77 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 110.683 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.85 73.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.681 0.793 . . . . 0.0 111.17 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -61.68 -27.46 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.068 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -57.76 -31.44 66.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.19 1.359 . . . . 0.0 111.603 173.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -83.33 -41.91 17.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.374 0.533 . . . . 0.0 111.254 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.7 -168.91 45.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -165.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.3 p -60.36 165.9 4.72 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 117.381 0.59 . . . . 0.0 110.92 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.47 -20.77 12.49 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.388 2.725 . . . . 0.0 114.756 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -103.78 -13.41 16.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.47 1.108 . . . . 0.0 111.53 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 m -68.71 165.65 19.05 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.025 -1.047 . . . . 0.0 111.166 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -143.47 138.47 29.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 156.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.4 t -110.22 140.73 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.0 p -123.26 -18.55 6.25 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.187 0.995 . . . . 0.0 110.965 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -153.54 149.46 27.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.76 144.11 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 m -142.09 159.5 42.11 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.195 1.398 . . . . 0.0 108.882 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 t -136.61 146.86 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.78 1.232 . . . . 0.0 107.679 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.74 167.6 20.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.681 1.993 . . . . 0.0 106.388 173.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -130.44 164.03 25.65 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.168 -0.957 . . . . 0.0 109.996 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -135.61 150.88 49.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 162.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -115.17 27.76 9.16 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 109.545 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.7 m -136.55 168.8 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.52 2.728 . . . . 0.0 105.425 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.65 129.66 47.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.657 0.783 . . . . 0.0 108.938 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -71.14 -25.4 62.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.063 0.392 . . . . 0.0 110.794 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 29.07 18.41 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.314 0.959 . . . . 0.0 112.903 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -59.42 151.16 24.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.178 1.489 . . . . 0.0 109.59 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -126.92 -6.96 6.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.382 1.073 . . . . 0.0 112.259 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -141.46 -178.12 5.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.985 2.114 . . . . 0.0 106.711 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -117.54 124.57 49.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.5 m -117.76 139.41 51.1 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.367 0.603 . . . . 0.0 111.103 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.6 mt -89.52 137.51 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.5 t -133.06 142.44 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.348 1.459 . . . . 0.0 107.315 -173.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -151.55 10.11 0.56 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.861 1.265 . . . . 0.0 111.647 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.681 1.592 . . . . 0.0 110.899 -179.437 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.9 mmm . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.92 168.28 14.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 107.259 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -120.19 137.07 54.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.162 1.785 . . . . 0.0 106.496 170.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -119.83 155.62 32.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.393 1.477 . . . . 0.0 107.794 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -125.03 138.83 54.2 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.3 mt -134.23 141.81 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mm -130.56 141.09 47.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.18 147.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -140.95 158.08 44.44 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.866 1.266 . . . . 0.0 109.623 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.96 -157.27 23.31 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.701 1.62 . . . . 0.0 109.595 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -75.12 85.71 2.37 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.77 14.96 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.862 0.865 . . . . 0.0 111.695 -171.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -138.39 149.34 45.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.49 33.45 76.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.06 -3.78 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.307 1.443 . . . . 0.0 111.841 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.52 22.69 33.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.796 1.189 . . . . 0.0 110.41 -175.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.36 -46.75 82.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.125 1.462 . . . . 0.0 110.377 -172.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -61.96 -42.35 99.02 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.236 0.926 . . . . 0.0 110.345 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -64.57 -42.41 95.65 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.948 0.499 . . . . 0.0 110.707 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.5 -50.69 72.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.321 0.648 . . . . 0.0 110.558 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.25 -37.8 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.672 -0.643 . . . . 0.0 110.127 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.739 0.699 . . . . 0.0 109.823 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 ptp -72.14 -33.46 67.77 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.758 0.708 . . . . 0.0 111.42 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -69.48 -33.82 73.44 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.047 0.839 . . . . 0.0 111.209 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.25 79.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.0 0.364 . . . . 0.0 110.344 170.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.08 -45.42 93.6 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.803 0.841 . . . . 0.0 110.99 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -9.61 35.49 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -122.27 10.37 9.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.044 1.338 . . . . 0.0 111.415 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 44.96 41.83 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.068 1.747 . . . . 0.0 112.626 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.9 166.59 7.18 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.11 159.05 26.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 163.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.31 -155.5 25.19 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.695 0.679 . . . . 0.0 112.62 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -147.75 166.81 26.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.4 144.56 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 108.014 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.23 149.28 33.61 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.557 0.743 . . . . 0.0 110.402 174.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -82.97 122.12 27.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 166.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -76.57 148.1 37.24 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.31 -30.33 71.38 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.563 0.345 . . . . 0.0 111.613 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.36 -5.2 21.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.513 1.125 . . . . 0.0 113.548 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.97 -13.75 52.66 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.323 0.963 . . . . 0.0 113.353 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -72.2 170.69 13.49 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.818 1.309 . . . . 0.0 110.551 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.28 148.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 161.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -131.96 143.66 50.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -141.11 147.06 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.68 128.82 27.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.63 158.53 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.184 0.593 . . . . 0.0 110.053 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -140.11 134.63 31.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.411 1.484 . . . . 0.0 107.37 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.67 -177.62 44.38 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.464 -0.631 . . . . 0.0 111.741 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 157.41 59.28 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.385 2.057 . . . . 0.0 110.287 169.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.0 -45.17 91.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.265 0.626 . . . . 0.0 111.137 -172.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.57 -38.02 85.96 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.622 0.646 . . . . 0.0 111.954 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.19 75.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.41 -35.87 80.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.385 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.72 -49.22 77.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.925 0.784 . . . . 0.0 109.977 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 m -61.5 -38.27 86.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 110.919 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -63.87 -44.32 93.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.114 0.966 . . . . 0.0 110.233 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.6 t -58.39 -50.07 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.992 0.815 . . . . 0.0 109.303 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.33 -38.49 68.8 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.687 0.795 . . . . 0.0 110.984 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -46.63 69.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 110.812 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.73 -28.55 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.762 0.825 . . . . 0.0 111.011 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -58.43 -35.2 71.72 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.107 1.321 . . . . 0.0 111.275 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -79.91 -42.93 23.12 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.245 0.475 . . . . 0.0 110.673 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.43 -165.99 54.1 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 p -59.84 166.8 3.15 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.682 . . . . 0.0 111.443 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.85 -14.17 3.27 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.94 3.093 . . . . 0.0 115.988 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -123.07 3.79 9.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.674 1.124 . . . . 0.0 112.053 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.3 m -66.86 159.25 28.64 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.02 -1.05 . . . . 0.0 110.357 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -140.94 77.35 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -59.72 140.49 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.6 p -122.46 -19.59 6.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.424 1.09 . . . . 0.0 111.177 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -154.57 151.9 29.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.154 0.982 . . . . 0.0 109.506 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.18 145.96 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.316 1.447 . . . . 0.0 107.356 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -140.31 152.36 45.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 108.475 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -139.19 145.52 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.522 1.129 . . . . 0.0 108.139 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -136.15 159.74 40.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.252 1.821 . . . . 0.0 106.118 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -148.81 163.29 37.81 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.318 -0.864 . . . . 0.0 111.398 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.7 m -148.76 144.95 27.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.482 1.913 . . . . 0.0 108.451 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.0 tpt85 -76.17 -30.77 58.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.191 162.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 m -57.51 148.56 23.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.625 1.17 . . . . 0.0 109.711 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.7 mt -131.44 168.18 18.06 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.363 1.465 . . . . 0.0 109.238 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 -29.41 2.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.816 1.646 . . . . 0.0 109.876 169.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.39 57.35 5.13 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -56.87 150.46 16.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.489 0.715 . . . . 0.0 110.726 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -67.86 -31.5 71.36 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -172.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -149.79 179.0 8.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.524 1.93 . . . . 0.0 107.346 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -94.7 132.8 39.06 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 154.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -138.59 144.42 39.79 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.7 139.83 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 164.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -133.88 155.03 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.365 1.866 . . . . 0.0 106.661 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -132.92 10.59 4.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.921 0.888 . . . . 0.0 112.117 -163.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.25 1.105 0 C-N-CA 125.401 1.48 . . . . 0.0 107.787 -174.939 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.764 0.316 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.7 170.73 14.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.249 1.82 . . . . 0.0 107.668 173.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -110.02 138.37 46.48 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.818 1.647 . . . . 0.0 106.817 164.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -116.17 156.95 25.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.144 1.378 . . . . 0.0 107.565 164.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -127.85 140.29 52.11 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 161.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -133.15 142.22 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.04 140.33 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.71 145.06 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.58 157.26 45.73 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.888 1.275 . . . . 0.0 109.709 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.57 -158.94 24.73 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.982 1.753 . . . . 0.0 109.597 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -75.26 88.77 2.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 157.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.67 20.59 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.445 1.098 . . . . 0.0 109.943 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -138.61 148.5 44.19 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.835 1.254 . . . . 0.0 107.84 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.95 41.53 97.89 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.91 -10.84 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.853 1.261 . . . . 0.0 111.842 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.0 16.98 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.872 1.225 . . . . 0.0 110.124 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.67 -41.73 98.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.307 1.554 . . . . 0.0 110.266 -171.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -55.75 -45.96 77.93 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.626 -0.671 . . . . 0.0 111.538 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.72 -39.65 80.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.548 0.613 . . . . 0.0 111.515 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.04 -52.09 66.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.199 0.6 . . . . 0.0 109.958 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.0 -38.11 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.44 -48.21 82.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.164 0.893 . . . . 0.0 110.019 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -75.35 -31.85 60.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.923 0.783 . . . . 0.0 111.684 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -68.79 -34.17 75.1 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.032 0.833 . . . . 0.0 110.805 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.31 83.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.162 0.437 . . . . 0.0 110.187 170.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.82 -45.18 93.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.563 0.745 . . . . 0.0 111.129 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -5.71 28.58 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.27 1.17 15.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.519 1.527 . . . . 0.0 111.565 170.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 39.88 42.75 1.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.345 1.858 . . . . 0.0 112.355 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 165.61 18.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 166.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.85 156.76 43.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.61 -154.42 25.79 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.121 0.873 . . . . 0.0 112.433 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -146.24 166.21 26.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 122.139 -0.624 . . . . 0.0 112.251 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.18 141.07 42.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 124.668 1.187 . . . . 0.0 108.239 166.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -138.1 158.65 43.89 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.789 1.236 . . . . 0.0 108.082 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.76 107.63 10.71 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -81.18 146.26 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.318 1.047 . . . . 0.0 109.642 -155.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.16 -25.08 66.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.809 0.444 . . . . 0.0 111.325 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -60.14 -16.92 36.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.439 1.896 . . . . 0.0 113.234 171.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.11 1.51 35.89 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.223 0.916 . . . . 0.0 113.533 171.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.6 mtt85 -117.28 153.74 32.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.751 1.221 . . . . 0.0 109.271 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.22 149.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 164.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -132.71 140.79 48.26 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 167.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.49 145.33 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -173.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -133.49 129.36 37.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.95 152.67 47.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.683 . . . . 0.0 109.575 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -139.48 134.85 32.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.252 1.421 . . . . 0.0 107.269 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.8 -172.13 41.16 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.396 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.42 151.89 54.17 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.711 2.274 . . . . 0.0 110.522 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -60.48 -35.95 77.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.128 0.971 . . . . 0.0 112.227 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.63 -39.54 77.09 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.936 -1.102 . . . . 0.0 111.604 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.39 83.24 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.98 -40.03 95.48 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.106 0.562 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.99 -47.42 84.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.763 0.711 . . . . 0.0 110.857 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -61.77 -38.37 87.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.352 0.596 . . . . 0.0 110.796 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -64.14 -43.35 95.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.458 1.103 . . . . 0.0 110.545 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.08 -50.39 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.293 0.952 . . . . 0.0 109.306 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -55.56 -39.38 70.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.821 0.849 . . . . 0.0 110.838 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.91 74.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.641 0.776 . . . . 0.0 110.967 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.81 -27.25 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.128 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -58.65 -38.62 78.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.256 1.389 . . . . 0.0 110.918 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.51 -43.17 50.4 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.111 0.414 . . . . 0.0 110.351 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.81 -172.99 48.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.76 159.28 10.17 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.511 0.724 . . . . 0.0 110.38 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.19 -26.19 64.87 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.068 1.845 . . . . 0.0 112.629 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -83.28 -15.33 50.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.044 0.938 . . . . 0.0 112.29 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -77.95 161.67 27.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.958 0.903 . . . . 0.0 110.93 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -137.11 82.04 1.91 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.1 t -59.77 140.53 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.3 p -123.91 -19.82 5.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.34 1.056 . . . . 0.0 111.267 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -154.01 152.69 30.82 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.128 0.971 . . . . 0.0 109.53 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.82 145.72 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 107.176 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -139.56 152.55 46.96 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.058 1.343 . . . . 0.0 108.238 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -138.61 145.45 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.319 1.048 . . . . 0.0 108.186 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 m -135.23 160.85 37.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.635 1.974 . . . . 0.0 106.052 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.4 166.51 26.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.252 -0.905 . . . . 0.0 110.825 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.5 m -157.0 147.95 21.78 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.982 1.713 . . . . 0.0 108.666 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -73.82 -41.35 62.45 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -56.1 137.87 50.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.525 1.13 . . . . 0.0 108.97 170.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 pp -151.12 156.85 41.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.116 1.367 . . . . 0.0 108.662 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.41 -23.36 21.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.852 0.861 . . . . 0.0 111.445 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 46.5 5.74 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -52.91 137.74 31.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.762 0.825 . . . . 0.0 109.528 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -12.18 39.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.095 0.558 . . . . 0.0 112.096 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -154.58 169.02 24.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.132 1.773 . . . . 0.0 108.412 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -99.79 137.56 38.08 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -134.59 137.71 43.95 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.555 0.616 . . . . 0.0 112.384 -170.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.03 142.53 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 163.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.6 t -132.54 155.63 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.002 2.121 . . . . 0.0 105.795 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -122.22 28.59 7.4 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.751 0.82 . . . . 0.0 111.581 -160.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.251 1.172 0 C-N-CA 126.243 1.817 . . . . 0.0 111.314 176.095 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mmm . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.45 164.84 19.57 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.693 1.997 . . . . 0.0 107.704 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -124.96 137.5 54.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.036 1.735 . . . . 0.0 106.389 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -119.85 154.75 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.549 1.54 . . . . 0.0 107.756 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -122.48 139.86 53.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.4 mt -131.94 142.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.3 mm -128.75 136.92 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.87 146.08 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -170.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -143.2 157.26 44.66 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.866 1.266 . . . . 0.0 109.526 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 -156.78 25.3 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.17 1.367 . . . . 0.0 110.474 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -75.05 78.43 2.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.94 20.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.752 0.821 . . . . 0.0 111.9 -168.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -140.93 151.74 44.46 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.44 0.696 . . . . 0.0 109.889 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.61 33.16 83.64 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.5 -10.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.378 1.471 . . . . 0.0 111.853 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.51 18.8 15.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.811 1.672 . . . . 0.0 110.696 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -63.89 -37.4 87.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.788 1.294 . . . . 0.0 111.117 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.406 HH21 ' P ' ' A' ' 92' ' ' PO4 . 60.2 mtm180 -56.02 -51.32 68.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.878 1.217 . . . . 0.0 110.675 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -68.09 -37.74 81.54 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.261 -0.274 . . . . 0.0 110.694 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.01 -50.8 72.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.187 0.595 . . . . 0.0 110.474 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.92 -40.07 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.674 -0.641 . . . . 0.0 109.772 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.9 -45.63 93.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.094 0.861 . . . . 0.0 110.541 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.36 -32.35 62.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 0.742 . . . . 0.0 111.525 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -73.36 -22.13 60.36 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.219 0.918 . . . . 0.0 111.807 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.27 -49.04 37.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.506 0.594 . . . . 0.0 109.54 164.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.63 -38.33 84.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.392 0.677 . . . . 0.0 111.771 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -22.12 61.61 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -127.15 25.16 6.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.446 1.021 . . . . 0.0 110.581 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 49.26 38.26 13.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 112.646 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.28 156.75 24.69 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.06 155.11 44.88 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.05 -154.22 25.67 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.958 0.799 . . . . 0.0 112.0 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -150.07 166.07 30.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.029 0.532 . . . . 0.0 112.39 174.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.56 151.55 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.694 1.598 . . . . 0.0 108.929 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -143.75 133.63 23.97 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.4 0.68 . . . . 0.0 110.856 171.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.93 115.9 10.61 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 162.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.97 143.85 26.87 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.98 -28.51 70.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.03 -8.12 34.97 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.51 -15.25 38.62 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.455 1.026 . . . . 0.0 113.502 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -76.7 171.87 13.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.72 1.26 . . . . 0.0 110.332 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.6 t -114.18 145.58 19.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 160.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.86 145.99 50.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.57 146.32 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.01 126.05 22.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.8 43.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -140.41 144.6 36.27 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.811 1.644 . . . . 0.0 108.052 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.49 -177.81 41.77 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.02 150.23 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.478 1.452 . . . . 0.0 109.251 167.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.22 -43.69 83.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.968 0.507 . . . . 0.0 110.914 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.64 -29.18 65.47 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.525 -0.735 . . . . 0.0 112.623 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.31 -38.8 81.97 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 118.674 0.67 . . . . 0.0 110.073 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.79 -33.12 74.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.088 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -62.18 -51.38 68.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.64 1.109 . . . . 0.0 110.26 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 p -63.39 -32.56 74.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.582 1.083 . . . . 0.0 111.418 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.21 -47.16 85.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.952 -0.547 . . . . 0.0 110.169 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.28 -43.45 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.021 0.828 . . . . 0.0 109.996 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -59.74 -41.14 90.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.067 0.849 . . . . 0.0 110.928 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.06 76.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.926 0.491 . . . . 0.0 110.826 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.8 -49.68 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -27.48 64.54 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.893 0.77 . . . . 0.0 112.148 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -64.32 -40.01 95.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.139 0.881 . . . . 0.0 110.459 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 171.97 31.52 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.566 1.079 . . . . 0.0 110.953 -171.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.7 p -64.0 168.8 5.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.977 0.911 . . . . 0.0 109.934 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.16 -2.82 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.186 1.924 . . . . 0.0 113.196 165.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -107.8 -5.48 17.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.882 1.273 . . . . 0.0 112.176 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -124.47 170.75 10.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.684 1.194 . . . . 0.0 111.623 -172.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -146.68 102.17 3.53 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.83 142.05 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.4 p -123.29 -17.81 6.47 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.135 0.974 . . . . 0.0 110.87 173.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -152.15 148.44 27.63 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.296 1.038 . . . . 0.0 109.205 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.77 146.67 16.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.9 m -138.14 150.99 47.32 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.463 1.505 . . . . 0.0 108.059 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.67 145.08 29.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -136.13 159.13 42.65 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.38 157.79 43.72 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.153 -0.967 . . . . 0.0 111.604 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.3 m -140.1 136.92 34.08 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.001 1.72 . . . . 0.0 108.45 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -35.08 61.24 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 m -59.39 150.85 25.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.135 1.374 . . . . 0.0 109.775 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.5 mt -132.84 165.76 23.85 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.392 1.477 . . . . 0.0 109.399 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.61 -21.71 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.661 1.584 . . . . 0.0 110.652 170.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 43.19 7.04 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.73 0.681 . . . . 0.0 112.249 166.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.86 160.04 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.709 0.755 . . . . 0.0 109.996 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -126.27 -20.5 4.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -139.1 -175.74 4.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.825 1.65 . . . . 0.0 107.624 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -120.78 130.75 54.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.522 0.601 . . . . 0.0 109.781 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.0 m -126.19 159.65 32.39 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.854 0.835 . . . . 0.0 111.721 -167.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.1 mt -111.81 124.89 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.17 175.26 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 109.567 -168.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -142.41 19.37 2.05 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.487 1.115 . . . . 0.0 111.389 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.25 1.091 0 C-N-CA 125.747 1.619 . . . . 0.0 111.131 -176.912 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . 0.406 ' P ' HH21 ' A' ' 18' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.3 tp -142.75 163.72 32.04 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 127.012 2.125 . . . . 0.0 107.204 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -120.1 137.78 53.94 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 107.737 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -116.64 153.85 31.58 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.654 1.582 . . . . 0.0 108.079 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -120.06 139.0 53.21 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 158.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.9 mt -130.96 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.8 mm -130.01 138.87 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 t -137.07 147.31 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -139.33 157.74 45.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.496 1.118 . . . . 0.0 109.717 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.87 -156.52 22.55 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.474 1.511 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -73.74 81.25 1.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 160.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.92 15.19 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.032 0.933 . . . . 0.0 111.693 -171.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -138.17 150.3 46.65 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 171.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.42 32.0 71.51 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 m -136.65 1.4 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.717 1.607 . . . . 0.0 111.546 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.0 20.13 50.98 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.856 1.217 . . . . 0.0 110.582 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -62.91 -45.28 93.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.757 1.278 . . . . 0.0 110.766 -169.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -62.1 -44.8 95.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.425 1.012 . . . . 0.0 110.99 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -68.51 -40.28 80.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 110.616 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -56.6 -52.28 65.43 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.25 0.62 . . . . 0.0 110.006 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.71 -39.82 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.168 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -60.69 -43.61 97.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.33 0.968 . . . . 0.0 110.647 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.6 mtm -71.74 -35.53 70.17 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.738 0.699 . . . . 0.0 111.499 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -67.38 -39.91 85.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.561 1.073 . . . . 0.0 110.158 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.3 99.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.121 0.569 . . . . 0.0 110.169 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.26 -47.54 85.58 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.65 0.78 . . . . 0.0 110.623 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -59.9 -36.15 76.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.367 1.067 . . . . 0.0 111.275 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -88.11 5.1 42.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.628 1.171 . . . . 0.0 112.729 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 48.82 31.71 3.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.896 1.678 . . . . 0.0 112.591 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.57 165.95 23.12 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.437 1.095 . . . . 0.0 109.62 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 161.48 30.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.348 1.459 . . . . 0.0 107.625 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.52 -148.85 20.76 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.256 0.934 . . . . 0.0 111.844 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -154.04 168.29 26.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.322 0.649 . . . . 0.0 112.689 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.92 147.72 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.868 1.667 . . . . 0.0 108.739 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -144.79 155.56 43.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.871 0.869 . . . . 0.0 110.384 170.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -84.0 124.2 30.8 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 164.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.12 147.08 38.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.42 -30.0 71.04 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.551 0.34 . . . . 0.0 111.627 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.94 -5.45 21.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.559 1.144 . . . . 0.0 113.518 174.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.48 49.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.332 0.967 . . . . 0.0 113.288 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -73.37 170.88 14.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 1.258 . . . . 0.0 110.551 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.4 t -105.42 150.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -132.73 140.33 48.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.76 146.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.64 153.44 50.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.674 0.79 . . . . 0.0 109.619 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -140.21 135.83 32.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.927 1.291 . . . . 0.0 108.103 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.43 38.84 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.064 -173.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.19 151.79 61.19 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.265 1.977 . . . . 0.0 110.542 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.15 -40.96 82.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 111.527 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.2 -40.08 95.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.821 0.737 . . . . 0.0 111.75 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.34 -41.14 85.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.04 -39.43 93.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.875 0.47 . . . . 0.0 111.1 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -66.65 -49.11 67.29 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.326 -0.859 . . . . 0.0 110.724 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 p -64.38 -31.94 73.36 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.713 -0.617 . . . . 0.0 111.059 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -63.87 -42.86 97.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.821 171.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.25 -46.64 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 120.254 1.388 . . . . 0.0 109.102 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -59.71 -36.97 77.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.891 0.769 . . . . 0.0 110.989 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.05 -43.48 82.63 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.92 -0.487 . . . . 0.0 111.533 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.97 -43.71 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.4 -0.813 . . . . 0.0 109.988 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -68.83 -20.76 64.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.819 1.19 . . . . 0.0 112.549 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.34 -43.28 73.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 120.112 1.324 . . . . 0.0 110.017 167.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.32 -177.62 39.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.236 0.922 . . . . 0.0 111.093 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.1 p -62.57 168.3 4.45 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.973 0.509 . . . . 0.0 110.834 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.87 -14.36 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.727 2.952 . . . . 0.0 115.261 168.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -116.01 -8.47 11.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.526 1.13 . . . . 0.0 111.902 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 m -72.41 164.47 26.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.878 0.871 . . . . 0.0 111.162 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -144.93 93.68 2.43 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 158.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.02 145.72 12.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -121.97 -22.96 5.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.654 1.182 . . . . 0.0 111.038 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -156.75 154.53 30.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.255 1.022 . . . . 0.0 109.88 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.7 tt -149.3 149.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.295 1.438 . . . . 0.0 107.739 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 m -141.88 152.86 43.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.094 1.357 . . . . 0.0 108.496 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.22 145.21 30.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.672 1.189 . . . . 0.0 107.802 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -135.59 160.38 38.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 166.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.43 161.14 41.03 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.985 -1.072 . . . . 0.0 111.009 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -144.19 140.44 29.33 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.96 1.304 . . . . 0.0 108.648 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.1 -41.82 73.53 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.516 0.726 . . . . 0.0 109.101 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.5 m -64.39 147.19 53.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.128 0.971 . . . . 0.0 109.051 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.5 148.12 29.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.998 1.319 . . . . 0.0 108.985 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -152.21 -10.79 0.19 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.849 0.86 . . . . 0.0 113.202 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.86 -20.28 17.09 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 121.128 -0.982 . . . . 0.0 113.743 -161.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -55.54 111.84 0.99 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.814 1.246 . . . . 0.0 112.722 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -146.63 -49.22 0.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.426 1.49 . . . . 0.0 109.358 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -153.18 -161.48 1.29 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.877 2.471 . . . . 0.0 106.053 172.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -118.26 96.97 5.55 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.88 1.218 . . . . 0.0 109.142 166.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.2 m -84.12 139.06 32.7 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.466 0.65 . . . . 0.0 110.955 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.54 137.04 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 155.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.64 152.58 37.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 125.456 1.502 . . . . 0.0 107.619 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -130.55 -15.81 3.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.461 1.105 . . . . 0.0 111.817 -171.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.04 1.336 . . . . 0.0 109.995 179.516 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.43 160.05 35.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.998 1.719 . . . . 0.0 108.092 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -119.85 139.15 52.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 164.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -122.31 155.13 36.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.894 1.677 . . . . 0.0 107.511 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -129.55 139.18 51.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 162.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.7 mt -134.99 137.7 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -172.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -127.69 137.98 56.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.57 147.23 27.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -146.73 158.45 43.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.753 1.221 . . . . 0.0 109.493 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.4 18.94 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.385 1.469 . . . . 0.0 109.608 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -72.82 89.81 1.4 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 158.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.54 18.31 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.266 1.026 . . . . 0.0 110.125 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -142.27 154.89 45.11 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.6 1.16 . . . . 0.0 108.161 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.98 93.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.8 -3.33 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.663 1.585 . . . . 0.0 111.301 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.02 26.57 40.5 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -173.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.21 -40.75 91.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.618 1.209 . . . . 0.0 110.331 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -58.93 -43.84 91.25 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.457 -0.777 . . . . 0.0 110.874 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -69.71 -42.03 74.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.931 0.492 . . . . 0.0 110.987 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -56.21 -48.95 75.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.416 0.553 . . . . 0.0 110.306 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.03 -40.01 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.52 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.06 -46.62 85.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.441 1.018 . . . . 0.0 109.968 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.7 mtt -66.96 -38.59 86.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.493 1.042 . . . . 0.0 111.016 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -70.87 -26.59 63.32 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.494 -0.753 . . . . 0.0 112.157 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.38 -39.03 59.6 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 110.043 168.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.66 -47.02 79.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.619 1.168 . . . . 0.0 110.482 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HE2' ' NH1' ' A' ' 28' ' ' ARG 0.281 0.0 OUTLIER -70.24 -12.82 61.86 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.749 -177.338 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.488 ' NH1' ' HE2' ' A' ' 27' ' ' LYS . 74.7 mtt85 -101.59 -3.17 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.508 1.523 . . . . 0.0 111.96 173.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 45.4 42.25 7.37 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.529 1.532 . . . . 0.0 112.234 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.38 167.44 10.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.47 156.13 44.61 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 167.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.28 -153.58 25.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 119.398 0.999 . . . . 0.0 112.905 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.01 166.4 24.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.626 0.771 . . . . 0.0 112.779 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.38 144.93 31.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 124.949 1.3 . . . . 0.0 107.544 163.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.37 143.29 32.64 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.715 0.689 . . . . 0.0 111.088 166.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -74.33 110.92 9.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 162.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -79.24 142.81 35.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.04 -23.95 66.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.769 0.428 . . . . 0.0 112.081 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.96 -20.57 62.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.876 1.27 . . . . 0.0 113.032 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.44 -12.38 36.27 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.646 1.117 . . . . 0.0 112.977 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -82.57 170.84 14.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.052 0.941 . . . . 0.0 110.363 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.07 146.14 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -117.97 145.92 44.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 166.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -134.39 146.84 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.82 130.61 34.23 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 167.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.78 157.79 44.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 110.253 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.55 134.41 33.82 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.37 -178.01 43.3 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -172.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.08 152.09 72.88 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.23 1.954 . . . . 0.0 109.941 170.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.49 -40.52 87.26 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.937 0.495 . . . . 0.0 111.415 -171.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -64.41 -38.69 91.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.976 0.807 . . . . 0.0 111.968 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -44.54 86.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.98 -35.28 79.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.202 0.455 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -63.83 -51.14 66.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.104 0.866 . . . . 0.0 110.3 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -66.0 -32.27 73.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.016 0.825 . . . . 0.0 111.062 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.59 -45.55 93.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.061 0.944 . . . . 0.0 109.534 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.75 -47.92 84.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 119.158 0.89 . . . . 0.0 109.595 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -57.31 -39.84 76.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.725 0.693 . . . . 0.0 110.765 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.59 81.09 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.857 0.863 . . . . 0.0 111.211 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.76 -32.38 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.653 0.781 . . . . 0.0 110.866 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -60.76 -31.65 70.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.998 1.272 . . . . 0.0 111.393 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -77.7 -45.0 26.13 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.458 0.572 . . . . 0.0 110.324 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.81 -168.86 46.22 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -54.98 153.65 11.29 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.615 166.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -50.61 -31.44 31.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.458 2.772 . . . . 0.0 115.339 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -84.33 -6.38 59.38 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.354 1.062 . . . . 0.0 112.999 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -70.82 163.84 26.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.614 0.766 . . . . 0.0 110.873 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -146.91 81.77 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.9 140.32 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.8 p -120.67 -23.09 6.11 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.448 1.099 . . . . 0.0 111.065 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -155.07 150.51 27.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.808 1.243 . . . . 0.0 108.481 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.7 tt -151.55 147.39 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -139.98 151.3 45.39 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.131 1.372 . . . . 0.0 108.164 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.36 145.12 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -137.04 158.66 43.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.83 162.09 40.97 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.323 -0.861 . . . . 0.0 110.898 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -146.26 140.86 26.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.615 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.41 -36.88 71.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 164.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 m -59.31 153.55 18.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.235 1.414 . . . . 0.0 110.106 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.86 169.16 15.53 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.024 1.33 . . . . 0.0 109.977 -173.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.85 -31.37 4.23 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.101 2.16 . . . . 0.0 108.76 170.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.32 54.64 7.6 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -55.48 145.99 21.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.768 0.827 . . . . 0.0 110.533 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -68.2 -32.9 73.45 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.347 0.659 . . . . 0.0 111.902 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -152.93 -172.03 4.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.914 1.686 . . . . 0.0 108.051 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -102.5 131.67 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 164.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.8 m -125.15 138.15 54.15 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.956 0.503 . . . . 0.0 111.405 -171.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -75.7 139.12 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 159.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.0 t -133.09 156.8 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.474 1.91 . . . . 0.0 106.402 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -130.02 13.88 5.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.991 0.917 . . . . 0.0 111.887 -162.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.248 1.014 0 C-N-CA 126.279 1.831 . . . . 0.0 107.15 -177.551 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mmm . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.8 tp -145.17 156.32 43.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 0.0 108.386 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.64 138.31 51.54 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.902 1.281 . . . . 0.0 108.229 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -123.71 156.42 36.0 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.714 1.606 . . . . 0.0 108.766 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -123.41 138.99 54.47 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.94 141.44 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.01 138.57 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.67 144.88 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -170.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -138.93 156.83 46.95 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.961 1.305 . . . . 0.0 109.833 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.0 -158.12 23.73 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.582 1.563 . . . . 0.0 110.027 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -74.66 83.84 2.08 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.4 15.98 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.25 1.02 . . . . 0.0 110.941 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -137.98 154.48 49.35 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.97 30.19 70.24 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.12 -9.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.018 1.327 . . . . 0.0 112.138 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.55 21.42 14.68 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.503 1.525 . . . . 0.0 110.494 -177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.61 -41.02 96.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.256 1.528 . . . . 0.0 110.876 -171.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -61.23 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.405 1.002 . . . . 0.0 110.56 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -64.65 -41.82 95.85 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.239 0.472 . . . . 0.0 110.677 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.13 -49.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.07 0.548 . . . . 0.0 110.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.19 -39.79 85.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 110.159 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -59.06 -49.7 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.793 0.724 . . . . 0.0 109.911 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.8 ptm -72.49 -33.65 67.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.374 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -68.63 -30.75 69.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.003 0.82 . . . . 0.0 111.673 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.26 64.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.184 0.447 . . . . 0.0 109.96 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.98 -43.64 98.54 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.971 0.908 . . . . 0.0 111.025 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -3.32 23.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -114.84 0.27 13.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.662 1.585 . . . . 0.0 111.465 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 45.25 40.02 4.73 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.357 1.463 . . . . 0.0 111.942 -168.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.13 165.37 13.73 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 155.48 45.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.234 1.013 . . . . 0.0 108.367 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.19 -156.14 26.35 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.797 0.726 . . . . 0.0 112.173 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.9 p-90 -153.36 167.13 30.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.975 -0.721 . . . . 0.0 112.211 176.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.9 142.89 34.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.092 1.357 . . . . 0.0 109.036 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 149.41 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.207 0.603 . . . . 0.0 110.608 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -75.73 134.63 40.45 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.23 143.8 30.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.58 -21.86 66.82 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.366 0.53 . . . . 0.0 111.648 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -28.95 59.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.029 1.732 . . . . 0.0 112.85 170.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.8 -25.02 10.47 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.493 1.044 . . . . 0.0 112.669 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -63.64 168.66 4.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.709 1.255 . . . . 0.0 110.754 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.8 150.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 169.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -139.62 140.08 36.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.98 146.63 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -170.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.01 129.12 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 164.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.24 48.07 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 109.443 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -136.79 138.19 40.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.701 1.6 . . . . 0.0 107.955 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.63 -175.22 44.51 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.279 -0.734 . . . . 0.0 111.885 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.37 137.79 40.82 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.365 2.043 . . . . 0.0 109.534 172.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.13 -34.86 61.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.886 1.674 . . . . 0.0 113.1 -168.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -71.34 -46.24 61.03 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.091 -1.006 . . . . 0.0 111.953 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.62 83.51 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.05 -49.6 76.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.631 1.172 . . . . 0.0 109.692 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 119.188 -0.435 . . . . 0.0 111.362 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 m -62.37 -37.52 86.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.586 0.63 . . . . 0.0 111.199 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.37 -43.82 98.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.01 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.9 t -61.94 -41.95 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.248 1.386 . . . . 0.0 110.593 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.22 -39.27 72.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.717 1.144 . . . . 0.0 110.561 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.7 77.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.294 0.638 . . . . 0.0 111.287 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.8 t -58.68 -32.84 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.455 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -60.88 -35.39 76.52 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.01 1.277 . . . . 0.0 111.535 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -72.7 -43.33 63.16 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.518 0.599 . . . . 0.0 110.288 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.92 -176.17 43.82 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.15 162.23 14.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.659 0.783 . . . . 0.0 110.669 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.92 -32.13 46.13 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.446 2.764 . . . . 0.0 114.52 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -94.33 -9.19 36.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 112.47 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -78.4 165.31 23.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.997 0.919 . . . . 0.0 110.966 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -144.49 93.18 2.39 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.2 t -61.41 143.38 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 p -124.52 -20.61 5.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.265 1.026 . . . . 0.0 111.101 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -155.85 154.12 30.8 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 0.0 109.243 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.12 148.07 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.904 1.281 . . . . 0.0 107.586 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.1 m -140.68 154.08 46.23 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.35 1.46 . . . . 0.0 108.663 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.43 145.64 29.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 108.178 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 m -134.42 161.25 35.53 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.12 162.92 34.24 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.154 -0.966 . . . . 0.0 110.942 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.4 m -139.8 126.26 20.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 169.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.42 -29.79 66.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.6 m -66.08 161.04 22.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.959 1.303 . . . . 0.0 109.772 167.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.8 mt -133.1 164.32 27.3 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.54 1.136 . . . . 0.0 109.948 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -119.9 -20.24 7.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.393 1.477 . . . . 0.0 110.666 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.37 48.29 5.7 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.443 0.544 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -59.96 156.47 14.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 117.587 0.694 . . . . 0.0 109.239 167.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -129.71 -6.27 4.6 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.856 0.863 . . . . 0.0 112.78 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.7 mtm-85 -141.31 169.04 18.35 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.901 1.68 . . . . 0.0 107.031 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -110.39 138.05 47.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -133.99 139.23 45.92 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.66 140.61 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 161.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.49 158.6 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.435 1.894 . . . . 0.0 106.533 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -128.89 -6.4 5.03 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.205 1.002 . . . . 0.0 111.814 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.25 1.098 0 C-N-CA 124.919 1.288 . . . . 0.0 109.396 172.934 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.6 mmm . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.4 tp -152.5 158.6 42.8 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.413 1.885 . . . . 0.0 107.225 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -123.67 138.33 54.55 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 107.244 173.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -110.53 151.06 28.04 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.233 1.413 . . . . 0.0 107.704 163.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -117.97 140.34 49.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 152.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -131.41 143.41 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.4 mm -131.99 136.56 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.19 146.34 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -140.46 155.67 46.61 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.748 1.219 . . . . 0.0 109.796 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.78 -155.16 23.56 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.451 1.5 . . . . 0.0 109.73 -176.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -76.91 79.11 3.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 162.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.46 14.6 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.066 0.946 . . . . 0.0 111.711 -170.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -137.76 150.14 47.01 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.15 30.28 63.22 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.83 -1.27 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.55 1.54 . . . . 0.0 112.021 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.58 20.94 42.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.973 1.273 . . . . 0.0 110.641 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -63.08 -44.58 95.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.109 1.454 . . . . 0.0 110.405 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -61.03 -47.08 88.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.231 0.923 . . . . 0.0 110.452 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -64.69 -42.17 95.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.717 0.407 . . . . 0.0 111.048 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -56.23 -52.38 64.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.954 0.502 . . . . 0.0 110.04 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.45 -39.72 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.546 0.612 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -59.2 -44.77 92.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.019 0.827 . . . . 0.0 110.029 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 92.8 mtp -73.5 -34.0 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.437 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -66.47 -38.79 88.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.019 1.282 . . . . 0.0 110.048 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.04 99.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.086 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.06 -44.99 94.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.664 0.665 . . . . 0.0 111.143 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.03 -8.65 7.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.137 1.775 . . . . 0.0 112.837 174.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -118.48 -0.21 11.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.358 -1.464 . . . . 0.0 111.934 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 39.07 41.72 0.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.03 1.732 . . . . 0.0 112.35 -165.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.92 165.94 23.98 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.571 0.748 . . . . 0.0 109.302 171.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 152.0 46.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.97 -159.17 28.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.506 1.048 . . . . 0.0 113.688 -169.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -141.48 165.52 27.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.812 0.845 . . . . 0.0 111.973 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.1 p -137.58 146.28 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.018 1.327 . . . . 0.0 108.226 165.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -146.54 152.41 38.91 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.908 0.883 . . . . 0.0 110.036 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -84.59 121.64 27.9 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -75.22 147.03 40.68 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.28 -29.99 71.06 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.658 0.383 . . . . 0.0 111.521 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.58 -5.52 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.58 1.152 . . . . 0.0 113.58 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.94 49.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.478 1.037 . . . . 0.0 113.29 170.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.49 170.55 15.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.64 1.22 . . . . 0.0 110.424 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.13 149.5 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -130.97 142.41 50.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mt -139.13 147.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.76 128.31 28.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 167.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.55 148.34 44.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -138.61 129.72 26.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.38 -167.66 39.0 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.357 -0.69 . . . . 0.0 111.837 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.58 155.68 49.8 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.818 2.345 . . . . 0.0 111.103 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.9 -44.31 91.18 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.69 0.796 . . . . 0.0 111.417 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -62.55 -39.35 93.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.098 0.863 . . . . 0.0 111.958 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.34 -44.2 83.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.6 mt -65.6 -37.76 87.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.435 0.294 . . . . 0.0 111.383 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -63.0 -52.76 61.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.756 0.823 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -64.1 -32.44 74.01 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.58 -0.7 . . . . 0.0 111.273 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.83 -50.0 70.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.529 175.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -63.94 -37.87 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.678 1.126 . . . . 0.0 110.04 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -56.39 -41.77 76.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.094 0.861 . . . . 0.0 110.571 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.6 83.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.932 0.493 . . . . 0.0 111.582 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.08 -32.22 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.658 0.783 . . . . 0.0 110.668 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.16 -31.18 68.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.821 1.191 . . . . 0.0 111.493 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -78.28 -41.96 32.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.477 0.58 . . . . 0.0 111.195 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.53 -169.28 47.73 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -166.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.2 p -60.69 165.78 5.28 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 117.111 0.455 . . . . 0.0 110.166 173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.02 -5.59 8.01 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.356 2.038 . . . . 0.0 113.703 171.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.21 -9.29 14.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.562 1.145 . . . . 0.0 111.761 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -75.46 167.66 21.47 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.077 0.951 . . . . 0.0 111.089 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -143.73 131.01 20.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 155.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.4 t -100.14 139.72 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.0 p -122.39 -19.23 6.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.051 0.941 . . . . 0.0 111.038 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -154.18 150.74 28.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 tt -152.46 145.77 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 m -142.6 153.45 43.51 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.052 1.341 . . . . 0.0 108.765 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.65 148.75 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.688 1.195 . . . . 0.0 109.399 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -137.06 158.18 45.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.01 152.43 47.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.61 0.764 . . . . 0.0 110.133 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -148.12 146.59 28.85 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.448 1.499 . . . . 0.0 108.391 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -83.6 -32.74 25.58 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.878 -0.514 . . . . 0.0 110.476 167.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -58.15 152.22 17.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 109.311 169.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.52 154.17 42.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.522 1.129 . . . . 0.0 109.131 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -77.23 -35.3 55.59 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 162.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.0 42.57 3.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.591 1.091 . . . . 0.0 111.375 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -62.21 157.6 19.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.986 0.893 . . . . 0.0 110.777 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -130.27 -1.24 4.53 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.858 1.263 . . . . 0.0 112.205 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -148.2 177.37 9.46 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.791 2.037 . . . . 0.0 107.177 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -121.4 122.37 39.64 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.0 m -124.48 139.69 53.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.635 0.731 . . . . 0.0 111.918 -163.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.6 mt -80.24 128.65 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 166.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.87 177.05 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.721 1.208 . . . . 0.0 108.998 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -133.08 2.33 3.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.541 0.736 . . . . 0.0 112.475 -167.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.248 1.024 0 C-N-CA 126.377 1.871 . . . . 0.0 106.751 -179.077 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.4 tp -133.98 163.83 28.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 -165.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -125.69 134.26 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.36 1.464 . . . . 0.0 108.44 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -117.31 157.9 25.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 108.572 167.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -126.34 140.19 52.7 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.1 mt -134.08 142.38 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mm -131.99 137.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -139.57 148.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -142.47 157.34 44.86 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.123 1.369 . . . . 0.0 109.883 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.15 -154.21 23.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.478 1.513 . . . . 0.0 110.387 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -73.27 79.99 1.32 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 160.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.94 19.27 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.858 0.863 . . . . 0.0 111.023 -171.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -136.64 146.68 46.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.275 1.03 . . . . 0.0 108.228 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.07 33.15 86.34 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.66 0.29 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.172 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.47 24.54 42.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -63.35 -46.17 87.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.207 1.504 . . . . 0.0 109.936 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -56.45 -46.13 80.47 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.818 0.736 . . . . 0.0 111.521 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.79 -40.94 83.9 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.068 0.395 . . . . 0.0 110.823 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.53 -51.86 67.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.276 0.63 . . . . 0.0 109.875 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.24 -40.42 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.213 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.61 -44.93 93.25 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.854 0.752 . . . . 0.0 110.258 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.5 mtm -71.33 -37.38 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.489 0.586 . . . . 0.0 111.305 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.94 -34.6 76.91 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.131 0.878 . . . . 0.0 110.711 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.42 88.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.901 0.48 . . . . 0.0 110.145 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.11 -49.24 76.67 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.729 0.811 . . . . 0.0 110.622 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -4.97 20.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -113.57 4.07 15.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.683 1.593 . . . . 0.0 111.807 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 11.4 mmpt? 43.45 38.76 1.91 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.5 1.52 . . . . 0.0 112.078 -172.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.29 165.54 20.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 157.28 43.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.71 1.204 . . . . 0.0 107.851 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.76 -152.13 22.43 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 119.231 0.923 . . . . 0.0 111.598 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -150.66 166.6 29.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.971 -0.723 . . . . 0.0 112.839 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 146.42 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.277 1.431 . . . . 0.0 108.669 171.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -142.96 160.57 40.09 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.014 0.925 . . . . 0.0 109.063 168.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.47 110.89 14.44 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -85.77 155.67 20.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.403 1.081 . . . . 0.0 110.662 -154.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.54 -28.34 69.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.702 0.401 . . . . 0.0 111.804 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.59 -5.34 32.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.017 0.927 . . . . 0.0 113.259 175.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.11 -16.37 46.12 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.629 1.109 . . . . 0.0 113.532 172.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -87.66 152.78 21.89 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 119.047 1.423 . . . . 0.0 110.002 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.7 147.82 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 162.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -137.7 139.81 40.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -140.45 146.58 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -170.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.37 124.04 25.1 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 166.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.05 150.29 46.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -140.11 138.21 35.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 108.082 -170.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.47 -171.48 39.97 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.72 152.93 64.71 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.291 1.994 . . . . 0.0 110.413 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.05 -40.89 91.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.385 0.674 . . . . 0.0 111.65 -171.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -65.3 -37.86 88.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.74 0.7 . . . . 0.0 111.97 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.29 81.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.26 -37.53 87.81 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.361 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.94 -47.54 82.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.169 0.895 . . . . 0.0 110.581 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.41 -37.52 83.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.105 0.562 . . . . 0.0 110.848 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.12 -45.38 81.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.389 1.076 . . . . 0.0 110.521 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.2 t -56.08 -49.5 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.345 0.975 . . . . 0.0 109.235 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.08 -42.22 69.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 110.863 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.4 74.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.503 0.721 . . . . 0.0 111.442 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.33 -24.6 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -57.54 -33.99 68.69 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.445 1.475 . . . . 0.0 111.042 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -83.2 -42.78 16.87 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.364 0.529 . . . . 0.0 111.053 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.6 -167.06 54.84 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -165.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.0 p -59.94 165.04 5.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.178 0.489 . . . . 0.0 110.319 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.13 -12.68 27.74 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.009 1.806 . . . . 0.0 113.22 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -98.51 -14.77 19.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.143 0.977 . . . . 0.0 111.768 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -71.61 163.46 27.7 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.88 0.872 . . . . 0.0 111.022 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -142.2 94.91 2.72 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.06 145.39 11.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.2 p -126.01 -18.72 4.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.311 1.045 . . . . 0.0 111.063 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -152.62 149.46 28.47 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.364 1.065 . . . . 0.0 109.264 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.6 tt -151.84 145.18 16.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.025 1.33 . . . . 0.0 107.807 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 m -141.71 154.04 45.04 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.286 1.434 . . . . 0.0 108.709 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.2 t -137.72 145.42 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.661 1.184 . . . . 0.0 107.852 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.07 164.27 28.41 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.661 1.985 . . . . 0.0 106.083 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.59 169.61 17.25 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.981 -1.074 . . . . 0.0 111.014 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.5 m -140.39 135.59 32.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -76.67 -28.87 56.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 119.099 -0.476 . . . . 0.0 110.245 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.5 m -73.42 165.54 24.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 161.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.41 162.89 38.67 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 109.88 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -76.92 -40.33 47.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.54 0.736 . . . . 0.0 109.468 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.06 50.82 3.76 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.14 150.84 10.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.683 0.793 . . . . 0.0 110.498 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -91.21 -31.26 16.23 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.612 0.765 . . . . 0.0 112.81 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -147.03 -179.38 6.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.941 1.696 . . . . 0.0 107.956 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.63 134.9 52.89 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -135.11 139.49 44.72 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 73.9 mt -75.75 133.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 162.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.19 172.48 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.272 1.429 . . . . 0.0 108.542 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -137.06 11.41 3.07 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -162.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.201 1.4 . . . . 0.0 107.68 -177.732 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.861 -0.052 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.7 tp -130.42 163.91 25.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.012 1.325 . . . . 0.0 109.297 -169.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -129.37 142.15 50.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.228 1.011 . . . . 0.0 108.437 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.14 155.89 33.51 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.746 1.618 . . . . 0.0 108.38 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm-85 -120.01 140.06 51.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 158.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.2 mt -130.85 143.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.1 mm -126.72 141.98 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.93 146.17 27.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.1 157.69 45.81 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.553 1.141 . . . . 0.0 109.477 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.45 -158.97 23.95 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.479 1.514 . . . . 0.0 109.643 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -74.0 89.2 1.91 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 159.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.25 15.91 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.484 0.713 . . . . 0.0 111.701 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -138.14 149.0 45.49 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.75 32.4 74.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.42 6.72 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.726 1.61 . . . . 0.0 111.314 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.63 21.2 60.31 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.518 1.056 . . . . 0.0 110.529 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.77 -43.91 91.72 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.392 1.096 . . . . 0.0 110.495 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -65.74 -40.76 92.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.134 0.879 . . . . 0.0 111.15 -177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.02 -41.95 90.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.658 0.663 . . . . 0.0 110.6 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -56.64 -49.8 73.93 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.821 0.737 . . . . 0.0 110.005 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.73 -39.85 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.102 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.5 -41.01 93.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.804 1.184 . . . . 0.0 110.491 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.96 -35.68 72.26 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 111.103 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -72.43 -21.82 61.2 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.171 -0.956 . . . . 0.0 112.038 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.68 -46.41 46.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.94 -37.58 87.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.226 1.01 . . . . 0.0 112.255 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -17.64 42.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -130.29 21.53 5.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.133 0.973 . . . . 0.0 110.747 173.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 28.61 54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.868 2.867 . . . . 0.0 113.763 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.14 165.86 15.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.391 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.3 164.48 23.44 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.635 1.574 . . . . 0.0 108.039 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.42 -150.98 23.3 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.68 0.673 . . . . 0.0 112.783 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -151.32 169.8 21.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.68 1.192 . . . . 0.0 110.295 162.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.1 144.66 34.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.855 1.662 . . . . 0.0 107.726 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.01 146.64 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.384 1.074 . . . . 0.0 109.251 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -83.93 120.9 26.65 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 161.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -73.88 149.37 41.55 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.05 -23.65 67.54 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.6 0.36 . . . . 0.0 111.684 172.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.38 -21.07 61.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.466 1.506 . . . . 0.0 112.97 172.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.49 -16.15 52.67 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.56 1.076 . . . . 0.0 112.395 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -71.93 170.44 13.76 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.121 0.968 . . . . 0.0 110.581 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.98 150.84 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 165.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.25 146.13 49.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.66 146.45 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -143.41 116.36 8.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.23 44.07 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.692 0.678 . . . . 0.0 111.911 -162.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -135.0 132.61 38.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.801 2.041 . . . . 0.0 107.551 -166.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.94 -177.49 41.02 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.59 152.74 74.53 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.233 1.955 . . . . 0.0 110.184 173.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.35 -33.87 73.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.96 -35.19 69.48 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.963 -1.086 . . . . 0.0 111.579 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -40.31 70.79 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.36 0.264 . . . . 0.0 110.604 176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.1 mp -58.79 -40.13 83.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.745 0.818 . . . . 0.0 110.552 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -65.32 -49.27 70.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.468 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 p -62.02 -34.16 75.69 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.559 1.527 . . . . 0.0 111.264 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -63.93 -47.03 82.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.677 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.3 t -57.21 -47.15 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 119.309 0.958 . . . . 0.0 109.462 173.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.8 -41.54 77.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.404 0.682 . . . . 0.0 110.555 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.89 -42.09 77.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.216 0.606 . . . . 0.0 111.84 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.62 -31.52 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 118.341 -0.837 . . . . 0.0 110.635 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -58.55 -36.2 73.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.991 1.269 . . . . 0.0 111.159 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.32 -43.07 71.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.939 0.336 . . . . 0.0 110.548 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.22 -178.29 30.76 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.848 0.737 . . . . 0.0 111.666 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.4 p -63.53 159.33 52.28 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 0.0 110.622 177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.17 -26.17 25.58 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.519 2.813 . . . . 0.0 115.333 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.28 -7.39 24.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 112.198 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.7 p -74.84 167.68 21.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.575 0.702 . . . . 0.0 110.863 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -139.39 77.86 1.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -59.51 140.07 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.4 p -123.65 -21.29 5.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.415 1.086 . . . . 0.0 111.547 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.23 154.86 31.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.886 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.08 145.88 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.564 1.546 . . . . 0.0 107.53 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -141.15 157.4 45.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.33 1.452 . . . . 0.0 109.123 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.54 145.63 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.803 1.241 . . . . 0.0 108.738 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 m -136.52 166.05 24.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.329 2.251 . . . . 0.0 106.095 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.2 163.56 33.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.633 -1.292 . . . . 0.0 111.287 -174.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.6 m -148.14 146.91 28.95 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.279 1.832 . . . . 0.0 108.284 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -81.64 -34.13 31.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.055 -0.403 . . . . 0.0 110.693 172.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.4 m -65.61 155.96 34.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.001 0.921 . . . . 0.0 109.679 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 164.52 37.95 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.536 1.535 . . . . 0.0 108.831 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -80.98 -34.65 32.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.877 0.762 . . . . 0.0 110.947 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.82 21.53 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.192 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . 0.251 30.1 p80 47.07 42.54 12.93 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.891 2.077 . . . . 0.0 114.188 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.52 -49.98 35.73 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.24 173.76 12.96 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.337 1.455 . . . . 0.0 109.458 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -122.65 100.11 6.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.584 1.084 . . . . 0.0 109.637 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 136.89 35.32 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.919 0.488 . . . . 0.0 110.766 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.6 mt -84.72 126.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 153.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 100.0 t -87.77 117.4 31.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -84.43 52.26 2.31 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.598 1.159 . . . . 0.0 110.683 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.662 -1.161 . . . . 0.0 109.452 165.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpt . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.6 tp -153.37 164.88 37.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.563 1.145 . . . . 0.0 109.409 -172.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -117.87 138.27 52.23 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.661 1.584 . . . . 0.0 107.697 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -114.65 155.54 26.39 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.072 1.349 . . . . 0.0 107.36 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -127.51 140.95 51.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 162.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.05 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.08 137.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -171.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -142.76 156.75 45.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.769 1.228 . . . . 0.0 110.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.67 -155.85 24.44 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.509 1.528 . . . . 0.0 110.082 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -74.35 82.25 1.9 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 159.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.96 21.87 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.884 1.274 . . . . 0.0 110.201 -174.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -137.72 149.79 46.77 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.503 1.121 . . . . 0.0 108.358 175.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.62 74.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.591 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.78 -10.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.376 1.071 . . . . 0.0 111.949 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 23.34 13.69 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.124 1.345 . . . . 0.0 110.243 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.16 -39.14 93.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.506 1.653 . . . . 0.0 110.48 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -55.51 -47.36 76.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.757 0.708 . . . . 0.0 111.448 171.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -68.01 -39.08 83.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.411 0.551 . . . . 0.0 111.291 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -56.29 -54.16 48.66 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 173.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.38 -39.64 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.388 0.54 . . . . 0.0 110.461 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -56.22 -47.52 78.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 0.0 109.943 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 77.6 mtm -73.78 -34.96 64.89 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.447 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.37 -43.85 93.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.503 1.047 . . . . 0.0 109.869 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.76 92.15 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.227 0.467 . . . . 0.0 110.727 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.21 -47.7 84.86 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.753 0.821 . . . . 0.0 110.304 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -61.2 -41.97 97.77 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.859 0.863 . . . . 0.0 111.007 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -74.98 -3.71 33.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.811 0.844 . . . . 0.0 112.37 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 49.52 35.17 7.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.098 1.759 . . . . 0.0 112.251 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.37 170.68 16.25 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 110.158 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.29 153.49 46.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.349 1.46 . . . . 0.0 107.583 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.15 -155.85 26.72 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.762 1.164 . . . . 0.0 113.67 -171.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.46 165.99 25.99 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.301 0.64 . . . . 0.0 112.542 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.4 144.65 36.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.819 1.248 . . . . 0.0 107.759 161.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.32 158.65 43.46 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.464 1.106 . . . . 0.0 108.265 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.74 118.51 25.73 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -94.13 153.5 18.07 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.829 0.852 . . . . 0.0 110.421 -155.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.48 -29.09 70.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.606 0.362 . . . . 0.0 111.953 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.87 -9.79 47.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.49 -19.63 26.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.441 1.019 . . . . 0.0 113.321 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -83.75 154.73 23.43 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.674 1.237 . . . . 0.0 109.995 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.95 150.64 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 162.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -132.06 141.43 49.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -135.26 144.1 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -134.25 126.01 28.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.5 149.43 48.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -137.11 130.8 31.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.35 -173.54 43.71 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -170.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.85 149.19 59.56 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.481 2.12 . . . . 0.0 110.031 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.97 -34.16 71.49 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.121 0.969 . . . . 0.0 111.939 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.16 -40.52 82.33 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.035 -1.041 . . . . 0.0 111.673 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -41.28 83.36 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.52 -41.58 96.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.05 -49.79 76.26 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.444 0.565 . . . . 0.0 110.362 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 m -65.22 -29.66 70.48 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.961 -0.462 . . . . 0.0 111.446 -177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -68.58 -45.17 72.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.403 1.081 . . . . 0.0 110.461 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.8 -49.18 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.641 1.11 . . . . 0.0 109.038 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -56.86 -41.69 78.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.763 0.825 . . . . 0.0 110.608 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.36 -48.13 74.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.827 0.451 . . . . 0.0 111.553 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.97 -30.15 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.838 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -59.05 -23.33 61.91 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.127 1.33 . . . . 0.0 112.191 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -68.25 -34.87 77.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.6 0.636 . . . . 0.0 111.582 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.36 171.9 3.41 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.252 0.93 . . . . 0.0 112.082 -164.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 157.59 65.71 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 121.88 -0.776 . . . . 0.0 110.157 171.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.69 -31.69 61.77 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.123 2.549 . . . . 0.0 113.66 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.46 1.92 39.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.52 1.528 . . . . 0.0 112.759 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 m -128.03 167.11 17.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.854 0.862 . . . . 0.0 110.759 -158.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -146.19 92.95 2.25 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.87 142.78 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 161.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.6 p -128.47 -17.03 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.958 1.303 . . . . 0.0 111.226 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -150.39 148.73 29.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.383 1.073 . . . . 0.0 108.918 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.26 143.85 13.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.653 1.181 . . . . 0.0 107.919 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m -142.97 154.46 44.06 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.263 1.425 . . . . 0.0 108.656 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.83 145.73 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.517 1.127 . . . . 0.0 108.293 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 m -136.33 162.6 32.57 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.892 2.077 . . . . 0.0 106.686 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -134.66 157.87 45.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.596 1.158 . . . . 0.0 109.759 -172.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -160.06 162.99 34.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.12 1.368 . . . . 0.0 109.623 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -120.05 -12.86 9.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.954 0.902 . . . . 0.0 111.561 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.8 m -78.25 68.6 4.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.436 1.095 . . . . 0.0 109.507 171.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.67 148.27 7.48 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.226 1.011 . . . . 0.0 111.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -71.65 -35.09 70.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.252 1.021 . . . . 0.0 109.335 163.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.76 44.73 3.84 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.356 0.979 . . . . 0.0 111.149 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -60.46 157.29 14.33 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.494 0.718 . . . . 0.0 110.612 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.22 -6.19 5.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.57 1.148 . . . . 0.0 111.901 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.75 171.12 14.54 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.447 1.899 . . . . 0.0 106.833 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -117.19 135.38 53.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -138.91 144.63 39.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.51 141.04 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -134.28 154.56 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.765 2.026 . . . . 0.0 106.607 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -133.55 13.17 4.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.113 0.965 . . . . 0.0 111.883 -164.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.529 1.532 . . . . 0.0 107.921 -174.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_